46. 悪性関節リウマチ Disease details / Clinical trials / Drug dev / DR info

0,35% povidone-iodine solution lavage
   Independent Public Healthcare Center in Rypin
      2022   -   NCT05972603   Poland
0109-0012A 100 MG/ML
   NOVO NORDISK
      2013   -   EUCTR2012-000610-11-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Novo Nordisk A/S
      2014   Phase 2   EUCTR2013-001492-20-PT   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-ES   Ireland;Portugal;Spain;United Kingdom
      2013   Phase 2   EUCTR2013-001492-20-GB   Belgium;Czech Republic;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2013   -   EUCTR2012-000610-11-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000610-11-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-000609-58-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000610-11-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000609-58-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000609-58-GB   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000609-58-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      -   -   EUCTR2012-000609-58-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
0109-0012A 25 MG/ML
   NOVO NORDISK
      2013   -   EUCTR2012-000610-11-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Novo Nordisk A/S
      2013   -   EUCTR2012-000610-11-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000610-11-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-000609-58-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000610-11-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000609-58-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000609-58-GB   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000609-58-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      -   -   EUCTR2012-000609-58-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
0109-0012A 50 MG/ML
   NOVO NORDISK
      2013   -   EUCTR2012-000610-11-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Novo Nordisk A/S
      2013   -   EUCTR2012-000610-11-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000610-11-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-000609-58-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000610-11-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000609-58-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000609-58-GB   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000609-58-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      -   -   EUCTR2012-000609-58-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
0114-0006B
   Novo Nordisk A/S
      2012   -   EUCTR2011-005376-42-LV   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   -   EUCTR2011-005376-42-HU   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   Phase 2   EUCTR2011-005376-42-ES   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   -   EUCTR2011-005376-42-BG   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
1 ML 0.9 % nacl
   Vrije Universiteit Brussel
      2010   -   NCT01154647   Belgium
1,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-YL]C
   Merck Sharp & Dohme (Sweden) AB
      2004   -   EUCTR2004-000074-31-SE   Sweden
   Merck Sharp & Dohme BV
      2005   Phase 2   EUCTR2004-000074-31-BE   Belgium;Sweden
1.0 G vancomycin powder into THE wound
   Independent Public Healthcare Center in Rypin
      2022   -   NCT05972603   Poland
100 MG
   Bristol-Myers K.K.
      2011   Phase 2   JPRN-jRCT2080221588   -
   CombinatoRx, Inc
      2004   -   EUCTR2004-001490-26-GB   Estonia;United Kingdom
   Department of Orthopedics, the First Affliated Hospital of Xinjiang Medical University
      2024   Phase 4   ChiCTR2400092488   China
   Hashimoto Motomu
      2022   -   JPRN-jRCTs051220027   -
   Hokusuikai Kinen Hospital
      2017   -   JPRN-UMIN000029797   Japan
      2017   -   JPRN-UMIN000026137   Japan
   Janssen Pharmaceutical K.K.
      2015   Phase 3   JPRN-jRCT2080223019   -
   Janssen Research & Development, LLC
      2011   Phase 2   NCT01480388   United States
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
   Osaka City University Medical School
      2012   Phase 4   JPRN-UMIN000009425   Japan
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
100 MG AP1189
   SynAct Pharma Aps
      2022   Phase 2   NCT05516979   Moldova, Republic of
100 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
1000MG RTX group
   Medical University of Vienna
      2015   Phase 4   NCT05116228   Austria
118-42-3
   Christine Bengtsson
      2015   Phase 2   EUCTR2014-005418-45-SE   Sweden
   Fundació Clínic per a la Recerca Biomèdica
      2019   Phase 4   EUCTR2017-004543-20-ES   Spain
   Karolinska Institutet
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
11C-MC1
   National Institute of Mental Health (NIMH)
      2019   Phase 1   NCT03912428   United States
13-valent pneumococcal conjugate vaccine
   Region Skane
      2016   Phase 4   NCT03762824   -
15-DAY taper prednisone
   VA Office of Research and Development
      2023   Phase 2   NCT06072768   United States
15-O labeled water
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      2001   Phase 1   NCT00014794   United States
150 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
150-DAY taper prednisone
   VA Office of Research and Development
      2023   Phase 2   NCT06072768   United States
18F-FDG
   GlaxoSmithKline
      2015   Phase 1   NCT02350426   United Kingdom
18F-GE-180
   GlaxoSmithKline
      2015   Phase 1   NCT02350426   United Kingdom
2 million hmsc/KG
   MetroHealth Medical Center
      2017   Phase 1   NCT03186417   United States
2-[(E)-[(E)-3-[1-(2-nitrophenyl)pyrrol-2-YL]PROP-2-enylidene]amino]guanidine
   SynAct Pharma ApS
      2022   Phase 2   EUCTR2022-002605-26-BG   Bulgaria;Moldova, Republic of;United States
2-hoba
   Vanderbilt University Medical Center
      2022   Phase 2   NCT05274243   United States
2-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[E]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[E]-indolium hydroxide,inner salt
   Knowledge Centre for Rheumatology and Back Diseases
      2013   Phase 4   EUCTR2013-004006-26-DK   Denmark
200 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
200MG cannabidiol BY capsules twice daily
   University of California, Los Angeles
      2021   Phase 1   NCT04911127   United States
23-valent pneumococcal polysaccharide vaccine
   Genentech, Inc.
      2010   Phase 4   NCT01163747   United States
      2006   Phase 2   NCT00282308   United States
   Region Skane
      2016   Phase 4   NCT03762824   -
250 MG LX3305 BID
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
250 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
300 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
331731-18-1
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-003053-21-PL   Israel;Poland;Puerto Rico;United States
      2016   Phase 3   EUCTR2015-003333-95-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Denmark;Egypt;European Union;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003333-95-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003333-95-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 4   EUCTR2014-001114-26-SE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 4   EUCTR2014-001114-26-NL   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 2   EUCTR2013-004019-37-DK   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   -   EUCTR2013-004019-37-DE   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   Phase 2   EUCTR2013-004019-37-BG   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 4   EUCTR2014-001114-26-IT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-IE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-HU   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-GR   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-GB   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-FR   Australia;Austria;Canada;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-ES   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-DE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-AT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 2   EUCTR2013-004019-37-RO   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   -   EUCTR2013-004019-37-HU   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-CZ   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2013   Phase 2   EUCTR2012-003881-42-SK   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   -   EUCTR2012-003881-42-RO   Germany;Puerto Rico;Romania;United States
      2013   -   EUCTR2012-003881-42-DE   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   Phase 2   EUCTR2012-003881-42-BE   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-DE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abbott GmbH & Co. KG
      2012   -   EUCTR2012-000535-36-SK   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-PL   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-CZ   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   Phase 2   EUCTR2012-000535-36-BE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2011-003953-25-DE   Australia;Canada;Germany
      2012   -   EUCTR2011-002275-41-CZ   Belgium;Czech Republic
      2012   -   EUCTR2011-002275-41-BE   Belgium;Czech Republic
      2011   -   EUCTR2010-019514-24-DE   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   Phase 3   EUCTR2010-019514-24-BE   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   -   EUCTR2010-019514-24-AT   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2008   -   EUCTR2007-005905-23-GB   Germany;United Kingdom
      2008   -   EUCTR2007-005905-23-DE   Germany;United Kingdom
   Abbott Japan Co., Ltd.
      -   -   EUCTR2014-004558-33-Outside-EU/EEA   Japan
   Abbott Laboratories
      -   -   EUCTR2011-001661-40-Outside-EU/EEA   United States
   Amgen Inc
      2014   -   EUCTR2013-000525-31-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000525-31-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   AstraZeneca AB
      2011   Phase 2   EUCTR2010-023692-26-SK   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023692-26-GB   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      -   -   EUCTR2010-023692-26-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2014   Phase 3   EUCTR2012-002945-40-HU   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-ES   Argentina;Belgium;Bulgaria;Chile;Colombia;Estonia;France;Germany;Hungary;Indonesia;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-EE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   CELLTRION, Inc.
      2019   Phase 3   EUCTR2019-000660-25-PL   Poland
   CHRU de TOURS
      2010   -   EUCTR2010-021449-28-FR   France
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   Celltrion, Inc
      2019   Phase 3   EUCTR2018-001690-25-LT   Bulgaria;Hungary;Lithuania;Peru;Poland;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-PL   Bosnia and Herzegovina;Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-HU   Bosnia and Herzegovina;Bulgaria;Hungary;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-BG   Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Ukraine
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-SK   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-SI   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-PT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-NL   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LV   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-HU   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-GB   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-DE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-CZ   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-BE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2008   Phase 4   EUCTR2007-000593-24-GB   Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
   F.Hoffmann-La Roche Ltd
      2008   -   EUCTR2007-000593-24-SE   Sweden;United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   EUCTR2014-000110-61-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-BG   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-DE   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-BG   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Spain;United States
      2010   -   EUCTR2010-021577-37-HU   Bulgaria;Germany;Hungary;Spain
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   EUCTR2016-000335-40-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000568-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   HEXAL AG
      2016   Phase 3   EUCTR2015-003433-10-IT   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Helsingin reumakeskus
      2010   -   EUCTR2009-017325-19-FI   Finland
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Hvidovre Hospital
      2009   Phase 4   EUCTR2009-014394-41-DK   Denmark
   Imperial College London South Kensington London
      2009   Phase 4   EUCTR2009-012424-87-GB   United Kingdom
   Janssen-Cilag International N.V.
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
   Karolinska Institute
      2010   Phase 4   EUCTR2009-017163-42-SE   Sweden
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Lilly S.A.
      2013   -   EUCTR2012-002322-73-ES   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Merck KGaA
      2017   Phase 3   EUCTR2016-002852-26-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002852-26-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2017   Phase 3   EUCTR2016-002852-26-BG   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2016   Phase 3   EUCTR2016-002852-26-LT   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-HU   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-CZ   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
   Novo Nordisk A/S
      2014   Phase 2   EUCTR2013-001492-20-PT   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-ES   Ireland;Portugal;Spain;United Kingdom
      2013   Phase 2   EUCTR2013-001492-20-GB   Belgium;Czech Republic;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Pfizer Inc
      2020   Phase 4   EUCTR2019-000284-24-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2019   Phase 3   EUCTR2019-000284-24-LT   Argentina;Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Mexico;Peru;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2009   -   EUCTR2008-008338-35-CZ   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2009   Phase 3   EUCTR2008-008338-35-SK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-GB   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-FI   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-008338-35-DK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-DE   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-BG   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
   R-Pharm
      2017   Phase 3   EUCTR2015-005307-83-RO   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-LV   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-LT   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-HU   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   R-Pharm International LLC
      2016   Phase 3   EUCTR2015-005307-83-CZ   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-BG   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Reade
      2019   Phase 4   EUCTR2019-001793-28-NL   Netherlands
      2019   Phase 1;Phase 4   EUCTR2019-001554-25-NL   Netherlands
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Takeda Development Centre Europe Ltd.
      2015   Phase 2   EUCTR2014-002945-23-GB   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-ES   Czech Republic;Estonia;Latvia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-CZ   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2014-002945-23-EE   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-002067-20-IT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
   University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine
      2015   Phase 4   EUCTR2013-002777-22-IT   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-HU   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-ES   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-DK   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-GB   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-DE   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   sanofi-aventis Recherche & Développement
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
4 million hmsc/KG
   MetroHealth Medical Center
      2017   Phase 1   NCT03186417   United States
4'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide
   Modern Biosciences plc
      2018   Phase 2   EUCTR2016-004038-24-RO   Georgia;Moldova, Republic of;Romania
4-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-YL] benzenesulfonamide
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL] benzenesulfonamide
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
4-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide
   Astellas Pharma Global Development
      2013   -   EUCTR2011-006021-23-HU   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
      2013   Phase 2   EUCTR2011-006021-23-CZ   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
      2013   Phase 2   EUCTR2011-006021-23-BG   Belgium;Bulgaria;Colombia;Czech Republic;Germany;Hungary;Mexico;Poland
      2012   -   EUCTR2011-006021-23-BE   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
   Astellas Pharma Global Development Inc. (APGD)
      2013   Phase 2   EUCTR2011-006021-23-PL   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
40 MG MSB11022
   Fresenius Kabi SwissBioSim GmbH
      2019   Phase 1   NCT04018599   United States
400 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
400MG cannabidiol BY capsules twice daily
   University of California, Los Angeles
      2021   Phase 1   NCT04911127   United States
5-chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2011   Phase 3   EUCTR2010-019871-31-SK   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2011   -   EUCTR2010-019871-31-CZ   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019871-31-BE   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2010   -   EUCTR2010-019871-31-LT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-FI   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-DE   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-AT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
50 MG AP1189
   SynAct Pharma Aps
      2019   Phase 2   NCT04004429   Denmark;Norway
50 MG etanercept
   Amgen
      2005   Phase 3   NCT00249041   Canada;United States
50 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
50 patients will have A free choice between filgotinib and anti TNF
   R.Bos
      2021   Phase 4   NCT04985435   Netherlands
500 MG LX3305 QD
   Lexicon Pharmaceuticals
      2011   Phase 1   NCT01417052   United States
500MG RTX group
   Medical University of Vienna
      2015   Phase 4   NCT05116228   Austria
6 million hmsc/KG
   MetroHealth Medical Center
      2017   Phase 1   NCT03186417   United States
6-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
68GA-bnota-PRGD2
   Peking Union Medical College Hospital
      2012   Early Phase 1   NCT01940926   China
68GA-fapi
   Peking Union Medical College Hospital
      2020   Early Phase 1   NCT04514614   China
68GA-NEB
   Peking Union Medical College Hospital
      2019   Phase 1   NCT04273334   China
7-valent pneumococcal conjugate vaccine
   Dept of Rheumatology, Lund University Hospital, Lund, Sweden
      2008   -   EUCTR2007-006539-29-SE   Sweden
70930.00.00
   medac Gesellschaft für klinische Spezialpräparate mbH
      2012   -   EUCTR2012-000222-21-DE   Germany
89ZR-DFO-CZP
   Robert Flavell, MD, PhD
      2018   Phase 1   NCT03546335   United States
9-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-B] quinoxaline
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-PL   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-GB   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-BE   Belgium;Bulgaria;Latvia;Poland;United Kingdom
99MTC-3prgd2
   First Affiliated Hospital of Fujian Medical University
      2015   Early Phase 1   NCT02723760   China
99MTC-rhannexin V-128
   Advanced Accelerator Applications
      2014   Phase 1/Phase 2   NCT02328027   Switzerland
99MTC-S-hynic certolizumab pegol
   Ghent University Hospital
      2017   Phase 4   EUCTR2016-004300-65-BE   Belgium
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
A natural remedy FOR rheumatoid arthritis VS. common drugs
   University of Minnesota - Clinical and Translational Science Institute
      2004   -   NCT01600521   China
AB-101
   IRIS Research and Development, LLC
      2024   Phase 1   NCT06581562   United States
AB1010
   AB Science
      2014   -   EUCTR2010-020992-21-DE   Argentina;Bosnia and Herzegovina;Czech Republic;Germany;Greece;India;Mexico;Monaco;Morocco;Philippines;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Tunisia;Ukraine;United States
      2012   Phase 3   EUCTR2010-020992-21-GR   Czech Republic;Germany;Greece;India;Monaco;Poland;Romania;Slovakia;Spain;Thailand;Turkey;United States
      2011   Phase 3   EUCTR2010-020992-21-SK   Czech Republic;France;Germany;Greece;India;Poland;Romania;Slovakia;Spain;Thailand;Tunisia;Turkey;United States
      2011   -   EUCTR2010-020992-21-ES   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
      2011   -   EUCTR2010-020992-21-CZ   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
      2004   Phase 2   NCT00831922   -
Abatacept
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2017   Phase 3   EUCTR2016-000933-37-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;European Union;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   AbbVie
      2017   Phase 3   NCT03086343   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2018   Phase 3   EUCTR2016-000933-37-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-DE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-BE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-LV   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-ES   Argentina;Australia;Belarus;Brazil;Canada;Chile;Colombia;European Union;Hungary;Israel;Korea, Democratic People's Republic of;Latvia;Mexico;New Zealand;Norway;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;United States
   Academisch Medisch Centrum Amsterdam
      2010   -   EUCTR2010-021435-14-NL   Netherlands
   Arthritis & Rheumatic Disease Specialties Research
      2011   Phase 3   NCT01351480   United States
   Astellas Pharma Inc
      2011   -   NCT01339481   United States
   Astellas Pharma Korea, Inc.
      2019   Phase 4   NCT03737708   Korea, Republic of
   BRISTOL-M.SQUIBB
      2005   -   EUCTR2004-005102-68-IT   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001275-50-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
   Brigham and Women's Hospital
      2020   -   NCT04529902   United States
      2020   -   NCT04529876   United States
      2020   -   NCT04529863   United States
   Bristol Myers Squibb International Corporation
      2011   Phase 3   EUCTR2008-001523-57-NO   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2010-018674-20-SE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;Sweden;United States
      2010   -   EUCTR2010-018674-20-IT   Denmark;Finland;France;Germany;Italy;Sweden
      2010   Phase 3   EUCTR2010-018674-20-FR   Belgium;Denmark;Finland;France;Germany;Italy;Sweden
      2010   -   EUCTR2010-018674-20-FI   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DK   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-BE   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2008-001523-57-HU   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2008-001523-57-DE   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-GB   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-ES   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   -   EUCTR2008-001523-57-DK   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-001523-57-FR   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   -   EUCTR2007-005434-37-NL   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-HU   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-GR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-FR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-DE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-BE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-AT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2006   -   EUCTR2005-000784-26-IT   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-000784-26-AT   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-IE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-GB   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-ES   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-DE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-BE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-000922-59-DK   Czech Republic;Denmark;Spain;Sweden
      2005   -   EUCTR2004-000922-59-CZ   Czech Republic;Denmark;Spain;Sweden
      2004   -   EUCTR2004-000922-59-SE   Czech Republic;Denmark;Spain;Sweden
      2004   Phase 3   EUCTR2004-000922-59-ES   Czech Republic;Denmark;Spain;Sweden
      -   -   EUCTR2005-000443-28-Outside-EU/EEA   Austria;Brazil;France;Germany;Italy;Mexico;Peru;Portugal;Spain;Switzerland;United States
   Bristol-Myers Squibb
      2021   Phase 3   NCT04909801   Argentina;Australia;Czechia;France;Germany;Italy;Japan;Mexico;Poland;Spain;Switzerland;Taiwan;United Kingdom;United States
      2020   Phase 2   NCT04186871   Argentina;Australia;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2018   Phase 1   NCT03714022   United States
      2016   -   NCT02037737   -
      2015   -   NCT02598466   -
      2015   Phase 4   NCT02557100   Algeria;Canada;Mexico;United States
      2015   Phase 3   NCT02504268   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Monaco;Netherlands;Peru;Poland;Puerto Rico;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom;United States
      2014   -   NCT02169544   -
      2013   Phase 1   NCT01890473   Argentina;Mexico;Peru;South Africa;United States
      2013   Phase 3   NCT01844895   -
      2013   Phase 4   NCT01758198   Japan
      2012   -   NCT02090556   Australia;Austria;France;Germany;Greece;Italy;Monaco;Netherlands;Spain;Switzerland;United Kingdom
      2011   Phase 1   NCT01439204   United States
      2010   Phase 1   NCT01221636   United States
      2010   Phase 3   NCT01142726   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Norway;Poland;Russian Federation;South Africa;Sweden;United States
      2009   Phase 3   NCT01173120   -
      2009   Phase 3   NCT00929864   Argentina;Canada;Chile;Peru;United States
      2008   -   NCT02109666   Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Greece;Ireland;Italy;Netherlands;Spain;Switzerland
      2008   Phase 3   NCT00767325   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2007   Phase 3   NCT00989235   -
      2007   Phase 3   NCT00547521   Australia;Brazil;Canada;Mexico;Peru;South Africa;United States
      2007   Phase 3   NCT00533897   Argentina;Brazil;Canada;Mexico;South Africa;United States
      2007   Phase 3   NCT00420199   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   NCT00409838   Korea, Republic of
      2006   Phase 3   NCT00484289   Japan
      2006   Phase 2   NCT00345748   Japan
      2006   Phase 1/Phase 2   NCT00254293   United States
      2005   Phase 3   NCT00124982   Belgium;Canada;Czech Republic;France;Germany;Ireland;Italy;Mexico;Spain;United Kingdom;United States
      2005   Phase 2   NCT00124449   Australia;Belgium;France;Germany;Italy;Mexico;Puerto Rico;Spain;United Kingdom;United States
      2005   Phase 3   NCT00122382   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;South Africa;Spain;United Kingdom;United States
      2005   Phase 3   NCT00095147   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Russian Federation;South Africa;Spain;Sweden;Switzerland;United States
      2003   Phase 1   NCT00162201   United Kingdom
      2003   Phase 3   NCT00095173   Austria;Brazil;France;Germany;Italy;Mexico;Peru;Portugal;Spain;Switzerland;United States
      2002   Phase 3   NCT00048581   United States
      2002   Phase 3   NCT00048568   United States
      2000   Phase 1/Phase 2   NCT00279760   Belgium;Canada;France;Germany;Ireland;Netherlands;Switzerland;United Kingdom;United States
      2000   Phase 2   NCT00162279   United States
      2000   Phase 2   NCT00162266   Argentina;Australia;Belgium;Canada;France;Germany;Ireland;Netherlands;South Africa;United Kingdom;United States
   Bristol-Myers Squibb Company
      -   Phase 2   EUCTR2015-005450-36-Outside-EU/EEA   United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001275-50-RO   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-NL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-SE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-GB   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FI   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2008   -   EUCTR2008-001523-57-IT   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-GB   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-004241-15-IT   Belgium;France;Germany;Italy;Netherlands;Spain;United Kingdom
      2007   -   EUCTR2006-003768-67-SE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-NL   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-GB   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-ES   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-DE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-BE   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-AT   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-005102-68-CZ   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-CZ   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-IE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-GB   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-ES   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-DE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-BE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-GB   Belgium;Germany;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-ES   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-DE   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-BE   Belgium;Germany;Italy;Spain;United Kingdom
   Bristol-Myers Squibb K.K.
      2015   Phase 3   JPRN-jRCT2080223027   Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
      2013   Phase 4   JPRN-jRCT1080222075   -
   Cambridge University Hospitals NHS Foundation Trust
      2018   Phase 2   NCT03084419   United Kingdom
      2018   Phase 2   EUCTR2016-002569-68-GB   United Kingdom
   Columbia University
      2019   Phase 4   NCT03619876   United States
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fundació Clínic per a la Recerca Biomèdica
      2019   Phase 4   EUCTR2017-004543-20-ES   Spain
   Hokkaido University Hospital
      2013   -   JPRN-UMIN000010286   Japan
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   Jiangsu Simcere Pharmaceutical Co., Ltd.
      2016   Phase 1   NCT02805010   -
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Kashiv BioSciences, LLC
      2024   Phase 1   NCT06929039   Canada
   Leiden University Medical Center
      2018   Phase 4   EUCTR2017-002878-38-NL   Netherlands
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Maldonado A Michael
      2021   Phase 3   JPRN-jRCT2071210068   Australia;France;Germany;Japan;Taiwan;USA
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   NHS Greater Glasgow and Clyde
      2016   Phase 4   NCT02652273   United Kingdom
      2015   Phase 4   EUCTR2014-004419-35-GB   United Kingdom
   NOVARTIS FARMA
      2011   -   EUCTR2011-000102-21-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   NYU Langone Health
      2019   Phase 4   NCT03652961   United States
   National Health Organization Nagoya Medical Center
      2010   -   JPRN-UMIN000011789   Japan
   Novartis Farmacéutica S.A.
      2011   -   EUCTR2011-000102-21-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma AG
      2011   -   EUCTR2011-000102-21-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma Services AG
      2011   -   EUCTR2011-000102-21-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharmaceuticals
      2011   Phase 3   NCT01350804   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Pfizer
      2024   -   NCT06418529   United States
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Shinshu University
      2018   Phase 2   NCT03784261   Japan
   St George's, University of London
      2020   Phase 4   EUCTR2019-004468-23-GB   United Kingdom
   The Cleveland Clinic
      2013   Phase 2   NCT02027298   United States
   The First Affiliated Hospital of Wenzhou Medical University
      2021   Phase 4   ChiCTR2100053713   China
   The First Hospital, Jilin University
      2016   Phase 1 study   ChiCTR-IIR-16008693   China
   University Hospital, Montpellier
      2022   Phase 3   NCT05428488   France;Monaco
      2016   -   NCT02547493   France;Monaco
   University of California, Los Angeles
      2014   -   NCT02053727   United States
      2011   Phase 3   NCT01299961   United States
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Occupational and Environmental Health, Japan
      2010   -   JPRN-UMIN000008756   Japan
   University of Washington
      2019   Phase 4   NCT03882008   United States
   Universitätsklinikum Erlangen
      2023   Phase 1;Phase 2   EUCTR2021-006669-40-DE   Germany
      2019   Phase 2   EUCTR2018-003877-91-DE   Germany
      2017   Phase 3   EUCTR2014-000555-93-ES   Brazil;Czech Republic;Germany;Spain
   Vastra Gotaland Region
      2017   -   NCT03440892   Sweden
   Yokohama City University Graduate School of Medicine
      2014   -   JPRN-UMIN000015217   Japan
   Zhejiang Provincial People's Hospital
      2022   Phase 3   NCT05451615   China
Abatacept + csdmard
   New York University School of Medicine
      2019   Phase 4   NCT03700021   United States
Abatacept + vaccines
   Bristol-Myers Squibb
      2004   Phase 1   NCT00279734   United States
Abatacept injection
   Fundacion Clinic per a la Recerca Biomédica
      2019   Phase 4   NCT03669367   Spain
   St George's, University of London
      2020   Phase 4   NCT04255134   United Kingdom
   University of Erlangen-Nürnberg Medical School
      2019   Phase 2   NCT04120831   Germany
Abatacept prefilled syringe
   Lille Catholic University
      2018   Phase 4   NCT03227419   France
Abatacept, rituximab or tocilizumab
   University Hospital, Strasbourg, France
      2009   Phase 4   NCT01000441   France;Monaco
ABBV-105
   AbbVie
      2019   Phase 2   NCT03823378   Belgium;Canada;Czechia;Hungary;Poland;Spain;United Kingdom
      2018   Phase 2   NCT03682705   Belgium;Canada;Czechia;Germany;Hungary;Ireland;Poland;Puerto Rico;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-002306-31-HU   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-BE   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-000666-10-BE   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
ABBV-105, A-1519938.0
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-000666-10-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000666-10-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2018   Phase 2   EUCTR2018-000666-10-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
ABBV-154
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2021   Phase 2   EUCTR2020-005303-39-IT   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2021   Phase 2   NCT04888585   Australia;Canada;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005303-39-SK   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-PL   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-NL   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-GR   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-ES   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-DE   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-CZ   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
ABBV-257
   AbbVie
      2015   Phase 1   NCT02531178   Germany
ABBV-3373
   AbbVie
      2019   Phase 2   NCT03823391   Germany;Hungary;Israel;Netherlands;Poland;Puerto Rico;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-003053-21-PL   Israel;Poland;Puerto Rico;United States
Abbvie care 2.0
   AbbVie
      2016   -   NCT02750800   Hungary
ABP 501
   Amgen
      2014   Phase 3   NCT02114931   Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   Phase 3   NCT01970475   Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   Amgen Inc
      2014   -   EUCTR2013-000525-31-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000525-31-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   Amgen Inc.
      2014   Phase 3   EUCTR2013-004654-13-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   -   EUCTR2013-004654-13-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
ABP 710
   Amgen
      2016   Phase 3   NCT02937701   Australia;Bulgaria;Canada;Czech Republic;Czechia;Germany;Hungary;Poland;Spain;United States
ABP 710 - biosimilar TO infliximab
   Amgen Inc.
      2016   Phase 3   EUCTR2014-004704-29-PL   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-HU   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-ES   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-DE   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-CZ   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-BG   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
ABP 798
   Amgen
      2016   Phase 3   NCT02792699   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Amgen Inc
      2015   Phase 1;Phase 3   EUCTR2013-005543-90-BG   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-PL   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-HU   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-DE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
ABP 798 biosimilar TO rituximab
   Amgen Inc
      2017   Phase 1;Phase 3   EUCTR2013-005543-90-EE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
ABT 494
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
ABT 494 12MG
   AbbVie Deutschland GmbH & Co. KG
      2014   -   EUCTR2013-003984-72-SK   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-LV   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-CZ   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003530-33-NL   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-LV   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-ES   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-NL   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   -   EUCTR2013-002358-57-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-CZ   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co.KG
      2014   -   EUCTR2013-003984-72-HU   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   AbbVie Inc.
      2014   -   EUCTR2013-003984-72-ES   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   -   EUCTR2013-002358-57-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
ABT 494 3MG
   AbbVie Deutschland GmbH & Co. KG
      2014   -   EUCTR2013-003984-72-SK   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-LV   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-CZ   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003530-33-NL   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-LV   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-ES   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-NL   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   -   EUCTR2013-002358-57-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-CZ   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co.KG
      2014   -   EUCTR2013-003984-72-HU   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   AbbVie Inc.
      2014   -   EUCTR2013-003984-72-ES   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   -   EUCTR2013-002358-57-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
ABT-122
   AbbVie
      2015   Phase 2   NCT02433340   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   NCT02141997   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania;Turkey;United States
      2013   Phase 1   NCT01853033   United States
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2014-001471-31-RO   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   Phase 2   EUCTR2014-001471-31-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2013-004019-37-DK   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   -   EUCTR2013-004019-37-DE   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   Phase 2   EUCTR2013-004019-37-BG   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-RO   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   -   EUCTR2013-004019-37-HU   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-CZ   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
ABT-494
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2017   Phase 3   EUCTR2016-000933-37-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;European Union;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003376-75-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003335-35-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-IT   Argentina;Australia;Austria;Barbados;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie
      2014   Phase 2   NCT02049138   Australia;Belgium;Bulgaria;Chile;Czech Republic;Czechia;Hungary;Israel;Latvia;Mexico;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2013   Phase 2   NCT01960855   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;New Zealand;Poland;Puerto Rico;Spain;United Kingdom;United States
   AbbVie (prior sponsor, Abbott)
      2012   Phase 1   NCT01741493   United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-002306-31-HU   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-BE   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-000666-10-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000666-10-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-000666-10-BE   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2018   Phase 2   EUCTR2018-000666-10-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000933-37-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-DE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-BE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-LV   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-ES   Argentina;Australia;Belarus;Brazil;Canada;Chile;Colombia;European Union;Hungary;Israel;Korea, Democratic People's Republic of;Latvia;Mexico;New Zealand;Norway;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;United States
      2016   Phase 3   EUCTR2015-003376-75-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-GR   Argentina;Australia;Austria;Belgium;Chile;Colombia;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-ES   Argentina;Australia;Austria;Chile;Colombia;European Union;Israel;Japan;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003335-35-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-SI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-NO   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-IE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-HU   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-FR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-DK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-SI   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PL   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LV   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-IE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-HU   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Greece;Hong Kong;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-HR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-GR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-GB   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-FI   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-ES   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Egypt;European Union;Greece;Hong Kong;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-CZ   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BG   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Denmark;Egypt;European Union;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003333-95-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-NO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-ES   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003334-27-SK   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003333-95-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-003984-72-SK   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-LV   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003984-72-CZ   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   Phase 2   EUCTR2013-003530-33-NL   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-ES   Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Netherlands;Puerto Rico;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-NL   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   -   EUCTR2013-002358-57-HU   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-CZ   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002358-57-BE   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
   AbbVie Deutschland GmbH & Co.KG
      2014   -   EUCTR2013-003984-72-HU   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   AbbVie Inc.
      2014   -   EUCTR2013-003984-72-ES   Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
      2014   -   EUCTR2013-002358-57-ES   Australia;Belgium;Canada;Czech Republic;Hungary;Netherlands;Poland;Puerto Rico;Spain;United Kingdom;United States
ABT-494 15MG
   AbbVie Deutschland GmbH & Co. KG
      2014   Phase 2   EUCTR2013-003530-33-LV   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
ABT-494 30MG
   AbbVie Deutschland GmbH & Co. KG
      2014   Phase 2   EUCTR2013-003530-33-LV   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
ABT-humira
   Abbott GmbH & Co. KG
      2008   -   EUCTR2007-005905-23-GB   Germany;United Kingdom
      2008   -   EUCTR2007-005905-23-DE   Germany;United Kingdom
      2008   -   EUCTR2006-004139-31-NO   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-004139-31-GR   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-SK   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-SE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-NL   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-HU   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-GB   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-FR   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-ES   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-DE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-CZ   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-BE   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-AT   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
   Abbott Scandinavia AB
      2008   -   EUCTR2008-004398-16-SE   Sweden
ABX464
   Abivax
      2020   Phase 2   EUCTR2019-001578-27-BE   Belgium;Hungary
      2019   Phase 2   EUCTR2019-001578-27-HU   Hungary
      2019   Phase 2   EUCTR2018-004677-27-HU   Belgium;Hungary
      2019   Phase 2   EUCTR2018-004677-27-BE   Belgium;Hungary
   Abivax S.A.
      2019   Phase 2   NCT04049448   Belgium;Czechia;France;Hungary;Poland
ABX464 100MG
   Abivax S.A.
      2019   Phase 2   NCT03813199   Belgium;Czechia;France;Hungary;Poland
ABX464 50MG
   Abivax S.A.
      2019   Phase 2   NCT03813199   Belgium;Czechia;France;Hungary;Poland
AC430
   Daiichi Sankyo Inc.
      2010   Phase 1   NCT01287858   United States
Acalabrutinib
   Acerta Pharma BV
      2015   Phase 2   NCT02387762   United States
Aceclofenac
   Chung Shan Medical University
      2007   Phase 4   NCT04144101   -
Acellbia
   Biocad
      2015   Phase 3   NCT02744196   -
Acetaminophen
   Hoffmann-La Roche
      2011   Phase 4   NCT01382940   United States
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
   Merck Sharp & Dohme (Sweden) AB
      2004   -   EUCTR2004-000074-31-SE   Sweden
   Merck Sharp & Dohme BV
      2005   Phase 2   EUCTR2004-000074-31-BE   Belgium;Sweden
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
   Nekoyama Miyao Hospital
      2016   -   JPRN-UMIN000018931   Japan
   Osaka City University Medical School, Department of Orthopedic Surgery
      2014   -   JPRN-UMIN000012364   Japan
   Yamaguchi University
      2018   -   JPRN-UMIN000031692   Japan
Acetaminophen tablets
   Maoxiang Group Jilin Pharmaceutical Co., Ltd.
      2014   Phase 2   NCT02029599   China
Acetate
   Bristol-Myers Squibb
      2017   Phase 1   NCT03262740   United States
Acetylsalicylic acid
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
Acide folique
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
Actemra
   AO GENERIUM
      2023   Phase 3   NCT06475508   Russian Federation
   Bio-Thera Solutions
      2018   Phase 3   NCT03830203   China
   F. Hoffmann- La Roche Ltd
      2009   -   EUCTR2008-000587-17-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   F. Hoffmann-La Roche Limited
      2007   -   EUCTR2007-001114-17-GB   United Kingdom
   F. Hoffmann-La Roche Ltd
      2010   Phase 3   EUCTR2008-006924-68-AT   Austria;Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-000587-17-HU   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-000587-17-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-SE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-IE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Hoffmann-La Roche
      2014   Phase 3   NCT02011334   Argentina;Brazil;Colombia;Dominican Republic;Ecuador;Mexico;Uruguay;Venezuela
      2013   Phase 3   NCT01995201   Ireland;Portugal;Spain
      2013   Phase 4   NCT01878318   Venezuela
      2012   Phase 3   NCT01730456   Macedonia, The Former Yugoslav Republic of
      2012   Phase 3   NCT01664598   Russian Federation
      2012   Phase 3   NCT01649804   Hungary
      2012   Phase 3   NCT01587989   Austria
      2011   Phase 4   NCT01399697   Spain
      2011   Phase 3   NCT01353859   Greece;Indonesia
      2011   Phase 3   NCT01332994   Germany
      2011   Phase 3   NCT01326962   Saudi Arabia
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 4   NCT01251120   Finland
      2011   Phase 3   NCT01245439   Turkey
      2011   Phase 3   NCT01235507   Bosnia and Herzegovina
      2011   Phase 4   NCT01219933   Belgium
      2010   Phase 4   NCT02010216   Kazakhstan
      2010   Phase 3   NCT01610791   Morocco
      2010   Phase 3   NCT01214733   South Africa
      2010   Phase 4   NCT01195272   United Kingdom
      2010   Phase 4   NCT01149057   Israel
      2010   Phase 4   NCT01089023   Bahrain;Iran, Islamic Republic of;Kuwait;Qatar;United Arab Emirates
      2010   Phase 3   NCT01063062   Egypt
      2010   Phase 4   NCT01034397   Portugal
      2010   Phase 3   NCT01034137   Netherlands
      2009   Phase 4   NCT01010503   Slovakia
      2009   Phase 4   NCT00996203   Russian Federation
      2009   Phase 3   NCT00977106   France
      2009   Phase 1   NCT00965653   Canada;New Zealand;Spain;United Kingdom
      2009   Phase 3   NCT00951275   Italy
      2009   Phase 3   NCT00891020   Puerto Rico;United Kingdom;United States
      2009   Phase 2   NCT00887341   Spain
      2009   Phase 3   NCT00883753   Australia;Austria;Canada;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Turkey;United Kingdom
      2009   Phase 2   NCT00845832   Belgium;France;Germany;Greece;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom
      2009   Phase 3   NCT00810199   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Monaco;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00754572   Argentina;Brazil;Chile;Colombia;Costa Rica;Ecuador;Mexico;Peru;Uruguay;Venezuela
      2008   Phase 3   NCT00848120   Philippines
      2008   Phase 3   NCT00810277   Finland
      2008   Phase 3   NCT00773461   China
      2008   Phase 3   NCT00750880   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Luxembourg;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2005   Phase 1   NCT00365001   New Zealand;United States
      2005   Phase 3   NCT00109408   Argentina;Australia;Canada;China;Croatia;Denmark;Former Serbia and Montenegro;France;Israel;Italy;Lithuania;Mexico;Norway;Peru;Portugal;Serbia;Slovenia;South Africa;Spain;United States
      2005   Phase 3   NCT00106574   Argentina;Australia;Brazil;Canada;China;Costa Rica;Czech Republic;Finland;France;Germany;Hong Kong;Mexico;Panama;Russian Federation;South Africa;Spain;Sweden;Thailand;United States
      2005   Phase 3   NCT00106548   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;France;Germany;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Spain;Switzerland;Thailand
      2005   Phase 3   NCT00106535   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;Puerto Rico;South Africa;Spain;Switzerland;United States
      2005   Phase 3   NCT00106522   Australia;Belgium;Canada;France;Germany;Iceland;Italy;Mexico;Netherlands;Puerto Rico;Sweden;Switzerland;United Kingdom;United States
   Huashan Hospital, Fudan University / Peking University, Reople’s Hospital
      2019   Phase 3   ChiCTR2300067652   China
   ROCHE
      2009   -   EUCTR2008-000587-17-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   UCB Pharma
      2010   Phase 2   NCT01242488   Belgium;United Kingdom;United States
   University of Athens
      2017   -   NCT03288584   Greece
Actemra +MTX
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2020   Phase 3   NCT06048224   China
Acthar
   Dartmouth-Hitchcock Medical Center
      2014   Phase 2   NCT01984268   United States
   Veena Ranganath, MD, MS
      2017   Phase 4   NCT02541955   United States
Acthar GEL
   Dana Ascherman
      2014   -   NCT02030028   United States
   Mallinckrodt
      2016   Phase 4   NCT02919761   Argentina;Colombia;Mexico;Peru;Puerto Rico;United States
Acthar injectable product
   Attune Health Research, Inc.
      2018   Phase 3   NCT03511625   United States
Active comparator
   Asahi Kasei Pharma Corporation
      2011   Phase 2   NCT01285752   Czech Republic;Germany;Hungary;Poland;Slovakia;Ukraine;United Kingdom
      2009   Phase 2   NCT00902369   Czech Republic;Germany;Hungary;Lithuania;Romania;United Kingdom
   Charite University, Berlin, Germany
      2024   Phase 1/Phase 2   NCT06475495   -
   Masaki Takeshi
      2023   Phase 2   JPRN-jRCT2031220628   Argentina;Canada;China;Greece;Hungary;Italy;Japan;Mexico;Poland;Puerto Rico;Spain;United States
   Yazawa Rie
      2017   Phase 1   JPRN-jRCT2071200057   -
   Yonemura Takuma
      2015   Phase 1   JPRN-jRCT2071200058   -
Active stimulation
   Galvani Bioelectronics
      2021   -   NCT05003310   Netherlands;United States
Acupuncture
   Chinese Academy of Sciences
      2012   -   NCT01619176   China
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
   Traditional Chinese Medicine Hospital of Dianjiang Chongqing
      2023   Phase 1   ChiCTR2300075439   China
Acycloguanosine
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02633332   Italy
ACZ885
   NOVARTIS FARMA
      2007   -   EUCTR2007-001665-15-IT   Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2006-001553-10-IT   Germany;Italy;Netherlands
   Novartis
      2007   Phase 2   NCT00554606   Belgium;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;Turkey;United States
      2007   Phase 1/Phase 2   NCT00505089   Belgium;Germany;Netherlands;Poland
      2007   Phase 2   NCT00504595   Russian Federation;Spain;Switzerland;Turkey
      2003   Phase 1/Phase 2   NCT00619905   Germany;Netherlands;Switzerland
   Novartis Farmacéutica S.A.
      2009   Phase 2   EUCTR2008-005320-81-ES   Austria;Belgium;Germany;Spain
   Novartis Pharma AG
      2007   -   EUCTR2006-001550-27-FI   Austria;Finland;Germany;Spain
      2007   -   EUCTR2006-001550-27-DE   Austria;Finland;Germany;Spain
      2006   -   EUCTR2006-001550-27-BE   Austria;Belgium;Finland;Germany;Spain
      2006   -   EUCTR2006-001550-27-AT   Austria;Finland;Germany;Spain
   Novartis Pharma Services AG
      2009   -   EUCTR2008-005320-81-DE   Austria;Germany;Spain
      2009   -   EUCTR2008-005320-81-BE   Austria;Belgium;Germany;Spain
      2008   -   EUCTR2008-005320-81-AT   Austria;Germany;Spain
      2007   -   EUCTR2007-001665-15-DE   Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-000491-16-DE   Austria;Germany;Spain
      2007   -   EUCTR2006-001553-10-DE   Germany;Italy;Netherlands
ACZ885 drug substance
   Novartis Farmaceutica S.A.
      2007   -   EUCTR2007-001665-15-ES   Belgium;Germany;Italy;Netherlands;Spain
   Novartis Farmacéutica S.A
      2007   -   EUCTR2006-004669-32-ES   Spain
   Novartis Farmacéutica, S.A.
      2007   -   EUCTR2007-000491-16-ES   Austria;Belgium;Germany;Spain
   Novartis Pharma Services AG
      2007   -   EUCTR2007-001665-15-NL   Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-001665-15-BE   Belgium;Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-000491-16-BE   Austria;Belgium;Germany;Spain
      2007   -   EUCTR2007-000491-16-AT   Austria;Germany;Spain
      2007   -   EUCTR2006-004666-14-DE   Germany
      2007   -   EUCTR2006-004666-14-BE   Belgium;Germany
      2007   -   EUCTR2006-001553-10-NL   Germany;Italy;Netherlands
      2007   Phase 2   EUCTR2006-001553-10-BE   Belgium;Germany;Italy;Netherlands
AD 452
   Arakis Ltd.
      2005   -   EUCTR2005-002421-31-DE   Germany;United Kingdom
   Sosei
      2005   Phase 2   NCT00141934   United States
AD 452 18 MG tablet
   Arakis Ltd
      2005   -   EUCTR2005-002421-31-GB   Germany;United Kingdom
AD 452 4.5 MG tablet
   Arakis Ltd
      2005   -   EUCTR2005-002421-31-GB   Germany;United Kingdom
AD 452 9 MG tablet
   Arakis Ltd
      2005   -   EUCTR2005-002421-31-GB   Germany;United Kingdom
AD26.COV2.S
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
Adalimuab, etanercept, tocilizumab, or abatacept
   Hanyang University
      2020   -   NCT04449224   Korea, Republic of
Adalimumab
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Aarhus University Hospital, Denmark
      2007   Phase 4   EUCTR2007-000082-38-DK   Denmark
   AbbVie
      2023   Phase 3   NCT05814627   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Romania;Serbia;South Africa;Spain;United Kingdom;United States
      2019   Phase 2   NCT03823391   Germany;Hungary;Israel;Netherlands;Poland;Puerto Rico;United States
      2016   -   NCT02750800   Hungary
      2016   -   NCT02668640   China
      2015   Phase 3   NCT02629159   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 4   NCT02198651   Australia;Austria;Canada;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 2   NCT02141997   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania;Turkey;United States
      2013   -   NCT01768858   Austria
      2007   Phase 1   NCT00650156   China
   AbbVie (prior sponsor, Abbott)
      2012   -   NCT01736189   Japan
      2012   Phase 2   NCT01561313   Belgium;Czech Republic
      2012   Phase 2   NCT01502423   Australia;Canada;Germany
      2010   Phase 3   NCT01185301   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Poland;Puerto Rico;Spain;United States
      2010   Phase 4   NCT01185288   Puerto Rico;United States
      2010   Phase 4   NCT01162421   Canada
      2009   Phase 4   NCT00808509   Sweden
      2000   Phase 3   NCT00195663   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-003053-21-PL   Israel;Poland;Puerto Rico;United States
      2016   Phase 3   EUCTR2015-003333-95-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Denmark;Egypt;European Union;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003333-95-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003333-95-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 4   EUCTR2014-001114-26-SE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 4   EUCTR2014-001114-26-NL   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-IT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-IE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-HU   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-GR   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-GB   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-FR   Australia;Austria;Canada;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-ES   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-DE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-AT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003881-42-SK   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   -   EUCTR2012-003881-42-RO   Germany;Puerto Rico;Romania;United States
      2013   -   EUCTR2012-003881-42-DE   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   Phase 2   EUCTR2012-003881-42-BE   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-DE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abbott
      2008   Phase 3   NCT00690573   Japan
      2007   Phase 3   NCT01231321   Russian Federation
      2007   Phase 3   NCT00647270   Australia;Canada;Germany;Puerto Rico;United Kingdom;United States
      2006   -   NCT01078571   Spain
      2006   Phase 4   NCT00761514   Puerto Rico
      2006   Phase 3   NCT00603993   Japan
      2006   Phase 4   NCT00420927   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Mexico;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2005   Phase 4   NCT00233558   United States
      2004   -   NCT00650390   -
      2004   Phase 2/Phase 3   NCT00647491   Japan
      2004   Phase 3   NCT00235872   Japan
      2004   Phase 4   NCT00234897   United States
      2003   Phase 4   NCT00649922   -
      2003   -   NCT00649545   -
      2003   Phase 3   NCT00647920   Taiwan
      2003   Phase 3   NCT00235859   -
      2003   Phase 2   NCT00235833   Japan
      2003   Phase 3   NCT00234936   -
      2003   -   NCT00234884   Australia;Austria;Belgium;France;Germany;Greece;Italy;Netherlands;Portugal;Spain;United Kingdom
      2003   Phase 3   NCT00234845   United States
      2002   -   NCT00650026   -
      2002   Phase 3   NCT00448383   -
      2002   Phase 3   NCT00049751   United States
      2000   Phase 3   NCT00195702   Canada;United States
      2000   Phase 3   NCT00195650   Canada;United States
   Abbott GmbH & Co. KG
      2012   -   EUCTR2012-000535-36-SK   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-PL   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-CZ   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   Phase 2   EUCTR2012-000535-36-BE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2011-003953-25-DE   Australia;Canada;Germany
      2012   -   EUCTR2011-002275-41-CZ   Belgium;Czech Republic
      2012   -   EUCTR2011-002275-41-BE   Belgium;Czech Republic
      2011   -   EUCTR2010-019514-24-ES   Austria;Czech Republic;Germany;Spain
      2011   -   EUCTR2010-019514-24-DE   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   Phase 3   EUCTR2010-019514-24-BE   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   -   EUCTR2010-019514-24-AT   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2008   -   EUCTR2007-005905-23-GB   Germany;United Kingdom
      2008   -   EUCTR2007-005905-23-DE   Germany;United Kingdom
      2008   -   EUCTR2006-004139-31-NO   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-004139-31-GR   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-SK   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-SE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-NL   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-HU   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-GB   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-FR   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-ES   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-DE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-CZ   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-BE   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-AT   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
   Abbott Japan Co., Ltd.
      2009   Phase 3   JPRN-jRCT2080220724   -
      -   -   EUCTR2014-004558-33-Outside-EU/EEA   Japan
   Abbott Laboratories
      -   -   EUCTR2011-001661-40-Outside-EU/EEA   United States
   Abbott Scandinavia AB
      2008   -   EUCTR2008-004398-16-SE   Sweden
   Amgen
      2013   Phase 3   NCT01970475   Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   Astellas Pharma Korea, Inc.
      2019   Phase 4   NCT03737708   Korea, Republic of
   AstraZeneca
      2011   Phase 2   NCT02092961   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;South Africa;United Kingdom;United States
      2011   Phase 2   NCT01264770   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2011   Phase 2   EUCTR2010-023692-26-SK   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023692-26-GB   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      -   -   EUCTR2010-023692-26-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Biogen
      2006   Phase 2   NCT00298272   United States
   Biologic Mate Study Group
      2014   -   JPRN-UMIN000015616   Japan
   Boehringer Ingelheim International GmbH
      2014   Phase 3   EUCTR2012-002945-40-HU   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-ES   Argentina;Belgium;Bulgaria;Chile;Colombia;Estonia;France;Germany;Hungary;Indonesia;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-EE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
   Bristol-Myers K.K.
      2011   Phase 2   JPRN-jRCT2080221588   -
   Bristol-Myers Squibb
      2021   Phase 3   NCT04909801   Argentina;Australia;Czechia;France;Germany;Italy;Japan;Mexico;Poland;Spain;Switzerland;Taiwan;United Kingdom;United States
      2015   Phase 4   NCT02557100   Algeria;Canada;Mexico;United States
      2009   Phase 3   NCT00929864   Argentina;Canada;Chile;Peru;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   CELLTRION, Inc.
      2019   Phase 3   EUCTR2019-000660-25-PL   Poland
   CHRU de TOURS
      2010   -   EUCTR2010-021449-28-FR   France
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   CSL Behring
      2011   Phase 2   NCT01373151   Argentina;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
   Celltrion
      2019   Phase 3   NCT04171414   Poland
   Celltrion HealthCare France
      2022   -   NCT05427942   France
   Celltrion, Inc
      2019   Phase 3   EUCTR2018-001690-25-LT   Bulgaria;Hungary;Lithuania;Peru;Poland;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-PL   Bosnia and Herzegovina;Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-HU   Bosnia and Herzegovina;Bulgaria;Hungary;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-BG   Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Ukraine
   Charité-Universitätsmedizin Berlin; Department of Rheumatology and Clinical Immunology
      2007   -   EUCTR2006-003146-41-DE   Germany
   Cinnagen
      2015   Phase 3   NCT03172325   Iran, Islamic Republic of
   Columbia University
      2019   Phase 4   NCT03619876   United States
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Department of Rheumatosurgery, Osaka City University Medical School
      2009   Phase 4   JPRN-UMIN000002340   Japan
   Dept. of Rhematology UMAS
      2005   -   EUCTR2005-000129-47-SE   Sweden
   Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences
      2011   -   JPRN-UMIN000013750   Japan
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   EMD Serono
      2007   Phase 2   NCT00595413   Germany;United States
   Eli Lilly Japan K.K.
      2013   Phase 3   JPRN-jRCT2080222079   -
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-SK   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-SI   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-PT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-NL   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LV   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-HU   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-GB   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-DE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-CZ   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-BE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2012   Phase 3   NCT01710358   Argentina;Belgium;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2008   Phase 4   EUCTR2007-000593-24-GB   Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
   F.Hoffmann-La Roche Ltd
      2008   -   EUCTR2007-000593-24-SE   Sweden;United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fen Li
      2016   Phase 4   NCT02878161   -
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   EUCTR2014-000110-61-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-BG   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-ES   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-DE   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-BG   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Spain;United States
      2010   -   EUCTR2010-021577-37-HU   Bulgaria;Germany;Hungary;Spain
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   NCT02833350   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
      2016   Phase 2   EUCTR2016-000335-40-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
      2010   Phase 2   NCT01225393   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Poland;Romania;Spain;United States
   Georgetown University
      2013   Phase 4   NCT01793519   United States
   Gilead Sciences
      2016   Phase 3   NCT02889796   Argentina;Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Glostrup University Hospital, Copenhagen
      2009   -   NCT01029613   Denmark
   Goupe d'Etudes et de Recherche Clinique En Rhumatologie
      2004   Phase 4   NCT00291915   France
   HEXAL AG
      2016   Phase 3   EUCTR2015-003433-10-IT   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Hamed Rezaei
      2012   Phase 4   NCT01609205   Sweden
   Heinrich-Heine University, Duesseldorf
      2014   Phase 3   NCT02150473   Germany
   Helsingin reumakeskus
      2010   -   EUCTR2009-017325-19-FI   Finland
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Hoffmann-La Roche
      2011   -   NCT01592292   Korea, Republic of
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2010   Phase 4   NCT01119859   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Norway;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Hvidovre Hospital
      2009   Phase 4   EUCTR2009-014394-41-DK   Denmark
   Hvidovre University Hospital
      2005   Phase 4   NCT00216177   Denmark
      2004   Phase 4   NCT00696059   Denmark
   Imperial College London South Kensington London
      2009   Phase 4   EUCTR2009-012424-87-GB   United Kingdom
   Jagiellonian University
      2013   Phase 4   NCT02132234   Poland
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   Janssen-Cilag International N.V.
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
   Jonathan Graf
      2013   Phase 4   NCT01893996   United States
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Kaneko Yuko
      2018   Phase 4   JPRN-jRCT1031180088   Japan;South Korea;Taiwan
   Karolinska Institute
      2010   Phase 4   EUCTR2009-017163-42-SE   Sweden
   Karolinska Institutet
      2010   -   NCT01197144   Sweden
   Keio University
      2018   Phase 4   NCT03505008   Japan;Korea, Republic of;Taiwan
      2011   Phase 4   NCT01270035   Japan
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Leeds University
      2014   -   JPRN-UMIN000016928   Japan,Europe
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Lilly S.A.
      2013   -   EUCTR2012-002322-73-ES   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   MERCK SERONO INTERNATIONAL SA
      2008   -   EUCTR2007-002536-29-IT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Maldonado A Michael
      2021   Phase 3   JPRN-jRCT2071210068   Australia;France;Germany;Japan;Taiwan;USA
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   Merck KGaA
      2017   Phase 3   EUCTR2016-002852-26-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002852-26-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2017   Phase 3   EUCTR2016-002852-26-BG   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2016   Phase 3   EUCTR2016-002852-26-LT   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-HU   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-CZ   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
   Merck Serono International
      2008   -   EUCTR2007-002536-29-PT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-GR   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-FR   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-ES   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-DE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-CZ   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BG   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BE   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-SE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   Phase 2   EUCTR2007-002536-29-FI   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-AT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      -   -   EUCTR2007-002536-29-PL   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Merck Sharp & Dohme Corp.
      2008   -   NCT00724672   -
   Mianyang Hospital of Traditional Chinese Medicine
      2021   Phase 4   ChiCTR2100044045   China
   NHS Greater Glasgow and Clyde
      2022   -   NCT05090124   United Kingdom
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   National Institute of Allergy and Infectious Diseases (NIAID)
      2009   Phase 4   NCT00837434   United States
      2008   Phase 4   NCT00796705   United States
   Newcastle-upon-Tyne Hospitals NHS Foundation Trust
      2007   Phase 4   EUCTR2006-006127-40-GB   United Kingdom
   Novo Nordisk A/S
      2014   Phase 2   NCT02097264   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-PT   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-ES   Ireland;Portugal;Spain;United Kingdom
      2013   Phase 2   EUCTR2013-001492-20-GB   Belgium;Czech Republic;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   OSPEDALE POLICLINICO S. MATTEO
      2006   -   EUCTR2006-003843-22-IT   Italy
   Osaka City University Medical School
      2012   -   JPRN-UMIN000010315   Japan
      2010   -   JPRN-UMIN000003880   Japan
   Osaka Medical College
      2015   -   JPRN-UMIN000016950   Japan
   Otani Tetsuya
      2023   Phase 4   JPRN-jRCT2071230022   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Greece;Hungary;Italy;Japan;Mexico;Portugal;Puerto Rico;Republic of Korea;Romania;Serbia;South Africa;Spain;United Kingdom;United States
   Ottawa Hospital Research Institute
      2022   Phase 4   NCT05153200   -
   PFIZER
      2008   -   EUCTR2007-002066-35-IT   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
   Pfizer
      2020   Phase 3   NCT04230213   Bosnia and Herzegovina;Bulgaria;Czechia;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2015   Phase 3   NCT02480153   Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 4   NCT02092467   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;Chile;China;Colombia;Czech Republic;Czechia;Finland;Hong Kong;Israel;Jordan;Lebanon;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;United Kingdom;United States
      2007   Phase 2   NCT00550446   Brazil;Bulgaria;Chile;Croatia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Romania;Slovakia;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2012   Phase 2   EUCTR2007-002066-35-SK   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2008   -   EUCTR2007-002066-35-HU   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-GR   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2008   -   EUCTR2007-002066-35-DE   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   -   EUCTR2007-002066-35-CZ   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-BG   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2009   -   EUCTR2008-008338-35-DE   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
   Pfizer, S.A
      2009   Phase 3   EUCTR2008-008338-35-ES   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
   R-Pharm
      2017   Phase 3   EUCTR2015-005307-83-RO   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-LV   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-LT   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-HU   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   R-Pharm International LLC
      2016   Phase 3   EUCTR2015-005307-83-CZ   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-BG   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Reade
      2019   Phase 4   EUCTR2019-001793-28-NL   Netherlands
      2019   Phase 1;Phase 4   EUCTR2019-001554-25-NL   Netherlands
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT04222920   Netherlands
   Rennes University Hospital
      2017   -   NCT03110094   France
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   Phase 3   NCT02167139   Lithuania;Poland
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   Sanofi
      2015   Phase 3   NCT02332590   Chile;Czech Republic;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2013   Phase 3   NCT01764997   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Czechia;Ecuador;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
   School of clinical medicine & the first affiliated hospital of chengdu Medical college
      2023   Phase 4   ChiCTR2300072896   China
   Skåne University Hospital
      2005   Phase 4   NCT01270087   Sweden
   Sungkyunkwan University
      2020   -   NCT04115423   Korea, Republic of
   Taizhou Hospital of Zhejiang Province
      2025   -   ChiCTR2500102023   China
   Takeda
      2015   Phase 2   NCT02393378   Czech Republic;Czechia;Estonia;Russian Federation;Spain;United Kingdom
   Takeda Development Centre Europe Ltd.
      2015   Phase 2   EUCTR2014-002945-23-GB   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-ES   Czech Republic;Estonia;Latvia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-CZ   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2014-002945-23-EE   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
   TcLand Expression S.A.
      2016   -   NCT03016260   Czech Republic;Czechia;France;Israel;Netherlands;Turkey
   The First Affiliated Hospital of Xi'an Jiaotong University
      2023   Phase 4   ChiCTR2300074783   China
   The Rheumatological Center of Helsinki
      2011   Phase 4   NCT01405326   Finland
   The Second Affiliated Hospital Of Nanchang University
      2022   Phase 4   ChiCTR2200058839   China
   Tufts Medical Center
      2025   -   NCT06016517   United States
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-002067-20-IT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2011   Phase 4   NCT01500278   Australia;Austria;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Monaco;Poland;Portugal;Romania;Spain;Switzerland;United Kingdom;United States
   Universita di Verona
      2024   Phase 4   NCT06527534   Italy
   University Hospital, Rouen
      2006   Phase 4   NCT00234234   France
   University Hospital, Tours
      2011   Phase 4   NCT01382160   France
      2006   -   NCT00497614   France
   University of Aarhus
      2007   Phase 3   NCT00660647   Denmark
   University of Leeds
      2013   Phase 4   NCT02056184   United Kingdom
   University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine
      2015   Phase 4   EUCTR2013-002777-22-IT   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-HU   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-ES   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-DK   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-GB   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-DE   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Sao Paulo
      2008   Phase 4   NCT01072058   Brazil
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   Université de Sherbrooke
      2013   Phase 4   NCT02035800   Canada
      2008   -   NCT00814866   Canada
   Yazawa Rie
      2017   Phase 1   JPRN-jRCT2071200057   -
   Yonemura Takuma
      2015   Phase 1   JPRN-jRCT2071200058   -
   Yunnan Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100042440   China
   sanofi-aventis Recherche & Développement
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
Adalimumab - GP2017
   Sandoz
      2016   Phase 3   NCT02744755   Czech Republic;Czechia;Germany;Hungary;Italy;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;United Kingdom;United States
Adalimumab - US licensed humira
   Sandoz
      2016   Phase 3   NCT02744755   Czech Republic;Czechia;Germany;Hungary;Italy;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;United Kingdom;United States
Adalimumab 40 MG
   Abbott
      2007   Phase 2/Phase 3   NCT00538902   China
      2000   Phase 3   NCT00233571   -
   Abbott Japan Co., Ltd.
      2008   Phase 3   JPRN-jRCT2080220565   -
   Janssen Research & Development, LLC
      2014   Phase 3   NCT02019472   Argentina;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
Adalimumab 40MG Q2W
   R-Pharm International, LLC
      2016   Phase 3   NCT02760407   Argentina;Brazil;Bulgaria;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   Shandong Provincial Hospital Affiliated to Shandong First Medical University
      2020   Phase 4   ChiCTR2200055876   China
Adalimumab 80 MG
   Abbott
      2007   Phase 2/Phase 3   NCT00538902   China
Adalimumab delivered IN current autoinjector
   AbbVie (prior sponsor, Abbott)
      2010   Phase 2   NCT01163617   United States
Adalimumab delivered IN current syringe
   AbbVie (prior sponsor, Abbott)
      2010   Phase 2   NCT01163617   United States
Adalimumab delivered IN physiolis autoinjector
   AbbVie (prior sponsor, Abbott)
      2010   Phase 2   NCT01163617   United States
Adalimumab delivered IN physiolis syringe
   AbbVie (prior sponsor, Abbott)
      2010   Phase 2   NCT01163617   United States
Adalimumab humira
   Pfizer Inc
      2020   Phase 4   EUCTR2019-000284-24-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2019   Phase 3   EUCTR2019-000284-24-LT   Argentina;Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Mexico;Peru;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
Adalimumab injection
   Qilu Hospital of Shandong University
      2021   Phase 4   NCT05626348   China
   St George's, University of London
      2020   Phase 4   NCT04255134   United Kingdom
Adalimumab PFS and PEN
   Samsung Bioepis Co., Ltd.
      2015   Phase 2   NCT02565810   Poland
Adalimumab serum trough concentration
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT04194827   Netherlands
Adalimumab trough concentration
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT04251741   Netherlands
Adalimumab with methotrexate
   Pfizer
      2014   Phase 4   NCT02187055   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Adalimumab, current formulation
   AbbVie (prior sponsor, Abbott)
      2012   Phase 2   NCT01712178   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
Adalimumab, NEW formulation
   AbbVie (prior sponsor, Abbott)
      2012   Phase 2   NCT01712178   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
Adalimumab, plus prednisone
   IRCCS Policlinico S. Matteo
      2007   Phase 4   NCT00480272   Italy
Adalimumab, solution FOR injection 40 MG/ (0.8 ML) PRE-filled syringe
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-004019-37-DK   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   -   EUCTR2013-004019-37-DE   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   Phase 2   EUCTR2013-004019-37-BG   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-RO   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   -   EUCTR2013-004019-37-HU   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-CZ   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
Adalimumab-800CW
   University Medical Center Groningen
      2023   Phase 1   NCT03938701   Netherlands
Adalimumab-EU
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
Adalimumab-pfizer
   Pfizer Inc
      2020   Phase 4   EUCTR2019-000284-24-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2019   Phase 3   EUCTR2019-000284-24-LT   Argentina;Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Mexico;Peru;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
Adalimummab
   Hvidovre Hospital
      2009   Phase 4   EUCTR2009-014394-41-DK   Denmark
Adefovir
   Department of general internal medicine, Kyushu-University hospital
      2012   -   JPRN-UMIN000018017   Japan
ADL5859
   Cubist Pharmaceuticals LLC
      2007   Phase 2   NCT00626275   United States
Aerobic exercise
   Instituto de Ciencias de la Salud, Universidad de O'Higgins
      2022   -   NCT05945693   Chile
AGM 719
   Amgen
      2002   Phase 2   NCT00038298   United States
AI-1000 G2
   Hoffmann-La Roche
      2016   Phase 4   NCT02682823   United States
AIN457
   NOVARTIS FARMA
      2012   -   EUCTR2012-002760-27-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-IT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   -   EUCTR2011-000275-13-IT   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Farma S.p.A.
      2013   -   EUCTR2013-000944-25-IT   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
   Novartis Farmaceutica, S.A.
      2012   -   EUCTR2012-002760-27-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Farmacéutica S.A.
      2011   -   EUCTR2011-000102-21-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma AG
      2012   -   EUCTR2012-002760-27-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-PT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2011-006058-94-GR   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   -   EUCTR2011-000275-13-HU   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000275-13-GB   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000275-13-BE   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2010-024516-34-SK   Bulgaria;Canada;Hungary;Italy;Slovakia;United States
      2011   -   EUCTR2010-024516-34-HU   Bulgaria;Canada;Hungary;Italy;United States
      2011   -   EUCTR2010-024516-34-BG   Bulgaria;Canada;Hungary;Italy;Slovakia;United States
   Novartis Pharma K.K.
      2013   Phase 3   JPRN-jRCT2080222163   -
      2013   Phase 3   JPRN-jRCT2080222045   -
   Novartis Pharma Services AG
      2013   -   EUCTR2012-002760-27-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma Services AG
      2013   -   EUCTR2013-000944-25-HU   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
      2013   -   EUCTR2011-006058-94-DE   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2012-002760-27-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-CZ   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   Phase 2   EUCTR2011-001220-38-GB   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   -   EUCTR2011-001220-38-DE   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   Phase 2   EUCTR2011-001220-38-BE   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2009   -   EUCTR2009-011000-34-SK   Czech Republic;Germany;Hungary;Slovakia
      2009   -   EUCTR2009-011000-34-HU   Czech Republic;Germany;Hungary;Slovakia
      2009   -   EUCTR2009-011000-34-DE   Czech Republic;Germany;Hungary;Slovakia
      2009   -   EUCTR2009-011000-34-CZ   Czech Republic;Germany;Hungary;Slovakia
      2009   -   EUCTR2009-011000-34-BE   Belgium;Czech Republic;Germany;Hungary;Slovakia
   Novartis Pharmaceuticals
      2013   Phase 3   NCT01901900   Argentina;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Puerto Rico;Thailand;United States
      2012   Phase 3   NCT01770379   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;Puerto Rico;South Africa;United States
      2012   Phase 3   NCT01640938   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   Phase 3   NCT01377012   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Puerto Rico;Romania;Thailand;Turkey;United Kingdom;United States
      2011   Phase 2   NCT01359943   Bulgaria;Canada;Hungary;Italy;Poland;Puerto Rico;Slovakia;United States
      2011   Phase 3   NCT01350804   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2005   Phase 1/Phase 2   NCT00669942   Belgium;Germany;Netherlands;Singapore;Spain;United States
AIN457F
   NOVARTIS FARMA
      2012   -   EUCTR2011-006058-94-IT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   -   EUCTR2011-000102-21-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2010-024516-34-IT   Bulgaria;Canada;Hungary;Italy;United States
AK106-001616
   Asahi Kasei Pharma Corporation
      2011   Phase 2   NCT01285752   Czech Republic;Germany;Hungary;Poland;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-SK   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-HU   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2011   -   EUCTR2010-021558-21-GB   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-DE   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2010   -   EUCTR2010-021558-21-CZ   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2009   Phase 2   NCT00902369   Czech Republic;Germany;Hungary;Lithuania;Romania;United Kingdom
      2009   -   EUCTR2008-006075-75-HU   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-GB   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-DE   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-CZ   Czech Republic;Germany;Hungary;United Kingdom
Alcohol intake
   University of Leeds
      2006   -   NCT06670183   -
      1995   -   NCT06670144   United Kingdom
ALD518
   Alder Biopharmaceuticals, Inc
      2008   -   EUCTR2008-004931-39-PL   Poland
   CSL Behring
      2008   Phase 2   NCT00867516   Canada;Georgia;India;Poland;Russian Federation;Serbia
Alemtuzumab
   Paul Szabolcs
      2014   Phase 2   NCT01962415   United States
Alemtuzumab (already received BY alemtuzumab cohort between 1991 and 1994
   The Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 4   EUCTR2010-021146-22-GB   United Kingdom
Alendronat teva
   Aarhus University Hospital
      2015   Phase 2   EUCTR2015-003638-28-DK   Denmark
Alendronate
   Chinese University of Hong Kong
      2012   Phase 4   NCT01770106   Hong Kong
   People's Hospital, Peking University
      2009   -   ChiCTR-TRC-09000473   China
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
   University of Aarhus
      2015   Phase 2   NCT02944799   Denmark
Alendronic acid
   Aarhus University Hospital
      2015   Phase 2   EUCTR2015-003638-28-DK   Denmark
Alfacalcidol
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
Alfacalcidol tablets
   Chinese SLE Treatment And Research Group
      2024   Phase 4   NCT06385093   China
Alkaline phosphatase
   Alloksys Life Sciences B.V.
      2011   -   EUCTR2008-007346-63-GB   United Kingdom
Allogeneic mesenchymal precursor cells
   Mesoblast, Inc
      2013   -   EUCTR2012-005674-61-LV   Belgium;Croatia;Czech Republic;Estonia;Hungary;Latvia;Poland;Serbia
      2013   Phase 2   EUCTR2012-005674-61-EE   Belgium;Croatia;Czech Republic;Estonia;Hungary;Latvia;Poland;Serbia
      2013   Phase 2   EUCTR2012-005674-61-BE   Belgium;Croatia;Czech Republic;Estonia;Hungary;Latvia;Poland;Serbia
   Mesoblast, Ltd.
      2013   Phase 2   NCT01851070   Australia;United States
Allopurinol
   University of Dundee
      2005   Phase 4   EUCTR2005-000551-15-GB   United Kingdom
Allorx
   The Foundation for Orthopaedics and Regenerative Medicine
      2021   Phase 1   NCT05003934   Antigua and Barbuda;Argentina;Mexico
ALX-0061
   Ablynx
      2015   Phase 2   NCT02518620   Belgium;Bulgaria;Georgia;Germany;Hungary;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;North Macedonia;Poland;Romania;Serbia;Spain
      2015   Phase 2   NCT02309359   Belgium;Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;North Macedonia;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   NCT02287922   Belgium;Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;North Macedonia;Poland;Romania;Serbia;Spain;United States
      2014   Phase 1   NCT02101073   Netherlands
      2011   Phase 1/Phase 2   NCT01284569   Czech Republic;Czechia;Hungary;Netherlands;Poland
   Ablynx NV
      2015   Phase 2   EUCTR2014-003034-42-HU   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain
      2015   Phase 2   EUCTR2014-003034-42-ES   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain
      2015   Phase 2   EUCTR2014-003034-42-DE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain
      2015   Phase 2   EUCTR2014-003034-42-BG   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain
      2015   Phase 2   EUCTR2014-003034-42-BE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain
      2015   Phase 2   EUCTR2014-003033-26-HU   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003033-26-ES   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003033-26-DE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003033-26-CZ   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003033-26-BG   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003033-26-BE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-HU   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-ES   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-DE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-CZ   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BG   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
ALX-0061 nanobody
   Ablynx NV
      2011   -   EUCTR2010-022865-81-HU   Czech Republic;Hungary
      2011   -   EUCTR2010-022865-81-CZ   Czech Republic;Hungary
AMG 108
   AMGEN S.P.A.
      2007   -   EUCTR2006-003698-29-IT   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-IT   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   Amgen
      2006   Phase 2   NCT00369473   Australia;Belgium;Canada;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Mexico;Netherlands;Poland;Puerto Rico;Slovakia;Spain;United Kingdom;United States
      2006   Phase 2   NCT00293826   Australia;Austria;Belgium;Canada;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Mexico;Netherlands;Poland;Puerto Rico;Slovakia;Spain;Sweden;United Kingdom;United States
   Amgen Inc.
      2007   -   EUCTR2006-003698-29-LV   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2007   -   EUCTR2006-003698-29-IE   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2007   -   EUCTR2006-003698-29-HU   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2007   -   EUCTR2006-003698-29-EE   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2007   -   EUCTR2006-003698-29-AT   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2007   -   EUCTR2005-003558-83-LV   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2005-003558-83-IE   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2005-003558-83-EE   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2006   Phase 2   EUCTR2006-003698-29-SK   Austria;Belgium;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Slovakia;Sweden;United Kingdom
      2006   -   EUCTR2006-003698-29-SE   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   -   EUCTR2006-003698-29-NL   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   -   EUCTR2006-003698-29-GB   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   Phase 2   EUCTR2006-003698-29-FR   Austria;Belgium;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Slovakia;Sweden;United Kingdom
      2006   -   EUCTR2006-003698-29-CZ   Austria;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   -   EUCTR2006-003698-29-BE   Austria;Belgium;Czech Republic;Estonia;France;Hungary;Ireland;Italy;Latvia;Netherlands;Sweden;United Kingdom
      2006   Phase 2   EUCTR2005-003558-83-SK   Austria;Belgium;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-SE   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-NL   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2006   Phase 2   EUCTR2005-003558-83-GB   Austria;Belgium;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2006   Phase 2   EUCTR2005-003558-83-ES   Austria;Belgium;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-CZ   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-BE   Austria;Belgium;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-003558-83-AT   Austria;Czech Republic;Estonia;Ireland;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
AMG 357
   Amgen
      2015   Phase 1   NCT02499315   United States
AMG 592
   Amgen
      2018   Phase 1/Phase 2   NCT03410056   Bulgaria;Germany;Poland;Spain;United States
   Amgen Inc
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-ES   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-BG   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2017   Phase 1;Phase 2   EUCTR2017-001944-36-PL   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
AMG 714
   Amgen
      2002   Phase 2   NCT00433875   -
AMG 719
   Amgen
      2002   Phase 2   NCT00038298   United States
AMG 827
   Amgen
      2010   Phase 2   NCT01059448   Bulgaria;Canada;Czech Republic;Latvia;Mexico;Poland;United Kingdom;United States
      2008   Phase 1/Phase 2   NCT00771030   Canada;Mexico;United States
   Amgen Inc
      2010   -   EUCTR2009-016119-38-PL   Bulgaria;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-016119-38-LV   Bulgaria;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-016119-38-GB   Australia;Bulgaria;Czech Republic;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-016119-38-CZ   Bulgaria;Czech Republic;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-016119-38-BG   Bulgaria;Latvia;Poland;United Kingdom
      2010   Phase 2   EUCTR2009-012566-32-HU   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-012566-32-CZ   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
      2010   -   EUCTR2009-012566-32-BG   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
      2009   -   EUCTR2009-012566-32-PL   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
      2009   -   EUCTR2009-012566-32-LV   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
      2009   -   EUCTR2009-012566-32-GB   Bulgaria;Czech Republic;Hungary;Latvia;Poland;United Kingdom
AMG 827 140 MG
   Amgen
      2009   Phase 2   NCT00950989   Bulgaria;Canada;Czech Republic;Hungary;Latvia;Mexico;Poland;United Kingdom;United States
AMG 827 210 MG
   Amgen
      2009   Phase 2   NCT00950989   Bulgaria;Canada;Czech Republic;Hungary;Latvia;Mexico;Poland;United Kingdom;United States
AMG 827 70 MG
   Amgen
      2009   Phase 2   NCT00950989   Bulgaria;Canada;Czech Republic;Hungary;Latvia;Mexico;Poland;United Kingdom;United States
AMG592
   Amgen Inc
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-ES   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-BG   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2017   Phase 1;Phase 2   EUCTR2017-001944-36-PL   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
Amino acid supplement
   Leeds Beckett University
      2024   -   NCT06400316   -
Amoxapine & dipyridamole
   CombinatoRx, Inc
      2004   -   EUCTR2004-001490-26-GB   Estonia;United Kingdom
Amoxicilina
   Dra Beatriz Lozano-Hospital Universitario de Canarias
      2018   Phase 4   EUCTR2017-003259-40-ES   Spain
Amoxicillin
   Dra Beatriz Lozano-Hospital Universitario de Canarias
      2018   Phase 4   EUCTR2017-003259-40-ES   Spain
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
AMP-110
   MedImmune LLC
      2014   Phase 1   NCT02277574   United States
      2013   Phase 1   NCT01878123   United States
AMT-101
   Applied Molecular Transport Inc.
      2020   Phase 2   EUCTR2020-003955-14-DE   Germany
Anakinra
   Amgen
      2005   Phase 4   NCT00111410   -
      2004   Phase 3   NCT00117091   -
      2002   Phase 4   NCT00121043   -
      2001   Phase 2   NCT00037700   United States
      2000   Phase 2   NCT00037648   United States
   Amgen Inc
      -   -   EUCTR2015-002466-22-Outside-EU/EEA   Australia;Canada;Costa Rica;New Zealand;United States
   OSPEDALE CIVILE SAN SALVATORE, ASL 04, L'AQUILA
      2013   Phase 4   EUCTR2012-005370-62-IT   Italy
   Prof. Roberto Giacomelli
      2013   Phase 4   NCT02236481   Italy
   Swedish Orphan Biovitrum
      2012   -   NCT02915094   Germany
   University of Athens
      2011   -   NCT01566201   Greece
   Xi-jing Hospital, the 4th Military Medical University, Shanghai Changzheng Hospital
      2008   Phase 3 study   ChiCTR-TRC-09000383   China
Anakinra and PEG STNF-R1
   Amgen
      2001   Phase 2   NCT00537667   -
Andecaliximab
   Gilead Sciences
      2016   Phase 2   NCT02862574   Australia;Hungary;Taiwan;United States
Angiotensin receptor blockers
   Sherief Abd-Elsalam
      2018   Phase 3   NCT03770702   Egypt
Anifrolumab
   Josef Smolen, Univ. Prof. Dr.
      2018   Phase 2   NCT03435601   Austria
   Medical University of Vienna
      2017   Phase 2   EUCTR2017-001717-92-AT   Austria;Italy;Switzerland
Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal
   GlaxoSmithKline Research & Development Limited
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
Anti CD19 CAR NK cells
   The First Affiliated Hospital with Nanjing Medical University
      2025   Early Phase 1   NCT06613490   China
Anti human granulocyte-macrophage colo
   GlaxoSmithKline Research & Development Limited
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2021   Phase 3   EUCTR2019-000878-30-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-ES   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-CZ   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-ES   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-ES   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-CZ   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-000878-30-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody
   GlaxoSmithKline Research & Development Limited
      2018   Phase 2   EUCTR2015-004386-91-PL   Germany;Poland;United States
      2016   Phase 2   EUCTR2015-004386-91-DE   Germany;Poland;United States
      2015   Phase 2   EUCTR2014-003453-34-PL   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-HU   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-GB   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-ES   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-EE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-DE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-CZ   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal
   GlaxoSmithKline Research & Development Limited
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
Anti IL 6 MAB
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
Anti IL-1ß antibody, subclass IGG4
   Eli Lilly and Company Limited
      2007   -   EUCTR2005-002660-29-HU   Hungary;Spain
Anti LP40 antibody, subclass IGG4 LA294
   Eli Lilly and Company
      2009   -   EUCTR2008-004875-23-PL   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-HU   Austria;Belgium;France;Germany;Hungary;Poland
      2009   Phase 2   EUCTR2008-004875-23-FR   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-DE   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-BE   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-AT   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-001105-42-PL   Austria;Belgium;France;Germany;Poland
      2008   Phase 2   EUCTR2008-001105-42-FR   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-DE   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-BE   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-AT   Austria;Belgium;France;Germany;Poland
   Eli Lilly and Company limited
      2009   -   EUCTR2008-004894-16-PL   Czech Republic;Germany;Hungary;Poland
      2009   Phase 2   EUCTR2008-004894-16-HU   Czech Republic;Germany;Hungary;Poland
      2009   -   EUCTR2008-004894-16-DE   Czech Republic;Germany;Hungary;Poland
      2009   -   EUCTR2008-004894-16-CZ   Czech Republic;Germany;Hungary;Poland
Anti lymphotoxin alpha
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-BG   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Spain;United States
Anti TNF + meth
   Hamad Medical Corporation
      2012   Phase 3   NCT01724268   Qatar
ANTI-C5AR
   Novo Nordisk A/S
      2012   -   EUCTR2009-011791-30-HU   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   Phase 2   EUCTR2009-011791-30-GB   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-DK   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-CZ   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
ANTI-CCP- and ANTI-P.G.-antibodies titers
   University of Copenhagen
      2017   -   NCT03225950   Denmark
ANTI-CD20 small modular immunopharmaceutical, WYE-400087
   Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company
      2010   -   EUCTR2009-010516-15-PL   Greece;Hungary;Poland;Spain
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2010   Phase 2   EUCTR2009-010516-15-GR   Greece;Hungary;Poland;Spain
      2010   Phase 2   EUCTR2009-010516-15-ES   Greece;Hungary;Poland;Spain
      2009   -   EUCTR2009-010516-15-HU   Greece;Hungary;Poland;Spain
ANTI-GM-CSF receptor alpha
   MedImmune Ltd
      2010   -   EUCTR2009-014735-20-PL   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-LT   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-HU   Bulgaria;Czech Republic;Estonia;Hungary;Lithuania;Poland
      2010   -   EUCTR2009-014735-20-CZ   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-BG   Bulgaria;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland
      2009   -   EUCTR2009-014735-20-LV   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2009   -   EUCTR2009-014735-20-EE   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
ANTI-IL-20
   NOVO NORDISK
      2011   -   EUCTR2010-021283-14-IT   Hungary;Italy;Portugal;Spain;United Kingdom
   Novo Nordisk A/S
      2011   Phase 2   EUCTR2010-021283-14-PT   Czech Republic;Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-HU   Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-GB   Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-ES   Hungary;Italy;Portugal;Spain;United Kingdom
      2010   Phase 1   NCT01038674   Belgium;Poland
      2010   -   EUCTR2010-021283-14-CZ   Czech Republic;Hungary;Italy;Portugal;Spain;United Kingdom
      2008   Phase 1   NCT00818064   Netherlands
ANTI-IL-6 MAB
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
ANTI-IL6
   Marie Hudson, MD
      2023   -   NCT05305066   Canada
ANTI-inflammatory drugs
   Genentech, Inc.
      2007   Phase 3   NCT00443651   United States
ANTI-interleukin-6 monoclonal
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
ANTI-interleukin-6 monoclonal antibody
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
ANTI-pandemic H1n1 influenza vaccine
   University of Sao Paulo
      2010   Phase 4   NCT01151644   Brazil
ANTI-thymocyte globulin
   Fairview University Medical Center
      2000   -   NCT00006055   United States
ANTI-TNF
   Abu Dhabi Stem Cells Center
      2022   Phase 3   NCT05379322   United Arab Emirates
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   Hospital Universitari Vall d'Hebron Research Institute
      2016   -   NCT02804204   Spain
ANTI-TNF biologics therapy
   Queen Mary University of London
      2015   -   NCT02620189   United Kingdom
ANTI-TNF humanized antibody FAB fragment - PEG conjugate
   UCB Pharma S.A.
      2008   -   EUCTR2007-000830-38-FR   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-DE   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-AT   Austria;France;Germany;Italy;Poland
ANTI-TNF humanized antibody FAB' fragment - PEG conjugate
   UCB Pharma S.A.
      2009   Phase 3   EUCTR2007-005288-86-FR   France
ANTI-TNF suspended perioperatively
   CHU de Quebec-Universite Laval
      2015   Phase 4   NCT02242474   Canada
ANTI-TNF therapy
   Barts & The London NHS Trust
      2010   -   NCT02528292   United Kingdom
   Imperial College London
      2010   -   NCT01060098   United Kingdom
   University Hospital, Bordeaux
      2021   Phase 3   NCT04870203   France;Monaco
ANTI-TNF-alpha
   Hoffmann-La Roche
      2016   Phase 2   NCT03001219   Argentina;Austria;Colombia;Czech Republic;Czechia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
ANTI-tnfa continued perioperatively
   CHU de Quebec-Universite Laval
      2015   Phase 4   NCT02242474   Canada
ANTI-tumor necrosing factor (TNF) therapy
   Bristol-Myers Squibb
      2005   Phase 3   NCT00124982   Belgium;Canada;Czech Republic;France;Germany;Ireland;Italy;Mexico;Spain;United Kingdom;United States
Anticorpo monoclonale anti GM-CSF umano
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2015   Phase 2   EUCTR2014-003453-34-IT   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom
Antihistamine
   Hoffmann-La Roche
      2011   Phase 4   NCT01382940   United States
Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal
   GlaxoSmithKline Research & Development Limited
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
AP1189
   SynAct Pharma ApS
      2020   Phase 2   EUCTR2019-001185-15-NO   Bulgaria;Denmark;Moldova, Republic of;Norway;Sweden
      2020   Phase 2   EUCTR2019-001185-15-BG   Bulgaria;Denmark;Moldova, Republic of;Norway;Sweden
      2019   Phase 2   EUCTR2019-001185-15-SE   Bulgaria;Denmark;Moldova, Republic of;Norway;Sweden
      2019   Phase 2   EUCTR2019-001185-15-DK   Bulgaria;Denmark;Moldova, Republic of;Norway;Sweden
AP1189 tablet
   SynAct Pharma ApS
      2022   Phase 2   EUCTR2022-002605-26-BG   Bulgaria;Moldova, Republic of;United States
      2022   Phase 2   EUCTR2022-001828-15-BG   Bulgaria;Moldova, Republic of
AP1189, 100 MG
   SynAct Pharma Aps
      2024   Phase 2   NCT06671054   United States
      2022   Phase 2   NCT05604885   Moldova, Republic of
AP1189, 40 MG
   SynAct Pharma Aps
      2024   Phase 2   NCT06671054   United States
AP1189, 60 MG
   SynAct Pharma Aps
      2022   Phase 2   NCT05604885   Moldova, Republic of
AP1189, 70 MG
   SynAct Pharma Aps
      2024   Phase 2   NCT06671054   United States
AP1189, 80 MG
   SynAct Pharma Aps
      2022   Phase 2   NCT05604885   Moldova, Republic of
Apigenin and glycyrrhizin
   Adel A.Gomaa
      2023   -   NCT05788705   -
APLA12
   VA Office of Research and Development
      2009   Phase 1   NCT01123655   United States
Apratastat
   WYETH LEDERLE
      2005   -   EUCTR2004-000012-13-IT   Czech Republic;Estonia;Italy
Apremilast
   Baylor Research Institute
      2010   Phase 2   NCT01250548   United States
   Celgene Corporation
      2011   -   EUCTR2010-019926-15-CZ   Czech Republic;United States
Apremilast 20 MG
   Amgen
      2010   Phase 2   NCT01285310   Czech Republic;Czechia;Poland;Spain;United States
Apremilast 30 MG
   Amgen
      2010   Phase 2   NCT01285310   Czech Republic;Czechia;Poland;Spain;United States
ARA290
   LUMC
      2011   -   EUCTR2010-023469-22-NL   Netherlands
Arava
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Sandoz
      2002   Phase 1   NCT00946686   -
   University Hospitals Leuven
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
   University of Leeds
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   sanofi-aventis Groupe
      2008   -   EUCTR2007-000886-40-IT   Italy;Portugal
   sanofi-aventis groupe
      2007   -   EUCTR2007-000886-40-PT   Italy;Portugal
      2007   Phase 3   EUCTR2007-000886-40-CZ   Czech Republic;Italy;Portugal
Arava 20 MG filmdrasjerte tabletter
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Arcoxia
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2011   Phase 3   EUCTR2010-019871-31-SK   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2011   -   EUCTR2010-019871-31-CZ   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019871-31-BE   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2010   -   EUCTR2010-019871-31-LT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-FI   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-DE   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-AT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
ARRY-371797, P38 inhibitor
   Array Biopharma, now a wholly owned subsidiary of Pfizer
      2008   Phase 1   NCT00729209   United States
ARRY-438162
   Array BioPharma Inc.
      2008   -   EUCTR2007-007859-14-PL   Hungary;Poland
      2008   -   EUCTR2007-007859-14-HU   Hungary;Poland
ARRY-438162, MEK inhibitor
   Array Biopharma, now a wholly owned subsidiary of Pfizer
      2008   Phase 2   NCT00650767   Argentina;Brazil;Hungary;Peru;Poland;Romania;United States
ART-I02
   Arthrogen
      2018   Phase 1   NCT03445715   Canada
ART621
   Arana Therapeutics Ltd
      2009   Phase 2   NCT00928317   Argentina;Australia;Czech Republic;India;Malaysia;New Zealand;Poland;United States
      2009   Phase 2   NCT00854685   Sri Lanka
      2009   -   EUCTR2009-014824-40-CZ   Czech Republic
      2009   -   EUCTR2008-006930-92-CZ   Czech Republic
Arthroscopic synovectomy OF THE wrist
   Maasstad Hospital
      2021   -   NCT04755127   Netherlands
Arthroscopic synovial tissue biopsy
   Nathan Wei, MD, FACP, FACR:
      2011   Phase 3   NCT01374971   United States
Arthroscopy & saline irrigation alone
   Newcastle University
      2012   Phase 1   NCT01352858   United Kingdom
Artilog
   GlaxoSmithKline s.a.
      2005   Phase 3   EUCTR2005-000158-61-ES   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
Ascal(R) / carbasalate calcium
   Leiden University Medical Center
      2006   -   EUCTR2006-001359-36-NL   Netherlands
Asendis 50 MG
   CombinatoRx, Inc
      2004   -   EUCTR2004-001490-26-GB   Estonia;United Kingdom
ASK8007
   Astellas Pharma Inc
      2007   Phase 1/Phase 2   NCT00411424   Belgium;France;Hungary;Ireland;Netherlands;Spain;United Kingdom
ASP015K
   Astellas Pharma Global Development
      2013   -   EUCTR2011-006021-23-HU   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
      2013   Phase 2   EUCTR2011-006021-23-CZ   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
      2013   Phase 2   EUCTR2011-006021-23-BG   Belgium;Bulgaria;Colombia;Czech Republic;Germany;Hungary;Mexico;Poland
      2012   -   EUCTR2011-006021-23-BE   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
   Astellas Pharma Global Development Inc. (APGD)
      2013   Phase 2   EUCTR2011-006021-23-PL   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Mexico;Poland
ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide
   Astellas Pharma Global Development, Inc. (APGD)
      2013   -   EUCTR2011-006020-20-PL   Bulgaria;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2013   -   EUCTR2011-006020-20-BG   Bulgaria;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2013   -   EUCTR2011-006018-15-PL   Belgium;Bulgaria;Colombia;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2013   -   EUCTR2011-006018-15-HU   Belgium;Bulgaria;Colombia;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2013   -   EUCTR2011-006018-15-BG   Belgium;Bulgaria;Colombia;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2012   -   EUCTR2011-006020-20-HU   Bulgaria;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2012   -   EUCTR2011-006020-20-CZ   Bulgaria;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2012   -   EUCTR2011-006018-15-CZ   Belgium;Bulgaria;Colombia;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
      2012   Phase 2   EUCTR2011-006018-15-BE   Belgium;Bulgaria;Colombia;Czech Republic;Hungary;Mexico;Poland;Ukraine;United States
ASP1707
   Astellas Pharma Global Development, Inc.
      2016   Phase 1   NCT02867306   Moldova, Republic of
   Astellas Pharma Inc
      2016   Phase 2   NCT02884635   Japan
ASP2408
   Astellas Pharma Global Development, Inc.
      2012   Phase 1   NCT02052375   United States
ASP2409
   Astellas Pharma Global Development, Inc.
      2012   Phase 1   NCT02171143   United States
ASP5094
   Astellas Pharma Global Development, Inc.
      2016   Phase 1   NCT02698657   Poland;United States
   Astellas Pharma Inc
      2017   Phase 2   NCT03257852   Japan
Aspirin
   Department of Orthopedics, the First Affliated Hospital of Xinjiang Medical University
      2024   Phase 4   ChiCTR2400092488   China
Aspirin 81MG tablet
   Inova Health Care Services
      2018   Phase 4   NCT03699293   United States
Aspirin tablets
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
Atacicept
   EMD Serono
      2006   Phase 2   NCT00430495   Canada;United States
   MERCK SERONO INTERNATIONAL SA
      2008   -   EUCTR2007-002536-29-IT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Merck KGaA
      2008   Phase 2   NCT00664521   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Serono Int, a branch of Laboratoires Seron SA an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-DE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt, Germany
      2008   -   EUCTR2006-004140-23-GB   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   Phase 2   EUCTR2006-004140-23-SK   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-PT   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-CZ   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-BE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch of Laboratoires Serono SA, an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-FI   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-SE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int.a branch of Laboratoires Serono SA an affiliate of Merck KgaA, Darmstadt, Germany
      2006   -   EUCTR2006-004140-23-NL   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono International
      2008   -   EUCTR2007-003647-75-SE   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-NL   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-FR   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-003647-75-FI   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-002536-29-PT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-GR   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-FR   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-ES   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-DE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-CZ   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BG   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BE   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-SE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   Phase 2   EUCTR2007-002536-29-FI   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-AT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      -   -   EUCTR2007-002536-29-PL   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Merck Serono International S.A.
      2007   -   EUCTR2006-004140-23-GR   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono SA - Geneva
      2008   Phase 2   EUCTR2007-003647-75-GB   Finland;France;Netherlands;Sweden;United Kingdom
   SERONO INTERNATIONAL SA
      2007   -   EUCTR2006-004140-23-IT   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Serono International S.A.
      2007   Phase 2   EUCTR2006-004140-23-ES   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-BG   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
Atacicept: with loading dose
   EMD Serono
      2007   Phase 2   NCT00595413   Germany;United States
ATI-450
   Aclaris Therapeutics, Inc.
      2022   Phase 2   EUCTR2021-002860-31-CZ   Bulgaria;Czech Republic;Czechia;Poland;United States
      2022   Phase 2   EUCTR2021-002860-31-BG   Bulgaria;Czech Republic;Czechia;Poland;United States
      2020   Phase 2   NCT04247815   United States
ATI-450 20 MG oral tablet BID
   Aclaris Therapeutics, Inc.
      2022   Phase 2   NCT05279417   Bulgaria;Czechia;Poland;United States
ATI-450 50 MG oral tablet BID
   Aclaris Therapeutics, Inc.
      2022   Phase 2   NCT05279417   Bulgaria;Czechia;Poland;United States
ATN-103
   Ablynx
      2010   Phase 2   NCT01063803   Canada;Hungary;Japan;Russian Federation;Serbia;South Africa;Switzerland;United States
      2009   Phase 1/Phase 2   NCT00959036   Belgium;Canada;Germany;Hungary;Russian Federation;Serbia;South Africa;Switzerland;United States
   Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company
      2010   -   EUCTR2009-015636-15-HU   Belgium;Canada;Germany;Hungary;Japan;Russian Federation;South Africa;Switzerland;United States
      2010   -   EUCTR2008-007185-33-DE   Belgium;Germany;Hungary;Netherlands;United Kingdom
      2010   -   EUCTR2008-007185-33-BE   Belgium;Germany;Hungary;Netherlands;United Kingdom
   Wyeth Pharmaceuticals Inc., Acting through its division Wyeth Research, a Pfizer Company
      2009   -   EUCTR2008-007185-33-GB   Belgium;Germany;Hungary;Netherlands;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2010   Phase 1;Phase 2   EUCTR2008-007185-33-NL   Belgium;Germany;Hungary;Netherlands;United Kingdom
      2009   -   EUCTR2008-007185-33-HU   Belgium;Germany;Hungary;Netherlands;United Kingdom
ATN-103 10 MG Q4WKS
   Ablynx
      2009   Phase 1/Phase 2   NCT01007175   Japan
ATN-103 10 MG Q8WKS
   Ablynx
      2009   Phase 1/Phase 2   NCT01007175   Japan
ATN-103 30 MG Q4WKS
   Ablynx
      2009   Phase 1/Phase 2   NCT01007175   Japan
ATN-103 80 MG Q4WKS
   Ablynx
      2009   Phase 1/Phase 2   NCT01007175   Japan
ATN-103 80 MG Q8WKS
   Ablynx
      2009   Phase 1/Phase 2   NCT01007175   Japan
Atorvastatin
   Gilead Sciences
      2020   Phase 1   NCT04608344   United States
   Hospital Central Dr. Ignacio Morones Prieto
      2018   Phase 2   NCT04056039   Mexico
   Inner Mongolia University of Science and Technology Baotou Medical College First Affiliated Hospital
      2017   -   ChiCTR-INR-17011772   China
   Pfizer
      2010   Phase 2   NCT01059864   Korea, Republic of;United States
   Reade
      2015   Phase 4   EUCTR2013-005524-42-NL   Netherlands
   University of California, Los Angeles
      2003   Phase 4   NCT00356473   -
   University of Manchester
      2007   Phase 3   EUCTR2006-006032-22-GB   United Kingdom
Atorvastatin tablet 20 MG
   Chengdu PLA General Hospital
      2014   -   NCT02219191   China
Autoinjector
   Momenta Pharmaceuticals, Inc.
      2016   Phase 3   NCT02722044   United States
   Samsung Bioepis Co., Ltd.
      2017   Phase 2   NCT03193957   Poland
Autologous adipose derived stem cells
   Celltex Therapeutics Corporation
      2023   Phase 1/Phase 2   NCT04170426   -
Autologous apoptotic cells injection
   Centre Hospitalier Universitaire de Besancon
      2023   Phase 1/Phase 2   NCT02903212   -
Autologous mature tolerogenic monocyte-derived dendritic cells loaded with THE B29 peptide OF HSP70
   UMC Utrecht
      2021   Phase 1/Phase 2   NCT05251870   Netherlands
Autologous mesenchymal stem cells
   Mashhad University of Medical Sciences
      2016   Phase 1   NCT03333681   -
Autologous peripheral blood stem cell transplantation
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Autologous stromal vascular fraction cells
   Translational Biosciences
      2013   Phase 1/Phase 2   NCT01885819   Panama
Avelox- moxifloxacin
   AstraZeneca AB
      2009   -   EUCTR2009-011044-20-GB   United Kingdom
AVT05
   Alvotech Swiss AG
      2023   Phase 3   NCT05842213   Bulgaria
      2023   Phase 3   EUCTR2022-001825-63-LT   Bulgaria;Czechia;Georgia;Lithuania;Poland;Serbia
      2023   Phase 3   EUCTR2022-001825-63-BG   Bulgaria;Georgia;Lithuania;Poland
Azathioprin
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Azathioprine
   Hoffmann-La Roche
      2013   Phase 3   NCT01941095   Greece
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Sanofi
      2018   Phase 4   NCT03449758   France
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
AZD5672
   ASTRAZENECA
      2008   -   EUCTR2007-007539-14-IT   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
   AstraZeneca
      2009   Phase 1   NCT00887770   United Kingdom
      2009   Phase 1   NCT00871767   United Kingdom
      2008   Phase 2   NCT00713544   Argentina;Bulgaria;Colombia;Czech Republic;Hungary;Italy;Latvia;Malta;Netherlands;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine
      2008   Phase 1   NCT00711074   United Kingdom
   AstraZeneca AB
      2009   -   EUCTR2009-011044-20-GB   United Kingdom
      2008   Phase 2   EUCTR2007-007539-14-SK   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland;Slovakia
      2008   -   EUCTR2007-007539-14-PL   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-MT   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-LV   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-HU   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-CZ   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-BG   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
AZD6912
   AstraZeneca
      2023   Phase 1   NCT06115967   Canada;United Kingdom
AZD9056
   AstraZeneca
      2009   Phase 1   NCT00920608   -
      2008   Phase 1   NCT00700986   United Kingdom
      2007   Phase 2   NCT00520572   Argentina;Australia;Belgium;Canada;Czech Republic;France;Hungary;Mexico;Poland;Romania;Russian Federation;Slovakia;Sweden;United States
AZD9056 hydrochloride
   AstraZeneca AB
      2008   -   EUCTR2007-001420-12-CZ   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-SK   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-SE   Czech Republic;France;Poland;Sweden
      2007   -   EUCTR2007-001420-12-PL   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-FR   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-BE   Belgium;Czech Republic;France;Poland;Sweden
AZD9567
   AstraZeneca
      2018   Phase 2   NCT03368235   Denmark;Netherlands;Sweden
AZD9567 10 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 125 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 155 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 20 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 40 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 80 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
AZD9567 monohydrat
   AstraZeneca
      2015   Phase 1   NCT02512575   Germany
AZD9567 monohydrate
   AstraZeneca AB
      2017   Phase 2   EUCTR2017-000838-64-SE   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-NL   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-DK   Denmark;Netherlands;Sweden
B03bb01
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
Background treatment
   Galvani Bioelectronics
      2021   -   NCT05003310   Netherlands;United States
Baminercept alfa
   Biogen Idec
      2007   Phase 2   NCT00664716   Argentina;Brazil;Hungary;Mexico;Poland;Romania;Russian Federation;United Kingdom
      2007   Phase 2   NCT00664573   Argentina;Brazil;Hungary;Mexico;Poland;Romania;Russian Federation;United Kingdom
Baricitinib
   ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP)
      2021   Phase 4   EUCTR2020-005773-27-FR   France
   Assistance Publique - Hôpitaux de Paris
      2022   Phase 4   NCT05238896   France
   Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University
      2020   -   JPRN-UMIN000040094   Japan
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   ELI LILLY AND COMPANY
      2013   -   EUCTR2012-002339-27-IT   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002324-32-IT   Argentina;Austria;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002323-15-IT   Argentina;Australia;Austria;Belgium;Canada;Croatia;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Turkey;United Kingdom;United States
   Eli Lilly Japan K.K.
      2014   Phase 3   JPRN-jRCT2080222355   -
      2013   Phase 3   JPRN-jRCT2080222110   -
      2013   Phase 3   JPRN-jRCT2080222092   -
      2013   Phase 3   JPRN-jRCT2080222088   -
      2013   Phase 3   JPRN-jRCT2080222079   -
   Eli Lilly and Company
      2020   Phase 4   NCT04086745   United States
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 4   NCT03915964   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2014   Phase 3   NCT02265705   Argentina;Brazil;China
      2014   Phase 3   EUCTR2012-003686-17-SI   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2012-003686-17-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   NCT01885078   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   NCT01721044   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002339-27-SK   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-PT   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-HU   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   Phase 3   EUCTR2012-002339-27-GB   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-DE   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-CZ   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-BE   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002324-32-SE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-PT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-GR   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-GB   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-DE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-BE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-AT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-PL   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-NL   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-HR   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-GR   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-GB   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-DK   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-BE   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-AT   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-SK   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-SI   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-PT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-NL   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LV   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-HU   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-GB   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-DE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-CZ   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-BE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2012   Phase 3   NCT01721057   Argentina;Australia;Belgium;Canada;Croatia;Czech Republic;Czechia;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   NCT01711359   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2012   Phase 3   NCT01710358   Argentina;Belgium;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2011   Phase 2   NCT01469013   Japan
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
      2019   Phase 4   EUCTR2018-004558-30-ES   Spain
   Galvani Bioelectronics
      2021   -   NCT05003310   Netherlands;United States
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   Kaneko Yuko
      2022   Phase 4   JPRN-jRCTs031220473   -
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Lilly S.A.
      2013   Phase 3   EUCTR2012-003686-17-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002339-27-ES   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002323-15-ES   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-ES   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   Shinshu University
      2018   Phase 2   NCT03755466   Japan
   Transparency in Healthcare
      2019   Phase 4   EUCTR2019-000505-72-NL   Netherlands
   Ueno Masanobu
      2023   Phase 4   JPRN-jRCTs051220168   -
   University of Erlangen-Nürnberg Medical School
      2018   Phase 3   NCT03701789   Germany
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
Baricitinib (LY3009104) 4 MG
   University Hospital, Toulouse
      2025   Phase 4   NCT06687551   -
Baricitinib 2 MG
   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
      2022   Phase 4   NCT05660655   Bangladesh
Baricitinib 4 MG
   Chinese University of Hong Kong
      2023   Phase 4   NCT05955066   Hong Kong
   Ogasawara Michihiro
      2023   Phase 4   JPRN-jRCT1031230107   -
Baricitinib 4 MG oral tablet
   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
      2022   Phase 4   NCT05660655   Bangladesh
Baricitinib blinded
   Universitätsklinikum Erlangen
      2022   Phase 2   EUCTR2021-006562-20-DE   Germany
Baricitinib treatment
   University Hospital, Bordeaux
      2021   Phase 3   NCT04870203   France;Monaco
Baseline serum vitamin D level AT or above 50 nmol/L
   Odense University Hospital
      1999   -   NCT02932644   -
Baseline serum vitamin D level below 50 nmol/L
   Odense University Hospital
      1999   -   NCT02932644   -
BAT1806
   Bio-Thera Solutions
      2018   Phase 3   NCT03830203   China
   Bio-Thera Solutions, Ltd.
      2019   Phase 3   EUCTR2018-002202-31-BG   Bulgaria;China;Georgia;Poland;Ukraine
BAT1806 injection
   Bio-Thera Solutions
      2018   Phase 1   NCT03606876   China
BCD-055
   Biocad
      2016   Phase 3   NCT02762838   Belarus;India;Russian Federation
BCD-089
   Biocad
      2019   Phase 3   NCT04227366   Russian Federation
BCD-089, 162 MG, S/C, Q2W
   Biocad
      2018   Phase 2   NCT03455842   Belarus;Russian Federation
BCD-089, 162 MG, S/C, QW
   Biocad
      2018   Phase 2   NCT03455842   Belarus;Russian Federation
Bdmard
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
Bdmards
   Universidade Nova de Lisboa
      2020   -   NCT04973787   Portugal
   University Hospital Bispebjerg and Frederiksberg
      2013   -   NCT06402396   -
Belatacept
   Bristol-Myers Squibb
      2000   Phase 1/Phase 2   NCT00279760   Belgium;Canada;France;Germany;Ireland;Netherlands;Switzerland;United Kingdom;United States
Belimumab
   Human Genome Sciences Inc.
      2005   Phase 2   NCT00583557   Poland;United States
   Human Genome Sciences Inc., a GSK Company
      2009   Phase 4   NCT00931086   United States
Belimumab 1 MG/KG
   Human Genome Sciences Inc.
      2003   Phase 2   NCT00071812   United States
Belimumab 10 MG/KG
   Human Genome Sciences Inc.
      2003   Phase 2   NCT00071812   United States
Belimumab 4 MG/KG
   Human Genome Sciences Inc.
      2003   Phase 2   NCT00071812   United States
Belimumab IN SLE patients / rituximab IN RA patients
   University of Cagliari
      2020   -   NCT05659407   Italy
Benepali
   Biogen
      2017   -   NCT03327454   Germany
      2017   -   NCT03100734   Germany
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   University of Leeds
      2019   Phase 4   NCT03813771   United Kingdom
      2018   Phase 4   EUCTR2016-002344-16-GB   United Kingdom
Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 H-benzimidazole
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Berberine
   Peking University People's Hospital
      2024   Phase 2   ChiCTR2400085087   China
Betamethasone acibutate
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
   Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet
      2017   Phase 4   EUCTR2017-003425-15-DK   Denmark
BG00012
   Biogen Idec
      2008   Phase 2   NCT00810836   Australia;Canada;Czech Republic;India;Poland;Slovakia
   Biogen Idec Limited
      2009   Phase 2   EUCTR2008-004754-33-SK   Czech Republic;Poland;Slovakia
      2009   -   EUCTR2008-004754-33-PL   Czech Republic;Poland
      2009   -   EUCTR2008-004754-33-CZ   Czech Republic;Poland
BG9924
   Biogen Idec
      2007   Phase 2   NCT00664573   Argentina;Brazil;Hungary;Mexico;Poland;Romania;Russian Federation;United Kingdom
      2007   Phase 2   NCT00523328   Belgium;Canada;United Kingdom;United States
      2007   Phase 2   NCT00458861   United States
      2005   Phase 2   NCT00292422   Poland;United States
   Biogen Idec Ltd
      2007   -   EUCTR2007-000734-38-GB   United Kingdom
      2007   -   EUCTR2007-000734-38-BE   Belgium;United Kingdom
      2007   -   EUCTR2007-000733-19-HU   Hungary;United Kingdom
      2007   -   EUCTR2007-000733-19-GB   Hungary;United Kingdom
      2007   Phase 2   EUCTR2006-005467-26-GB   Belgium;United Kingdom
      2007   -   EUCTR2006-005467-26-BE   Belgium;United Kingdom
      2007   -   EUCTR2006-005466-39-HU   Hungary;United Kingdom
      2007   Phase 2   EUCTR2006-005466-39-GB   Hungary;United Kingdom
BGX-0214
   Coherus BioSciences, Inc.
      2015   Phase 3   EUCTR2015-000665-30-GB   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-ES   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-DE   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
BI 655064
   Boehringer Ingelheim B.V
      2013   -   EUCTR2012-004090-16-NL   Czech Republic;Germany;Netherlands;New Zealand;Poland;Spain
   Boehringer Ingelheim España, S.A.
      2013   -   EUCTR2012-004090-16-ES   Australia;Czech Republic;Germany;Netherlands;New Zealand;Spain
   Boehringer Ingelheim Pharma GmbH & Co. KG
      2013   -   EUCTR2012-004090-16-DE   Czech Republic;Germany;Netherlands;New Zealand;Poland;Spain
   Boehringer Ingelheim RCV GmbH & Co KG
      2013   Phase 1;Phase 2   EUCTR2012-004090-16-CZ   Czech Republic;Germany;Netherlands;New Zealand;Poland;Spain
BI 655064 high dose
   Boehringer Ingelheim
      2012   Phase 1   NCT01751776   Czech Republic;Germany;Netherlands;New Zealand;Poland;Romania;Spain
BI 655064 LOW dose
   Boehringer Ingelheim
      2012   Phase 1   NCT01751776   Czech Republic;Germany;Netherlands;New Zealand;Poland;Romania;Spain
BI 655064 medium dose
   Boehringer Ingelheim
      2012   Phase 1   NCT01751776   Czech Republic;Germany;Netherlands;New Zealand;Poland;Romania;Spain
BI 695500
   Boehringer Ingelheim
      2013   Phase 3   NCT01955733   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Germany;Greece;Hungary;Ireland;Mexico;Netherlands;Poland;Portugal;Spain;United Kingdom;United States
      2012   Phase 3   NCT01682512   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2014   Phase 3   EUCTR2013-002622-23-PT   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-HU   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-GR   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-ES   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-DE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002622-23-BG   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-002622-23-BE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-NO   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-ES   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-DE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-BG   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-002894-48-PT   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-HU   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GR   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GB   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-EE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-BE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
BI 695501
   Boehringer Ingelheim
      2016   Phase 3   NCT02640612   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2015   Phase 3   NCT02137226   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
   Boehringer Ingelheim International GmbH
      2016   Phase 3   EUCTR2015-002634-41-PL   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-HU   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2015   Phase 3   EUCTR2015-002634-41-ES   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-HU   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-ES   Argentina;Belgium;Bulgaria;Chile;Colombia;Estonia;France;Germany;Hungary;Indonesia;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-EE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
BI 695501 autoinjector
   Boehringer Ingelheim
      2016   Phase 2   NCT02636907   Poland;Ukraine;United States
BI 695501 prefilled syringe
   Boehringer Ingelheim
      2016   Phase 2   NCT02636907   Poland;Ukraine;United States
Biap
   Alloksys Life Sciences B.V.
      2011   -   EUCTR2008-007346-63-GB   United Kingdom
Bibr 796 BS
   Boehringer Ingelheim
      2001   Phase 2   NCT02209779   -
Bicain spinal
   Helsinki University Central Hospital
      2016   Phase 4   EUCTR2016-002035-15-FI   Finland
BIIB023
   Biogen Idec
      2008   Phase 1   NCT00771329   Russian Federation;Ukraine;United States
BIIB057
   Biogen Idec
      2012   Phase 2   NCT01652937   Canada
Biil 284 BS high dose
   Boehringer Ingelheim
      2001   Phase 2   NCT02251210   -
Biil 284 BS LOW dose
   Boehringer Ingelheim
      2001   Phase 2   NCT02251210   -
Biil 284 BS medium dose
   Boehringer Ingelheim
      2001   Phase 2   NCT02251210   -
Bimekizumab
   UCB Biopharma Sprl
      2016   Phase 2   EUCTR2016-000393-37-BG   Bulgaria;Georgia;Hungary;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;United Kingdom
   UCB Celltech
      2015   Phase 2   NCT02430909   Czech Republic;Czechia;Hungary;Moldova, Republic of;Poland;Russian Federation;Slovakia;United Kingdom
   UCB Celltech, UK Registered Branch of UCB Pharma SA
      2015   Phase 2   EUCTR2014-003307-30-SK   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-HU   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-GB   Czech Republic;Hungary;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-CZ   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
Binyrebarkhormon
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
Binyrebsrkhormon
   Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet
      2017   Phase 4   EUCTR2017-003425-15-DK   Denmark
Biodmards
   Pfizer
      2012   -   NCT01438892   United States
Biologic agents
   Simon Krabbe
      2006   -   NCT03496831   -
Biologic or targeted synthetic dmard
   Seoul National University Hospital
      2012   -   NCT01965132   Korea, Republic of
Biologic tnfi
   Pfizer
      2009   Phase 3   NCT00853385   Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;Germany;Korea, Republic of;Mexico;Philippines;Poland;Slovakia;Spain;Thailand;United Kingdom;United States
Biologic/targeted therapy
   Tuen Mun Hospital
      2022   -   NCT05182203   China
Biological agents
   Astellas Pharma Inc
      2012   -   NCT01870908   Japan
   University of Athens
      2017   -   NCT03288584   Greece
Biological drug
   Sohag University
      2022   -   NCT05267431   Egypt
Biological: SM03
   SinoMab Pty Ltd
      2012   Phase 1   NCT04704492   China
Biologics
   AA amyloidosis clinical research conference
      2008   -   JPRN-UMIN000002421   Japan
   Japan Association of Rheumatologists in Private Practice
      2010   -   JPRN-UMIN000003807   Japan
   Keio University Hospital
      2015   -   JPRN-UMIN000018848   Japan
   Osaka City University Medical School
      2010   -   JPRN-UMIN000003880   Japan
   Shinshu University
      2018   Phase 2   NCT03755466   Japan
   Tokyo Medical and Dental University
      2012   -   JPRN-UMIN000006702   Japan
Biosimilar
   ARCHIGEN BIOTECH LIMITED
      2017   Phase 1;Phase 3   EUCTR2014-005368-13-IT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Alvotech Swiss AG
      2023   Phase 3   NCT05842213   Bulgaria
   Amgen Inc
      2015   Phase 1;Phase 3   EUCTR2013-005543-90-BG   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-PL   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-HU   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-DE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Archigen Biotech Limited
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-HU   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-ES   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-DE   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Jamp Pharma Corporation
      2023   -   NCT05913817   Canada
   Mabion SA
      2023   Phase 3   NCT04680962   -
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
   Opal Rheumatology Ltd.
      2018   -   NCT03470688   Australia
   Samsung Bioepis Co., Ltd.
      2014   Phase 3   NCT02167139   Lithuania;Poland
      2013   Phase 3   NCT01936181   Bulgaria;Lithuania
      2013   Phase 3   NCT01895309   Poland;United Kingdom
   Yazawa Rie
      2017   Phase 1   JPRN-jRCT2071200057   -
   Yonemura Takuma
      2015   Phase 1   JPRN-jRCT2071200058   -
   mAbxience Research S.L.
      2024   Phase 3   NCT06596772   Bulgaria;Georgia;Moldova, Republic of;Poland;Romania;Serbia
Biosimilar infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
   Hikma Pharmaceuticals LLC
      2017   -   NCT03348046   Jordan
   Janssen Scientific Affairs, LLC
      2016   -   NCT02728934   United States
Biosimilar product TO adalimumab
   Amgen Inc
      2014   -   EUCTR2013-000525-31-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000525-31-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
Biospecimen collection
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
Biotherapy prescription with sinnotest® software
   University Hospital, Grenoble
      2021   -   NCT04117165   France
Birb 796 BS, high dose
   Boehringer Ingelheim
      2003   Phase 2   NCT02214888   -
Birb 796 BS, LOW dose
   Boehringer Ingelheim
      2003   Phase 2   NCT02214888   -
Blinatumomab
   Amgen
      2025   Phase 2   NCT06570798   Belgium;France;Germany;Italy;United States
Blood sample
   Centre Hospitalier Universitaire de Saint Etienne
      2020   Phase 4   NCT04470453   France
      2018   Phase 4   NCT03445871   France
   University Hospital, Bordeaux
      2018   -   NCT03550833   France
Blood samples
   Assistance Publique Hopitaux De Marseille
      2011   Phase 3   NCT01954381   France
Blood sampling
   University Hospital, Toulouse
      2021   -   NCT05039216   France
Blood sampling from infant
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blood sampling from mother
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blood sampling from umbilical cord
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
Blood tests
   Assistance Publique - Hôpitaux de Paris
      2020   -   NCT04584541   France
BMS-188667
   Academisch Medisch Centrum Amsterdam
      2010   -   EUCTR2010-021435-14-NL   Netherlands
   BRISTOL-M.SQUIBB
      2005   -   EUCTR2004-005102-68-IT   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-IT   Belgium;Germany;Italy;Spain;United Kingdom
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2015   Phase 3   EUCTR2015-001275-50-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
   Bristol Myers Squibb International Corporation
      2011   Phase 3   EUCTR2008-001523-57-NO   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2010-018674-20-SE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;Sweden;United States
      2010   -   EUCTR2010-018674-20-IT   Denmark;Finland;France;Germany;Italy;Sweden
      2010   Phase 3   EUCTR2010-018674-20-FR   Belgium;Denmark;Finland;France;Germany;Italy;Sweden
      2010   -   EUCTR2010-018674-20-FI   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DK   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-BE   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2008-001523-57-HU   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2008-001523-57-DE   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-GB   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-ES   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   -   EUCTR2008-001523-57-DK   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-001523-57-FR   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   -   EUCTR2007-005434-37-NL   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-HU   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-GR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-FR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-DE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-BE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-AT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2006   -   EUCTR2005-000784-26-IT   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2006   -   EUCTR2005-000784-26-AT   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-IE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-GB   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-ES   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-DE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-BE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-000922-59-DK   Czech Republic;Denmark;Spain;Sweden
      2005   -   EUCTR2004-000922-59-CZ   Czech Republic;Denmark;Spain;Sweden
      2004   -   EUCTR2004-000922-59-SE   Czech Republic;Denmark;Spain;Sweden
      2004   Phase 3   EUCTR2004-000922-59-ES   Czech Republic;Denmark;Spain;Sweden
      -   -   EUCTR2005-000443-28-Outside-EU/EEA   Austria;Brazil;France;Germany;Italy;Mexico;Peru;Portugal;Spain;Switzerland;United States
   Bristol-Myers Squibb
      2011   Phase 1   NCT01439204   United States
      2000   Phase 2   NCT00162266   Argentina;Australia;Belgium;Canada;France;Germany;Ireland;Netherlands;South Africa;United Kingdom;United States
   Bristol-Myers Squibb Company
      -   Phase 2   EUCTR2015-005450-36-Outside-EU/EEA   United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001275-50-RO   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-NL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-SE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-GB   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FI   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-GB   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-004241-15-IT   Belgium;France;Germany;Italy;Netherlands;Spain;United Kingdom
      2007   -   EUCTR2006-003768-67-SE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-NL   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-GB   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-ES   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-DE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-BE   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-AT   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-005102-68-CZ   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-CZ   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-IE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-GB   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-ES   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-DE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-BE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-GB   Belgium;Germany;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-ES   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-DE   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-BE   Belgium;Germany;Italy;Spain;United Kingdom
BMS-582949
   Bristol Myers Squibb International Corporation
      2008   Phase 2   EUCTR2008-000170-20-FR   Czech Republic;France;Spain
      2008   Phase 2   EUCTR2008-000170-20-ES   Czech Republic;France;Spain
      2008   -   EUCTR2008-000170-20-CZ   Czech Republic;France;Spain
   Bristol-Myers Squibb
      2008   Phase 2   NCT00605735   Argentina;Brazil;Czech Republic;France;Korea, Republic of;Mexico;Spain;Taiwan;United States
BMS-582949 and methotrexate
   Bristol-Myers Squibb
      2005   Phase 1   NCT00162292   Mexico;United States
BMS-817399
   Bristol-Myers Squibb
      2011   Phase 2   NCT01404585   Argentina;Korea, Republic of;Mexico;Russian Federation;South Africa;Spain;United States
   Bristol-Myers Squibb International Corporation
      2012   Phase 2   EUCTR2011-002024-40-ES   Argentina;Korea, Republic of;Mexico;Russian Federation;South Africa;Spain;United States
BMS-945429
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
   Bristol-Myers Squibb International Corporation
      2014   -   EUCTR2013-003780-65-IT   Argentina;Australia;Canada;Czech Republic;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2014   -   EUCTR2013-003780-65-HU   Argentina;Australia;Canada;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   CSL Behring
      2011   Phase 2   NCT01373151   Argentina;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
BMS-986104
   Bristol-Myers Squibb
      2014   Phase 1   NCT02211469   United States
BMS-986142
   Bristol-Myers Squibb
      2016   Phase 2   NCT02638948   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
   Bristol-Myers Squibb International Corporation
      2017   Phase 2   EUCTR2015-002887-17-FR   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-NL   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-ES   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-BE   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-AT   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
   Bristol-Myers Squibb K.K.
      2016   Phase 2   JPRN-jRCT2080223262   Asia except Japan;Europe;Japan;North America;Oceania;South America
BMS-986142 200MG
   Bristol-Myers Squibb
      2016   Phase 1   NCT02762123   United States
BMS-986142 350MG
   Bristol-Myers Squibb
      2016   Phase 1   NCT02762123   United States
BMS-986195
   Bristol-Myers Squibb
      2017   Phase 1   NCT03262740   United States
      2017   Phase 1   NCT03245515   Netherlands
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02705989   Australia
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
BMS-986251
   Bristol-Myers Squibb
      2017   Phase 1/Phase 2   NCT03329885   Netherlands
BMS188667
   Bristol Myers Squibb International Corporation
      2010   -   EUCTR2010-018674-20-IT   Denmark;Finland;France;Germany;Italy;Sweden
BMS986142
   Bristol-Myers Squibb International Corporation
      2017   Phase 2   EUCTR2015-002887-17-FR   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-NL   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-ES   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-BE   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-AT   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
BMS986195
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
BNT162b2, bivalent
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
Bortezomib
   Charite University, Berlin, Germany
      2014   Phase 2   NCT02102594   Germany
   Chinese SLE Treatment And Research Group
      2023   -   NCT05805891   China
BOW015
   Epirus Biopharmaceuticals (Switzerland) GmbH
      2016   Phase 3   NCT02683564   -
BR9001
   Boryung Pharmaceutical Co., Ltd
      2018   Phase 1   NCT03718611   Korea, Republic of
BR900A
   Boryung Pharmaceutical Co., Ltd
      2018   Phase 1   NCT03718611   Korea, Republic of
Branebrutinib
   Bristol-Myers Squibb
      2020   Phase 2   NCT04186871   Argentina;Australia;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
Breast milk sampling
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02154425   France;Netherlands;Switzerland;United States
Bredinin tablet 150MG
   Chong Kun Dang Pharmaceutical
      2013   Phase 2   NCT02005757   Korea, Republic of
Bredinin tablet 50MG
   Chong Kun Dang Pharmaceutical
      2013   Phase 2   NCT02005757   Korea, Republic of
Brief resilient coping scale
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
BRL-049653
   GlaxoSmithKline Research & Development Ltd.
      2005   -   EUCTR2004-000482-35-LT   Lithuania;United Kingdom
      2004   Phase 2   EUCTR2004-000482-35-GB   Lithuania;United Kingdom
BT061
   Biotest
      2010   Phase 2   NCT01481493   Czech Republic;Germany;Hungary;Italy;Latvia;Poland;Spain
   Biotest AG
      2013   -   EUCTR2013-000114-38-SK   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-LT   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-HU   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-EE   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-DE   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2013-000114-38-CZ   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-BG   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2012   Phase 2   EUCTR2010-018485-24-LV   Czech Republic;Germany;Hungary;Latvia;Spain
      2012   -   EUCTR2010-018485-24-HU   Czech Republic;Germany;Hungary;Latvia;Spain
      2011   Phase 2   EUCTR2010-018485-24-ES   Czech Republic;Germany;Hungary;Latvia;Spain
      2011   -   EUCTR2010-018485-24-DE   Czech Republic;Germany;Hungary;Latvia;Spain
      2010   -   EUCTR2010-018485-24-CZ   Czech Republic;Germany;Hungary;Latvia;Spain
      2008   -   EUCTR2008-001241-26-HU   Bulgaria;Hungary
      2008   -   EUCTR2008-001241-26-BG   Bulgaria;Hungary
BT971
   Biotest AG
      2008   -   EUCTR2008-001241-26-HU   Bulgaria;Hungary
      2008   -   EUCTR2008-001241-26-BG   Bulgaria;Hungary
BTK inhibitor
   Bristol-Myers Squibb International Corporation
      2017   Phase 2   EUCTR2015-002887-17-FR   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-NL   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-ES   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2016   Phase 2   EUCTR2015-002887-17-BE   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
BTT-1023
   Biotie Therapies Corp.
      2009   Phase 1   NCT00851240   Bulgaria
Bucillamine
   BASIC study group
      2007   -   JPRN-UMIN000000837   Japan
   Higashi-Hiroshima Memorial Hospital
      2009   Phase 4   JPRN-UMIN000002169   Japan
   Japan Association of Rheumatologists in Private Practice
      2010   -   JPRN-UMIN000003807   Japan
   KONAMON Study Group
      2013   -   JPRN-UMIN000007404   Japan
   National hospital organization Chiba east national hospital Clinical Research Center
      2013   -   JPRN-UMIN000012690   Japan
   Saitama Medical University
      2007   Phase 4   NCT00716248   Japan
   Sanofi
      2015   Phase 3   NCT02373202   Japan
   St Luke's International Hospital
      2010   -   JPRN-UMIN000003615   Japan
   Tokyo Medical and Dental University
      2012   -   JPRN-UMIN000006702   Japan
Bumekizumab
   UCB Celltech, UK Registered Branch of UCB Pharma SA
      2015   Phase 2   EUCTR2014-003307-30-SK   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
Bupivacaine hydrochloride
   Helsinki University Central Hospital
      2016   Phase 4   EUCTR2016-002035-15-FI   Finland
   Sohag University
      2020   Phase 4   NCT04361513   Egypt
Buprenorphine transdermal patch
   Mundipharma Pharmaceuticals Sdn. Bhd.
      2013   Phase 4   NCT02519387   Malaysia
   Mundipharma Pte Ltd.
      2013   Phase 4   NCT01961271   Hong Kong;Korea, Republic of;Philippines
Burfiralimab
   ImmuneMed, Inc.
      2024   Phase 2   NCT06306339   Netherlands
Bushen quhan zhiwang decoction
   Liu Longxiao
      2024   -   NCT06309030   -
Butyrate
   NYU Langone Health
      2023   -   NCT05718583   United States
C. albicans
   Genentech, Inc.
      2006   Phase 2   NCT00282308   United States
C10aa05
   Reade
      2015   Phase 4   EUCTR2013-005524-42-NL   Netherlands
Caffeine
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
   R-Pharm International, LLC
      2021   Phase 1   NCT04246762   Bulgaria;Moldova, Republic of
Calcitriol
   Atlanta VA Medical Center
      2007   -   NCT00427804   United States
   Guangdong Provincial Hospital of Chinese Medicine
      2016   -   ChiCTR-IPR-16009029   China
   The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100042329   China
Calcium
   University of Aarhus
      2015   Phase 2   NCT02944799   Denmark
Calcium and cholecalciferol
   University of Missouri-Columbia
      1995   Phase 3   NCT00570934   United States
Calcium carbonate
   Children's Hospital Medical Center, Cincinnati
      1996   Phase 2   NCT00000429   United States
Calcium carbonate tablets
   Chinese SLE Treatment And Research Group
      2024   Phase 4   NCT06385093   China
Calcium citrate
   Brigham and Women's Hospital
      2011   Phase 4   NCT01400516   United States
CAM-3001
   MedImmune Limited
      2013   Phase 2   EUCTR2011-005649-10-GB   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   MedImmune Ltd
      2013   -   EUCTR2011-005649-10-SK   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-PT   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-HU   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-DE   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-CZ   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   Phase 2   EUCTR2011-005648-93-SK   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2013   -   EUCTR2011-005648-93-PT   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2013   Phase 2   EUCTR2011-005648-93-GB   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005649-10-GR   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-ES   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005648-93-HU   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-GR   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-ES   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005648-93-EE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-DE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005648-93-CZ   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-BG   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005634-19-PL   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-HU   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-ES   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-EE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-DE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-CZ   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-BG   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2010   -   EUCTR2009-014735-20-PL   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-LT   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-HU   Bulgaria;Czech Republic;Estonia;Hungary;Lithuania;Poland
      2010   -   EUCTR2009-014735-20-CZ   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-BG   Bulgaria;Czech Republic;Estonia;Hungary;Latvia;Lithuania;Poland
      2009   -   EUCTR2009-014735-20-LV   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2009   -   EUCTR2009-014735-20-EE   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2008   Phase 1   NCT00771420   Germany
Canakinumab
   NOVARTIS FARMA
      2007   -   EUCTR2007-001665-15-IT   Germany;Italy;Netherlands;Spain
   Novartis
      2007   Phase 2   NCT00487825   Belgium;Germany;Italy;Netherlands;Spain;United States
      2006   Phase 2   NCT00424346   Austria;Belgium;Canada;Finland;Germany;Spain;United States
   Novartis Farmaceutica S.A.
      2007   -   EUCTR2007-001665-15-ES   Belgium;Germany;Italy;Netherlands;Spain
   Novartis Farmacéutica S.A
      2007   -   EUCTR2006-004669-32-ES   Spain
   Novartis Farmacéutica S.A.
      2009   Phase 2   EUCTR2008-005320-81-ES   Austria;Belgium;Germany;Spain
   Novartis Farmacéutica, S.A.
      2007   -   EUCTR2007-000491-16-ES   Austria;Belgium;Germany;Spain
   Novartis Pharma Services AG
      2009   -   EUCTR2008-005320-81-DE   Austria;Germany;Spain
      2009   -   EUCTR2008-005320-81-BE   Austria;Belgium;Germany;Spain
      2008   -   EUCTR2008-005320-81-AT   Austria;Germany;Spain
      2007   -   EUCTR2007-001665-15-NL   Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-001665-15-DE   Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-001665-15-BE   Belgium;Germany;Italy;Netherlands;Spain
      2007   -   EUCTR2007-000491-16-DE   Austria;Germany;Spain
      2007   -   EUCTR2007-000491-16-BE   Austria;Belgium;Germany;Spain
      2007   -   EUCTR2007-000491-16-AT   Austria;Germany;Spain
      2007   -   EUCTR2006-004666-14-DE   Germany
      2007   -   EUCTR2006-004666-14-BE   Belgium;Germany
Canakinumab injection
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
Cannabidiol
   Incannex Healthcare Ltd
      2023   Phase 2   NCT05942911   Australia
Cannabidiol tablet 10 MG
   King Christian 10th Hospital for Rheumatology
      2018   Phase 2   EUCTR2017-004226-15-DK   Denmark
Cannabigerol
   Raphael Pharma
      2024   -   NCT06513507   United States
Cannabis
   Brown University
      2022   Phase 2   NCT04269993   United States
Cannabis questionnaire
   University Hospital, Clermont-Ferrand
      2020   -   NCT04402554   France
Capture
   Centocor Ortho Biotech Services, L.L.C.
      2004   Phase 4   NCT00378261   -
   Dept. of orthopedic surgery, Osaka Medical College
      2014   -   JPRN-UMIN000012650   Japan
Carnitine
   German University in Cairo
      2024   Phase 2   NCT06753565   Egypt
Carvedilol
   Tanta University
      2024   Early Phase 1   NCT06108518   -
CC-10004
   Celgene Corporation
      2011   -   EUCTR2010-019926-15-CZ   Czech Republic;United States
CC-292
   Celgene
      2013   Phase 2   NCT01975610   United States
CC312
   CytoCares Inc
      2024   Early Phase 1   NCT06888960   China
CCI-779
   Wyeth is now a wholly owned subsidiary of Pfizer
      2003   Phase 2   NCT00076206   United States
CCR1 antagonist
   Bristol-Myers Squibb International Corporation
      2012   Phase 2   EUCTR2011-002024-40-ES   Argentina;Korea, Republic of;Mexico;Russian Federation;South Africa;Spain;United States
CCX 354-C
   Amgen
      2009   Phase 1/Phase 2   NCT01027728   Belgium;Romania
CCX-354-C
   Amgen
      2010   Phase 2   NCT01242917   Belgium;Czech Republic;Czechia;Germany;Hungary;Netherlands;Poland;Romania;Ukraine
CCX354-C
   Amgen
      2010   Phase 2   NCT01242917   Belgium;Czech Republic;Czechia;Germany;Hungary;Netherlands;Poland;Romania;Ukraine
   ChemoCentryx, Inc.
      2010   -   EUCTR2010-019964-36-HU   Belgium;Czech Republic;Hungary
      2010   -   EUCTR2010-019964-36-DE   Belgium;Czech Republic;Germany;Hungary
      2010   -   EUCTR2010-019964-36-CZ   Belgium;Czech Republic;Germany;Hungary
      2010   Phase 2   EUCTR2010-019964-36-BE   Belgium;Czech Republic;Germany;Hungary
Cdmard
   Eli Lilly Japan K.K.
      2013   Phase 3   JPRN-jRCT2080222110   -
      2013   Phase 3   JPRN-jRCT2080222092   -
   Eli Lilly and Company
      2013   Phase 3   NCT01721044   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;Spain;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   NCT01721057   Argentina;Australia;Belgium;Canada;Croatia;Czech Republic;Czechia;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom;United States
CDP 6038 SC
   UCB Pharma
      2009   Phase 1/Phase 2   NCT01009242   Germany;United States
CDP6038
   R-Pharm
      2017   Phase 3   EUCTR2015-005309-35-LV   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-HU   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-GB   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-RO   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-LV   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005308-27-HU   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;United States
      2016   Phase 3   EUCTR2015-005308-27-DE   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United States
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-LT   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-HU   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004719-36-BG   Belarus;Bulgaria;Russian Federation;Turkey
   R-Pharm International LLC
      2017   Phase 3   EUCTR2015-005309-35-PL   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-LT   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-DE   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-CZ   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005308-27-CZ   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;United States
      2016   Phase 3   EUCTR2015-005307-83-CZ   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-BG   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   R-Pharm International, LLC.
      2017   Phase 3   EUCTR2015-005309-35-BG   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
   UCB BIOSCIENCES, Inc.
      2012   Phase 2   NCT01533714   Japan;Korea, Republic of;Taiwan
      2011   Phase 2   NCT01296711   Belgium;United Kingdom;United States
   UCB Biosciences Inc
      2011   -   EUCTR2010-022224-77-GB   Belgium;United Kingdom;United States
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
   UCB Biosciences, Inc.
      2011   Phase 2   EUCTR2010-022224-77-BE   Belgium;United Kingdom;United States
   UCB Biosciences, Inc. A Member of the UCB Group of Companies
      2011   Phase 2   EUCTR2010-020839-39-BE   Belgium;United Kingdom;United States
   UCB Celltech
      2009   -   EUCTR2009-010813-57-DE   Germany
   UCB Pharma
      2010   Phase 2   NCT01242488   Belgium;United Kingdom;United States
      2009   Phase 1/Phase 2   NCT01009242   Germany;United States
CDP870
   Astellas Pharma Inc
      2011   Phase 3   NCT02586246   Japan
   Celltech R&D Ltd
      2005   -   EUCTR2004-002993-49-LV   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-HU   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-GB   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden;United Kingdom
      2005   Phase 3   EUCTR2004-002993-49-FI   Belgium;Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Slovakia;Sweden
      2005   -   EUCTR2004-002993-49-DE   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-BE   Belgium;Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Sweden
   Otsuka Pharmaceutical Co., Ltd.
      2008   Phase 3   NCT00791921   Japan
   UCB Celltech
      2007   -   EUCTR2004-002993-49-EE   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2006   Phase 3   EUCTR2005-002629-30-SK   Czech Republic;Estonia;Latvia;Lithuania;Slovakia
      2006   -   EUCTR2005-002629-30-LV   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002326-63-EE   Czech Republic;Estonia;Latvia;Lithuania
      2005   Phase 3   EUCTR2005-002326-63-SK   Czech Republic;Estonia;Latvia;Lithuania;Slovakia
      2005   -   EUCTR2005-002326-63-LV   Czech Republic;Estonia;Latvia;Lithuania
      2005   -   EUCTR2005-002326-63-LT   Czech Republic;Estonia;Latvia;Lithuania
      2005   Phase 3   EUCTR2004-002993-49-SK   Belgium;Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Slovakia;Sweden
      2005   -   EUCTR2004-002993-49-LT   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-CZ   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
   UCB Inc
      2006   -   EUCTR2005-002629-30-LT   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002629-30-EE   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002629-30-CZ   Czech Republic;Estonia;Latvia;Lithuania
   UCB PHARMA
      2011   -   EUCTR2011-000385-35-IT   Italy
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-001729-25-IT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   UCB Pharma
      2005   Phase 3   NCT00152386   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Israel;Latvia;Russian Federation;Ukraine;United States
      2003   Phase 3   NCT00548834   -
      2002   Phase 3   NCT00544154   -
   UCB Pharma S.A.
      2011   -   EUCTR2009-013758-33-NL   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-SE   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-DK   Denmark;Netherlands;Sweden
      2010   -   EUCTR2007-000830-38-PL   Austria;France;Germany;Italy;Poland
      2009   Phase 3   EUCTR2007-005288-86-FR   France
      2009   -   EUCTR2007-000828-40-PL   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-FR   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-DE   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-AT   Austria;France;Germany;Italy;Poland
      2008   Phase 3   EUCTR2007-000828-40-FR   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-DE   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-AT   Austria;France;Germany;Italy;Poland
      2005   -   EUCTR2005-002326-63-CZ   Czech Republic;Estonia;Latvia;Lithuania
      2005   -   EUCTR2004-002993-49-SE   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2009   -   EUCTR2008-005427-28-NL   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-IT   France;Germany;Italy;Netherlands;Spain
      2009   Phase 3   EUCTR2008-005427-28-FR   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-ES   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-DE   France;Germany;Italy;Netherlands;Spain
   UCB S.A. (Casa Madre)
      2008   -   EUCTR2007-000830-38-IT   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-IT   Austria;France;Germany;Italy;Poland
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
CDP870 100MG
   Otsuka Pharmaceutical Co., Ltd.
      2008   Phase 2/Phase 3   NCT00791999   Japan
CDP870 200MG
   Korea Otsuka Pharmaceutical Co., Ltd.
      2009   Phase 3   NCT00993317   Korea, Republic of
   Otsuka Pharmaceutical Co., Ltd.
      2008   Phase 2/Phase 3   NCT00791999   Japan
CDP870 400MG
   Otsuka Pharmaceutical Co., Ltd.
      2008   Phase 2/Phase 3   NCT00791999   Japan
CDP870 FAB'-PEG
   UCB Celltech
      2005   Phase 3   EUCTR2005-001350-24-SK   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Slovakia
   UCB Inc.
      2005   -   EUCTR2005-001350-24-LV   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-LT   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-HU   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-FI   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-EE   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-CZ   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
CE 224,535
   Pfizer
      2009   Phase 1   NCT00838058   United States
CE-224,535
   PFIZER S.A.
      2008   Phase 2   EUCTR2008-000327-25-ES   Czech Republic;Poland;Spain
   Pfizer
      2009   Phase 1   NCT00838058   United States
      2008   Phase 2/Phase 3   NCT00628095   Chile;Czech Republic;Korea, Republic of;Mexico;Poland;Spain;United States
      2007   Phase 1   NCT00446784   United States
   Pfizer Inc. 235 East 42nd Street NY10017
      2008   Phase 2   EUCTR2008-000327-25-PL   Czech Republic;Poland;Spain
      2008   -   EUCTR2008-000327-25-CZ   Czech Republic;Poland;Spain
Celebra
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   University of Dundee
      2007   Phase 4   EUCTR2007-000012-90-DK   Denmark;Netherlands;United Kingdom
Celebrex
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Dong-A ST Co., Ltd.
      2015   Phase 4   NCT02780323   Korea, Republic of
   Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP
      2019   Phase 4   EUCTR2018-004539-54-DE   Germany
   GlaxoSmithKline Research & Development Limited
      2006   -   EUCTR2005-000158-61-LT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-EE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-CZ   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-IE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-AT   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline s.a.
      2005   Phase 3   EUCTR2005-000158-61-ES   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   University of Dundee
      2011   -   EUCTR2007-000012-90-NL   Denmark;Netherlands;United Kingdom
      2008   Phase 4   EUCTR2007-000012-90-GB   Denmark;Netherlands;United Kingdom
Celebrex 200 MG
   Daewon Pharmaceutical Co., Ltd.
      2010   Phase 3   NCT01781702   -
Celebrex 200 MG capsule, hard
   GlaxoSmithKline Research & Development Limited
      2005   -   EUCTR2005-000158-61-GB   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
Celebrex 200 MG hartkapseln
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Celebrex 200MG 20CPS
   GLAXO SMITHKLINE
      2005   -   EUCTR2005-000158-61-IT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
Celecoxib
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   GLAXO SMITHKLINE
      2005   -   EUCTR2005-000158-61-IT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline Research & Development Limited
      2006   -   EUCTR2005-000158-61-LT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-EE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-DE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-CZ   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-LV   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-IE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-HU   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-GB   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-DK   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-AT   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline s.a.
      2005   Phase 3   EUCTR2005-000158-61-ES   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   Guangdong Provincial Hospital of Chinese Medicine
      2016   -   ChiCTR-IPR-16009029   China
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
   Mito medical center, Mito Kyodo General Hospital, University of Tsukuba
      2014   Phase 4   JPRN-UMIN000014624   Japan
   National Institute of Mental Health (NIMH)
      2019   Phase 1   NCT03912428   United States
   Pfizer
      2006   Phase 2   NCT00424294   United States
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
      2006   Phase 4   NCT00346216   Australia;Brazil;Canada;Colombia;Costa Rica;Hong Kong;Mexico;Panama;Peru;Philippines;Taiwan;Ukraine;United States
      2005   Phase 4   NCT00141102   Belgium;Brazil;Canada;China;Colombia;Costa Rica;Croatia;Czech Republic;Czechia;Ecuador;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Guatemala;Hong Kong;India;Ireland;Korea, Republic of;Latvia;Lithuania;Netherlands;Panama;Peru;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Taiwan;Ukraine;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Traditional Chinese Medicine Hospital of Dianjiang Chongqing
      2023   Phase 1   ChiCTR2300075439   China
   University of Dundee
      2007   Phase 4   NCT00447759   Denmark;Netherlands;United Kingdom
      2007   Phase 4   EUCTR2007-000012-90-DK   Denmark;Netherlands;United Kingdom
Celecoxib 200MG capsule
   Inova Health Care Services
      2018   Phase 4   NCT03699293   United States
Cellular senescence
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
Ceramic ON ceramic articulation
   Zimmer Biomet
      2013   -   NCT02036931   France;Germany;Ireland;Netherlands;Spain;United States
Ceramic ON polyethylene articulation
   Zimmer Biomet
      2013   -   NCT02036931   France;Germany;Ireland;Netherlands;Spain;United States
Certolizumab
   Brigham and Women's Hospital
      2016   -   NCT02714881   United States
   Jagiellonian University
      2013   Phase 4   NCT02132234   Poland
   Janssen Research & Development, LLC
      2023   Phase 2   NCT06028438   Argentina;Germany;Hungary;Poland;United Kingdom;United States
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Rochester
      2010   -   NCT01098201   United States
Certolizumab pegol
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Astellas Pharma Inc
      2009   Phase 3   NCT00851318   Japan
      2009   Phase 3   NCT00850343   Japan
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   Celltech R&D Ltd
      2005   -   EUCTR2004-002993-49-LV   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-HU   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-GB   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden;United Kingdom
      2005   -   EUCTR2004-002993-49-DE   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-BE   Belgium;Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Sweden
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Korea Otsuka Pharmaceutical Co., Ltd.
      2010   Phase 3   NCT01197066   Korea, Republic of
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Nathan Wei, MD, FACP, FACR:
      2011   Phase 3   NCT01374971   United States
   Oklahoma Medical Research Foundation
      2010   Phase 3   NCT01213017   United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   RenJi Hospital
      2020   -   NCT04569890   China
   Rüdiger B. Müller
      2013   Phase 2   NCT02293590   Switzerland
   TcLand Expression S.A.
      2016   -   NCT03016260   Czech Republic;Czechia;France;Israel;Netherlands;Turkey
   UCB BIOSCIENCES, Inc.
      2014   Phase 1   NCT02154425   France;Netherlands;Switzerland;United States
      2014   Phase 1   NCT02019602   France;Netherlands;Switzerland;United States
   UCB Biopharma SRL
      2021   Phase 1   NCT04740814   United States
      2018   -   NCT03559686   -
   UCB Celltech
      2015   Phase 2   NCT02430909   Czech Republic;Czechia;Hungary;Moldova, Republic of;Poland;Russian Federation;Slovakia;United Kingdom
      2007   -   EUCTR2004-002993-49-EE   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2006   Phase 3   EUCTR2005-002629-30-SK   Czech Republic;Estonia;Latvia;Lithuania;Slovakia
      2006   -   EUCTR2005-002629-30-LV   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002326-63-EE   Czech Republic;Estonia;Latvia;Lithuania
      2005   Phase 3   EUCTR2005-002326-63-SK   Czech Republic;Estonia;Latvia;Lithuania;Slovakia
      2005   -   EUCTR2005-002326-63-LV   Czech Republic;Estonia;Latvia;Lithuania
      2005   -   EUCTR2005-002326-63-LT   Czech Republic;Estonia;Latvia;Lithuania
      2005   Phase 3   EUCTR2005-001350-24-SK   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Slovakia
      2005   Phase 3   EUCTR2004-002993-49-SK   Belgium;Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania;Slovakia;Sweden
      2005   -   EUCTR2004-002993-49-LT   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
      2005   -   EUCTR2004-002993-49-CZ   Czech Republic;Estonia;Finland;Germany;Hungary;Latvia;Lithuania;Sweden
   UCB Celltech, UK Registered Branch of UCB Pharma SA
      2015   Phase 2   EUCTR2014-003307-30-SK   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-HU   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-GB   Czech Republic;Hungary;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-CZ   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
   UCB Inc
      2006   -   EUCTR2005-002629-30-LT   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002629-30-EE   Czech Republic;Estonia;Latvia;Lithuania
      2006   -   EUCTR2005-002629-30-CZ   Czech Republic;Estonia;Latvia;Lithuania
   UCB Inc.
      2005   -   EUCTR2005-001350-24-LV   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-LT   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-HU   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-FI   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-EE   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
      2005   -   EUCTR2005-001350-24-CZ   Czech Republic;Estonia;Finland;Hungary;Latvia;Lithuania
   UCB Italy s.p.a.
      2011   Phase 4   NCT01443364   Italy
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-002067-20-IT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-IT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   UCB Pharma
      2012   Phase 3   NCT01521923   Argentina;Australia;Austria;Belgium;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Mexico;Monaco;Netherlands;Poland;Romania;Spain;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 3   NCT01292265   United States
      2010   Phase 4   NCT01255761   United States
      2009   Phase 4   NCT00993668   United States
      2009   Phase 3   NCT00843778   Austria;France;Germany;Italy;Poland
      2008   Phase 3   NCT00753454   Canada;United States
      2008   Phase 3   NCT00717236   Canada;France;Germany;Italy;Netherlands;Spain;United States
      2008   Phase 3   NCT00674362   Austria;France;Germany;Italy;Poland
      2007   Phase 4   NCT00580840   Austria;Canada;France;United States
      2005   Phase 3   NCT00175877   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;Finland;Former Serbia and Montenegro;France;Hungary;Israel;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United States
      2005   Phase 3   NCT00160641   Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Former Serbia and Montenegro;Israel;Latvia;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2005   Phase 3   NCT00160602   Bulgaria;Chile;Croatia;Czech Republic;Czechia;Estonia;Former Serbia and Montenegro;Israel;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2005   Phase 3   NCT00152386   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Israel;Latvia;Russian Federation;Ukraine;United States
      2003   Phase 3   NCT00160693   Austria;Belgium;Czech Republic;Czechia;Germany;Ireland;United Kingdom;United States
   UCB Pharma S.A.
      2011   -   EUCTR2009-013758-33-NL   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-SE   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-DK   Denmark;Netherlands;Sweden
      2010   -   EUCTR2007-000830-38-PL   Austria;France;Germany;Italy;Poland
      2009   Phase 3   EUCTR2007-005288-86-FR   France
      2009   -   EUCTR2007-000828-40-PL   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-FR   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-DE   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000830-38-AT   Austria;France;Germany;Italy;Poland
      2008   Phase 3   EUCTR2007-000828-40-FR   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-DE   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-AT   Austria;France;Germany;Italy;Poland
      2005   -   EUCTR2005-002326-63-CZ   Czech Republic;Estonia;Latvia;Lithuania
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2014   Phase 3   NCT02319642   China
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 3   NCT01519791   Argentina;Australia;Austria;Belgium;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Mexico;Monaco;Netherlands;Poland;Romania;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 4   NCT01500278   Australia;Austria;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Monaco;Poland;Portugal;Romania;Spain;Switzerland;United Kingdom;United States
      2009   -   EUCTR2008-005427-28-NL   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-IT   France;Germany;Italy;Netherlands;Spain
      2009   Phase 3   EUCTR2008-005427-28-FR   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-ES   France;Germany;Italy;Netherlands;Spain
      2009   -   EUCTR2008-005427-28-DE   France;Germany;Italy;Netherlands;Spain
   UCB Pharma SA, Belgium
      2014   Phase 3   NCT02151851   China
   UCB S.A. (Casa Madre)
      2008   -   EUCTR2007-000830-38-IT   Austria;France;Germany;Italy;Poland
      2008   -   EUCTR2007-000828-40-IT   Austria;France;Germany;Italy;Poland
   University of Erlangen-Nürnberg Medical School
      2013   Phase 3   NCT01864265   Belgium;Germany;Portugal;Serbia;United Kingdom;United States
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   Universitätsklinikum Erlangen
      2015   Phase 3   EUCTR2013-000337-13-PT   Germany;Portugal;Serbia;United States
      2013   Phase 3   EUCTR2013-000337-13-DE   Germany;Portugal;Serbia
Certolizumab pegol (CZP) 200 MG
   UCB Pharma
      2010   Phase 3   NCT01235598   Denmark;Netherlands;Poland;Sweden
Certolizumab pegol (CZP) 400 MG
   UCB Pharma
      2010   Phase 3   NCT01235598   Denmark;Netherlands;Poland;Sweden
Certolizumabpegol injection
   Qilu Hospital of Shandong University
      2021   -   NCT05651373   China
Certoluzimab pegol
   UCB PHARMA
      2011   -   EUCTR2011-000385-35-IT   Italy
Cetrorelix
   Betanien Hospital
      2008   Phase 2   NCT00667758   Norway
Cevidoplenib
   Oscotec Inc.
      2019   Phase 2   EUCTR2018-003330-32-PL   Czech Republic;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
CF101
   Can-Fite BioPharma
      2010   Phase 2   NCT01034306   Bulgaria;Israel
      2008   Phase 2   NCT00556894   Bulgaria;Czech Republic;Czechia;Former Serbia and Montenegro;Israel;Poland;Serbia;Ukraine
      2006   Phase 2   NCT00280917   Bulgaria;Former Serbia and Montenegro;Israel;Poland;Romania;Serbia;Ukraine;United States
   Can-Fite BioPharma Ltd.
      2008   -   EUCTR2007-006527-13-BG   Bulgaria
   Can-Fite BioPharma, Ltd.
      2019   Phase 3   EUCTR2016-003682-26-PL   Bosnia and Herzegovina;Bulgaria;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
CF101 1 MG
   Can-Fite BioPharma
      2017   Phase 3   NCT02647762   Bosnia and Herzegovina;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
CF101 2 MG
   Can-Fite BioPharma
      2017   Phase 3   NCT02647762   Bosnia and Herzegovina;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
CFZ533
   Novartis Pharmaceuticals
      2013   Phase 1   NCT02089087   Taiwan;United States
CH-1504
   Chelsea Therapeutics
      2008   Phase 2   NCT00658047   Canada
CH-4051
   Chelsea Therapeutics
      2010   Phase 2   NCT01116141   -
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-CZ   Bulgaria;Czech Republic
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
Chadox1 NCOV-19
   Skåne University Hospital, department of rheumatology in Lud and Malmö
      2021   Phase 4   EUCTR2021-000880-63-SE   Sweden
Chicken type II collagen
   National Eye Institute (NEI)
      1997   Phase 1   NCT00001614   United States
Chimeric human-murine IGG1
   Centocor BV
      2009   Phase 4   EUCTR2007-003288-36-GB   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2007-003288-36-ES   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-NL   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-003288-36-FR   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-FI   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-DE   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-AT   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
Chimeric human/mouse ANTI-CD-20 monoclonal antibody
   Samsung Electronics Co. Ltd.
      2012   -   EUCTR2011-004171-36-PL   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-HU   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-GB   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-ES   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-CZ   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
Chloroquine
   Hoffmann-La Roche
      2013   Phase 3   NCT01941095   Greece
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00521924   Austria
   Sanofi
      2018   Phase 4   NCT03449758   France
Cholecalciferol
   University Hospital, Clermont-Ferrand
      2011   Phase 3   NCT02243800   France
Chong KUN dang tofacitinib tablet
   Chong Kun Dang Pharmaceutical
      2019   Phase 1   NCT03868072   Korea, Republic of
Chromium
   Akiyama Haruhiko
      2011   Phase 4   JPRN-jRCTs032180273   -
   Kume Shinichiro
      2012   Phase 4   JPRN-jRCTs032180245   -
CHS-0214
   COHERUS BIOSCIENCES, INC.
      2015   Phase 3   EUCTR2015-000665-30-IT   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
   Coherus BioSciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-PL   Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-GB   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus BioSciences, Inc.
      2015   Phase 3   EUCTR2015-000665-30-GB   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-ES   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-DE   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
   Coherus Biosciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-IT   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-HU   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-ES   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-DE   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus Biosciences, Inc.
      2015   Phase 3   NCT02486939   Japan
      2014   Phase 3   NCT02115750   Belarus;France;Germany;Hungary;Israel;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   DAIICHISANKYO Co.,Ltd.
      2014   Phase 3   JPRN-jRCT2080222570   -
Ciclosporin
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   PFIZER
      2007   -   EUCTR2007-001984-31-IT   Belgium;Czech Republic;France;Germany;Italy;Netherlands;Portugal;Spain
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Cilostazol
   Tanta University
      2022   Phase 3   NCT05594680   Egypt
Cilostazol 100 MG
   Ain Shams University
      2022   Phase 2/Phase 3   NCT05671497   Egypt
Cimzia
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Michael Schiff, MD
      2010   Phase 4   NCT01147341   United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   RenJi Hospital
      2020   -   NCT04569890   China
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   The Karolinska Instutute, ClinTRID
      2013   Phase 4   EUCTR2011-004720-35-IS   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   UCB Celltech, UK Registered Branch of UCB Pharma SA
      2015   Phase 2   EUCTR2014-003307-30-SK   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-HU   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-GB   Czech Republic;Hungary;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-CZ   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
   UCB PHARMA
      2011   -   EUCTR2011-000385-35-IT   Italy
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-002067-20-IT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-IT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   UCB Pharma S.A.
      2011   -   EUCTR2009-013758-33-NL   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-SE   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-DK   Denmark;Netherlands;Sweden
      2010   -   EUCTR2007-000830-38-PL   Austria;France;Germany;Italy;Poland
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
   University Hospital, Ghent
      2012   Phase 3   NCT01590966   Belgium
   University of California, San Francisco
      2013   -   NCT01773681   United States
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   Universitätsklinikum Erlangen
      2015   Phase 3   EUCTR2013-000337-13-PT   Germany;Portugal;Serbia;United States
      2013   Phase 3   EUCTR2013-000337-13-DE   Germany;Portugal;Serbia
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Cimzia 200 MG injeksjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Cimzia 200 MG solution FOR injection
   Ghent University Hospital
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
Ciprofloxacin
   Sanofi
      2023   Phase 1   NCT05844735   United States
CIT-013 high dose
   Citryll BV
      2024   Phase 2   NCT06567470   Belgium;Germany;Hungary;Netherlands;Poland;Spain
CIT-013 LOW dose
   Citryll BV
      2024   Phase 2   NCT06567470   Belgium;Germany;Hungary;Netherlands;Poland;Spain
Citalopram
   Vrije Universiteit Brussel
      2010   -   NCT01154647   Belgium
CKD-506
   Chong Kun Dang Pharmaceutical
      2018   Phase 2   NCT04204603   Czechia;Georgia;Poland;Russian Federation;Ukraine
   Chong Kun Dang Pharmaceutical Corporation (CKD)
      2018   Phase 2   EUCTR2018-001377-24-CZ   Czech Republic;Georgia;Poland;Russian Federation;Ukraine
Clarithromycin
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
Classic dmards treatment group
   Zhang, Xiao, M.D.
      2013   -   NCT01915537   China
Clazakizumab
   Bristol-Myers K.K.
      2014   Phase 2   JPRN-jRCT2080222447   -
      2011   Phase 2   JPRN-jRCT2080221588   -
   Bristol-Myers Squibb International Corporation
      2014   -   EUCTR2013-003780-65-IT   Argentina;Australia;Canada;Czech Republic;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2014   -   EUCTR2013-003780-65-HU   Argentina;Australia;Canada;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   CSL Behring
      2012   Phase 2   NCT02015520   Argentina;Australia;Canada;France;Hungary;Italy;Japan;Mexico;South Africa;United States
Clindamycin
   Hammersmith Hospitals NHS trust
      2005   Phase 3   EUCTR2004-004893-96-GB   United Kingdom
Clinical foot evaluation
   Rigshospitalet, Denmark
      2023   -   NCT05698563   Denmark
Clobetasol propionate
   Cairo University
      2020   Phase 3   NCT04649697   Egypt
CMAB008
   Shanghai Biomabs Pharmaceutical Co., Ltd.
      2018   Phase 3   NCT03478111   China
Cnto 136
   JANSSEN-CILAG INTERNATIONAL N.V.
      2012   -   EUCTR2010-022243-38-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Portugal;Spain;Taiwan;United Kingdom;United States
   Janssen-Cilag International N.V.
      2015   Phase 3   EUCTR2012-001176-10-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2012-001176-10-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2010-022243-38-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2010-022242-24-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
      2012   -   EUCTR2010-022243-38-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022243-38-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Serbia;Spain;Sweden;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022242-24-LT   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
Cnto 136 100 MG
   Centocor, Inc.
      2008   Phase 2   NCT00718718   Argentina;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Taiwan;Ukraine;United States
Cnto 136 25 MG
   Centocor, Inc.
      2008   Phase 2   NCT00718718   Argentina;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Taiwan;Ukraine;United States
Cnto 136 50 MG
   Centocor, Inc.
      2008   Phase 2   NCT00718718   Argentina;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Taiwan;Ukraine;United States
Cnto 136 IGG
   Centocor B.V.
      2009   -   EUCTR2007-006603-20-HU   Hungary
Cnto 148
   CENTOCOR
      2010   -   EUCTR2009-010582-23-IT   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-001742-16-NL   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-ES   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2010   -   EUCTR2009-010582-23-GR   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   Janssen Biologics B.V.
      2010   -   EUCTR2009-010582-23-DE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-010582-23-BE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2009-010582-23-SE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-010582-23-GB   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2009-010582-23-AT   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
   Janssen Pharmaceutical K.K.
      2008   Phase 3   NCT00771251   Japan
      2008   Phase 3   NCT00727987   Japan
Cnto 1959
   Janssen Research & Development, LLC
      2012   Phase 2   NCT01645280   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Republic of;Mexico;Peru;Poland;Russian Federation;Singapore;Turkey;Ukraine;United States
Cnto 1959 IGG
   Janssen-Cilag International NV
      2013   -   EUCTR2011-001122-18-BG   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   -   EUCTR2011-001122-18-HU   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   Phase 2   EUCTR2011-001122-18-CZ   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
Cnto 6785 100 MG
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01909427   Argentina;Colombia;Czech Republic;Philippines;Poland;Russian Federation;Thailand
Cnto 6785 15 MG
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01909427   Argentina;Colombia;Czech Republic;Philippines;Poland;Russian Federation;Thailand
Cnto 6785 200 MG
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01909427   Argentina;Colombia;Czech Republic;Philippines;Poland;Russian Federation;Thailand
Cnto 6785 50 MG
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01909427   Argentina;Colombia;Czech Republic;Philippines;Poland;Russian Federation;Thailand
CNTO1275
   Janssen-Cilag International NV
      2013   -   EUCTR2011-001122-18-BG   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   -   EUCTR2011-001122-18-HU   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   Phase 2   EUCTR2011-001122-18-CZ   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
CNTO136
   Centocor B.V.
      2009   -   EUCTR2007-006603-20-HU   Hungary
   JANSSEN-CILAG INTERNATIONAL N.V.
      2012   -   EUCTR2010-022243-38-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Portugal;Spain;Taiwan;United Kingdom;United States
   Janssen-Cilag International N.V.
      2015   Phase 3   EUCTR2012-001176-10-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2012-001176-10-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2010-022243-38-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2010-022242-24-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
      2012   -   EUCTR2010-022243-38-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022243-38-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Serbia;Spain;Sweden;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022242-24-LT   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
CNTO148
   CENTOCOR
      2006   Phase 3   EUCTR2004-003295-10-IT   Austria;Hungary;Italy;Spain;United Kingdom
   Centocor B.V.
      2010   -   EUCTR2008-006064-11-HU   Hungary;Lithuania
   Centocor BV
      2010   -   EUCTR2009-010582-23-GR   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
   Janssen Biologics B.V.
      2011   -   EUCTR2009-015019-42-DE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Peru;Poland;Russian Federation;United States
      2011   Phase 3   EUCTR2009-015019-42-BE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-LT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-FI   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-AT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2009   -   EUCTR2008-006064-11-LT   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
      -   -   EUCTR2009-015019-42-Outside-EU/EEA   Argentina;Brazil;Canada;Mexico;Peru;Russian Federation;United States
CNTO6785
   Janssen-Cilag International NV
      2013   -   EUCTR2012-003629-40-CZ   Argentina;China;Colombia;Czech Republic;India;Philippines;Poland;Russian Federation;Thailand
CO-medication: synthetic dmards
   Diakonhjemmet Hospital
      2013   Phase 4   NCT01881308   Norway
Cobalt
   Akiyama Haruhiko
      2011   Phase 4   JPRN-jRCTs032180273   -
   Kume Shinichiro
      2012   Phase 4   JPRN-jRCTs032180245   -
Cobalt™ bone cement
   Zimmer Biomet
      2006   -   NCT00589485   United States
Cobiprostone
   Sucampo Pharma Americas, LLC
      2007   Phase 2   NCT00597818   United States
COD liver OIL
   National Institute of Nutrition and Seafood Research, Norway
      2008   -   NCT00805116   Norway
Coenzyme Q10
   the Second Hospital of Shanxi Medical University
      2017   -   ChiCTR-IPR-17010325   China
Coffee consumption
   University of Leeds
      1995   -   NCT06670144   United Kingdom
Colchicine
   Hospital Central Dr. Ignacio Morones Prieto
      2018   Phase 2   NCT04056039   Mexico
Colecalciferol
   AZIENDA OSPEDALIERA ORDINE MAURIZIANO
      2010   Phase 3   EUCTR2009-015835-34-IT   Italy
   CHU de Clermont-Ferrand
      2011   -   EUCTR2009-012615-18-FR   France
Collect OF 10 ML OF peripheric blood FOR DNA extraction
   Centre Hospitalier Universitaire de Fort-de-France
      2010   -   NCT01111357   Martinique
Combination fish OIL and borage seed OIL
   National Center for Complementary and Integrative Health (NCCIH)
      2006   Phase 3   NCT00072982   United States
Combination OF minocycline and MTX or MTX alone
   University of Nebraska
      2001   Phase 3   NCT00579644   United States
Combination steroid
   All India Institute of Medical Sciences, New Delhi
      2009   Phase 3   NCT01870128   India
Combined therapy OF iguratimod and tofacitinib
   Jie Chang
      2025   Phase 4   NCT06945666   China
Comirnaty
   Sint Maartenskliniek
      2021   Phase 4   EUCTR2021-000710-42-NL   Netherlands
   Skåne University Hospital, department of rheumatology in Lud and Malmö
      2021   Phase 4   EUCTR2021-000880-63-SE   Sweden
Commercial formulation etanercept
   Amgen
      2016   Phase 3   NCT02986139   Puerto Rico;United States
Computed tomography
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
   University of California, San Francisco
      2013   -   NCT01773681   United States
Conventional dmard combination
   Karolinska Institutet
      2002   Phase 4   NCT00764725   -
Conventional dmards
   AA amyloidosis clinical research conference
      2008   -   JPRN-UMIN000002421   Japan
   Ain Shams University
      2019   Phase 2   NCT03863405   Egypt
   Noha Mansour
      2021   Phase 2   NCT05447520   Egypt
Conventional synthetic antirheumatic drugs
   Ain Shams University
      2023   Phase 2   NCT06640309   Egypt
      2022   Phase 2/Phase 3   NCT05671497   Egypt
Conventional synthetic dmard
   SetPoint Medical Corporation
      2021   Phase 3   NCT04539964   United States
Corn OIL capsules
   Zhejiang University
      2014   -   NCT02173587   China
Corticosteroid injection
   Rigshospitalet, Denmark
      2023   -   NCT05698563   Denmark
Corticosteroid or nsaid
   Hoffmann-La Roche
      2007   Phase 4   NCT00462345   Korea, Republic of
Corticosteroids
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Genentech, Inc.
      2003   Phase 2   NCT00074438   United States
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
Corticotrophin 80 units
   Gaylis, Norman B., M.D.
      2013   Phase 4   NCT01948388   United States
Covid-19 vaccine
   Paul R Fortin
      2022   Phase 2/Phase 3   NCT05236491   Canada
Covid-19 vaccine astrazeneca
   Sint Maartenskliniek
      2021   Phase 4   EUCTR2021-000710-42-NL   Netherlands
   Skåne University Hospital, department of rheumatology in Lud and Malmö
      2021   Phase 4   EUCTR2021-000880-63-SE   Sweden
Covid-19 vaccine moderna
   Sint Maartenskliniek
      2021   Phase 4   EUCTR2021-000710-42-NL   Netherlands
   Skåne University Hospital, department of rheumatology in Lud and Malmö
      2021   Phase 4   EUCTR2021-000880-63-SE   Sweden
Covid-19 vaccines AT A 3-month interval
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
Covid-19 vaccines AT A 6-month interval
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
CP 690,550
   PFIZER
      2005   -   EUCTR2004-002846-36-IT   Germany;Italy;Spain
   PFIZER INC
      2017   Phase 3   EUCTR2016-001825-15-IT   Bulgaria;Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;Spain
   Pfizer
      2009   Phase 3   NCT00853385   Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;Germany;Korea, Republic of;Mexico;Philippines;Poland;Slovakia;Spain;Thailand;United Kingdom;United States
   Pfizer Inc.
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-SK   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-CZ   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, New York
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-PL   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-GB   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BG   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BE   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
CP 690550 MR
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
CP-195,543
   Pfizer
      2006   Phase 2   NCT00424294   United States
CP-690, 550 - 10
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
CP-690,55-10
   Arthritis Alapítvány
      2016   Phase 4   EUCTR2015-002523-26-HU   Hungary
CP-690,550
   PFIZER
      2010   Phase 3   EUCTR2009-016987-34-ES   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Poland;Slovakia;Spain;Sweden
      2008   -   EUCTR2007-002066-35-IT   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2007   -   EUCTR2007-001984-31-IT   Belgium;Czech Republic;France;Germany;Italy;Netherlands;Portugal;Spain
      2007   Phase 2   EUCTR2006-005035-19-IT   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;Sweden;United Kingdom
   Pfizer
      2016   Phase 4   NCT02831855   Australia;Belgium;Bulgaria;Czechia;Germany;Hungary;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2012   Phase 1   NCT01484561   Czech Republic;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2011   Phase 2   NCT01359150   Poland;United States
      2011   Phase 1   NCT01262118   Hungary;United States
      2010   Phase 2   NCT01059864   Korea, Republic of;United States
      2010   Phase 3   NCT01039688   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Czechia;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2009   Phase 3   NCT00960440   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Ireland;Italy;Korea, Republic of;Puerto Rico;Spain;Taiwan;United Kingdom;United States
      2009   Phase 3   NCT00856544   Australia;Chile;China;Colombia;Croatia;Denmark;Finland;Germany;Greece;Malaysia;Mexico;Poland;Russian Federation;Slovakia;Spain;Sweden;Thailand;United Kingdom;United States;Venezuela
      2009   Phase 3   NCT00853385   Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;Germany;Korea, Republic of;Mexico;Philippines;Poland;Slovakia;Spain;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00847613   Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Greece;India;Japan;Korea, Republic of;Mexico;Poland;Taiwan;Ukraine;United States;Venezuela
      2009   Phase 3   NCT00814307   Brazil;Bulgaria;Chile;Colombia;Czech Republic;Dominican Republic;Germany;India;Malaysia;Mexico;Philippines;Poland;Puerto Rico;Russian Federation;Ukraine;United States
      2009   Phase 2   NCT00687193   Japan
      2008   Phase 3   NCT00661661   Japan
      2008   Phase 2   NCT00603512   Japan
      2007   Phase 2   NCT00550446   Brazil;Bulgaria;Chile;Croatia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Romania;Slovakia;Ukraine;United States
      2007   -   NCT00414661   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Costa Rica;Czech Republic;Dominican Republic;Finland;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Puerto Rico;Romania;Slovakia;Spain;Sweden;Ukraine;United States
      2007   Phase 3   NCT00413699   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Czechia;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;United States Minor Outlying Islands
      2007   Phase 2   NCT00413660   Argentina;Brazil;Bulgaria;Chile;Czech Republic;Hungary;Mexico;Poland;Slovakia;Spain;Sweden;Turkey;United States
      2005   Phase 1   NCT01745055   United States
      2005   Phase 2   NCT00147498   Austria;Belgium;Brazil;Canada;Germany;Italy;Mexico;Slovakia;Spain;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2010   Phase 2;Phase 3   EUCTR2006-005035-19-HU   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008337-11-GB   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-007023-26-PL   Bulgaria;Czech Republic;Poland
      2009   Phase 3   EUCTR2008-007023-26-GR   Bulgaria;Czech Republic;Greece;Poland
      2009   -   EUCTR2008-007023-26-BG   Bulgaria;Czech Republic;Poland
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA
      2009   -   EUCTR2008-008337-11-DE   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2011   -   EUCTR2010-020890-18-CZ   Czech Republic;Hungary
      2009   -   EUCTR2008-008338-35-CZ   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-008337-11-SK   Denmark;Finland;Germany;Greece;Poland;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008337-11-SE   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008337-11-GR   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008337-11-FI   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-008337-11-DK   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-007023-26-CZ   Bulgaria;Czech Republic;Poland
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-020890-18-HU   Czech Republic;Hungary
      2009   -   EUCTR2008-008337-11-PL   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
   Pfizer Inc. 235 East 42nd Street, New York, NY10017
      2009   Phase 2;Phase 3   EUCTR2006-006373-25-GB   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Slovakia;Spain;Sweden;United Kingdom
      2009   -   EUCTR2006-006373-25-FI   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-006373-25-GR   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-006373-25-BG   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-005036-24-BG   Bulgaria;Czech Republic;Hungary;Sweden
      2008   Phase 2;Phase 3   EUCTR2006-005035-19-GR   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-006373-25-CZ   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-005036-24-HU   Bulgaria;Czech Republic;Hungary;Sweden
      2007   -   EUCTR2006-005036-24-CZ   Bulgaria;Czech Republic;Hungary;Sweden
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2010   -   EUCTR2009-016987-34-SE   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-PL   Bulgaria;Czech Republic;Germany;Hungary;Poland;Spain;Sweden
      2010   -   EUCTR2009-016987-34-HU   Bulgaria;Czech Republic;Germany;Hungary;Poland;Spain;Sweden
      2009   Phase 3   EUCTR2008-008338-35-SK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-GB   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-FI   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-008338-35-DK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-DE   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-BG   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2010   Phase 3   EUCTR2009-016987-34-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   Phase 3   EUCTR2009-016987-34-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
   Pfizer Ltd - Ramsgate Road, Sandwich CT139NJ, UK.
      2007   Phase 2   EUCTR2006-005036-24-SK   Bulgaria;Czech Republic;Hungary;Slovakia;Sweden
      2007   -   EUCTR2006-005036-24-SE   Bulgaria;Czech Republic;Hungary;Sweden
   Pfizer Ltd, Ramsgate Road, Sandwich CT139NJ, UK
      2007   Phase 2   EUCTR2006-006373-25-SK   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-006373-25-SE   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-006373-25-AT   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
   Pfizer S.A.
      2007   Phase 2   EUCTR2006-005035-19-ES   Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Slovakia;Spain;Sweden;United Kingdom
   Pfizer, S.A
      2009   Phase 3   EUCTR2008-008338-35-ES   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
   Pfizer, S.A.
      2009   -   EUCTR2008-008337-11-ES   Denmark;Finland;Germany;Greece;Poland;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-006373-25-ES   Austria;Bulgaria;Czech Republic;Finland;Germany;Greece;Spain;Sweden;United Kingdom
CP-690,550 + methotrexate
   Pfizer
      2009   Phase 2   NCT00976599   United States
CP-690,550 – 10
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2014   -   EUCTR2014-000706-34-GB   Germany;Hungary;United Kingdom;United States
CP-690,550-10
   Pfizer Inc, 235 East 42nd Street, New York 10017
      2013   -   EUCTR2011-005689-39-HU   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2012   Phase 2   EUCTR2007-002066-35-SK   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2010   Phase 2;Phase 3   EUCTR2006-005035-19-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2008   -   EUCTR2007-002066-35-HU   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-GR   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2008   -   EUCTR2007-002066-35-DE   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   -   EUCTR2007-002066-35-CZ   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-BG   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2;Phase 3   EUCTR2006-005035-19-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2008   Phase 2;Phase 3   EUCTR2006-005035-19-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-SK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-002337-30-CZ   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2009   -   EUCTR2008-007788-17-CZ   Bulgaria;Czech Republic;Germany
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2011-005689-39-SK   Belgium;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2014   Phase 2   EUCTR2011-005689-39-NL   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2014   -   EUCTR2011-005689-39-DE   Belgium;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2013   Phase 2   EUCTR2011-005689-39-ES   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2013   -   EUCTR2011-005689-39-CZ   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United States
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2010   -   EUCTR2009-014296-40-IT   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
   Pfizer Inc., 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-002337-30-HU   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-HR   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-ES   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-DE   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-BG   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-014296-40-IE   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
      2010   -   EUCTR2009-014296-40-GB   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-014296-40-FR   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
      2010   -   EUCTR2009-014296-40-BE   Australia;Austria;Belgium;Brazil;Canada;France;Germany;Ireland;Italy;Korea, Republic of;Spain;Sweden;Taiwan;Tanzania, United Republic of;United Kingdom;United States
      2010   -   EUCTR2009-014296-40-AT   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
      2009   -   EUCTR2009-014296-40-DE   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
      2009   -   EUCTR2008-007788-17-DE   Bulgaria;Czech Republic;Germany
      2009   -   EUCTR2008-007788-17-BG   Bulgaria;Czech Republic;Germany
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
   Pfizer S.A.
      2009   Phase 3   EUCTR2009-014296-40-ES   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
CP-690-550
   Pfizer
      2007   Phase 2   NCT00550446   Brazil;Bulgaria;Chile;Croatia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Romania;Slovakia;Ukraine;United States
CP690,550
   Pfizer Corporation Austria Ges.m.b.H.
      2005   -   EUCTR2004-002846-36-AT   Austria;Germany;Italy;Spain
   Pfizer Global & Developement, Pfizer Limited
      2005   Phase 2   EUCTR2004-002846-36-SK   Austria;Germany;Italy;Slovakia;Spain
   Pfizer Pharma GmbH
      2005   -   EUCTR2004-002846-36-DE   Germany;Italy;Spain
   Pfizer, S.A.
      2005   Phase 2   EUCTR2004-002846-36-ES   Austria;Germany;Italy;Slovakia;Spain
CPL409116
   Celon Pharma SA
      2022   Phase 2   NCT05374785   Poland;Ukraine
CR 1
   Pfizer
      2008   Phase 1   NCT00782600   United States
CR 2
   Pfizer
      2008   Phase 1   NCT00782600   United States
CR 3
   Pfizer
      2008   Phase 1   NCT00782600   United States
CR0686
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-GB   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
CR6086
   Rottapharm Biotech
      2017   Phase 2   NCT03163966   Czechia
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-PL   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-GB   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-DK   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-CZ   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-BG   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
CR6086Z
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-PL   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-GB   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-DK   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-CZ   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-BG   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
Creatine
   Bangor University
      2013   -   NCT01767844   United Kingdom
Creatinine
   Affiliated Hospital of North Sichuan Medical College
      2018   -   ChiCTR1800018637   China
CRQ
   Centre Hospitalier Universitaire de Saint Etienne
      2020   Phase 4   NCT04470453   France
      2018   Phase 4   NCT03445871   France
CRX-102
   CombinatoRx, Inc
      2006   -   EUCTR2004-001930-18-EE   Estonia
   CombinatoRx, Incorporated
      2008   -   EUCTR2007-004399-38-LT   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-GB   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-EE   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-LT   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-HU   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-GB   Estonia;Hungary;Lithuania;United Kingdom
      2007   -   EUCTR2007-003069-42-EE   Estonia;Hungary;Lithuania;United Kingdom
   Zalicus
      2007   Phase 2   NCT00551707   Argentina;Canada;Estonia;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Serbia;South Africa;United States
      2004   Phase 2   NCT00747214   -
CRX-139
   CombinatoRx, Inc.
      2006   Phase 2   EUCTR2004-004995-35-GB   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
      2006   -   EUCTR2004-004995-35-DK   Czech Republic;Denmark;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-004995-35-DE   Czech Republic;Denmark;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-004995-35-CZ   Czech Republic;Denmark;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-004995-35-AT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
CRX-150
   CombinatoRx, Inc
      2006   -   EUCTR2004-001490-26-EE   Estonia;United Kingdom
      2004   -   EUCTR2004-001490-26-GB   Estonia;United Kingdom
Csdmards
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Dazhou Central Hospital
      2024   -   ChiCTR2400094366   China
      2023   -   ChiCTR2400081970   China
   Gilead Sciences
      2016   Phase 3   NCT02873936   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
   GlaxoSmithKline
      2019   Phase 3   NCT04134728   Argentina;Belgium;Canada;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   NCT03970837   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
   Hoffmann-La Roche
      2014   Phase 3   NCT02001987   France
   Kawakami Atsushi
      2021   -   JPRN-jRCTs071200107   -
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
   Lanzhou University Second Hospital
      2020   Phase 1   ChiCTR2400081609   China
   The First Affiliated Hospital of Xiamen University
      2022   -   NCT05424393   China
CT- P10
   CELLTRION, Inc.
      2014   Phase 3   EUCTR2013-004555-21-SK   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-PT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-LV   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-HU   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-GR   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-DE   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
CT-P10
   Celltrion
      2014   Phase 3   NCT02149121   Austria;Korea, Republic of
CT-P13
   CELLTRION, INC.
      2012   -   EUCTR2011-004468-31-IT   Austria;Bosnia and Herzegovina;Chile;Colombia;Italy;Jordan;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Spain;Ukraine;United Kingdom
   CELLTRION, Inc
      2012   -   EUCTR2011-004468-31-PL   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-LV   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-LT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   Phase 3   EUCTR2011-004468-31-GB   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   Phase 3   EUCTR2011-004468-31-ES   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2011   -   EUCTR2011-004468-31-SK   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2010   Phase 3   EUCTR2010-018646-31-SK   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-PT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LV   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Indonesia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2010   -   EUCTR2010-018646-31-IT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-GB   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018646-31-ES   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-BG   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-AT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
   Celltrion
      2018   Phase 3   NCT03707535   China
      2016   Phase 3   NCT03147248   Korea, Republic of
   Celltrion, Inc
      2017   Phase 1;Phase 3   EUCTR2016-002125-11-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-LV   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-HU   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-EE   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Russian Federation;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
   Pfizer
      2015   -   NCT02605642   Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Italy;Spain;United Kingdom
CT-P13 SC AUTO-injector
   Celltrion
      2025   Phase 3   NCT06738719   Poland
CT-P17
   CELLTRION, Inc.
      2019   Phase 3   EUCTR2019-000660-25-PL   Poland
   Celltrion, Inc
      2019   Phase 3   EUCTR2018-001690-25-LT   Bulgaria;Hungary;Lithuania;Peru;Poland;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-PL   Bosnia and Herzegovina;Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-HU   Bosnia and Herzegovina;Bulgaria;Hungary;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-BG   Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Ukraine
CT-P17 SC
   Celltrion
      2019   Phase 3   NCT04171414   Poland
      2018   Phase 3   NCT03789292   Bulgaria
CT-P47
   CELLTRION, Inc.
      2023   Phase 3   EUCTR2022-002928-12-PL   Poland
      2022   Phase 3   EUCTR2022-001066-36-PL   Poland
   Celltrion
      2023   Phase 3   NCT05725434   -
CTLA4IG
   BRISTOL-M.SQUIBB
      2005   -   EUCTR2004-002620-18-IT   Belgium;Germany;Italy;Spain;United Kingdom
   Bristol Myers Squibb International Corporation
      2011   Phase 3   EUCTR2008-001523-57-NO   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2010-018674-20-SE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-FR   Belgium;Denmark;Finland;France;Germany;Italy;Sweden
      2010   -   EUCTR2010-018674-20-FI   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DK   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-BE   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2008-001523-57-HU   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2008-001523-57-DE   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-GB   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-ES   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   -   EUCTR2008-001523-57-DK   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-001523-57-FR   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   -   EUCTR2007-005434-37-NL   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-HU   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-GR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-FR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-DE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-BE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-AT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2006   -   EUCTR2005-000784-26-AT   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-IE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-GB   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-ES   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-DE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-BE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-000922-59-DK   Czech Republic;Denmark;Spain;Sweden
      2005   -   EUCTR2004-000922-59-CZ   Czech Republic;Denmark;Spain;Sweden
      2004   -   EUCTR2004-000922-59-SE   Czech Republic;Denmark;Spain;Sweden
      2004   Phase 3   EUCTR2004-000922-59-ES   Czech Republic;Denmark;Spain;Sweden
   Bristol-Myers Squibb International Corporation
      2008   Phase 3   EUCTR2007-005434-37-GB   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2007   -   EUCTR2006-003768-67-SE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-NL   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-GB   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-003768-67-ES   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-DE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-BE   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-AT   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-005102-68-CZ   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-CZ   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-IE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-GB   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2004-005102-68-ES   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-DE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-005102-68-BE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-GB   Belgium;Germany;Italy;Spain;United Kingdom
      2005   Phase 2   EUCTR2004-002620-18-ES   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-DE   Belgium;Germany;Italy;Spain;United Kingdom
      2005   -   EUCTR2004-002620-18-BE   Belgium;Germany;Italy;Spain;United Kingdom
CURA-100
   Cura Biotech LLC
      2007   Phase 1/Phase 2   NCT00455208   United States
Curcumin
   University of California, Los Angeles
      2010   Early Phase 1   NCT00752154   United States
Current treatment
   Chugai Pharmaceutical
      2003   Phase 3   NCT00144508   -
   School of Medicine, University of Occupational and Environmental Health, Japan
      2014   -   JPRN-UMIN000015462   Japan
Cyclophosphamide
   Fairview University Medical Center
      2000   -   NCT00006055   United States
   Hoffmann-La Roche
      2001   Phase 2   NCT02693210   Australia;Belgium;Canada;Czech Republic;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   IRIS Research and Development, LLC
      2024   Phase 1   NCT06581562   United States
Cyclosporin A
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00521924   Austria
Cyclosporine
   Fairview University Medical Center
      2000   -   NCT00006055   United States
   Hvidovre University Hospital
      1998   Phase 4   NCT00209859   Denmark
CZP
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
   Astellas Pharma Inc
      2011   Phase 3   NCT01451203   Japan
   Nathan Wei, MD, FACP, FACR:
      2011   Phase 3   NCT01374971   United States
   UCB Pharma
      2010   Phase 4   NCT01255761   United States
      2008   Phase 3   NCT00717236   Canada;France;Germany;Italy;Netherlands;Spain;United States
   UCB Pharma S.A.
      2011   -   EUCTR2009-013758-33-NL   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-SE   Denmark;Netherlands;Sweden
      2010   -   EUCTR2009-013758-33-DK   Denmark;Netherlands;Sweden
   UCB Pharma SA
      2011   Phase 4   NCT01500278   Australia;Austria;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Monaco;Poland;Portugal;Romania;Spain;Switzerland;United Kingdom;United States
D2e7
   Reade
      2019   Phase 4   EUCTR2019-001793-28-NL   Netherlands
      2019   Phase 1;Phase 4   EUCTR2019-001554-25-NL   Netherlands
Dalacin C phosphate
   Hammersmith Hospitals NHS trust
      2005   Phase 3   EUCTR2004-004893-96-GB   United Kingdom
Daratumumab
   Universitätsklinikum Erlangen
      2023   Phase 1;Phase 2   EUCTR2021-006669-40-DE   Germany
Dead SEA solar and water treatment
   Soroka University Medical Center
      2013   -   NCT01861782   Israel
Decortin
   Pfizer Inc.
      2009   Phase 2   EUCTR2009-013223-37-CZ   Czech Republic;Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-023782-22-CZ   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2009   -   EUCTR2009-013223-37-HU   Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2011   -   EUCTR2010-023782-22-DE   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2012   -   EUCTR2010-023782-22-SK   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-HU   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-BG   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer, S.L.U.
      2011   -   EUCTR2010-023782-22-ES   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
Decortin (prednisona) 5 MG comprimidos
   Pfizer S.A.
      2009   Phase 2   EUCTR2009-013223-37-ES   Czech Republic;Hungary;Spain
Decortin 5MG tablets
   Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc.
      2009   -   EUCTR2007-006150-25-DE   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
      2008   -   EUCTR2007-006150-25-HU   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-006150-25-NL   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-FR   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-BE   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   -   EUCTR2007-006150-25-AT   Austria;Belgium;France;Germany;Hungary;Netherlands
Decrease tocilizumab, abatacept
   Assistance Publique - Hôpitaux de Paris
      2012   Phase 4   NCT01557374   France
Defanyl 50 and 100 MG
   CombinatoRx, Inc
      2006   -   EUCTR2004-001490-26-EE   Estonia;United Kingdom
Dekavil
   Philogen S.p.A.
      2015   Phase 2   EUCTR2013-005418-37-DE   Germany;Italy;Switzerland
      2014   Phase 2   EUCTR2013-005418-37-IT   Germany;Italy
Deltacortene forte*10CPR 25MG
   OSPEDALE POLICLINICO S. MATTEO
      2006   -   EUCTR2006-003843-22-IT   Italy
Deltacortril enteric
   GlaxoSmithKline Research & Development Limited
      2005   Phase 2   EUCTR2005-001977-82-GB   United Kingdom
Denosumab
   Amgen
      2011   Phase 1   NCT01294397   United States
      2004   Phase 2   NCT00095498   United States
   Chinese University of Hong Kong
      2017   Phase 2   NCT03239080   China
      2012   Phase 4   NCT01770106   Hong Kong
   DAIICHISANKYO Co., Ltd.
      2018   -   JPRN-jRCT1080224168   Japan
      2017   -   JPRN-jRCT1080223691   Japan
   DAIICHISANKYO Co.,Ltd.
      2013   Phase 3   JPRN-jRCT2080222228   Japan
      2010   Phase 2   JPRN-jRCT2080221226   Japan
   Daiichi Sankyo Company, Limited
      2018   -   JPRN-UMIN000030575   Japan
   Daiichi Sankyo, Inc.
      2013   -   NCT01973569   Japan
   Hokkaido Medical Center for Rheumatic Diseases
      2017   -   JPRN-UMIN000028376   Japan
   Indiana University
      2019   Phase 1/Phase 2   NCT02418273   United States
   Kawakami Atsushi
      2018   Phase 4   JPRN-jRCTs071180018   -
   Osaka City University Graduate School of Medicine
      2018   -   JPRN-UMIN000030828   Japan
   Peking University First Hospital
      2024   Phase 4   ChiCTR2400090526   China
   Tokyo Metropolitan Tama medical center
      2022   -   JPRN-UMIN000049741   Japan
   Yokohama City University Medical Center
      2014   -   JPRN-UMIN000014737   Japan
Depalgos*20+325MG 28CPR RP
   A.U.S.L. RIMINI
      2006   -   EUCTR2006-004062-13-IT   Italy
Depemedrone
   University Hospital Birmingham
      2007   Phase 4   NCT00523692   United Kingdom
Depo medrol
   Attune Health Research, Inc.
      2018   Phase 3   NCT03511625   United States
   Sun Pharma Global FZE
      2016   Phase 3   EUCTR2015-002924-17-BE   Belgium;Netherlands
      2015   Phase 3   EUCTR2015-002924-17-NL   Belgium;Netherlands
DEPO-medrone
   University Hospitals Birmingham NHS Foundation Trust
      2006   Phase 4   EUCTR2006-001428-38-GB   United Kingdom
Determination OF calcium intake BY A dietician interview
   Centre Hospitalier Universitaire de Nimes
      2016   -   NCT02636829   France
Dexa scan
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
Dexamethason
   UMC Utrecht
      2010   Phase 4   EUCTR2009-017051-10-NL   Netherlands
Dexmedetomidine
   First Affiliated Hospital of Gannan Medical University
      2025   Phase 0   ChiCTR2500100098   China
   West China Hospital, Sichuan University
      2021   Phase 0   ChiCTR2000036316   China
      2021   Phase 0   ChiCTR2000036164   china
Dextromethorphan hydrobromide
   Taichung Veterans General Hospital
      2010   -   NCT02368093   -
Dezocine
   Quanzhou First Hospital Affiliated to Fujian Medical University
      2019   -   ChiCTR2200057200   China
DHA
   Rabin Medical Center
      2011   -   NCT01274910   Israel
Diacerein
   TRB Chemedica
      2010   Phase 2   NCT01264211   Thailand
Diazepam, melatonin
   Kobe University
      2006   -   NCT00287794   Japan
Dibase*IM OS 2F 1ML 300000UI/M
   AZIENDA OSPEDALIERA ORDINE MAURIZIANO
      2010   Phase 3   EUCTR2009-015835-34-IT   Italy
Diclofenac
   Mallinckrodt
      2012   -   NCT01579890   -
   Northumbria Healthcare NHS Foundation Trust
      2010   Phase 4   NCT01067430   United Kingdom
   Organon and Co
      2006   Phase 2   NCT00264147   Canada;Colombia;Puerto Rico;Switzerland;United States
   University Hospital Macau
      2022   Phase 0   ChiCTR2200063782   China
   University of Dundee
      2007   Phase 4   NCT00447759   Denmark;Netherlands;United Kingdom
Diclofenac + omeprazole
   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
      2005   Phase 4   NCT00141102   Belgium;Brazil;Canada;China;Colombia;Costa Rica;Croatia;Czech Republic;Czechia;Ecuador;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Guatemala;Hong Kong;India;Ireland;Korea, Republic of;Latvia;Lithuania;Netherlands;Panama;Peru;Portugal;Russian Federation;Serbia;Singapore;South Africa;Spain;Sweden;Taiwan;Ukraine;United Kingdom
Diclofenac sodium
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Organon and Co
      2003   Phase 3   NCT00250445   -
      2003   Phase 3   NCT00092742   United States
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Dietary counseling
   Veena Ranganath, MD, MS
      2016   -   NCT02881307   United States
Dietary fiber supplementation
   University Hospital, Montpellier
      2020   -   NCT04421313   France
Dietary guidance
   Haukeland University Hospital
      2020   -   NCT04586933   Norway
Dietary pattern
   University of Leeds
      1995   -   NCT06670144   United Kingdom
Dietary patterns
   University of Leeds
      2006   -   NCT06670183   -
Dietary recommendations
   Veena Ranganath, MD, MS
      2016   -   NCT02881307   United States
Dietary supplement omega3 fatty acids aand vitamins
   Physicians Committee for Responsible Medicine
      2011   -   NCT01544101   United States
Digoxin
   AstraZeneca
      2011   Phase 1   NCT01355354   United Kingdom
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02762123   United States
Digoxin 0.25 MG
   Tanta University
      2021   Phase 2   NCT04834557   Egypt
Dihuang
   Shanghai Traditional Chinese Medicine Hospital
      2020   Phase 0   ChiCTR2000037675   China
Dimeythl fumarate
   Biogen Idec Limited
      2009   Phase 2   EUCTR2008-004754-33-SK   Czech Republic;Poland;Slovakia
      2009   -   EUCTR2008-004754-33-PL   Czech Republic;Poland
      2009   -   EUCTR2008-004754-33-CZ   Czech Republic;Poland
Diosmin and hesperidin combination
   Alexandria University
      2023   Phase 3   NCT05756179   Egypt
Diphtheria toxoid
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
   Tel-Aviv Sourasky Medical Center
      2011   Phase 4   NCT01301703   Israel
Dipotassium salt
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-CZ   Bulgaria;Czech Republic
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
Diprofos depot
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
   Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet
      2017   Phase 4   EUCTR2017-003425-15-DK   Denmark
Dipyridamole
   CombinatoRx, Incorporated
      2008   -   EUCTR2007-004399-38-LT   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-GB   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-EE   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-LT   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-HU   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-GB   Estonia;Hungary;Lithuania;United Kingdom
      2007   -   EUCTR2007-003069-42-EE   Estonia;Hungary;Lithuania;United Kingdom
   Zalicus
      2011   Phase 2   NCT01369745   United States
      2007   Phase 2   NCT00551707   Argentina;Canada;Estonia;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Serbia;South Africa;United States
   Zalicus, Inc.
      2012   -   EUCTR2011-002392-41-HU   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2012   -   EUCTR2011-002392-41-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-PL   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-HU   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-BG   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
Dipyridamole and amoxapine
   CombinatoRx, Inc
      2006   -   EUCTR2004-001490-26-EE   Estonia;United Kingdom
Disease modified antirheumatic drugs or biological agents
   Nanfang Hospital of Southern Medical University
      2018   -   NCT03508713   -
Disease-modifying ANTI-rheumatic drugs
   German University in Cairo
      2024   Phase 2   NCT06753565   Egypt
   Hoffmann-La Roche
      2005   Phase 3   NCT00720798   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Puerto Rico;Russian Federation;Serbia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
   Shunichi Shiozawa
      2013   -   JPRN-UMIN000018816   Japan
Disease-modifying antirheumatic drug
   Pfizer
      2010   Phase 3   NCT01039688   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Czechia;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
Dmard
   Amgen
      2001   -   NCT00116714   United States
   Bristol-Myers Squibb
      2005   Phase 3   NCT00124982   Belgium;Canada;Czech Republic;France;Germany;Ireland;Italy;Mexico;Spain;United Kingdom;United States
   Diakonhjemmet Hospital
      2013   Phase 4   NCT01881308   Norway
   Hoffmann-La Roche
      2013   Phase 3   NCT01995201   Ireland;Portugal;Spain
      2011   Phase 4   NCT01251120   Finland
   The Second Affiliated Hospital of Guangxi Medical University
      2022   Phase 4   ChiCTR2100052492   China
   University of Zurich
      2011   -   NCT01292616   Switzerland
Dmard cessation
   Newcastle-upon-Tyne Hospitals NHS Trust
      2014   -   NCT02219347   United Kingdom
Dmard maintenance
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 4   NCT00780793   France
Dmard therapy
   Amgen
      2011   Phase 4   NCT01313208   Canada;United States
   Zalicus
      2004   Phase 2   NCT00747214   -
Dmards
   Astellas Pharma China, Inc.
      2018   Phase 3   NCT03660059   China;Korea, Republic of;Taiwan
   Columbia University
      2011   Phase 4   NCT01548768   United States
   Hoffmann-La Roche
      2014   Phase 3   NCT02046603   United Kingdom
      2013   Phase 3   NCT01941940   Italy
      2013   Phase 4   NCT01715831   Brazil
      2010   Phase 3   NCT01194414   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00996606   Italy
      2009   Phase 4   NCT00996203   Russian Federation
      2009   Phase 3   NCT00951275   Italy
   Inner Mongolia University of Science and Technology Baotou Medical College First Affiliated Hospital
      2017   -   ChiCTR-INR-17011772   China
   JW Pharmaceutical
      2010   Phase 3   NCT01256736   Korea, Republic of
      2009   Phase 3   NCT01211834   Korea, Republic of
   Japan Association of Rheumatologists in Private Practice
      2010   -   JPRN-UMIN000003807   Japan
   Mycenax Biotech Inc.
      2013   Phase 3   NCT01787149   Taiwan
   NYU Langone Health
      2019   Phase 4   NCT03652961   United States
   National and Kapodistrian University of Athens
      2022   -   NCT05671627   Greece
   St Luke's International Hospital
      2010   -   JPRN-UMIN000003615   Japan
   Sun Yat-sen University
      2018   Phase 4   NCT04066803   China
   University of California, Los Angeles
      2012   Phase 4   NCT01717846   United States
   Wyeth is now a wholly owned subsidiary of Pfizer
      2008   Phase 4   NCT00783536   -
   Zhejiang Chinese Medical University
      2021   -   ChiCTR2100048795   China
   the Second Hospital of Shanxi Medical University
      2017   -   ChiCTR-IPR-17010325   China
      2017   -   ChiCTR-IPR-17010307   China
      2016   -   ChiCTR-INR-16009546   China
Dmards (methotrexate
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00521924   Austria
Dmards or biologics
   Pfizer
      2009   -   NCT00929357   Denmark
Dnaj peptide
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      1999   Phase 2   NCT00000435   United States
Dolasetron
   Quanzhou First Hospital Affiliated to Fujian Medical University
      2019   -   ChiCTR2200057200   China
Dolquine
   Fundació Clínic per a la Recerca Biomèdica
      2019   Phase 4   EUCTR2017-004543-20-ES   Spain
Donepezil
   RenJi Hospital
      2018   Phase 3   NCT02927522   China
Dose level 1
   Bristol-Myers Squibb K.K.
      2016   Phase 2   JPRN-jRCT2080223262   Asia except Japan;Europe;Japan;North America;Oceania;South America
   Pfizer
      2009   Phase 1   NCT00838565   Korea, Republic of;Spain;United States
Dose level 2
   Bristol-Myers Squibb K.K.
      2016   Phase 2   JPRN-jRCT2080223262   Asia except Japan;Europe;Japan;North America;Oceania;South America
   Pfizer
      2009   Phase 1   NCT00838565   Korea, Republic of;Spain;United States
Dose level 3
   Pfizer
      2009   Phase 1   NCT00838565   Korea, Republic of;Spain;United States
Dose level 4
   Pfizer
      2009   Phase 1   NCT00838565   Korea, Republic of;Spain;United States
Dose reduction TO 2MG/L
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT04222920   Netherlands
Dose reduction TO 5MG/L
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT04222920   Netherlands
Double-blind abatacept
   Bristol-Myers Squibb
      2002   Phase 3   NCT00048932   United States
Double-blind adalimumab
   Abbott
      2009   Phase 3   NCT00870467   Japan
Doxycycline
   Hong Kong Baptist University
      2015   -   ChiCTR-OPB-15007284   China
   New York University School of Medicine
      2010   -   NCT01198509   United States
Doxycycline tablets
   Assiut University
      2019   -   NCT03194204   Egypt
DR. reddy’S rituximab (drl_ri) 100MG
   Dr. Reddy’s Laboratories S.A.
      2020   Phase 3   EUCTR2019-002810-37-PL   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-LT   Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
DR. reddy’S rituximab (drl_ri) 500MG
   Dr. Reddy’s Laboratories S.A.
      2020   Phase 3   EUCTR2019-002810-37-PL   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-LT   Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
Drl_ri
   Dr. Reddy's Laboratories Limited
      2020   Phase 3   NCT04268771   United States
      2014   Phase 1/Phase 2   NCT02296775   India;Ukraine
Dronabinol capsule 2.5. MG
   King Christian 10th Hospital for Rheumatology
      2018   Phase 2   EUCTR2017-004226-15-DK   Denmark
Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom
   Groupe Hospitalier Pitie-Salpetriere
      2018   -   NCT03480529   France
Drug protocol
   Federal University of São Paulo
      2014   -   NCT04752748   -
DW1809-1
   Daewon Pharmaceutical Co., Ltd.
      2020   Phase 1   NCT05214690   Korea, Republic of
      2020   Phase 1   NCT05214677   Korea, Republic of
DW1809-T2
   Daewon Pharmaceutical Co., Ltd.
      2020   Phase 1   NCT05214690   Korea, Republic of
DWP422 25MG
   Daewoong Pharmaceutical Co. LTD.
      2012   Phase 1   NCT01635686   Korea, Republic of
E-device
   UCB Biopharma S.P.R.L.
      2017   Phase 3   NCT03357471   United States
E6011
   Eisai Co., Ltd.
      2016   Phase 2   NCT02960490   Japan
      2016   Phase 2   NCT02960438   Japan
      2014   Phase 1/Phase 2   NCT02196558   Japan
Ebetrexat
   Ludwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation
      2008   -   EUCTR2007-006288-56-AT   Austria
EC 3.1.3.1
   Alloksys Life Sciences B.V.
      2011   -   EUCTR2008-007346-63-GB   United Kingdom
Edoxaban
   Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      2016   -   JPRN-UMIN000026819   Japan
   Yokohama City University School of Medicine
      2012   -   JPRN-UMIN000018101   Japan
Efalizumab
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal
   XOMA (US) LLC
      2002   Phase 2   NCT00034203   United States
Efexor XL 75 MG
   Newcastle upon Tyne Hospitals NHS Trust
      2005   -   EUCTR2004-002482-20-GB   United Kingdom
Eldecalcitol
   Department of Orthopaedic Surgery Shinshu University School of Medicine
      2016   -   JPRN-UMIN000022364   Japan
Eldecalcitol capsules
   Chinese SLE Treatment And Research Group
      2024   Phase 4   NCT06385093   China
Emea/H/C/004214
   Erasmus Medical Center
      2022   Phase 4   EUCTR2021-004131-84-NL   Netherlands
Emea/H/C000262
   University Hospitals Leuven
      2013   Phase 4   EUCTR2012-004631-22-BE   Belgium
Empagliflozin 25MG TAB
   Tanta University
      2024   Phase 4   NCT06641128   Egypt
Enalapril maleate
   University of Guadalajara
      2017   Phase 2   NCT03667131   Mexico
Enbrel
   AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA
      2018   Phase 3   EUCTR2017-004079-30-IT   Belgium;Italy;Portugal;Spain
   Amgen
      2002   -   NCT00121056   -
      2002   -   NCT00116727   United States
      2000   Phase 4   NCT00132418   United States
      2000   -   NCT00078793   Canada;United States
   Amgen Inc.
      2017   Phase 3   EUCTR2014-004868-38-DE   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-PT   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-HU   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-GR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-FR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-ES   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-BG   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2015   Phase 3   EUCTR2014-004868-38-CZ   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
   Amgen, Inc. One Amgen Center Drive Thousand Oaks, California 91320
      -   -   EUCTR2012-001171-37-Outside-EU/EEA   Canada;United States
      -   -   EUCTR2012-001145-40-Outside-EU/EEA   Canada;United States
   AstraZeneca AB
      2008   Phase 2   EUCTR2007-007539-14-SK   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland;Slovakia
      2008   -   EUCTR2007-007539-14-PL   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-MT   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-LV   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-HU   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-CZ   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-BG   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-001420-12-CZ   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-SK   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-SE   Czech Republic;France;Poland;Sweden
      2007   -   EUCTR2007-001420-12-PL   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-FR   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-BE   Belgium;Czech Republic;France;Poland;Sweden
   Biogen
      2017   -   NCT03100734   Germany
   CHU Saint-Etienne
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   Coherus BioSciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-PL   Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-GB   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus Biosciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-IT   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-HU   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-ES   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-DE   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   DAIICHISANKYO Co.,Ltd.
      2014   Phase 3   JPRN-jRCT2080222570   -
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Derby Hospitals NHS Foundation Trust
      2008   Phase 4   EUCTR2006-006562-42-GB   United Kingdom
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   EMS
      2013   Phase 3   NCT01394913   Brazil
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2008   Phase 4   EUCTR2007-000593-24-GB   Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-ES   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
   F.Hoffmann-La Roche Ltd
      2008   -   EUCTR2007-000593-24-SE   Sweden;United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP
      2019   Phase 4   EUCTR2018-004539-54-DE   Germany
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
      2019   Phase 4   EUCTR2018-004558-30-ES   Spain
   Greater Glasgow Health Board
      2006   Phase 4   EUCTR2006-000363-28-GB   United Kingdom
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Imperial College London South Kensington London
      2009   Phase 4   EUCTR2009-012424-87-GB   United Kingdom
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-ES   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-BE   Belgium;Italy;Portugal;Spain
      2014   Phase 3   EUCTR2014-003529-16-GB   United Kingdom
   Joint Stock Company Farmak
      2018   Phase 3   NCT04079374   Ukraine
   Kawakami Atsushi
      2020   Phase 4   JPRN-jRCTs071190046   -
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   LG Life Sciences
      2015   Phase 3   NCT02357069   Japan;Korea, Republic of
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   NHS Greater Glasgow and Clyde
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   National Eye Institute (NEI)
      1999   Phase 2   NCT00001862   United States
   Pfizer
      2020   -   NCT04428424   Iraq
      2011   -   NCT01411215   China
      2007   -   NCT00503139   Japan
   Pfizer Inc.
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-003644-71-ES   Australia;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Israel;Netherlands;Russian Federation;Spain
      2013   Phase 4   EUCTR2012-003644-71-BE   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;New Zealand;Poland;Russian Federation;Spain
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 EAst 42nd Street, New York, NY 10017, United States
      2013   -   EUCTR2012-003644-71-NL   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;Russian Federation;Spain
   Pfizer Inc., 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Samsung Bioepis Co., Ltd.
      2013   Phase 3   NCT01895309   Poland;United Kingdom
      2013   -   EUCTR2012-005026-30-PL   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-LT   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005026-30-HU   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-CZ   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-BG   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
   Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
      2015   Phase 1   NCT02481180   China
   Sorrento Therapeutics, Inc.
      2021   Phase 1   NCT04559412   United States
   University Hospital Birmingham NHS Foundation Trust
      2007   Phase 4   EUCTR2006-006275-21-GB   United Kingdom
   University Hospitals Birmingham NHS Foundation Trust
      2006   Phase 4   EUCTR2006-001428-38-GB   United Kingdom
   University Hospitals Leuven
      2013   Phase 4   EUCTR2012-004631-22-BE   Belgium
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Pharmaceuticals France
      2008   Phase 4   EUCTR2007-007888-24-FR   France
      2008   -   EUCTR2007-001625-10-PL   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-IT   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-001625-10-ES   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-000896-41-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2007-000896-41-NL   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-DE   Denmark;Finland;France;Germany;Sweden;United Kingdom
   Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company)
      2009   Phase 4   EUCTR2008-002623-85-GB   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2008   -   EUCTR2007-000896-41-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2010   -   EUCTR2007-000896-41-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002623-85-IE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   -   EUCTR2008-002623-85-DE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   Phase 4   EUCTR2007-000896-41-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth is now a wholly owned subsidiary of Pfizer
      2005   -   NCT00503503   -
      2004   -   NCT00484809   -
      2003   -   NCT00245934   -
   YL Biologics Ltd
      2016   Phase 3   EUCTR2015-002809-12-BG   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-LV   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-HU   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-ES   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-CZ   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
   mAbxience Research S.L.
      2024   Phase 3   NCT06596772   Bulgaria;Georgia;Moldova, Republic of;Poland;Romania;Serbia
Enbrel - 50 MG polv soluz iniet sottoc. polv. flac vetro solv. siri. VET. solv 1 ML (50 MG/ML) 12 flac+12 siri. PRE+12 aghi+12 adat PER flac+24 tamp. PRE iniez
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
Enbrel - 50 MG soluzione iniettabile IN siringa (vetro DA 1 ML) preriempita - USO sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti DI alcol
   AMGEN INC.
      2016   Phase 3   EUCTR2014-004868-38-IT   Bulgaria;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
Enbrel 25 MG
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
   Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA
      2008   -   EUCTR2007-000896-41-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel 25 MG powder and solvent FOR solution FOR injection
   Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom
      2010   -   EUCTR2007-006657-63-IS   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-SE   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-FI   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-DK   Denmark;Finland;Hungary;Iceland;Norway;Sweden
   Wyeth Pharmaceuticals France
      2010   Phase 4   EUCTR2007-006657-63-HU   Denmark;Finland;Hungary;Iceland;Sweden
Enbrel 25MG PFS
   Daewoong Pharmaceutical Co. LTD.
      2012   Phase 1   NCT01635686   Korea, Republic of
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-NL   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel 50 MG
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
   Wyeth Pharmaceuticals France
      2008   -   EUCTR2007-001625-10-DE   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-AT   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
   Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA
      2008   -   EUCTR2007-000896-41-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel 50 MG powder and solvent FOR solution FOR injection
   Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom
      2010   -   EUCTR2007-006657-63-IS   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-SE   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-FI   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-DK   Denmark;Finland;Hungary;Iceland;Norway;Sweden
   Wyeth Pharmaceuticals France
      2010   Phase 4   EUCTR2007-006657-63-HU   Denmark;Finland;Hungary;Iceland;Sweden
Enbrel 50 MG solution FOR injection IN PRE-filled syringe
   Hexal AG
      2016   Phase 3   EUCTR2012-002009-23-HU   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2012-002009-23-DE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-SK   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-PL   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LV   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-ES   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-EE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-CZ   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2015   Phase 3   EUCTR2013-004569-16-DE   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
   sanofi-aventis Recherche & Développement
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Enbrel 50MG PFS
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-NL   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel 50MG PRE-filled PEN
   University of Leeds
      2011   Phase 4   EUCTR2010-023910-30-GB   United Kingdom
Enbrel 50MG PRE-filled syringe
   University of Leeds
      2011   Phase 4   EUCTR2010-023910-30-GB   United Kingdom
Enbrel auto injector
   Wyeth Pharmaceuticals France
      2008   -   EUCTR2006-006591-37-GR   Austria;Greece
      2008   -   EUCTR2006-006591-37-AT   Austria;Greece
      2007   -   EUCTR2006-006591-37-BE   Austria;Belgium;Greece
      2007   -   EUCTR2006-005137-38-SE   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-005137-38-GB   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-005137-38-FR   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-FI   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-DK   Denmark;Finland;France;Germany;Sweden;United Kingdom
Enbrel liquid
   Amgen
      2005   Phase 3   NCT00249041   Canada;United States
Enbrel PRE-filled PEN
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
Enbrel PRE-filled syringe
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
   Wyeth Pharmaceuticals France
      2007   Phase 3   EUCTR2006-005137-38-FR   Denmark;Finland;France;Germany;Sweden;United Kingdom
Enbrel*SC 4FL 25MG+4SIR 1ML
   WYETH LEDERLE
      2004   -   EUCTR2004-000563-96-IT   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Pharmaceuticals France, Wyeth Research Division
      2008   -   EUCTR2007-000896-41-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel*SC 4SIR 25MG 0,5ML+8TAM
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-IT   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel*SC 4SIR 50MG 1ML+8tamp
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-IT   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Enbrel, benepali, erelzi
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
Enbrel® 50 MG solution FOR injection IN PRE-filled syringe
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2012   -   EUCTR2011-005448-87-HU   Argentina;Brazil;China;Colombia;Czech Republic;Egypt;Hungary;India;Malaysia;Mexico;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;Slovakia;South Africa;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates
      2012   -   EUCTR2011-005448-87-CZ   Argentina;Brazil;China;Colombia;Czech Republic;Egypt;Hungary;India;Malaysia;Mexico;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;Slovakia;South Africa;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates
Encorton, 5 MG, tablets
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
ENIA11
   Mycenax Biotech Inc.
      2012   Phase 3   NCT01709760   Taiwan
Enoxaparin
   Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
      2016   -   JPRN-UMIN000026819   Japan
Entanercept
   Peking University First Hospital
      2015   -   NCT02320630   China
Entecavir
   Department of general internal medicine, Kyushu-University hospital
      2012   -   JPRN-UMIN000018017   Japan
   Seoul National University Hospital
      2012   Phase 3   NCT01694264   Korea, Republic of
   Taipei Veterans General Hospital, Taiwan
      2013   Phase 4   NCT01907230   Taiwan
EPA
   Rabin Medical Center
      2011   -   NCT01274910   Israel
Epaxal
   HY, HUS
      2011   -   EUCTR2009-016055-22-SE   Finland;Sweden
      2009   -   EUCTR2009-016055-22-FI   Finland;Sweden
   Lars Rombo
      2009   Phase 2   NCT01360970   Finland;Sweden
Epinephrine
   Nekoyama Miyao Hospital
      2017   -   JPRN-UMIN000029759   Japan
      2017   -   JPRN-UMIN000029003   Japan
Epoetin alfa
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2004   Phase 2   NCT00236678   -
   Ortho Biotech Products, L.P.
      2005   Phase 2   NCT00123149   -
ERB-041
   WYETH LEDERLE
      2005   -   EUCTR2005-001319-23-IT   Hungary;Italy;Spain
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical resaearch and Development
      2005   -   EUCTR2005-001319-23-HU   Hungary;Italy;Spain
      2005   Phase 2   EUCTR2005-001319-23-ES   Hungary;Italy;Spain
Erbium citrate
   CIS bio international
      2007   Phase 4   EUCTR2006-006380-22-DE   Germany
Ergocalciferol
   Johns Hopkins University
      2009   -   NCT01426347   United States
Ergocalciferol 1.25 MG tablet
   Tanta University
      2019   Phase 4   NCT04472481   Egypt
ERMM-1
   CIS bio international
      2007   Phase 4   EUCTR2006-006380-22-DE   Germany
Esaote mylab60
   University Hospital, Rouen
      2011   Phase 4   NCT01765374   France
Esbriet
   University Hospitals of Leicester NHS Trust
      2017   Phase 2   EUCTR2017-000149-30-GB   Australia;Canada;United Kingdom;United States
Escitalopram 10MG
   Tanta University
      2022   Phase 3   NCT05480878   Egypt
Esomeprazole
   AstraZeneca
      2008   Phase 3   JPRN-jRCT2080220543   -
      2008   Phase 3   JPRN-jRCT2080220521   -
      2007   Phase 3   NCT00542789   Japan
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
Esomeprazole 20 MG
   AstraZeneca
      2007   Phase 3   NCT00595517   Japan
Estimation OF P.gingivalis levels
   Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
      2015   -   NCT02503046   India
Estimation OF pentraxin3
   Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
      2015   -   NCT02503046   India
Eszopiclone
   Sunovion
      2004   Phase 3   NCT00367965   United States
Etanercepet, rituximab, abatacept, tocilizumab, sarilumab
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
Etanercept
      2010   -   EUCTR2009-015653-20-NL   Netherlands
   AMGEN INC.
      2016   Phase 3   EUCTR2014-004868-38-IT   Bulgaria;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
   ASTRAZENECA
      2008   -   EUCTR2007-007539-14-IT   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
   AZIENDA OSPEDALIERA SENESE
      2010   -   EUCTR2009-017379-90-IT   Italy
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Amgen
      2013   Phase 4   NCT01927757   Canada;Puerto Rico;United States
      2011   Phase 4   NCT01313208   Canada;United States
      2011   Phase 1   NCT01294397   United States
      2008   Phase 4   NCT00654368   Canada
      2006   Phase 3   NCT00413452   Canada;United States
      2006   Phase 1   NCT00361634   United Kingdom;United States
      2006   Phase 4   NCT00346294   United States
      2005   Phase 4   NCT00115219   United States
      2004   Phase 4   NCT00099554   Canada;United States
      2004   Phase 4   NCT00094341   United States
      2001   Phase 3   NCT00078806   Canada;United States
      2000   Phase 3   NCT03781375   -
      1998   Phase 3   NCT00356590   Canada;United States
      1997   Phase 2/Phase 3   NCT03780959   -
      1997   Phase 3   NCT00357903   Canada;United States
   Amgen Inc.
      2017   Phase 3   EUCTR2014-004868-38-DE   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-PT   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-HU   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-GR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-FR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-ES   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-BG   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2015   Phase 3   EUCTR2014-004868-38-CZ   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
   Amgen, Inc. One Amgen Center Drive Thousand Oaks, California 91320
      -   -   EUCTR2012-001171-37-Outside-EU/EEA   Canada;United States
      -   -   EUCTR2012-001145-40-Outside-EU/EEA   Canada;United States
   AryoGen Pharmed Co.
      2014   -   NCT04582084   Iran, Islamic Republic of
   Astellas Pharma Inc
      2014   Phase 3   NCT02308163   Japan;Korea, Republic of;Taiwan
   AstraZeneca
      2008   Phase 2   NCT00713544   Argentina;Bulgaria;Colombia;Czech Republic;Hungary;Italy;Latvia;Malta;Netherlands;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Ukraine
      2007   Phase 2   NCT00520572   Argentina;Australia;Belgium;Canada;Czech Republic;France;Hungary;Mexico;Poland;Romania;Russian Federation;Slovakia;Sweden;United States
   AstraZeneca AB
      2008   Phase 2   EUCTR2007-007539-14-SK   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland;Slovakia
      2008   -   EUCTR2007-007539-14-PL   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-MT   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-LV   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-HU   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-CZ   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-007539-14-BG   Bulgaria;Czech Republic;Hungary;Italy;Latvia;Malta;Poland
      2008   -   EUCTR2007-001420-12-CZ   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-SK   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-SE   Czech Republic;France;Poland;Sweden
      2007   -   EUCTR2007-001420-12-PL   Czech Republic;France;Poland;Sweden
      2007   Phase 2   EUCTR2007-001420-12-FR   Belgium;Czech Republic;France;Poland;Slovakia;Sweden
      2007   -   EUCTR2007-001420-12-BE   Belgium;Czech Republic;France;Poland;Sweden
   Biogen
      2006   Phase 2   NCT00298272   United States
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   COHERUS BIOSCIENCES, INC.
      2015   Phase 3   EUCTR2015-000665-30-IT   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
   Coherus BioSciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-PL   Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-GB   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus BioSciences, Inc.
      2015   Phase 3   EUCTR2015-000665-30-GB   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-ES   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-DE   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
   Coherus Biosciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-IT   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-HU   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-ES   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-DE   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus Biosciences, Inc.
      2014   Phase 3   NCT02115750   Belarus;France;Germany;Hungary;Israel;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
   DAIICHISANKYO Co.,Ltd.
      2014   Phase 3   JPRN-jRCT2080222570   -
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Department of Rheumatosurgery, Osaka City University Medical School
      2009   Phase 4   JPRN-UMIN000002340   Japan
   Dept. of orthopedic surgery, Osaka Medical College
      2012   -   JPRN-UMIN000012613   Japan
   Dr. Frank Behrens
      2019   Phase 4   NCT04485325   Germany
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   EMS
      2013   Phase 3   NCT01394913   Brazil
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2008   Phase 4   EUCTR2007-000593-24-GB   Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-ES   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
   F.Hoffmann-La Roche Ltd
      2008   -   EUCTR2007-000593-24-SE   Sweden;United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Faiq Gorial
      2017   Phase 1/Phase 2   NCT03160001   Iraq
   Fen Li
      2016   Phase 4   NCT02878161   -
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
      2019   Phase 4   EUCTR2018-004558-30-ES   Spain
   Gema Biotech S.A.
      2016   Phase 3   NCT03403140   Argentina
      2016   Phase 3   NCT03332719   Argentina
   Georgetown University
      2013   Phase 4   NCT01793519   United States
   Greater Glasgow Health Board
      2006   Phase 4   EUCTR2006-000363-28-GB   United Kingdom
   Hanwha Chemical
      2010   Phase 3   NCT01270997   Korea, Republic of
   Hexal AG
      2016   Phase 3   EUCTR2012-002009-23-HU   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2012-002009-23-DE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-SK   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-PL   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LV   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-ES   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-EE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-CZ   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
   Hoffmann-La Roche
      2011   -   NCT01592292   Korea, Republic of
      2011   Phase 4   NCT01331837   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Czechia;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
   Imperial College London South Kensington London
      2009   Phase 4   EUCTR2009-012424-87-GB   United Kingdom
   Innovaderm Research Inc.
      2014   Phase 4   NCT02109289   Canada
   Jagiellonian University
      2013   Phase 4   NCT02132234   Poland
   Johoku Biological Summit
      2006   Phase 4   JPRN-C000000452   Japan
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
   Joint Stock Company Farmak
      2018   Phase 3   NCT04079374   Ukraine
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Kawakami Atsushi
      2020   Phase 4   JPRN-jRCTs071200054   -
      2020   Phase 4   JPRN-jRCTs071190046   -
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Lawson Health Research Institute
      2020   Phase 4   NCT03976245   Canada
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   Merck Sharp & Dohme Corp.
      2008   -   NCT00724672   -
   NHS Greater Glasgow and Clyde
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   National Institute of Allergy and Infectious Diseases (NIAID)
      2009   Phase 4   NCT00837434   United States
      2008   Phase 4   NCT00796705   United States
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      2002   Phase 2   NCT00034060   United States
   Osaka City University Medical School
      2011   Phase 4   JPRN-UMIN000008164   Japan
   Pfizer
      2018   -   NCT04267614   Iraq
      2015   -   NCT02486302   Germany
      2015   Phase 3   NCT02378506   Bulgaria;Croatia;Germany;Greece;Hungary;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2014   -   NCT02202837   Belgium
      2014   Phase 4   NCT02092467   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;Chile;China;Colombia;Czech Republic;Czechia;Finland;Hong Kong;Israel;Jordan;Lebanon;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;United Kingdom;United States
      2013   Phase 4   NCT01783015   Australia;Belgium;France;Hong Kong;Israel;Netherlands;Russian Federation;Spain
      2013   -   NCT01558089   Greece
      2012   -   NCT01646385   -
      2012   -   NCT01623752   -
      2012   Phase 4   NCT01578850   Brazil;China;Colombia;Czech Republic;Egypt;Hungary;Jordan;Lebanon;Malaysia;Mexico;Philippines;Qatar;Romania;Russian Federation;Saudi Arabia;South Africa;Taiwan;Thailand;Ukraine;United Arab Emirates
      2011   -   NCT01557322   -
      2009   Phase 4   NCT00913458   France;Germany;Ireland;Italy;Monaco;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Switzerland;United Kingdom
      2009   Phase 4   NCT00858780   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2008   Phase 4   NCT00565409   Australia;Austria;Belgium;Brazil;Chile;Colombia;Czech Republic;Former Serbia and Montenegro;France;Germany;Hungary;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Taiwan;United Kingdom
      2007   -   NCT00503139   Japan
      2006   -   NCT00488475   Germany
      2006   Phase 3   NCT00445770   Japan
      2004   -   NCT00195403   Korea, Republic of
      2004   -   NCT00195338   Luxembourg
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2015   Phase 3   EUCTR2013-004569-16-DE   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2012   -   EUCTR2011-005448-87-HU   Argentina;Brazil;China;Colombia;Czech Republic;Egypt;Hungary;India;Malaysia;Mexico;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;Slovakia;South Africa;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates
      2012   -   EUCTR2011-005448-87-CZ   Argentina;Brazil;China;Colombia;Czech Republic;Egypt;Hungary;India;Malaysia;Mexico;Philippines;Poland;Romania;Russian Federation;Saudi Arabia;Slovakia;South Africa;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates
   Pfizer Inc.
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-003644-71-ES   Australia;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Israel;Netherlands;Russian Federation;Spain
      2013   Phase 4   EUCTR2012-003644-71-BE   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;New Zealand;Poland;Russian Federation;Spain
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 EAst 42nd Street, New York, NY 10017, United States
      2013   -   EUCTR2012-003644-71-NL   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;Russian Federation;Spain
   Pfizer Inc., 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2015   Phase 3   EUCTR2013-004569-16-SK   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-HU   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-HR   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-GR   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-BG   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
   Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom
      2010   -   EUCTR2007-006657-63-IS   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-SE   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-FI   Denmark;Finland;Hungary;Iceland;Norway;Sweden
      2009   -   EUCTR2007-006657-63-DK   Denmark;Finland;Hungary;Iceland;Norway;Sweden
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
   Samsung Bioepis Co., Ltd.
      2017   Phase 2   NCT03193957   Poland
      2013   Phase 3   NCT01895309   Poland;United Kingdom
   Sanofi
      2013   Phase 3   NCT01764997   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Czechia;Ecuador;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Sungkyunkwan University
      2020   -   NCT04115423   Korea, Republic of
   Takarazuka city hospital
      2014   -   JPRN-UMIN000013362   Japan
   Team RA, Rheumatosurgery, Osaka City University Medical School
      2008   -   JPRN-UMIN000001798   Japan
   Tufts Medical Center
      2025   -   NCT06016517   United States
   University Hospitals Leuven
      2018   Phase 4   EUCTR2017-004054-41-BE   Belgium
   University of Alabama at Birmingham
      2004   Phase 4   NCT00259610   United States
   University of California, Davis
      2017   -   NCT03178955   United States
   University of Leeds
      2018   Phase 4   EUCTR2016-002344-16-GB   United Kingdom
      2011   Phase 4   NCT02433184   United Kingdom
      2011   Phase 4   EUCTR2010-023910-30-GB   United Kingdom
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
      2006   Phase 4   NCT01303874   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Pittsburgh
      2009   Phase 4   NCT01009879   United States
   University of Sao Paulo
      2008   Phase 4   NCT01072058   Brazil
   University of Sulaimani
      2022   -   NCT05379049   Iraq
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02633332   Italy
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   VA Office of Research and Development
      2007   -   NCT00405275   Canada;United States
   WYETH LEDERLE
      2004   -   EUCTR2004-000563-96-IT   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Pharmaceuticals France
      2009   -   EUCTR2007-001625-10-GR   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2009   Phase 4   EUCTR2007-001625-10-GB   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-007888-24-FR   France
      2008   -   EUCTR2007-001625-10-PL   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-IT   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-IE   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-HU   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-001625-10-FR   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-001625-10-ES   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-DK   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-DE   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-001625-10-AT   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
      2008   -   EUCTR2007-000896-41-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-006591-37-GR   Austria;Greece
      2008   -   EUCTR2006-006591-37-AT   Austria;Greece
      2007   -   EUCTR2007-000896-41-NL   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-006591-37-BE   Austria;Belgium;Greece
      2007   -   EUCTR2006-005137-38-SE   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-005137-38-GB   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-005137-38-FR   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-FI   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-DK   Denmark;Finland;France;Germany;Sweden;United Kingdom
   Wyeth Pharmaceuticals France, Wyeth Research Division
      2008   -   EUCTR2007-000896-41-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company)
      2009   Phase 4   EUCTR2008-002623-85-GB   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-001625-10-CZ   Austria;Czech Republic;Denmark;France;Germany;Greece;Hungary;Ireland;Italy;Poland;Spain;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2010   Phase 4   EUCTR2008-002623-85-SE   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2010   -   EUCTR2007-000896-41-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002623-85-IE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   -   EUCTR2008-002623-85-DE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   Phase 4   EUCTR2007-000896-41-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-NL   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-002623-85-IT   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2008-002623-85-FR   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2008-002623-85-ES   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA
      2008   -   EUCTR2007-000896-41-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth is now a wholly owned subsidiary of Pfizer
      2008   Phase 4   NCT00768053   France;Monaco
      2008   Phase 4   NCT00706797   Austria;Croatia;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Turkey;United Kingdom;United States
      2007   Phase 3   NCT00484237   Japan
      2007   Phase 3   NCT00418717   Japan
      2006   Phase 3   NCT00443950   China
      2005   -   NCT00503503   -
      2004   -   NCT00484809   -
      2004   Phase 4   NCT00252668   -
      2004   Phase 4   NCT00195494   United States
      2003   Phase 4   NCT00546533   -
      2003   -   NCT00195377   Spain
      2003   -   NCT00195364   Spain
      2000   Phase 3   NCT00393471   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Israel;Italy;Netherlands;Norway;Poland;Portugal;Romania;Spain;Sweden;United Kingdom
   YL Biologics Ltd
      2016   Phase 3   EUCTR2015-002809-12-BG   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-LV   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-HU   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-ES   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-CZ   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
   mAbxience Research S.L.
      2024   Phase 3   NCT06596772   Bulgaria;Georgia;Moldova, Republic of;Poland;Romania;Serbia
   sanofi-aventis Recherche & Développement
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Etanercept + methotrexate
   Wyeth is now a wholly owned subsidiary of Pfizer
      2008   Phase 4   NCT00783536   -
Etanercept , methotrexate
   Wyeth is now a wholly owned subsidiary of Pfizer
      2007   Phase 4   NCT00422227   Hong Kong;India;Korea, Republic of;Malaysia;Philippines;Singapore;Taiwan;Thailand
Etanercept / autoinjector A
   Amgen
      2013   Phase 3   NCT01901185   United States
Etanercept 50MG
   Department of Rheumatology and infectious disease, Kitasato university school of medicine
      2012   -   JPRN-UMIN000008572   Japan
   Derby Hospitals NHS Foundation Trust
      2008   Phase 4   EUCTR2006-006562-42-GB   United Kingdom
   Taizhou Hospital of Zhejiang Province
      2025   -   ChiCTR2500102023   China
Etanercept AUTO-injector
   Wyeth Pharmaceuticals France
      2007   -   EUCTR2006-005137-38-DE   Denmark;Finland;France;Germany;Sweden;United Kingdom
Etanercept biosimilar
   Samsung Bioepis Co., Ltd.
      2013   -   EUCTR2012-005026-30-PL   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-LT   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005026-30-HU   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-CZ   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-BG   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
   TcLand Expression S.A.
      2016   -   NCT03016260   Czech Republic;Czechia;France;Israel;Netherlands;Turkey
   The First Affiliated Hospital of Xiamen University
      2022   -   NCT05424393   China
Etanercept liquid
   Amgen
      2004   Phase 3   NCT00110903   -
Etanercept optimal dosing
   Duke University
      2025   Phase 1   NCT04585711   United States
Etanercept or adalimumab
   Imperial College London
      2010   -   NCT01060098   United Kingdom
   University of Glasgow
      2010   Phase 4   NCT01021735   United Kingdom
Etanercept PRE-filled syringe
   Wyeth Pharmaceuticals France
      2007   -   EUCTR2006-005137-38-DE   Denmark;Finland;France;Germany;Sweden;United Kingdom
Etanercept PRE-filled syringe subcutaneous injection
   Amgen
      2015   Phase 3   NCT02373813   Argentina;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;South Africa;Spain;United States
Etanercept treatment
   Assistance Publique Hopitaux De Marseille
      2011   Phase 3   NCT02164214   France
Etanercept VIA autoinjector A
   Amgen
      2013   Phase 4   NCT01875991   Canada;United States
Etanercept VIA autoinjector B
   Amgen
      2013   Phase 4   NCT01875991   Canada;United States
Etanercept, methotrexate and depomedrone
   University Hospital Birmingham
      2007   Phase 4   NCT00523692   United Kingdom
Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), ETC
   Pfizer
      2013   -   NCT01932372   Japan
Ethinyl estradiol
   Bristol-Myers Squibb
      2017   Phase 1   NCT03262740   United States
ETN
      2010   -   EUCTR2009-015653-20-NL   Netherlands
   University of Leeds
      2006   Phase 4   NCT01303874   United Kingdom
ETN alone
   Japan Biological Agent Study Integrated Consortium
      2005   Phase 4   NCT00688103   Japan
ETN+MTX
   Japan Biological Agent Study Integrated Consortium
      2005   Phase 4   NCT00688103   Japan
Etoricoxib
   Chung Shan Medical University
      2007   Phase 4   NCT04144101   -
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2011   Phase 3   EUCTR2010-019871-31-SK   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2011   -   EUCTR2010-019871-31-CZ   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019871-31-BE   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2010   -   EUCTR2010-019871-31-LT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-FI   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-DE   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-AT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
   Northumbria Healthcare NHS Foundation Trust
      2010   Phase 4   NCT01067430   United Kingdom
   Organon and Co
      2006   -   NCT01685424   United States
      2006   Phase 2   NCT00264147   Canada;Colombia;Puerto Rico;Switzerland;United States
   Zhejiang Provincial People's Hospital
      2023   -   ChiCTR2300075010   China
Etoricoxib 60 MG
   Organon and Co
      2010   Phase 3   NCT01208181   Argentina;Austria;Canada;Colombia;Czech Republic;Finland;Germany;Guatemala;India;Lithuania;Mexico;Panama;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
Etoricoxib 90 MG
   Organon and Co
      2010   Phase 3   NCT01208181   Argentina;Austria;Canada;Colombia;Czech Republic;Finland;Germany;Guatemala;India;Lithuania;Mexico;Panama;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
EU-approved roactemra
   Fresenius Kabi SwissBioSim GmbH
      2020   Phase 3   NCT04512001   Bulgaria;Czechia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
EU-humira
   Fresenius Kabi SwissBioSim GmbH
      2017   Phase 3   NCT03052322   Bulgaria;Czech Republic;Czechia;Germany;Hungary;Poland;United Kingdom
EU/1/99/126/017
   University of Leeds
      2011   Phase 4   EUCTR2010-023910-30-GB   United Kingdom
EU/1/99/126/020
   University of Leeds
      2011   Phase 4   EUCTR2010-023910-30-GB   United Kingdom
Eupatilin
   Seoul National University Boramae Hospital
      2021   Phase 4   NCT04885751   -
Evobrutinib
   Merck KGaA
      2017   Phase 2   EUCTR2017-000384-32-CZ   Argentina;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Germany;Japan;Mexico;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2017   Phase 2   EUCTR2017-000384-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Germany;Japan;Mexico;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
Exercise
   Saglik Bilimleri Universitesi
      2018   -   NCT05914337   Turkey
Exercise followed cold water immersion
   Centre Hospitalier Universitaire de Besancon
      2017   -   NCT03911830   France
Exhaled nitric oxide assessment
   GlaxoSmithKline
      2004   -   NCT00242853   United Kingdom
Expression OF CDKN2A /P16ink4A
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
Extracorporeal photopheresis
   Mallinckrodt
      2003   Phase 2   NCT00221000   Australia;Austria;Belgium;Canada;France;Germany;Italy;Mexico;Slovakia;South Africa;United States
F8il10
   Philogen S.p.A.
      2023   Phase 1   NCT05622175   -
      2015   Phase 2   EUCTR2013-005418-37-DE   Germany;Italy;Switzerland
      2014   Phase 2   NCT02270632   Germany;Italy;Switzerland
      2014   Phase 2   EUCTR2013-005418-37-IT   Germany;Italy
      2011   Phase 1   NCT02076659   Italy
Faecal microbiota transplantation
   Odense University Hospital
      2023   Phase 2   NCT04924270   Denmark
Faecal sampling
   Assistance Publique - Hôpitaux de Paris
      2020   -   NCT04292067   France
Famotidine
   Hoshigaoka Koseinenkin Hospital
      2009   -   JPRN-UMIN000004271   Japan
Fang
   Juan C. Bertoglio, MD
      2006   Phase 2   NCT00749645   Chile
Fang YI qing feng SHI granule
   Maoxiang Group Jilin Pharmaceutical Co., Ltd.
      2014   Phase 2   NCT02029599   China
FB704A
   Fountain Biopharma Inc.
      2019   Phase 1   NCT03890302   United States
FBL-MTX
   SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
      2024   Phase 2   NCT06565273   Portugal
      2021   Phase 1   NCT05117593   Portugal
Fecal microbial transplant
   Lawson Health Research Institute
      2023   -   NCT05790356   Canada
Fendrix suspension FOR injection
   FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA (VHIR)
      2018   Phase 4   EUCTR2018-002368-18-ES   Spain
Fentanyl
   Yamaguchi University
      2018   -   JPRN-UMIN000031692   Japan
Fentanyl transdermal patch
   Janssen Pharmaceutica N.V., Belgium
      2001   Phase 4   NCT00524160   -
Ferrograd folic tablets
   University of Leeds
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
Fexofenadine
   October 6 University
      2022   Phase 1/Phase 2   NCT05264025   Egypt
Filgotinib
   Alfasigma S.p.A.
      2022   -   NCT05323591   France
      2021   -   NCT04871919   Belgium;Germany;Italy;Netherlands;Spain;United Kingdom
      2017   Phase 3   NCT03025308   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
   DeparShinshu University School of Medicine
      2021   -   JPRN-UMIN000043547   Japan
   Erasmus Medical Center
      2020   Phase 4   EUCTR2020-002802-21-NL   Netherlands
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Galapagos NV
      2019   Phase 2   EUCTR2018-003933-14-LV   Belgium;Bulgaria;Czech Republic;Estonia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-EE   Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Latvia;Poland;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-CZ   Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Latvia;Poland;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-BE   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2018   Phase 3   EUCTR2016-003630-25-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-PL   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2014   Phase 2   NCT02065700   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   Phase 2   EUCTR2012-003655-11-HU   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   Phase 2   EUCTR2012-003655-11-BG   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   Phase 2   EUCTR2012-003655-11-BE   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   -   EUCTR2012-003635-31-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   Phase 2   EUCTR2012-003655-11-LV   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      -   Phase 3   EUCTR2016-003630-25-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2012-003655-11-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
   Gilead Sciences
      2020   Phase 1   NCT04608344   United States
      2018   Phase 1   NCT03417778   Germany;New Zealand;United States
      2016   Phase 3   NCT02889796   Argentina;Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   NCT02886728   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 2   NCT02885181   Bulgaria;Czech Republic;Czechia;Georgia;Hungary;Moldova, Republic of;Poland;Ukraine;United States
      2016   Phase 3   NCT02873936   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
   Gilead Sciences, Inc.
      2018   Phase 3   EUCTR2016-003630-25-NL   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-GB   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-PL   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-NL   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-FR   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-ES   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-DE   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-BE   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001496-75-PL   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
      2016   Phase 2   EUCTR2016-001496-75-CZ   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
      2016   Phase 3   EUCTR2016-000570-37-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000569-21-HU   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000569-21-GB   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Kawakami Atsushi
      2021   -   JPRN-jRCTs071200107   -
   Universita di Verona
      2024   Phase 4   NCT06527534   Italy
Filgotinib 200MG/DAY
   Atsushi Kawakami
      2021   Phase 3   NCT05090410   Japan
   University Hospital, Toulouse
      2025   Phase 4   NCT06687551   -
Filgotinib maleate
   Eisai Korea Inc.
      2024   Phase 4   NCT06625242   Korea, Republic of
Filgrastim
   Fairview University Medical Center
      2000   -   NCT00006055   United States
Fish intake
   University of Leeds
      1995   -   NCT06670144   United Kingdom
Fish OIL
   Brigham and Women's Hospital
      2011   -   NCT01351805   United States
Fish OIL supplement
   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2004   Phase 2   NCT00094562   United States
Fish OIL, gamma-linolenic acid
   Charite University, Berlin, Germany
      2008   Phase 2   NCT01179971   -
FKB327
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   NCT02405780   Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-BG   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   NCT02260791   Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
   Yazawa Rie
      2017   Phase 1   JPRN-jRCT2071200057   -
   Yonemura Takuma
      2015   Phase 1   JPRN-jRCT2071200058   -
FKB327 AI
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
FKB327 PFS
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
Fludarabine
   IRIS Research and Development, LLC
      2024   Phase 1   NCT06581562   United States
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      1998   Phase 2   NCT00001677   United States
   Paul Szabolcs
      2014   Phase 2   NCT01962415   United States
Fluorescence imaging
   University Medical Center Groningen
      2023   Phase 1   NCT03938701   Netherlands
Fluorine F 18 clofarabine
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
Flurbiprofen
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02762123   United States
Focetria
   Div KIR AMC
      2010   -   EUCTR2009-016789-10-NL   Netherlands
   Tel-Aviv Sourasky Medical Center
      2009   Phase 2   NCT01006681   -
Folate
   Biogen
      2006   Phase 2   NCT00298272   United States
   Genentech, Inc.
      2006   Phase 3   NCT00299104   United States
      2006   Phase 3   NCT00266227   United States
      2005   Phase 3   NCT00299130   United States
      2005   Phase 2   NCT00243412   United States
   Hoffmann-La Roche
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2007   Phase 4   NCT00462345   Korea, Republic of
   VU Medical Center, department of Rheumatology
      2020   Phase 4   EUCTR2018-004429-94-NL   Netherlands
      2018   Phase 4   EUCTR2018-001114-15-NL   Netherlands
   XBiotech, Inc.
      2022   Phase 2   NCT05363917   -
Folic (or folinic) acid
   GlaxoSmithKline
      2016   Phase 2   NCT02799472   Germany;Poland;United States
Folic acid
   4SC AG
      2009   Phase 2   NCT01010581   Bulgaria;Czech Republic;Poland;Romania
   Amgen
      2015   Phase 3   NCT02373813   Argentina;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;South Africa;Spain;United States
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Biocad
      2016   Phase 3   NCT02762838   Belarus;India;Russian Federation
   Bird Rock Bio, Inc.
      2018   Phase 2   NCT02795299   -
   Chelsea Therapeutics
      2010   Phase 2   NCT01116141   -
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-CZ   Bulgaria;Czech Republic
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
   Cinnagen
      2015   Phase 3   NCT03172325   Iran, Islamic Republic of
   Eli Lilly and Company
      2012   Phase 3   NCT01711359   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Russian Federation;South Africa;Sweden;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   NCT02833350   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
   GlaxoSmithKline
      2017   Phase 1/Phase 2   NCT03028467   Japan
      2015   Phase 2   NCT02504671   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
   Hoffmann-La Roche
      2009   Phase 1   NCT00965653   Canada;New Zealand;Spain;United Kingdom
      2002   Phase 2   NCT02093026   Australia;Belgium;Brazil;Canada;Czech Republic;Finland;Germany;Israel;Italy;Mexico;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
      2015   Phase 4   NCT02644499   India
   Kaneko Yuko
      2018   Phase 4   JPRN-jRCT1031180088   Japan;South Korea;Taiwan
   Peking University People's Hospital
      2022   Phase 4   ChiCTR2200055292   China
      2015   Phase 2   NCT02467504   China
   Postgraduate Institute of Medical Education and Research
      2012   Phase 4   NCT01583959   India
   Sanofi
      2014   Phase 3   NCT02293902   Japan
      2013   Phase 1   NCT01850680   Japan
      2010   Phase 2/Phase 3   NCT01061736   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
   Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
      2024   Phase 4   ChiCTR2400090996   China
   Sun Yat-sen University
      2018   Phase 4   NCT04066803   China
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2015   Phase 2   JPRN-jRCT2080222927   -
   Takeda
      2015   Phase 2   NCT02393378   Czech Republic;Czechia;Estonia;Russian Federation;Spain;United Kingdom
   The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2022   Phase 0   ChiCTR2300067710   China
      2021   Phase 0   ChiCTR2100042659   China
      2021   Phase 0   ChiCTR2100042329   China
   The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041819   China
   Traditional Chinese Medicine Hospital of Dianjiang Chongqing
      2023   Phase 1   ChiCTR2300075439   China
   University of Alabama at Birmingham
      1996   Phase 2   NCT00000395   United States
   University of Dundee
      2005   Phase 4   EUCTR2005-000551-15-GB   United Kingdom
   University of Leeds
      2006   Phase 4   NCT01308255   United Kingdom
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
   Yunnan Hospital of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100053999   China
      2021   Phase 0   ChiCTR2100041894   China
   Yunnan Hospital of Traditional Chinese Medicine (The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine)
      2021   Phase 0   ChiCTR2100042328   China
   Yunnan Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Chinese Medicine
      2023   Phase 0   ChiCTR2300070837   China
   Yunnan Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100042440   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100054305   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041821   China
Folic acid or folate
   Hoffmann-La Roche
      2007   Phase 3   NCT00578305   Argentina;Brazil;Canada;Czech Republic;Denmark;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Latvia;Lithuania;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;United Kingdom
Folic/folinic acid
   Sanofi
      2010   Phase 2   NCT01217814   Brazil;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;Italy;Mexico;Norway;Spain;United States
   Takeda
      2014   Phase 2   NCT02379091   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Germany;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom
Folimet
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
Folinic acid
   University of Alabama at Birmingham
      1996   Phase 2   NCT00000395   United States
Fontolizumab
   PDL BioPharma, Inc.
      2005   Phase 2   NCT00281294   United States
Food groups and nutrients
   University of Leeds
      2006   -   NCT06670183   -
Fosd
   ASTRAZENECA
      2011   -   EUCTR2010-020892-22-IT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-020745-27-IT   Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-020744-35-IT   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
   Astra Zeneca AB
      2010   -   EUCTR2010-020743-12-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
   AstraZeneca AB
      2013   -   EUCTR2010-020892-22-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020892-22-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020892-22-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020745-27-HU   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-020745-27-DE   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-020744-35-DE   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020743-12-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020743-12-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-PT   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020892-22-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-020892-22-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-ES   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020892-22-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020892-22-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020745-27-PT   Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-020745-27-GB   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020745-27-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020745-27-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020745-27-CZ   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020745-27-BE   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-PT   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020744-35-LV   Canada;Czech Republic;Germany;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-LT   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-GB   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-ES   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020744-35-CZ   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020743-12-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020743-12-HU   Bulgaria;Estonia;France;Germany;Hungary;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-GB   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-FR   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020743-12-BE   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
Fosfamatinib disodium
   RIGEL PHARMACEUTICALS INC
      2009   -   EUCTR2008-000744-13-IT   Bulgaria;France;Germany;Italy
Fostamatinib
   AstraZeneca
      2012   Phase 1   NCT01725230   United States
      2012   Phase 2   NCT01640054   Hong Kong;Japan;Korea, Republic of;Taiwan;Thailand;Vietnam
      2012   Phase 2   NCT01569074   Hong Kong;Japan;Korea, Republic of;Taiwan;Thailand;Vietnam
      2012   Phase 2   NCT01563978   Argentina;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   Phase 2   JPRN-jRCT2080221945   -
      2012   Phase 2   JPRN-jRCT2080221801   -
      2011   Phase 2   NCT02092961   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;South Africa;United Kingdom;United States
      2011   Phase 1   NCT01355354   United Kingdom
      2011   Phase 1   NCT01336218   United States
      2011   Phase 1   NCT01311622   United Kingdom
      2011   Phase 1   NCT01309854   United States
      2011   Phase 1   NCT01276262   United Kingdom
      2011   Phase 2   NCT01264770   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 3   NCT01242514   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 1   NCT01245790   United States
      2010   Phase 3   NCT01197755   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   Phase 3   NCT01197534   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   Phase 3   NCT01197521   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
Fostamatinib 50 MG blue FILM-coated tablet
   AstraZeneca AB
      2012   -   EUCTR2011-006070-73-DE   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-CZ   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-BG   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
Fostamatinib disodium
   ASTRAZENECA
      2011   -   EUCTR2010-020892-22-IT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-020745-27-IT   Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-020744-35-IT   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
   Astra Zeneca AB
      2010   -   EUCTR2010-020743-12-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
   AstraZeneca
      2008   Phase 2   NCT00805467   Belgium;Bulgaria;Colombia;France;Germany;Italy;Mexico;Peru;Poland;Romania;United States
   AstraZeneca AB
      2013   -   EUCTR2010-020892-22-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-006070-73-DE   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-CZ   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-BG   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2011   Phase 2   EUCTR2010-023692-26-SK   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023692-26-GB   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020892-22-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020892-22-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020745-27-HU   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-020745-27-DE   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2011   -   EUCTR2010-020744-35-DE   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020743-12-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-020743-12-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-PT   Belgium;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020892-22-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-020892-22-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-ES   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020892-22-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020892-22-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020892-22-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Lithuania;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020745-27-PT   Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-020745-27-GB   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020745-27-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020745-27-ES   Belgium;Czech Republic;France;Germany;Hungary;Italy;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020745-27-CZ   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020745-27-BE   Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Mexico;Portugal;South Africa;Spain;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-PT   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020744-35-LV   Canada;Czech Republic;Germany;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-LT   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-GB   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020744-35-ES   Czech Republic;Germany;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-020744-35-CZ   Canada;Czech Republic;Germany;India;Israel;Italy;Latvia;Lithuania;Portugal;Romania;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020743-12-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   -   EUCTR2010-020743-12-HU   Bulgaria;Estonia;France;Germany;Hungary;Poland;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-GB   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-FR   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
      2010   Phase 3   EUCTR2010-020743-12-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Chile;Estonia;France;Germany;Hungary;India;Mexico;Peru;Poland;Russian Federation;Slovakia;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-020743-12-BE   Belgium;Bulgaria;Estonia;France;Germany;Hungary;Poland;Slovakia;United Kingdom
      2009   -   EUCTR2008-000744-13-BG   Belgium;Bulgaria;Colombia;France;Germany;Italy;Mexico;Peru;Poland;Romania;United States
      2008   Phase 2   EUCTR2008-000744-13-BE   Belgium;Bulgaria;France;Germany;Italy
      -   -   EUCTR2010-023692-26-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      -   -   EUCTR2008-000744-13-DE   Belgium;Bulgaria;France;Germany;Italy
   Rigel Pharmaceuticals
      2008   Phase 2   NCT00665925   Bulgaria;Colombia;Israel;Mexico;Poland;Romania;United States
      2008   Phase 2   NCT00665626   Belgium;Brazil;Colombia;France;Germany;Italy;Peru;United States
   Rigel Pharmaceuticals, Inc
      2009   -   EUCTR2008-000744-13-FR   Bulgaria;France;Germany;Italy
   Rigel Pharmaceuticals, Inc.
      2008   Phase 2   EUCTR2008-000743-34-FR   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000743-34-DE   France;Germany;Italy
      2008   -   EUCTR2008-000743-34-BE   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000742-30-PL   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-HU   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-BG   Bulgaria;Hungary;Poland
FPA008
   Five Prime Therapeutics, Inc.
      2013   Phase 1   NCT01962337   Hungary;Netherlands;Poland
FR104
   OSE Immunotherapeutics
      2015   Phase 1   NCT02800811   Belgium
Fruit and vegetables intake
   University of Leeds
      1995   -   NCT06670144   United Kingdom
FSME-immun
   Mälarsjukhuset Eskilstuna
      2010   -   EUCTR2010-019438-28-SE   Sweden
Full history , clinical examination, assesment OF disease activity ,laboratory investigations ( CBC , ESR, CRP serum creatinine and blood urea, random plas
   Assiut University
      2024   -   NCT06586567   -
Furestem-RA INJ
   Kang Stem Biotech Co., Ltd.
      2018   Phase 1/Phase 2   NCT03618784   Korea, Republic of
      2016   -   NCT03106259   Korea, Republic of
      2014   Phase 1   NCT02221258   Korea, Republic of
FX125L
   Funxional Therapeutics Ltd
      2011   -   EUCTR2011-005036-26-GB   United Kingdom
G1567970
   Galapagos NV
      2020   Phase 2   EUCTR2020-000658-83-BG   Bulgaria;Georgia;Poland;Ukraine
Gadobutrol
   GlaxoSmithKline
      2015   Phase 1   NCT02350426   United Kingdom
Gadolinium
   Tokyo Medical and Dental University
      2013   -   JPRN-UMIN000012399   Japan
Gamma-linolenic acid
   FDA Office of Orphan Products Development
      1994   -   NCT00004420   -
GB224 10MG
   Genor Biopharma Co., Ltd.
      2019   Phase 1   NCT04179513   China
      2017   Phase 1   NCT04178070   China
GB224 15MG
   Genor Biopharma Co., Ltd.
      2017   Phase 1   NCT04178070   China
GB224 20MG
   Genor Biopharma Co., Ltd.
      2019   Phase 1   NCT04179513   China
      2017   Phase 1   NCT04178070   China
GB224 2MG
   Genor Biopharma Co., Ltd.
      2017   Phase 1   NCT04178070   China
GB224 30MG
   Genor Biopharma Co., Ltd.
      2017   Phase 1   NCT04178070   China
GB224 5MG
   Genor Biopharma Co., Ltd.
      2017   Phase 1   NCT04178070   China
GB242
   Genor Biopharma Co., Ltd.
      2017   Phase 3   NCT04178850   China
GCK 100 MG
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2017   Phase 1   NCT03755258   China
GCK 200 MG
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2017   Phase 1   NCT03755258   China
GCK 300 MG
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2017   Phase 1   NCT03755258   China
GDC-0853
   Genentech, Inc.
      2016   Phase 2   NCT02983227   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
      2016   Phase 2   NCT02833350   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
GDC-0853 RO7010939
   Genentech, Inc.
      2016   Phase 2   EUCTR2016-000498-19-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
      2016   Phase 2   EUCTR2016-000335-40-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
Geleli
   Peking University People's Hospital
      2022   -   NCT05240859   China
Gene expressions OF mirna
   Saglik Bilimleri Universitesi
      2018   -   NCT05914337   Turkey
General anesthesia with tourniquet
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
General anesthesia without tourniquet
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
General population
   Janssen Biotech, Inc.
      2009   -   NCT01081717   United States
Genetically engineered biological drugs, janus-kinase inhibitors, tumor necrosis factor inhibitors
   Institute of Biomedical Chemistry, Russia
      2021   -   NCT06177405   Russian Federation
Gensci048
   Changchun GeneScience Pharmaceutical Co., Ltd.
      2023   Phase 2   NCT06189495   China
Gerilimzumab
   Bird Rock Bio, Inc.
      2018   Phase 2   NCT02795299   -
GFI 38518168-AEK-B-007
   Janssen-Cilag International NV
      2009   -   EUCTR2009-012118-27-NL   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-GB   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-ES   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-CZ   Czech Republic;Netherlands;Spain;United Kingdom
Ginger
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
Ginseng
   Zhejiang Provincal Hospital of TCM
      2019   Phase 2   ChiCTR1900026257   China
Ginsenoside
   Institute of Clinical Pharmacology, Central South University
      2015   Phase 1 study   ChiCTR-IPR-15006107   China
      2015   Phase 1 study   ChiCTR-IPR-15005787   China
      2014   Phase 1 study   ChiCTR-TRC-14004824   China
GLPG0259
   Galápagos NV
      2010   -   EUCTR2009-015898-12-NL   Belgium;Netherlands
      2010   -   EUCTR2009-015898-12-BE   Belgium;Netherlands
GLPG0259 oral capsule
   Galapagos NV
      2010   Phase 2   NCT01211249   Belgium;Netherlands;Poland;Russian Federation;Ukraine
GLPG0634
   Galapagos NV
      2019   Phase 2   EUCTR2018-003933-14-LV   Belgium;Bulgaria;Czech Republic;Estonia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-EE   Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Latvia;Poland;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-CZ   Belgium;Bulgaria;Czech Republic;Czechia;Estonia;Latvia;Poland;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Czechia;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2019   Phase 2   EUCTR2018-003933-14-BE   Belgium;Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Georgia;Germany;India;Latvia;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine
      2017   Phase 2   EUCTR2012-003655-11-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003635-31-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   Phase 2   NCT01894516   Argentina;Australia;Austria;Bulgaria;Chile;Colombia;Germany;Guatemala;Hungary;Latvia;Mexico;Moldova, Republic of;New Zealand;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2013   Phase 2   NCT01888874   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2012   Phase 2   NCT01668641   Hungary;Moldova, Republic of;Russian Federation;Ukraine
      2011   Phase 2   NCT01384422   Moldova, Republic of
   Galapagos SASU
      2012   -   EUCTR2011-005008-14-HU   European Union;Hungary;Moldova, Republic of;Russian Federation;Ukraine
   Gilead Sciences Inc.
      2014   Phase 2   EUCTR2012-003655-11-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
GLPG3970
   Galapagos NV
      2020   Phase 2   NCT04577781   Bulgaria;Georgia;Poland;Ukraine
      2020   Phase 2   EUCTR2020-000658-83-BG   Bulgaria;Georgia;Poland;Ukraine
Glucocorticoid
   Department of Pain, Guizhou Provincial People's Hospita
      2020   Phase 0   ChiCTR2000033004   China
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
   Osaka City University Medical School
      2011   Phase 4   JPRN-UMIN000008164   Japan
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2022   Phase 4   NCT05606107   China
   University Hospital, Toulouse
      2017   Phase 4   NCT02997605   France
Glucocorticoid agent
   Hoffmann-La Roche
      2017   -   NCT03291457   Belgium
Glucoside
   Caidian District People's Hospital of Wuhan
      2023   Phase 0   ChiCTR2300076293   Chin
Glucotrace
      2023   Phase 4   EUCTR2021-005613-14-NL   Netherlands
Glycyrrhizin
   The Second Affiliated Hospital of Guangxi Medical University
      2022   Phase 4   ChiCTR2100052492   China
Glycyrrhizin and boswellic acid
   Adel A.Gomaa
      2023   -   NCT05788705   -
GNC-038
   Sichuan Baili Pharmaceutical Co., Ltd.
      2025   Phase 1   NCT06857227   China
GOL
   University Medical Center Utrecht (UMCU)
      2016   Phase 4   EUCTR2015-004858-17-NL   Netherlands
Golimumab
   Alvotech Swiss AG
      2023   Phase 3   NCT05842213   Bulgaria
      2023   Phase 3   EUCTR2022-001825-63-LT   Bulgaria;Czechia;Georgia;Lithuania;Poland;Serbia
      2023   Phase 3   EUCTR2022-001825-63-BG   Bulgaria;Georgia;Lithuania;Poland
   CENTOCOR
      2010   -   EUCTR2009-010582-23-IT   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-IT   Austria;Hungary;Italy;Spain;United Kingdom
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   Centocor B.V.
      2010   -   EUCTR2008-006064-11-HU   Hungary;Lithuania
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-001742-16-NL   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-ES   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   Centocor, Inc.
      2010   Phase 3   NCT01248780   China
      2009   Phase 3   NCT00973479   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
      2007   Phase 1   NCT01362153   United States
      2006   Phase 3   NCT00361335   Argentina;Australia;Belgium;Colombia;Germany;Hungary;Latvia;Lithuania;Malaysia;Malta;Mexico;New Zealand;Peru;Poland;Russian Federation;Ukraine;United States
      2003   Phase 2   NCT00207714   -
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Janssen Biologics B.V.
      2009   -   EUCTR2008-006064-11-LT   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
   Janssen Biotech, Inc.
      2009   -   NCT01081717   United States
   Janssen Inc.
      2019   -   NCT03729349   Canada
   Janssen-Cilag, S.A.
      2015   -   NCT02414984   Colombia
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   MedImmune Limited
      2013   Phase 2   EUCTR2011-005649-10-GB   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   MedImmune Ltd
      2013   -   EUCTR2011-005649-10-SK   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-PT   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-HU   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-DE   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-CZ   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-GR   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-ES   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2010   -   EUCTR2009-011137-26-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Osaka City University Medical School
      2012   Phase 4   JPRN-UMIN000009425   Japan
   Osaka Medical College
      2015   -   JPRN-UMIN000016950   Japan
   Peking Union Medical College Hospital
      2019   -   NCT04188249   China
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   Rheumatology, Internal MedicineJuntendo University School of Medicine, Juntendo Koshigaya Hospital
      2013   -   JPRN-UMIN000014485   Japan
   SCHERING PLOUGH RESEARCH INSTITUTE, A DIVISION OF SCHERING CORPORATION
      2012   -   EUCTR2011-000311-34-IT   Canada;Finland;Germany;Greece;Italy;Russian Federation;Spain;Turkey;United Kingdom;United States
   Sanofi
      2010   Phase 2   NCT01217814   Brazil;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;Italy;Mexico;Norway;Spain;United States
   Sanofi-aventis Recherche & D?veloppement
      2010   -   EUCTR2010-021020-94-IT   Czech Republic;Germany;Hungary;Italy;Spain
   Sanofi-aventis Recherche & Développement
      2011   -   EUCTR2010-021020-94-HU   Czech Republic;Germany;Hungary;Italy;Spain
      2011   -   EUCTR2010-021020-94-DE   Czech Republic;Germany;Hungary;Italy;Spain
      2010   -   EUCTR2010-021020-94-ES   Czech Republic;Germany;Hungary;Italy;Spain
      2010   -   EUCTR2010-021020-94-CZ   Czech Republic;Germany;Hungary;Italy;Spain
   Schering-Plough Research Institute, A Division of Schering Corporation
      2010   -   EUCTR2009-011137-26-PL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-011137-26-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-SK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-IE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-HU   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-ES   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Shering Plough Research Institute, A division of Schering Plough Corporation
      2010   -   EUCTR2009-011137-26-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Sint Maartenskliniek
      2020   Phase 4   EUCTR2019-004101-27-NL   Netherlands
   St.Marianna University School of Medicine
      2013   -   JPRN-UMIN000011891   Japan
   Sungkyunkwan University
      2020   -   NCT04115423   Korea, Republic of
   Takarazuka city hospital
      2014   -   JPRN-UMIN000016844   Japan
   TcLand Expression S.A.
      2016   -   NCT03016260   Czech Republic;Czechia;France;Israel;Netherlands;Turkey
   University Medical Center Utrecht (UMCU)
      2016   Phase 4   EUCTR2015-004858-17-NL   Netherlands
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Golimumab 100 MG
   Centocor, Inc.
      2006   Phase 3   NCT00299546   Australia;Austria;Canada;Finland;France;Germany;Netherlands;New Zealand;Spain;Switzerland;United Kingdom;United States
      2005   Phase 3   NCT00264550   Argentina;Australia;Brazil;Canada;Chile;Germany;Hungary;India;Korea, Republic of;Mexico;New Zealand;Poland;Taiwan;Turkey;United States
Golimumab 100 MG injections
   Centocor, Inc.
      2005   Phase 3   NCT00264537   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Golimumab 2 MG/KG IV
   Janssen Biotech, Inc.
      2013   Phase 3   NCT01962974   Argentina;Brazil;Canada;Colombia;Mexico;United States
      2009   Phase 3   NCT01004432   Austria;Belgium;Canada;France;Germany;Greece;Spain;Sweden;United Kingdom;United States
Golimumab 50 MG
   Centocor, Inc.
      2006   Phase 3   NCT00299546   Australia;Austria;Canada;Finland;France;Germany;Netherlands;New Zealand;Spain;Switzerland;United Kingdom;United States
      2005   Phase 3   NCT00264550   Argentina;Australia;Brazil;Canada;Chile;Germany;Hungary;India;Korea, Republic of;Mexico;New Zealand;Poland;Taiwan;Turkey;United States
   MedImmune LLC
      2013   Phase 2   NCT01715896   Argentina;Colombia;Czech Republic;France;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Serbia;Slovakia;Spain;Turkey;United Kingdom
Golimumab 50 MG injections
   Centocor, Inc.
      2005   Phase 3   NCT00264537   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Golimumab 50 MG SC
   Janssen Biotech, Inc.
      2009   Phase 3   NCT01004432   Austria;Belgium;Canada;France;Germany;Greece;Spain;Sweden;United Kingdom;United States
Golimumab intravenous
   Janssen Inc.
      2015   -   NCT02390700   Canada
   Janssen Scientific Affairs, LLC
      2016   -   NCT02728934   United States
Golimumab liquid IN prefilled PEN
   Janssen Biologics B.V.
      2010   -   EUCTR2009-010582-23-DE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2009-010582-23-SE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
Golimumab liquid IN prefilled PEN or prefilled syringe
   Janssen Biologics B.V.
      2010   Phase 3   EUCTR2009-010582-23-BE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2009-010582-23-AT   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
Golimumab liquid IN prefilled syringe
   Janssen Biologics B.V.
      2011   -   EUCTR2009-015019-42-DE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Peru;Poland;Russian Federation;United States
      2011   Phase 3   EUCTR2009-015019-42-BE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-LT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-FI   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-AT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      -   -   EUCTR2009-015019-42-Outside-EU/EEA   Argentina;Brazil;Canada;Mexico;Peru;Russian Federation;United States
Golimumab liquid IN vial
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
   Janssen Biologics B.V.
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
Golimumab PRE-filled syringe
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
   Janssen Biologics B.V.
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
Golimumab prefilled PEN
   Centocor BV
      2010   -   EUCTR2009-010582-23-GR   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
Golimumab prefilled PEN or prefilled syringe
   Janssen Biologics B.V.
      2009   Phase 3   EUCTR2009-010582-23-GB   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
GP2013
   Hexal AG
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-PL   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-HU   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2012   Phase 2   EUCTR2010-021184-32-EE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2011   Phase 2   EUCTR2010-021184-32-IT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2011   Phase 2   EUCTR2010-021184-32-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-FR   Austria;Belgium;Bulgaria;Estonia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-DE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
   Hexal AG (a Sandoz company)
      2015   Phase 3   EUCTR2012-003876-38-PL   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-HU   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-DE   Germany;Hungary;Poland;United States
   Sandoz
      2011   Phase 1/Phase 2   NCT01274182   Argentina;Austria;Belgium;Brazil;Estonia;France;Germany;Hungary;India;Italy;Romania;Spain;Turkey;United States
GP2013 - A proposed biosimilar rituximab
   Sandoz
      2015   Phase 3   NCT02514772   Germany;Hungary;Poland;United States
GP2015
   Hexal AG
      2016   Phase 3   EUCTR2012-002009-23-HU   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2016   Phase 3   EUCTR2012-002009-23-DE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-SK   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-PL   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LV   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-LT   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-ES   Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-EE   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-CZ   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
      2015   Phase 3   EUCTR2012-002009-23-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
   Sandoz
      2015   Phase 3   NCT02638259   Bulgaria;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Spain;United Kingdom;United States
GP2017
   HEXAL AG
      2016   Phase 3   EUCTR2015-003433-10-IT   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
Grapefruit
   Department of Rheumatology and Clinical Immunology, Kyoto University Hospital
      2014   -   JPRN-UMIN000013546   Japan
GRC 4039
   Glenmark Pharmaceuticals SA
      2011   -   EUCTR2011-000107-40-GB   India;Philippines;Poland;Sri Lanka;United Kingdom
Green TEA group
   King Saud University
      2015   -   NCT03719469   -
Group 1 or orencia treated group
   University of California, Los Angeles
      2012   Phase 4   NCT01717846   United States
Growth hormone
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
GS-0151
   Gilead Sciences
      2025   Phase 1   NCT06902519   -
GS-0272
   Gilead Sciences
      2023   Phase 1   NCT06031415   Georgia;Korea, Republic of;Moldova, Republic of;United Kingdom;United States
GS-5718
   Gilead Sciences
      2022   Phase 2   NCT05165771   -
GS-5745
   Gilead Sciences
      2014   Phase 1   NCT02176876   Czech Republic;Hungary
   Gilead Sciences, Inc.
      2017   Phase 2   EUCTR2016-000897-39-HU   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
      2017   Phase 2   EUCTR2016-000897-39-DE   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
      2017   Phase 2   EUCTR2016-000897-39-BE   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
GS-6034
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Galapagos NV
      2018   Phase 3   EUCTR2016-003630-25-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-PL   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2012-003655-11-HU   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   Phase 2   EUCTR2012-003655-11-BG   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   Phase 2   EUCTR2012-003655-11-BE   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2013   Phase 2   EUCTR2012-003655-11-LV   Argentina;Australia;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      -   Phase 3   EUCTR2016-003630-25-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      -   Phase 2   EUCTR2012-003655-11-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Czechia;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Spain;Ukraine;United States
   Gilead Sciences Inc.
      2014   Phase 2   EUCTR2012-003655-11-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
   Gilead Sciences, Inc.
      2018   Phase 3   EUCTR2016-003630-25-NL   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-GB   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-PL   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-NL   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-FR   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-ES   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-DE   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000569-21-BE   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 2   EUCTR2016-001496-75-PL   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
      2016   Phase 2   EUCTR2016-001496-75-CZ   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
      2016   Phase 3   EUCTR2016-000570-37-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000569-21-HU   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000569-21-GB   Argentina;Australia;Belgium;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
GS-9876
   Gilead Sciences
      2016   Phase 2   NCT02885181   Bulgaria;Czech Republic;Czechia;Georgia;Hungary;Moldova, Republic of;Poland;Ukraine;United States
   Gilead Sciences, Inc.
      2016   Phase 2   EUCTR2016-001496-75-PL   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
      2016   Phase 2   EUCTR2016-001496-75-CZ   Bulgaria;Czech Republic;Hungary;Poland;Serbia;Ukraine;United States
GSK 3196165
   GlaxoSmithKline Research & Development Limited
      2021   Phase 3   EUCTR2019-000878-30-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-000878-30-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
GSK1827771
   GlaxoSmithKline
      2007   Phase 1   NCT00539760   United States
GSK1841157
   GlaxoSmithKline Research & Development Ltd
      2008   Phase 1;Phase 2   EUCTR2008-002046-27-FR   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-DE   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-BE   Belgium;France;Germany;Spain
   GlaxoSmithKline S.A.
      2008   -   EUCTR2008-002046-27-ES   Belgium;France;Germany;Spain
GSK2982772
   GlaxoSmithKline Research & Development Ltd
      2016   Phase 2   EUCTR2016-000912-13-PL   Germany;Italy;Poland;Romania;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000912-13-GB   Germany;Italy;Poland;Romania;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000912-13-DE   Germany;Italy;Poland;Romania;Spain;United Kingdom
GSK2982772 60 MG
   GlaxoSmithKline
      2016   Phase 2   NCT02858492   Germany;Italy;Poland;Russian Federation;Spain;United Kingdom
GSK2982772A, where A denotes THE free base
   GlaxoSmithKline Research & Development Ltd
      2016   Phase 2   EUCTR2016-000912-13-PL   Germany;Italy;Poland;Romania;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000912-13-GB   Germany;Italy;Poland;Romania;Spain;United Kingdom
      2016   Phase 2   EUCTR2016-000912-13-DE   Germany;Italy;Poland;Romania;Spain;United Kingdom
GSK3117391
   GlaxoSmithKline
      2016   Phase 2   NCT02965599   Mexico;Poland;Romania
   GlaxoSmithKline Research & Development Ltd
      2016   Phase 2   EUCTR2015-005800-27-PL   Poland;Romania;Russian Federation
GSK3152314A
   GlaxoSmithKline
      2008   Phase 2   NCT00674635   Australia;Former Serbia and Montenegro;New Zealand;Russian Federation;Serbia;Ukraine;United Kingdom
GSK315234
   GlaxoSmithKline Research & Development Ltd
      2008   -   EUCTR2006-000923-32-GB   United Kingdom
GSK315234 injection 100MG/ML
   GlaxoSmithKline Research & Development Limited
      2010   -   EUCTR2009-012055-19-IE   Belgium;France;Ireland;United Kingdom
      2010   -   EUCTR2009-012055-19-GB   Belgium;France;Ireland;United Kingdom
      2010   Phase 2   EUCTR2009-012055-19-FR   Belgium;France;Ireland;United Kingdom
      2010   -   EUCTR2009-012055-19-BE   Belgium;France;Ireland;United Kingdom
GSK3196165
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-IT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2014-003453-34-IT   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom
   GlaxoSmithKline
      2020   Phase 3   NCT04333147   Argentina;Australia;Belgium;Bulgaria;Canada;China;Colombia;Czechia;Estonia;Germany;Hungary;India;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT04134728   Argentina;Belgium;Canada;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   NCT03980483   Argentina;Canada;China;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT03970837   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2016   Phase 2   NCT02799472   Germany;Poland;United States
      2015   Phase 2   NCT02504671   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
   GlaxoSmithKline Research & Development Limited
      2021   Phase 3   EUCTR2019-000878-30-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-ES   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-CZ   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-ES   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-ES   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-CZ   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2018   Phase 2   EUCTR2015-004386-91-PL   Germany;Poland;United States
      2016   Phase 2   EUCTR2015-004386-91-DE   Germany;Poland;United States
      2015   Phase 2   EUCTR2014-003453-34-PL   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-HU   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-GB   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-ES   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-EE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-DE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-CZ   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      -   Phase 3   EUCTR2019-000878-30-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
GSK3196165 dose 1
   GlaxoSmithKline
      2017   Phase 1/Phase 2   NCT03028467   Japan
GSK3196165 dose 2
   GlaxoSmithKline
      2017   Phase 1/Phase 2   NCT03028467   Japan
GSK3196165 dose 3
   GlaxoSmithKline
      2017   Phase 1/Phase 2   NCT03028467   Japan
GSK706769
   GlaxoSmithKline
      2010   Phase 2   NCT00979771   Netherlands
   GlaxoSmithKline Research & Development Limited
      2009   -   EUCTR2009-012204-42-IE   Belgium;Ireland
      2009   -   EUCTR2009-012204-42-BE   Belgium;Ireland
GUM arabic
   Lamis Kaddam
      2016   Phase 2   NCT02804581   Sudan
GUNA-anti interleukin 1
   GUNA SPA
      2011   -   EUCTR2011-003016-23-IT   Italy
GUNA-antiinterleukin 1 alfa
   GUNA SPA
      2011   -   EUCTR2011-003016-23-IT   Italy
GUNA-antiinterleukin 1 beta
   GUNA SPA
      2011   -   EUCTR2011-003016-23-IT   Italy
GUNA-interleukin 10
   GUNA SPA
      2011   -   EUCTR2011-003016-23-IT   Italy
GUNA-interleukin 4
   GUNA SPA
      2011   -   EUCTR2011-003016-23-IT   Italy
GW274150
   GlaxoSmithKline
      2006   Phase 2   NCT00379990   Serbia;United Kingdom
      2005   Phase 2   NCT00370435   United Kingdom
GW274150 tablets
   GlaxoSmithKline Research & Development Limited
      2005   Phase 2   EUCTR2005-001977-82-GB   United Kingdom
GW406381
   GLAXO SMITHKLINE
      2005   -   EUCTR2005-000158-61-IT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline
      2005   Phase 3   NCT00113308   Argentina;Austria;Belgium;Bulgaria;Canada;Chile;Costa Rica;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Pakistan;Peru;Philippines;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2006   -   EUCTR2005-000158-61-LT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-EE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-DE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-CZ   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-LV   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-IE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-HU   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-GB   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-DK   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-AT   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      2004   -   EUCTR2004-000106-41-SE   Sweden
   GlaxoSmithKline s.a.
      2005   Phase 3   EUCTR2005-000158-61-ES   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
GW406381X
   GlaxoSmithKline Research & Development Limited
      2006   -   EUCTR2005-000158-61-LT   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-EE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-DE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2006   -   EUCTR2005-000158-61-CZ   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-LV   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-IE   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-HU   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-GB   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-DK   Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
      2005   -   EUCTR2005-000158-61-AT   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
   GlaxoSmithKline s.a.
      2005   Phase 3   EUCTR2005-000158-61-ES   Austria;Czech Republic;Denmark;Estonia;Germany;Hungary;Ireland;Italy;Latvia;Lithuania;Spain;United Kingdom
GW856553
   GlaxoSmithKline
      2007   Phase 1   NCT00517543   United States
      2006   Phase 2   NCT00393146   Romania;Russian Federation;Spain
      2005   Phase 2   NCT00256919   Bulgaria;Germany;Spain;Sweden;Ukraine
   GlaxoSmithKline Research & Development Ltd
      2005   -   EUCTR2005-002969-37-SE   Germany;Spain;Sweden
      -   -   EUCTR2005-002969-37-DE   Germany;Spain;Sweden
   GlaxoSmithKline S.A.
      2005   Phase 2   EUCTR2005-002969-37-ES   Germany;Spain;Sweden
H.P. acthar GEL
   Iraj Sabahi Research Inc.
      2017   Phase 4   NCT03082573   United States
   Ronald J. Rapoport, MD
      2014   -   NCT02434757   United States
H02ab04
   Leiden University medical Centre
      2015   Phase 2   EUCTR2014-004472-35-NL   Netherlands
H02ab07
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
Hand training
   Vastra Gotaland Region
      2020   -   NCT04378621   Sweden
HarkáNY medicinal water
   University of Pecs
      2020   -   NCT04275206   Hungary
Havrix
   HY, HUS
      2011   -   EUCTR2009-016055-22-SE   Finland;Sweden
   Lars Rombo
      2009   Phase 2   NCT01360970   Finland;Sweden
HB-admscs
   Hope Biosciences
      2018   Phase 1/Phase 2   NCT03691909   United States
Hbvaxpro
   Radboud University Nijmegen Medical Centre
      2008   -   EUCTR2008-001282-28-NL   Netherlands
Hbvaxpro 5 micrograms/0.5 ML
   FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA (VHIR)
      2018   Phase 4   EUCTR2018-002368-18-ES   Spain
Hbvaxpro® 40 micrograms
   FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA (VHIR)
      2018   Phase 4   EUCTR2018-002368-18-ES   Spain
HCQ
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   National Institute of Allergy and Infectious Diseases (NIAID)
      2016   Phase 2   NCT02603146   United States
   Peking University First Hospital
      2015   -   NCT02320630   China
   Qilu Hospital of Shandong University
      2016   Phase 4   NCT03855007   China
HD-TIV
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2016   Phase 4   NCT02936180   Canada
HE3286
   Harbor Therapeutics
      2008   Phase 1/Phase 2   NCT00712114   United States
Healthy volunteers
   Rennes University Hospital
      2017   -   NCT03110094   France
Hematopoietic stem cell transplantation
   Northwestern University
      2002   Phase 1   NCT00282412   United States
Hemay007 1200 MG QD group
   Tianjin Hemay Pharmaceutical Co., Ltd
      2021   Phase 2   NCT05247216   China
Hemay007 600 MG QD group
   Tianjin Hemay Pharmaceutical Co., Ltd
      2021   Phase 2   NCT05247216   China
Hemay007 800 MG QD group
   Tianjin Hemay Pharmaceutical Co., Ltd
      2021   Phase 2   NCT05247216   China
Hepatitis A vaccine
   Lars Rombo
      2009   Phase 2   NCT01360970   Finland;Sweden
   Sormland County Council, Sweden
      2011   Phase 2   NCT01446978   Sweden
Hepatitis A vaccine and tetanus vaccine
   University of Zurich
      2013   -   NCT01947465   Switzerland
Hepatitis B vaccine
   FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA (VHIR)
      2018   Phase 4   EUCTR2018-002368-18-ES   Spain
Herpes zoster vaccine
   University of Alabama at Birmingham
      2016   Phase 2   NCT02538341   United States
      2014   Phase 2   NCT01967316   United States
      2013   Phase 2   NCT02538757   United States
   University of Sao Paulo General Hospital
      2023   Phase 4   NCT05879419   Brazil
High dose OF biil 284 BS tablets
   Boehringer Ingelheim
      2000   Phase 1   NCT02247375   -
High dose ORTD-1
   Oryn Therapeutics, LLC
      2021   Phase 1   NCT04286789   United States
High dose vehicle control
   Oryn Therapeutics, LLC
      2021   Phase 1   NCT04286789   United States
High frequency ultrasonography
   GlaxoSmithKline
      2004   -   NCT00242853   United Kingdom
Hiscs
   Shanghai Changzheng Hospital
      2025   -   NCT06947746   China
HL237
   Hanlim Pharm. Co., Ltd.
      2018   Phase 1   NCT03896594   Korea, Republic of
      2017   Phase 1   NCT03278470   Korea, Republic of
HL237 tablet
   Hanlim Pharm. Co., Ltd.
      2020   Phase 2   NCT04638426   Korea, Republic of
HLX01
   Shanghai Henlius Biotech
      2018   Phase 3   NCT03522415   China
      2016   Phase 1/Phase 2   NCT03355872   -
HM71224 food effect
   Hanmi Pharmaceutical Company Limited
      2013   Phase 1   NCT01765478   Netherlands
HM71224 multiple ascending dose
   Hanmi Pharmaceutical Company Limited
      2013   Phase 1   NCT01765478   Netherlands
HM71224 single ascending dose
   Hanmi Pharmaceutical Company Limited
      2013   Phase 1   NCT01765478   Netherlands
HMPL-523
   Hutchison Medipharma Limited
      2014   Phase 1   NCT02105129   Australia
HRIL-2 active
   Peking University People's Hospital
      2015   Phase 2   NCT02467504   China
HS628+MTX
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2020   Phase 3   NCT06048224   China
Huang QI GUI ZHI WU WU granule
   Cui xuejun
      2018   Phase 2/Phase 3   NCT03593837   -
HUC-MSC + dmards
   Shenzhen Hornetcorn Bio-technology Company, LTD
      2016   Phase 1   NCT02643823   China
HUC-MSC suspension
   Baylx Inc.
      2025   Phase 1   NCT03828344   -
Human anti TNF-alpha monoclonal
   Centocor BV
      2010   -   EUCTR2009-010582-23-GR   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
Human anti TNF-alpha monoclonal antibody
   Janssen Biologics B.V.
      2010   -   EUCTR2009-010582-23-DE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-010582-23-BE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2009-010582-23-SE   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-010582-23-GB   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
Human ANTI-IL6 monoclonal antibody
   JANSSEN-CILAG INTERNATIONAL N.V.
      2012   -   EUCTR2010-022243-38-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Portugal;Spain;Taiwan;United Kingdom;United States
   Janssen-Cilag International N.V.
      2015   Phase 3   EUCTR2012-001176-10-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2010-022243-38-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2010-022242-24-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
      2012   -   EUCTR2010-022243-38-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022243-38-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Serbia;Spain;Sweden;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022242-24-LT   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
Human ANTI-TNF IGG1 monoclonal antibody
   Centocor B.V.
      2006   -   EUCTR2005-001742-16-NL   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-ES   Austria;Germany;Netherlands;Spain;United Kingdom
   Janssen Biologics B.V.
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
Human ANTI-TNF-alpha monoclonal antibody
   Centocor B.V.
      2010   -   EUCTR2008-006064-11-HU   Hungary;Lithuania
   Janssen Biologics B.V.
      2011   -   EUCTR2009-015019-42-DE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Peru;Poland;Russian Federation;United States
      2011   Phase 3   EUCTR2009-015019-42-BE   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-LT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-FI   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-015019-42-AT   Argentina;Austria;Belgium;Brazil;Canada;Finland;Germany;Lithuania;Mexico;Netherlands;Poland;Russian Federation;Serbia;United States
      2009   -   EUCTR2009-010582-23-AT   Austria;Belgium;Germany;Greece;Italy;Sweden;United Kingdom
      2009   -   EUCTR2008-006064-11-LT   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
      -   -   EUCTR2009-015019-42-Outside-EU/EEA   Argentina;Brazil;Canada;Mexico;Peru;Russian Federation;United States
Human ANTI-tnfalfa
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-001742-16-NL   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-ES   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   Janssen Biologics B.V.
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
Human IGG4 monoclonal antibody against CD40
   Kiniksa Pharmaceuticals, Ltd.
      2023   Phase 2   EUCTR2022-000169-42-HU   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2023   Phase 2   EUCTR2022-000169-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2022   Phase 2   EUCTR2022-000169-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2022   Phase 2   EUCTR2022-000169-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
Human monoclonal antibody directed against CD20 ON B-cells
   Genmab A/S
      2006   -   EUCTR2004-003771-37-HU   Hungary
Human recombinant IGG1, lambda
   MorphoSys AG
      2010   -   EUCTR2007-006129-29-PL   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2010   -   EUCTR2007-006129-29-NL   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2010   -   EUCTR2007-006129-29-BG   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2009   -   EUCTR2007-006129-29-DE   Bulgaria;Germany;Netherlands;Poland;Ukraine
Humanised ANTI-CD 20 antibody
   Nycomed GmbH
      2011   -   EUCTR2010-022378-15-HU   Czech Republic;Germany;Hungary;Spain;United Kingdom
      2011   -   EUCTR2010-022378-15-GB   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-ES   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-DE   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-CZ   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
Humanised ANTI-CD4 IGG1 monoclonal
   Biotest AG
      2012   Phase 2   EUCTR2010-018485-24-LV   Czech Republic;Germany;Hungary;Latvia;Spain
      2012   -   EUCTR2010-018485-24-HU   Czech Republic;Germany;Hungary;Latvia;Spain
      2011   Phase 2   EUCTR2010-018485-24-ES   Czech Republic;Germany;Hungary;Latvia;Spain
      2011   -   EUCTR2010-018485-24-DE   Czech Republic;Germany;Hungary;Latvia;Spain
      2010   -   EUCTR2010-018485-24-CZ   Czech Republic;Germany;Hungary;Latvia;Spain
Humanized immunoglobulin gamma 1 (IGG1) kappa monoclonal antibody
   NovImmune S.A.
      2017   Phase 2   EUCTR2016-005017-45-PL   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-HU   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-GB   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-BG   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
Humanized tnfa monoclonal antibody
   Shenyang Sunshine Pharmaceutical Co., LTD.
      2015   Phase 1   NCT02460393   China
Humax-CD20
   GENMAB A/S
      2007   -   EUCTR2007-002945-18-IT   Czech Republic;Italy
   Genmab A/S
      2008   -   EUCTR2007-002951-18-SE   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2007-002951-18-FR   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002951-18-DK   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002950-42-BE   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002951-18-NL   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2007-002951-18-IT   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2007-002951-18-ES   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2007-002950-42-LT   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-HU   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-ES   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002945-18-CZ   Czech Republic
      2006   -   EUCTR2004-003771-37-HU   Hungary
   GlaxoSmithKline Research & Development
      2008   Phase 3   EUCTR2007-002951-18-GB   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002951-18-DE   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002950-42-GB   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      2008   Phase 1;Phase 2   EUCTR2008-002046-27-FR   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-DE   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-BE   Belgium;France;Germany;Spain
      2007   Phase 2   EUCTR2007-004878-31-GB   Denmark;Hungary;United Kingdom
      2007   -   EUCTR2007-004878-31-DK   Denmark;Hungary;United Kingdom
   GlaxoSmithKline Research & Development Ltd.
      2008   -   EUCTR2007-004878-31-HU   Denmark;Hungary;United Kingdom
   GlaxoSmithKline Research and Development
      2008   -   EUCTR2007-002950-42-PL   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-CZ   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
   GlaxoSmithKline S.A.
      2008   -   EUCTR2008-002046-27-ES   Belgium;France;Germany;Spain
Humax-CD4
   Genmab
      2002   Phase 2/Phase 3   NCT00042406   Canada;United States
Humira
   Aarhus University Hospital, Denmark
      2007   Phase 4   EUCTR2007-000082-38-DK   Denmark
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-003053-21-PL   Israel;Poland;Puerto Rico;United States
      2015   Phase 2   EUCTR2013-004019-37-DK   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   -   EUCTR2013-004019-37-DE   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2015   Phase 2   EUCTR2013-004019-37-BG   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-RO   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   -   EUCTR2013-004019-37-HU   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2014   Phase 2   EUCTR2013-004019-37-CZ   Australia;Bulgaria;Canada;Czech Republic;Denmark;Germany;Hungary;New Zealand;Poland;Romania;Turkey
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abbott
      2006   -   NCT01078571   Spain
      2006   Phase 4   NCT00761514   Puerto Rico
   Abbott GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-DE   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   Phase 3   EUCTR2010-019514-24-BE   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   -   EUCTR2010-019514-24-AT   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Amgen Inc
      2014   -   EUCTR2013-000525-31-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000525-31-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   AstraZeneca AB
      2011   Phase 2   EUCTR2010-023692-26-SK   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023692-26-GB   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      -   -   EUCTR2010-023692-26-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim
      2015   Phase 3   NCT02137226   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
   Boehringer Ingelheim International GmbH
      2014   Phase 3   EUCTR2012-002945-40-HU   Argentina;Bulgaria;Chile;Colombia;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-ES   Argentina;Belgium;Bulgaria;Chile;Colombia;Estonia;France;Germany;Hungary;Indonesia;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-EE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
      2014   Phase 3   EUCTR2012-002945-40-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;New Zealand;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   CHRU de TOURS
      2010   -   EUCTR2010-021449-28-FR   France
   CHU Saint-Etienne
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   Celltrion, Inc
      2019   Phase 3   EUCTR2018-001690-25-LT   Bulgaria;Hungary;Lithuania;Peru;Poland;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-PL   Bosnia and Herzegovina;Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-HU   Bosnia and Herzegovina;Bulgaria;Hungary;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-BG   Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Ukraine
   Charité-Universitätsmedizin Berlin; Department of Rheumatology and Clinical Immunology
      2007   -   EUCTR2006-003146-41-DE   Germany
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Dept. of Rhematology UMAS
      2005   -   EUCTR2005-000129-47-SE   Sweden
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-SK   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-SI   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-PT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-NL   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LV   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-HU   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-GB   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-DE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-CZ   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-BE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2008   Phase 4   EUCTR2007-000593-24-GB   Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
   F.Hoffmann-La Roche Ltd
      2008   -   EUCTR2007-000593-24-SE   Sweden;United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   NCT02405780   Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000109-11-BG   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   NCT02260791   Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2014-000109-11-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-DE   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-BG   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Spain;United States
      2010   -   EUCTR2010-021577-37-HU   Bulgaria;Germany;Hungary;Spain
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   EUCTR2016-000335-40-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
   HEXAL AG
      2016   Phase 3   EUCTR2015-003433-10-IT   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Helsingin reumakeskus
      2010   -   EUCTR2009-017325-19-FI   Finland
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Hvidovre Hospital
      2009   Phase 4   EUCTR2009-014394-41-DK   Denmark
   Hvidovre Hospital, Dept. Rheumatology
      2006   -   EUCTR2005-001633-14-SE   Denmark;Sweden
      2005   -   EUCTR2005-001633-14-DK   Denmark;Sweden
   Hvidovre University Hospital
      2004   Phase 4   NCT00696059   Denmark
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Imperial College London South Kensington London
      2009   Phase 4   EUCTR2009-012424-87-GB   United Kingdom
   Janssen-Cilag International N.V.
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
   Karolinska Institute
      2010   Phase 4   EUCTR2009-017163-42-SE   Sweden
   King's College London
      2010   Phase 4   EUCTR2010-020738-24-GB   United Kingdom
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   LG Life Sciences
      2016   Phase 3   NCT02746380   Japan;Korea, Republic of
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Lilly S.A.
      2013   -   EUCTR2012-002322-73-ES   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   MERCK SERONO INTERNATIONAL SA
      2008   -   EUCTR2007-002536-29-IT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Merck KGaA
      2017   Phase 3   EUCTR2016-002852-26-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002852-26-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2017   Phase 3   EUCTR2016-002852-26-BG   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2016   Phase 3   EUCTR2016-002852-26-LT   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-HU   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-CZ   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
   Merck Serono International
      2008   -   EUCTR2007-002536-29-PT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-GR   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-FR   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-ES   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-DE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-CZ   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BG   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BE   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-SE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   Phase 2   EUCTR2007-002536-29-FI   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-AT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      -   -   EUCTR2007-002536-29-PL   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   NHS Greater Glasgow and Clyde
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   Novo Nordisk A/S
      2014   Phase 2   EUCTR2013-001492-20-PT   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-ES   Ireland;Portugal;Spain;United Kingdom
      2013   Phase 2   EUCTR2013-001492-20-GB   Belgium;Czech Republic;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   PFIZER
      2008   -   EUCTR2007-002066-35-IT   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2009   -   EUCTR2008-008338-35-CZ   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2009   Phase 3   EUCTR2008-008338-35-SK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-GB   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-FI   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-008338-35-DK   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-DE   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
      2009   -   EUCTR2008-008338-35-BG   Bulgaria;Czech Republic;Denmark;Finland;Germany;Spain;United Kingdom
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Samsung Bioepis Co., Ltd.
      2014   Phase 3   NCT02167139   Lithuania;Poland
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
   St George's, University of London
      2020   Phase 4   EUCTR2019-004468-23-GB   United Kingdom
   The Karolinska Institute, ClinTRID
      2012   Phase 4   EUCTR2012-002573-62-SE   Sweden
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-002067-20-IT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
   University Hospital Birmingham NHS Foundation Trust
      2007   Phase 4   EUCTR2006-006275-21-GB   United Kingdom
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine
      2015   Phase 4   EUCTR2013-002777-22-IT   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-HU   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-ES   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-DK   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-GB   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-DE   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Humira (adalimumab) 40 MG IN 0.4 ML S.C. injection
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000568-41-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Humira (adalimumab) 40 MG S.C. injection
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000568-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-NL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000568-41-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Humira (adalimumab) 40MG IN 0.4 ML S.C. injection
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000568-41-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000568-41-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Humira (adalimumab) 40MG IN 0.4ML S.C.injection
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000568-41-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Humira - 40 MG soluzione iniettabile USO sottocutaneo 2 siringhe preriempite 0.8 ML + 2 tamponi imbevuti DI alcol IN 1 blister
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
Humira - 40MG/0.8ML soluz. iniettabile- USO sottocutaneo-flaconcino(vetro) 0.8ML 2 astucci:1 flaconcino+1siringa+1AGO+1adatt.sterile-2tamponi imbevuti alcool
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
Humira 40 MG injeksjonsvæSKE, oppløsning, I ferdigfylt SPRøYTE
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Humira 40 MG solucióN inyectable EN jeringa precargada
   Abbott GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-ES   Austria;Czech Republic;Germany;Spain
   F. Hoffmann-La Roche Ltd.
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-ES   Bulgaria;Germany;Hungary;Spain
   Pfizer, S.A
      2009   Phase 3   EUCTR2008-008338-35-ES   Bulgaria;Czech Republic;Denmark;Finland;Germany;Slovakia;Spain;United Kingdom
Humira 40 MG solution FOR injection IN PRE-filled syringe
   AbbVie Deutschland GmbH & Co. KG
      2012   -   EUCTR2012-000535-36-DE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
   Abbott GmbH & Co. KG
      2012   -   EUCTR2012-000535-36-SK   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-PL   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2012-000535-36-CZ   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   Phase 2   EUCTR2012-000535-36-BE   Belgium;Czech Republic;Germany;Poland;Puerto Rico;Romania;Slovakia;United States
      2012   -   EUCTR2011-003953-25-DE   Australia;Canada;Germany
      2012   -   EUCTR2011-002275-41-CZ   Belgium;Czech Republic
      2012   -   EUCTR2011-002275-41-BE   Belgium;Czech Republic
      2008   -   EUCTR2007-005905-23-GB   Germany;United Kingdom
      2008   -   EUCTR2007-005905-23-DE   Germany;United Kingdom
   R-Pharm
      2017   Phase 3   EUCTR2015-005307-83-RO   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-LV   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-LT   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-HU   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   R-Pharm International LLC
      2016   Phase 3   EUCTR2015-005307-83-CZ   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-BG   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   Takeda Development Centre Europe Ltd.
      2015   Phase 2   EUCTR2014-002945-23-GB   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-ES   Czech Republic;Estonia;Latvia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-CZ   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2014-002945-23-EE   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
   sanofi-aventis Recherche & Développement
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Humira 40 MG/0.8 ML solution FOR injection
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 4   EUCTR2014-001114-26-SE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2015   Phase 4   EUCTR2014-001114-26-NL   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-IT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-IE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-HU   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-GR   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-GB   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-FR   Australia;Austria;Canada;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-ES   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2014   Phase 4   EUCTR2014-001114-26-DE   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
      2014   Phase 4   EUCTR2014-001114-26-AT   Australia;Austria;Canada;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom;United States
   Abbott Japan Co., Ltd.
      -   -   EUCTR2014-004558-33-Outside-EU/EEA   Japan
Humira 40MG injektionslösung
   Heinrich-Heine-Universität Düsseldorf
      2014   Phase 3   EUCTR2013-004604-19-DE   Germany
Humira 40MG solution FOR injection IN PRE-filled syringe
   Newcastle-upon-Tyne Hospitals NHS Foundation Trust
      2007   Phase 4   EUCTR2006-006127-40-GB   United Kingdom
   R-Pharm
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
Humira 40MG/0.8 ML solution FOR injection FOR paediatric USE
   Abbott Laboratories
      -   -   EUCTR2011-001661-40-Outside-EU/EEA   United States
Humira 40MG/0.8ML solution FOR injection IN PRE-filled syringe
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003333-95-RO   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-ES   Argentina;Australia;Belarus;Bosnia and Herzegovina;Brazil;Canada;Chile;Colombia;Croatia;Denmark;Egypt;European Union;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003333-95-DK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003333-95-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
Humira SC
   Celltrion
      2018   Phase 3   NCT03789292   Bulgaria
Humira ® (adalimumab) 40MG/0.8ML PRE-filled syringe
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Humira*SC 2SIR+F 40MG 0,8ML+2T
   OSPEDALE POLICLINICO S. MATTEO
      2006   -   EUCTR2006-003843-22-IT   Italy
Humira, 40 MG solution FOR injection IN PRE-filled syringe
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
Humira, hulio, amgevita, hyrimoz, idacio, imraldi
   Reade
      2019   Phase 4   EUCTR2019-001793-28-NL   Netherlands
      2019   Phase 1;Phase 4   EUCTR2019-001554-25-NL   Netherlands
Humira® 40 MG injektionslösung IN fertigspritze
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2008   -   EUCTR2007-002066-35-DE   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
Humira® 40 MG solution FOR injection IN PRE-filled syringe
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2012   Phase 2   EUCTR2007-002066-35-SK   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2008   -   EUCTR2007-002066-35-HU   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-GR   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Slovakia
      2008   -   EUCTR2007-002066-35-CZ   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
      2008   Phase 2   EUCTR2007-002066-35-BG   Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy
Humira® 40 MG/ 0.8 ML solution FOR injection IN PRE-filled syringe
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Hyaluronic acid
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
Hydrocortisone 10MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
Hydroxychloroquine
   Assiut University
      2020   -   NCT04389320   Egypt
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Brigham and Women's Hospital
      2020   -   NCT04691505   United States
      2010   Phase 3   NCT01132118   United States
   Christine Bengtsson
      2015   Phase 2   EUCTR2014-005418-45-SE   Sweden
   Dazhou Central Hospital
      2023   -   ChiCTR2400081970   China
   Fundació Clínic per a la Recerca Biomèdica
      2019   Phase 4   EUCTR2017-004543-20-ES   Spain
   Hoffmann-La Roche
      2013   Phase 3   NCT01941095   Greece
   Incannex Healthcare Ltd
      2023   Phase 2   NCT05942911   Australia
   Indonesia University
      2017   -   NCT03085940   Indonesia
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
      2015   Phase 4   NCT02644499   India
   Kaneko Yuko
      2017   Phase 2-3   JPRN-jRCTs031180050   -
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   National Institute of Allergy and Infectious Diseases (NIAID)
      2016   Phase 2   NCT02603146   United States
   North Glasgow NHS Trust
      2004   -   EUCTR2004-002006-30-GB   United Kingdom
   Qilu Hospital of Shandong University
      2021   -   NCT05651373   China
      2021   Phase 4   NCT05626348   China
   RenJi Hospital
      2020   -   NCT04569890   China
   Sanofi
      2018   Phase 4   NCT03449758   France
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   NCT01709578   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
   School of clinical medicine & the first affiliated hospital of chengdu Medical college
      2023   Phase 4   ChiCTR2300072896   China
   The Affiliated ZhuZhou Hospital Of XiangYa School Of Medicine CSU.
      2019   Phase 4   ChiCTR2000032534   China
   University of Alabama at Birmingham
      2004   Phase 4   NCT00259610   United States
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of Leeds
      2019   Phase 4   NCT03813771   United Kingdom
      2011   Phase 4   NCT02433184   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   VA Office of Research and Development
      2007   -   NCT00405275   Canada;United States
   Wyeth is now a wholly owned subsidiary of Pfizer
      2007   Phase 4   NCT00422227   Hong Kong;India;Korea, Republic of;Malaysia;Philippines;Singapore;Taiwan;Thailand
   Zhejiang Chinese Medical University
      2021   -   ChiCTR2100048802   China
Hydroxychloroquine sulfate
   Dongzhimen Hospital, Beijing University of Chinese Medicine
      2024   Phase 0   ChiCTR2400088173   China
   General Hospital of Chengdu Military Region
      2014   Phase 1 study   ChiCTR-TRC-14004520   China
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
Hydroxychloroquine/chloroquine
   University of Alberta
      2020   -   NCT04347798   Canada
Hydroxycholoquine
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
Hydroxycloroquina
   Fundacion Clinic per a la Recerca Biomédica
      2019   Phase 4   NCT03669367   Spain
Hydroxyurea
   Paul Szabolcs
      2014   Phase 2   NCT01962415   United States
Hylase
   Assiut University
      2017   -   NCT03394131   Egypt
Hyperbaric oxygen
   David Grant U.S. Air Force Medical Center
      2017   -   NCT02984943   United States
HZT-501
   Horizon Pharma Ireland, Ltd., Dublin Ireland
      2009   Phase 3   NCT00984815   United States
      2007   Phase 3   NCT00613106   United States
IA-14069
   ILAb Co., Ltd.
      2022   Phase 1   NCT05533372   United States
Ianalumab
   Novartis Pharmaceuticals
      2018   Phase 1   NCT03574545   Germany;Jordan
IB-meca
   Can-Fite BioPharma Ltd.
      2008   -   EUCTR2007-006527-13-BG   Bulgaria
   Can-Fite BioPharma, Ltd.
      2019   Phase 3   EUCTR2016-003682-26-PL   Bosnia and Herzegovina;Bulgaria;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
Ibandronate
   Yeong-Wook Song
      2010   Phase 4   NCT01287533   Korea, Republic of
Ibuprofen
   Horizon Pharma Ireland, Ltd., Dublin Ireland
      2007   Phase 3   NCT00613106   United States
   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
      2006   Phase 4   NCT00346216   Australia;Brazil;Canada;Colombia;Costa Rica;Hong Kong;Mexico;Panama;Peru;Philippines;Taiwan;Ukraine;United States
ICG-pulsion
   Knowledge Centre for Rheumatology and Back Diseases
      2013   Phase 4   EUCTR2013-004006-26-DK   Denmark
ICP-022
   Innocare Pharma Australia Pty Ltd
      2017   Phase 1   NCT03189017   Australia
Iguratimod
   Anhui Medical University
      2008   Phase 3 study   ChiCTR-TRC-10000850   China
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Eisai Co., Ltd.
      2013   -   JPRN-jRCT1080222005   -
      2012   -   NCT01850966   Japan
   Jiangsu Simcere Pharmaceutical Co., Ltd.
      2013   Phase 4   NCT02275299   China
      2012   Phase 4   NCT01893151   China
      2012   Phase 4   NCT01554917   China
      2012   Phase 4   NCT01548001   China
   Osaka Medical College
      2017   -   JPRN-UMIN000027719   Japan
   Qilu Hospital of Shandong University
      2022   Phase 4   ChiCTR2200062645   China
      2021   Phase 4   NCT05626348   China
      2021   Phase 0   ChiCTR2100048699   China
      2020   Phase 4   NCT04928066   China
      2016   Phase 4   NCT03855007   China
   The First Affiliated Hospital of Henan University of Chinese Medicine
      2023   -   ChiCTR2300072567   China
   The Second Affiliated Hospital of Guangzhou Medical University
      2022   Phase 0   ChiCTR2200066368   China
   Toyama Chemical Co., Ltd. (Current FUJIFILM Toyama Chemical Co., Ltd.)
      2015   -   JPRN-jRCT1080222730   -
   Yanfeng Hou
      2021   Phase 4   NCT06146972   China
IHL-675A
   Incannex Healthcare Ltd
      2023   Phase 2   NCT05942911   Australia
IL-2
   the Second Hospital of Shanxi Medical University
      2016   -   ChiCTR-INR-16009546   China
IL-6
   Alder Biopharmaceuticals, Inc
      2008   -   EUCTR2008-004931-39-PL   Poland
   Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences
      2011   -   JPRN-UMIN000013750   Japan
   Kawakami Atsushi
      2021   -   JPRN-jRCTs071200107   -
   the Second Hospital of Shanxi Medical University
      2016   -   ChiCTR-INR-16009546   China
IL-6 receptor inhibitor, humanized monoclonal antibody
   F. Hoffmann-La Roche Ltd
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
IL-6 receptor inhibitor, recombinant humanized monoclonal antibody
   F Hoffmann La-Roche AG
      2006   -   EUCTR2005-002909-23-SI   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
   F Hoffmann La-Roche Ltd.
      2006   -   EUCTR2005-002909-23-SE   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. Hoffmann La-Roche Ltd
      -   -   EUCTR2005-002423-13-BG   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;France;Germany;Hong Kong;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Switzerland;Thailand
   F. Hoffmann La-Roche Ltd.
      2005   Phase 3   EUCTR2004-003733-14-FI   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;South Africa;Spain;United States
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
   Roche Products Limited
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
   Roche a/s
      2011   -   EUCTR2011-002363-15-DK   Denmark;Iceland
IL-6R monoclonal antibody injection 4MG/KG
   Beijing VDJBio Co., LTD.
      2021   Phase 1/Phase 2   NCT05232396   China
IL-6R monoclonal antibody injection 6MG/KG
   Beijing VDJBio Co., LTD.
      2021   Phase 1/Phase 2   NCT05232396   China
IL-6R monoclonal antibody injection 8MG/KG
   Beijing VDJBio Co., LTD.
      2021   Phase 1/Phase 2   NCT05232396   China
ILV-094
   Pfizer
      2009   Phase 2   NCT00883896   Belgium;Colombia;Croatia;Denmark;Germany;Hungary;Japan;Mexico;Netherlands;Romania;Russian Federation;United States
   Wyeth Pharmaceuticals Inc., acting through its division Wyeth Research, a Pfizer company
      2009   -   EUCTR2008-006936-37-DE   Belgium;Germany;Hungary;Netherlands
   Wyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development
      2009   -   EUCTR2008-006936-37-NL   Belgium;Germany;Hungary;Netherlands
      2009   -   EUCTR2008-006936-37-HU   Belgium;Germany;Hungary;Netherlands
      2009   Phase 2   EUCTR2008-006936-37-BE   Belgium;Germany;Hungary;Netherlands
Imatinib
   Novartis Pharmaceuticals
      2004   Phase 2   NCT00154336   Austria;Canada;Finland;United Kingdom
IMB-101
   IMBiologics Corp.
      2023   Phase 1   NCT06181786   -
Imeth
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
Immune ablation and hematopoietic stem cell transplant
   Richard Burt, MD
      1997   Phase 1   NCT00278551   United States
Immunophenotype OF leukocyte subpopulations
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
Immunosporin
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Implant procedure
   SetPoint Medical Corporation
      2021   Phase 3   NCT04539964   United States
Imraldi 40MG
   CHU de Bordeaux
      2021   Phase 3   EUCTR2020-004345-37-FR   France;Monaco
Imurel
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
Imvotamab
   IGM Biosciences, Inc.
      2023   Phase 1   NCT06087406   Poland;United States
IMVT-1402
   Immunovant Sciences GmbH
      2025   Phase 2   NCT06754462   Georgia;Germany;Puerto Rico;Spain;United States
IN vitro stimulation OF blood with periodontitis-associated- and control bacteria
   University of Copenhagen
      2017   -   NCT03225950   Denmark
Inactivated hepatitis A virus
   HY, HUS
      2011   -   EUCTR2009-016055-22-SE   Finland;Sweden
Inactivated influenza vaccine (IIV) AT baseline
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
Inactivated influenza vaccine AT month 1
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2024   Phase 2   NCT06599658   Canada
INCB018424
   Incyte Corporation
      2007   Phase 2   NCT00550043   Poland;United States
INCB028050
   Incyte Corporation
      2009   Phase 2   NCT00902486   Czech Republic;Czechia;United States
INCB028050 phosphate salt
   Incyte Corporation
      2009   -   EUCTR2009-011206-42-CZ   Czech Republic
INCB047986
   Incyte Corporation
      2014   Phase 2   NCT02151474   United States
Indocyanine green
   Knowledge Centre for Rheumatology and Back Diseases
      2013   Phase 4   EUCTR2013-004006-26-DK   Denmark
   Shanghai University of Traditional Chinese Medicine
      2014   -   NCT02876874   China
   Tokyo Medical and Dental University
      2013   -   JPRN-UMIN000012399   Japan
   University of Rochester
      2021   Phase 1   NCT05197530   United States
      2019   Phase 1   NCT04046146   United States
      2015   Phase 1   NCT02680067   United States
Inebilizumab
   Amgen
      2025   Phase 2   NCT06570798   Belgium;France;Germany;Italy;United States
Inflectra
   Pfizer
      2022   -   NCT05375942   United States
Infliximab
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Amgen
      2016   Phase 3   NCT02937701   Australia;Bulgaria;Canada;Czech Republic;Czechia;Germany;Hungary;Poland;Spain;United States
   Bristol Myers Squibb International Corporation
      2005   -   EUCTR2004-000922-59-DK   Czech Republic;Denmark;Spain;Sweden
      2005   -   EUCTR2004-000922-59-CZ   Czech Republic;Denmark;Spain;Sweden
      2004   -   EUCTR2004-000922-59-SE   Czech Republic;Denmark;Spain;Sweden
      2004   Phase 3   EUCTR2004-000922-59-ES   Czech Republic;Denmark;Spain;Sweden
   CELLTRION, INC.
      2012   -   EUCTR2011-004468-31-IT   Austria;Bosnia and Herzegovina;Chile;Colombia;Italy;Jordan;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Spain;Ukraine;United Kingdom
   CELLTRION, Inc
      2012   -   EUCTR2011-004468-31-PL   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-LV   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-LT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   Phase 3   EUCTR2011-004468-31-GB   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   Phase 3   EUCTR2011-004468-31-ES   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-004468-31-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2011   -   EUCTR2011-004468-31-SK   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Slovakia;Spain;Ukraine;United Kingdom
      2010   Phase 3   EUCTR2010-018646-31-SK   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-PT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LV   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Indonesia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2010   -   EUCTR2010-018646-31-IT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-GB   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018646-31-ES   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-BG   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-AT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
   CHRU de Tours
      2007   -   EUCTR2007-002752-42-FR   France
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   Celltrion
      2012   Phase 3   NCT01571219   Korea, Republic of;United Kingdom
      2010   Phase 3   NCT01217086   Korea, Republic of
   Celltrion, Inc
      2017   Phase 1;Phase 3   EUCTR2016-002125-11-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-LV   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-HU   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-EE   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Russian Federation;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
   Centocor BV
      2009   Phase 4   EUCTR2007-003288-36-GB   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2007-003288-36-ES   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-NL   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-003288-36-FR   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-FI   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-DE   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-AT   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
   Centocor Ortho Biotech Services, L.L.C.
      2008   Phase 4   NCT00714493   Austria;Belgium;Canada;Finland;France;Germany;Israel;Netherlands;Spain;United Kingdom;United States
      2001   Phase 4   NCT00246064   -
   Centocor, Inc.
      2004   Phase 3   NCT00236028   -
      2003   Phase 2   NCT00207714   -
      2001   Phase 3   NCT00036387   United States
      2001   Phase 3   NCT00036374   United States
   Chiba University
      2016   Phase 4   NCT02770794   Japan
      2016   -   JPRN-UMIN000021929   Japan
   Chinese University of Hong Kong
      2008   -   NCT00901550   China
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Department of Orthopaedic surgery, Tohoku University Hospital
      2013   -   JPRN-UMIN000009887   Japan
   Department of Rheumatosurgery, Osaka City University Medical School
      2009   Phase 4   JPRN-UMIN000002340   Japan
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fen Li
      2016   Phase 4   NCT02878161   -
   Genentech, Inc.
      2009   Phase 2   NCT00808210   United States
   Genor Biopharma Co., Ltd.
      2017   Phase 3   NCT04178850   China
   Georgetown University
      2013   Phase 4   NCT01793519   United States
   Greater Glasgow Health Board
      2006   Phase 4   EUCTR2006-000363-28-GB   United Kingdom
   Hoffmann-La Roche
      2011   -   NCT01592292   Korea, Republic of
   Hvidovre University Hospital
      2005   Phase 4   NCT00216177   Denmark
   Ikeda Kei
      2016   Phase 4   JPRN-jRCTs031180001   -
   Institute of Health Biosciences, The University of Tokushima Graduate School
      2014   -   JPRN-UMIN000014311   Japan
   Integrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp.
      2006   Phase 3   EUCTR2005-001889-13-FR   Austria;Belgium;Denmark;France;Germany;Netherlands;Portugal;Sweden
   Jagiellonian University
      2013   Phase 4   NCT02132234   Poland
   Janssen Korea, Ltd., Korea
      2007   -   NCT00760669   Korea, Republic of
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Karolinska Institute
      2008   -   EUCTR2008-005212-40-SE   Sweden
   Karolinska Institutet
      2006   -   NCT05051137   Sweden
   Kawakami Atsushi
      2021   Phase 4   JPRN-jRCTs071200007   -
      2020   Phase 4   JPRN-jRCTs071190030   -
   Keio University
      2012   -   JPRN-UMIN000007432   Japan
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medical University of Graz
      2012   Phase 4   NCT01602302   Austria
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Merck Sharp & Dohme Corp.
      2011   Phase 2   NCT01313520   Moldova, Republic of;Romania
      2008   -   NCT00741104   -
      2008   -   NCT00724672   -
      2007   Phase 3   NCT00521924   Austria
      2006   Phase 3   NCT00732875   -
      2006   -   NCT00724243   Slovakia
      2005   -   NCT00705289   -
      2005   Phase 3   NCT00202852   Korea, Republic of
      2004   -   NCT00725621   Austria
      2003   Phase 4   NCT00794898   -
   Mitsubishi Tanabe Pharma Corporation
      2005   Phase 3   JPRN-jRCT2080220144   -
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      2002   Phase 2   NCT00029042   United States
      2000   Phase 2   NCT00006292   United States
   National Sciences Foundation of China
      2008   -   ChiCTR-CCC-10001054   China
   Nichi-Iko Pharmaceutical Co., Ltd.
      2017   Phase 3   EUCTR2016-001064-11-PL   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-GB   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-ES   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-CZ   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Nichi-Iko Pharmaceutical Co.,Ltd.
      2013   Phase 3   NCT01927263   Japan
      2012   Phase 1   NCT01567358   Japan
   Osaka Medical College
      2015   -   JPRN-UMIN000016950   Japan
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2004   -   EUCTR2005-000492-18-IT   Italy
   Patrick Durez
      2007   -   NCT01245361   Belgium
   Peking Union Medical College Hospital
      2010   Phase 4   NCT01282528   China
   People's Hospital, Beijing University; Shanghai Changzheng Hospital
      2008   Phase 3 study   ChiCTR-TRC-10001060   China
   Pfizer
      2014   Phase 3   NCT02222493   Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Rheumatosurgery, Osaka City University Medical School
      2006   -   JPRN-UMIN000000512   Japan
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
   Saint-Luc Universitary Hospital
      2007   Phase 3   EUCTR2007-004694-26-BE   Belgium
   Saitama Medical Center. Saitama Medical University
      2012   -   JPRN-UMIN000007786   Japan
   Samsung Bioepis Co., Ltd.
      2013   Phase 3   NCT01936181   Bulgaria;Lithuania
   Schering Plough Research Institute, a Division of Schering Corporation
      2006   -   EUCTR2005-001889-13-PT   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
      2006   Phase 3   EUCTR2005-001889-13-BE   Austria;Belgium;Denmark;France;Germany;Netherlands;Portugal;Sweden
   Schering-Plough Research Institute (SPRI)
      2007   -   EUCTR2005-001889-13-DE   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
   Schering-Plough Research Institute, a division of Schering Corporation
      2005   -   EUCTR2005-001889-13-SE   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
   Sungkyunkwan University
      2020   -   NCT04115423   Korea, Republic of
   Taizhou Mabtech Pharmaceutical Co.,Ltd
      2020   Phase 1   NCT04779892   China
   Takarazuka city hospital
      2014   -   JPRN-UMIN000016844   Japan
   University Hospital, Tours
      2007   -   NCT00840957   France
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
      2006   Phase 4   NCT01308255   United Kingdom
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Rochester
      2007   Phase 4   NCT00462072   United States
   University of Sao Paulo
      2008   Phase 4   NCT01072058   Brazil
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   Xian-Janssen Pharmaceutical Ltd.
      2007   Phase 4   NCT00896168   -
Infliximab (INF) + MTX, DB
   Bristol-Myers Squibb
      2005   Phase 3   NCT00095147   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Russian Federation;South Africa;Spain;Sweden;Switzerland;United States
Infliximab 10 MG/KG
   Centocor, Inc.
      1997   Phase 3   NCT00269867   -
Infliximab 3 MG/KG
   Centocor, Inc.
      1997   Phase 3   NCT00269867   -
Infliximab biosimilar
   Inoue Hospital
      2016   -   JPRN-UMIN000021492   Japan
   Pfizer
      2019   -   NCT03885037   Japan
   Samsung Bioepis Co., Ltd.
      2013   -   EUCTR2012-005733-37-LV   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   -   EUCTR2012-005733-37-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-GB   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
   TcLand Expression S.A.
      2016   -   NCT03016260   Czech Republic;Czechia;France;Israel;Netherlands;Turkey
Infliximab control
   Merck Sharp & Dohme Corp.
      2006   Phase 3   NCT00394589   Austria;Belgium;Denmark;France;Germany;Netherlands;Sweden;Turkey
Infliximab group
   Zhang, Xiao, M.D.
      2013   -   NCT01915537   China
Infliximab increased dose
   Merck Sharp & Dohme Corp.
      2006   Phase 3   NCT00394589   Austria;Belgium;Denmark;France;Germany;Netherlands;Sweden;Turkey
Infliximab increased frequency
   Merck Sharp & Dohme Corp.
      2006   Phase 3   NCT00394589   Austria;Belgium;Denmark;France;Germany;Netherlands;Sweden;Turkey
Infliximab infusion
   Chiba University Hospital
      2012   Phase 2   JPRN-UMIN000015297   Japan
      2012   Phase 2   JPRN-UMIN000007806   Japan
Infliximab, etanercept
   Centocor Ortho Biotech Services, L.L.C.
      2003   Phase 3   NCT00317538   -
   Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences
      2011   -   JPRN-UMIN000013750   Japan
Infliximab, etanercept, adalimumab
   University Hospital, Strasbourg, France
      2009   Phase 4   NCT01000441   France;Monaco
Infliximab, methylprednisolone, methotrexate
   Université Catholique de Louvain
      2003   Phase 4   NCT00396747   Belgium
Infliximab-EU
   Pfizer Inc.
      2015   Phase 3   EUCTR2013-004148-49-FR   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-PL   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-HU   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-GB   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-DE   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-CZ   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
Infliximab-pfizer
   Pfizer Inc.
      2015   Phase 3   EUCTR2013-004148-49-FR   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-PL   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-HU   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-GB   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-DE   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-CZ   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
Infliximab: adalimumab
   University of Sulaimani
      2022   -   NCT05379049   Iraq
Influenza vaccine
   Bassett Healthcare
      2014   Phase 4   NCT02311855   United States
   Div KIR AMC
      2010   -   EUCTR2009-016789-10-NL   Netherlands
   Tel-Aviv Sourasky Medical Center
      2005   -   NCT00466037   -
Influvac
   Radboud University Nijmegen Medical Centre
      2008   -   EUCTR2008-001282-28-NL   Netherlands
Information collected AS standard OF care
   University of Colorado, Denver
      2024   -   NCT06397677   United States
INN - filgotinib
   Gilead Sciences Inc.
      2014   Phase 2   EUCTR2012-003655-11-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
INN NOT available
   GlaxoSmithKline Research & Development Limited
      2018   Phase 2   EUCTR2015-004386-91-PL   Germany;Poland;United States
      2016   Phase 2   EUCTR2015-004386-91-DE   Germany;Poland;United States
      2015   Phase 2   EUCTR2014-003453-34-PL   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-HU   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-GB   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-ES   Argentina;Belgium;Bulgaria;Canada;Chile;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Netherlands;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-EE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-DE   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
      2015   Phase 2   EUCTR2014-003453-34-CZ   Argentina;Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
Innovator infliximab
   Diakonhjemmet Hospital
      2014   Phase 4   NCT02148640   Norway
Insulin
   Assiut University
      2017   -   NCT03394131   Egypt
Integra titan modular shoulder system 2.5
   Smith & Nephew, Inc.
      2017   -   NCT03250767   United States
Integra titan™ total shoulder generation 1.0
   Smith & Nephew, Inc.
      2017   -   NCT03245320   United States
Integrative medicine
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2014   Phase 2/Phase 3   NCT02551575   China
Interleukin 2
   Assistance Publique - Hôpitaux de Paris
      2014   Phase 2   NCT01988506   France
Intra-articular compound betamethasone
   Chinese PLA General Hospital
      2017   Phase 4   NCT03215407   -
Intra-articular corticosteroid injection
   Maasstad Hospital
      2021   -   NCT04755127   Netherlands
Intra-articular injection OF etanercept
   Centre Hospitalier Universitaire de Nice
      2005   Phase 3   NCT00522184   France
Intra-articular injection OF steroid
   Centre Hospitalier Universitaire de Nice
      2005   Phase 3   NCT00522184   France
Intra-articular tocilizumab
   Chinese PLA General Hospital
      2017   Phase 4   NCT03215407   -
Intraarticular betamethasone
   Hvidovre University Hospital
      1998   Phase 4   NCT00209859   Denmark
Intraarticular dexamethasone
   Charite University, Berlin, Germany
      2004   Phase 1/Phase 2   NCT00244153   Germany
Intraarticular injection
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Federal University of São Paulo
      2004   Phase 2   NCT00506896   Brazil
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
Intraarticular morphine
   Charite University, Berlin, Germany
      2004   Phase 1/Phase 2   NCT00244153   Germany
Intravenous (IV) abatacept
   Bristol-Myers Squibb
      2009   Phase 2/Phase 3   NCT01001832   Japan
      2008   Phase 3   NCT00559585   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Turkey;United Kingdom;United States
Intravenous dexamethasone 1 MG
   University of Calgary
      2016   -   NCT02666443   Canada
Iodine
   Fukui General Hospital
      2012   -   JPRN-UMIN000033222   Japan
IPI 145
   Infinity Pharmaceuticals, Inc
      2013   Phase 2   EUCTR2012-003724-20-RO   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-HU   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-DE   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-BG   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
IPI-145
   Infinity Pharmaceuticals, Inc
      2013   Phase 2   EUCTR2012-003724-20-RO   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-HU   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-DE   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003724-20-BG   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
   SecuraBio
      2013   Phase 2   NCT01851707   Bulgaria;Colombia;Germany;Hungary;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Ukraine
IR prednisone
   Merck KGaA, Darmstadt, Germany
      2004   Phase 3   NCT00146640   Germany;Poland
Irak 4
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
IRL201805
   Revolo Biotherapeutics Ltd
      2023   Phase 2   EUCTR2021-005771-39-HU   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
      2023   Phase 2   EUCTR2021-005771-39-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
      2022   Phase 2   EUCTR2021-005771-39-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
Isis 104838
   Ionis Pharmaceuticals, Inc.
      2002   Phase 2   NCT00048321   Canada;United States
Isis CRP RX
   Isis Pharmaceuticals
      2011   Phase 2   NCT01414101   Canada;Russian Federation
Itacitinib
   Incyte Corporation
      2012   Phase 2   NCT01626573   Puerto Rico;United States
Itis diet
   University of California, San Diego
      2018   -   NCT04999683   United States
Itraconazole? SHR0302 tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05404724   China
IV abatacept
   Osaka Medical College
      2014   -   JPRN-UMIN000013440   Japan
   Rüdiger B. Müller
      2013   Phase 4   NCT01846975   Switzerland
IV golimumab
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00975130   Argentina;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Mexico;Monaco;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom
Ixekizumab
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
JAK 3
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
JAK 3 ritlecitinib
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
JAK inhibitor
   Abu Dhabi Stem Cells Center
      2022   Phase 3   NCT05379322   United Arab Emirates
   Qilu Hospital of Shandong University
      2021   Phase 0   ChiCTR2100048699   China
JAK1 / JAK2 inhibitor
   Eli Lilly and Company
      2011   -   EUCTR2010-022504-42-HU   Argentina;Croatia;Czech Republic;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
JAK1 / JAK2 inhibtor
   Eli Lilly and Company
      2011   -   EUCTR2010-022504-42-HU   Argentina;Croatia;Czech Republic;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-022504-42-GB   Hungary;United Kingdom
Jaki
   Marie Hudson, MD
      2023   -   NCT05305066   Canada
Janus kinase inhibitor
   Zhejiang Provincial People's Hospital
      2022   Phase 3   NCT05451615   China
JHL1101
   JHL Biotech, Inc.
      2017   Phase 1   NCT03161457   Bosnia and Herzegovina;Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;Russian Federation;Taiwan;Ukraine;United Kingdom
Jing SI herbal TEA liquid packets
   Buddhist Tzu Chi General Hospital
      2022   -   NCT05257174   Taiwan
JNJ 38518168
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2010   Phase 2   NCT00941707   Belgium;Czech Republic;Ireland;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;Ukraine;United Kingdom
JNJ-16240159-AAC
   Janssen-Cilag International N.V.
      2007   -   EUCTR2006-003983-73-CZ   Czech Republic;Germany
   Janssen-Cliag International N.V.
      -   -   EUCTR2006-003983-73-DE   Czech Republic;Germany
JNJ-38518168
   Janssen Research & Development, LLC
      2013   Phase 2   NCT01862224   Moldova, Republic of;United States
      2012   Phase 2   NCT01679951   Argentina;Chile;Colombia;Czech Republic;Czechia;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168 / MTX
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2011   Phase 1   NCT01450982   United States
JNJ-38518168 50-MG over encapsulated tablet
   Janssen-Cilag International NV
      2009   -   EUCTR2009-012118-27-NL   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-GB   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-ES   Czech Republic;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2009-012118-27-CZ   Czech Republic;Netherlands;Spain;United Kingdom
JNJ-38518168-AEK - over encapsulated tablet - 50 MG
   Janssen-Cilag International NV
      2010   -   EUCTR2009-012118-27-BE   Belgium;Czech Republic;Netherlands;Spain;United Kingdom
JNJ-38518168-ZBQ - FILM-coated tablet - 10 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002840-29-LV   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-HU   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-CZ   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168-ZBQ - FILM-coated tablet - 10MG
   Janssen-Cilag International NV
      2013   Phase 2   EUCTR2011-002840-29-RO   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168-ZBQ - FILM-coated tablet - 3 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002840-29-LV   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-HU   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-CZ   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168-ZBQ - FILM-coated tablet - 30 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002840-29-LV   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-HU   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   -   EUCTR2011-002840-29-CZ   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168-ZBQ - FILM-coated tablet - 30MG
   Janssen-Cilag International NV
      2013   Phase 2   EUCTR2011-002840-29-RO   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-38518168-ZBQ - FILM-coated tablet - 3MG
   Janssen-Cilag International NV
      2013   Phase 2   EUCTR2011-002840-29-RO   Argentina;Chile;Colombia;Czech Republic;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
JNJ-39758979
   Janssen Research & Development, LLC
      2011   Phase 2   NCT01480388   United States
JNJ-39758979 / MTX
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2011   Phase 1   NCT01442545   Germany;United States
JNJ-39758979-AAC - enteric coated tablet - 10 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002849-36-LV   Argentina;Chile;Colombia;Czech Republic;Japan;Latvia;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;Ukraine;United States
JNJ-39758979-AAC - enteric coated tablet - 100 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002849-36-LV   Argentina;Chile;Colombia;Czech Republic;Japan;Latvia;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;Ukraine;United States
JNJ-39758979-AAC - enteric coated tablet - 30 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-002849-36-LV   Argentina;Chile;Colombia;Czech Republic;Japan;Latvia;Malaysia;Mexico;Poland;Romania;Russian Federation;Singapore;Ukraine;United States
JNJ-40346527
   Janssen Research & Development, LLC
      2012   Phase 2   NCT01597739   Argentina;Bulgaria;Chile;Czech Republic;Hungary;Korea, Republic of;Poland;Russian Federation;Singapore;Ukraine
JNJ-40346527-AAC - capsule - 50 MG
   Janssen-Cilag International NV
      2012   -   EUCTR2011-004529-28-PL   Bulgaria;Hungary;Poland
      2012   -   EUCTR2011-004529-28-HU   Argentina;Bulgaria;Chile;Czech Republic;Hungary;Korea, Republic of;Poland;Russian Federation;Singapore;Ukraine
      2012   -   EUCTR2011-004529-28-CZ   Argentina;Bulgaria;Chile;Czech Republic;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation
      2012   -   EUCTR2011-004529-28-BG   Bulgaria;Hungary;Poland
JNJ-67484703
   Janssen Research & Development, LLC
      2021   Phase 1   NCT04985812   Georgia;Hungary;Moldova, Republic of;Spain;Ukraine;United States
JNJ-80202135
   Janssen-Cilag International NV
      2021   Phase 2   EUCTR2021-000510-42-ES   Germany;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000510-42-DE   Germany;Poland;Spain;United Kingdom;United States
JTE-051
   Akros Pharma Inc.
      2017   Phase 2   EUCTR2015-003140-39-PL   Argentina;Bulgaria;Colombia;Mexico;Peru;Poland;Romania;Russian Federation;Ukraine;United States
      2016   Phase 2   NCT02919475   Argentina;Bulgaria;Colombia;Mexico;Peru;Poland;Romania;Russian Federation;Ukraine;United States
      2016   Phase 2   EUCTR2015-003140-39-BG   Argentina;Bulgaria;Colombia;Mexico;Peru;Poland;Romania;Russian Federation;Ukraine;United States
Juanbi pill
   Cui xuejun
      2018   Phase 2/Phase 3   NCT02885597   China
Jyseleca
   Erasmus Medical Center
      2020   Phase 4   EUCTR2020-002802-21-NL   Netherlands
Jyseleca 100 MG FILM-coated tablets
   Galapagos NV
      2018   Phase 3   EUCTR2016-003630-25-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003630-25-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Jyseleca 100MG FILM-coated tablets
   Galapagos NV
      2017   Phase 3   EUCTR2016-003630-25-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Jyseleca 200 MG FILM-coated tablets
   Galapagos NV
      2018   Phase 3   EUCTR2016-003630-25-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-SK   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-HU   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-DE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-003630-25-BE   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2016-003630-25-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Czech Republic;Czechia;France;Georgia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
K-832
   Kowa Research Europe Ltd
      2004   -   EUCTR2004-000362-12-CZ   Czech Republic
KB003
   KaloBios Pharmaceuticals
      2010   Phase 2   NCT00995449   United States
KC706
   Kémia, Inc.
      2006   -   EUCTR2006-002645-37-HU   Hungary
KD6005
   Shanghai Kanda Biotechnology Co., Ltd.
      2024   Phase 1   NCT06213259   China
Kenalog
   Trafford NHS Trust
      2008   -   EUCTR2007-006729-28-GB   United Kingdom
Ketoprofen
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000033059   Japan
   Nekoyama Miyao Hospital
      2013   -   JPRN-UMIN000012257   Japan
   Nekoyama miyao hospital
      2012   -   JPRN-UMIN000011181   Japan
      2012   -   JPRN-UMIN000010902   Japan
Kevzara
   Cliniques universitaires Saint-Luc
      2020   Phase 4   EUCTR2019-003138-17-BE   Belgium
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-ES   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-CZ   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
   IDIVAL
      2020   Phase 4   EUCTR2019-004078-24-ES   Spain
   Instituto de Investigación Marqués de Valdecilla
      2020   Phase 4   NCT04350216   -
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
   University of Southern Denmark
      2021   Phase 1;Phase 2   EUCTR2020-005998-27-DK   Denmark
Keyhole limpet hemocyanin
   Genentech, Inc.
      2006   Phase 2   NCT00282308   United States
Kineret*SC 7SIR 100MG 0,67ML
   OSPEDALE CIVILE SAN SALVATORE, ASL 04, L'AQUILA
      2013   Phase 4   EUCTR2012-005370-62-IT   Italy
KN019, 10 MG/KG
   Jiangsu Alphamab Biopharmaceuticals Co., Ltd
      2019   Phase 2   NCT04038970   China
KN019, 5MG/KG
   Jiangsu Alphamab Biopharmaceuticals Co., Ltd
      2019   Phase 2   NCT04038970   China
KPL-404
   Kiniksa Pharmaceuticals, Ltd.
      2023   Phase 2   EUCTR2022-000169-42-HU   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2023   Phase 2   EUCTR2022-000169-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2022   Phase 2   EUCTR2022-000169-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2022   Phase 2   EUCTR2022-000169-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Poland;Serbia;South Africa;United States
      2021   Phase 2   NCT05198310   Bulgaria;Czechia;Georgia;Germany;Hungary;Poland;South Africa;United States
KR002524
   Kémia, Inc.
      2006   -   EUCTR2006-002645-37-HU   Hungary
Kunxian capsule
   Chinese SLE Treatment And Research Group
      2015   Phase 4   NCT02764515   China
KYV101
   Charite University, Berlin, Germany
      2024   Phase 1/Phase 2   NCT06475495   -
L-000124467-009J (succinat
   Merck Sharp & Dohme (Sweden) AB
      2004   -   EUCTR2004-000074-31-SE   Sweden
   Merck Sharp & Dohme BV
      2005   Phase 2   EUCTR2004-000074-31-BE   Belgium;Sweden
L-000883191
   Merck & Co. Inc.
      2005   Phase 2   EUCTR2004-004302-24-ES   Czech Republic;Finland;Germany;Italy;Spain
      2005   -   EUCTR2004-004302-24-DE   Czech Republic;Finland;Germany;Italy;Spain
   Merck & Co., Inc.
      2005   Phase 2   EUCTR2004-004302-24-CZ   Czech Republic;Finland;Germany;Italy;Spain
   Suomen MSD Oy
      2005   -   EUCTR2004-004302-24-FI   Czech Republic;Finland;Germany;Italy;Spain
L-001069957
   Merck Sharp & Dohme (Sweden) AB
      2004   Phase 2   EUCTR2004-000612-54-SE   Sweden
L-883191
   MERCK SHARP DOHME
      2005   Phase 2   EUCTR2004-004302-24-IT   Czech Republic;Finland;Germany;Italy;Spain
L-arginine
   RenJi Hospital
      2021   Phase 2   NCT04535427   China
L-carnitine
   Tanta University
      2023   Phase 3   NCT05792527   Egypt
L01ba01
   Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company)
      2009   Phase 4   EUCTR2008-002623-85-GB   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2010   Phase 4   EUCTR2008-002623-85-SE   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2009   -   EUCTR2008-002623-85-IE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   -   EUCTR2008-002623-85-DE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   Phase 4   EUCTR2008-002623-85-FR   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2008-002623-85-ES   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
L01X CO2
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2016   Phase 4   EUCTR2012-002535-28-NL   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
L01xc02
   CELLTRION, Inc.
      2014   Phase 3   EUCTR2013-004555-21-SK   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-PT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-LV   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-HU   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-GR   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-DE   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
L04 AB04
   Abbott GmbH & Co. KG
      2012   -   EUCTR2011-003953-25-DE   Australia;Canada;Germany
L04aa11
   Wyeth Pharmaceuticals France
      2007   -   EUCTR2006-005137-38-DE   Denmark;Finland;France;Germany;Sweden;United Kingdom
L04aa24
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
L04ab0
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
L04ab01
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
L04ab04
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
L04ab05
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
L04ac07
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-GR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-EE   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2016   Phase 4   EUCTR2012-002535-28-NL   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
L04ax03
   Leiden University medical Centre
      2015   Phase 2   EUCTR2014-004472-35-NL   Netherlands
LAB work
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
Lacosamide
   Indiana University School of Medicine
      2014   Phase 2   NCT02342977   United States
Lamivudine
   Department of general internal medicine, Kyushu-University hospital
      2012   -   JPRN-UMIN000018017   Japan
Land exercises
   Federal University of São Paulo
      2009   Phase 3   NCT01447264   Brazil
Lantarel
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Large protein molecule
   Halozyme Therapeutics
      2006   Phase 4   NCT00369187   United States
Laser, exercise, and methotrexate
   Cairo University
      2020   -   NCT04758689   Egypt
LB-P6
   LISCure Biosciences
      2022   Phase 1   NCT05053165   Australia
LB-P8
   LISCure Biosciences
      2022   Phase 1   NCT05053165   Australia
Lbal
   LG Life Sciences
      2016   Phase 3   NCT02746380   Japan;Korea, Republic of
LBEC0101
   LG Life Sciences
      2016   Phase 3   NCT02715908   Korea, Republic of
      2015   Phase 3   NCT02357069   Japan;Korea, Republic of
LD-aminopterin
   Syntrix Biosystems, Inc.
      2013   Phase 2   NCT01724931   Ukraine
Ledertrexate
   University Hospitals Leuven
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
Ledertrexato
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
Ledertrexato 2,5 MG compriméS
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
Leflunomide
   Anhui Provincial Hospital Department of Rheumatism
      2011   -   ChiCTR-TRC-11001789   China
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Caidian District People's Hospital of Wuhan
      2023   Phase 0   ChiCTR2300076293   Chin
   Chinese Academy of Sciences
      2012   -   NCT01619176   China
   Dazhou Central Hospital
      2023   -   ChiCTR2400081970   China
   Dongzhimen Hospital, Beijing University of Chinese Medicine
      2024   Phase 0   ChiCTR2400088173   China
   Fen Li
      2016   Phase 4   NCT02878161   -
   Genentech, Inc.
      2010   Phase 2   NCT01225393   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Poland;Romania;Spain;United States
      2007   Phase 3   NCT00476996   Argentina;Australia;Belgium;Brazil;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Mexico;Netherlands;New Zealand;Panama;Peru;Poland;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;United States
   Hoffmann-La Roche
      2013   Phase 3   NCT01941095   Greece
   Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine
      2013   -   ChiCTR-TRC-13003948   China
   Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
      2012   -   ChiCTR-TRC-12001859   China
   Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
      2010   Phase 1 study   ChiCTR-TRC-10001014   China
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
      2015   Phase 4   NCT02644499   India
   Jiangsu Simcere Pharmaceutical Co., Ltd.
      2013   Phase 4   NCT02275299   China
   Jiangxi Provincial People's Hospital
      2022   Phase 1   ChiCTR2300077294   China
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   P. Verschueren
      2009   Phase 4   NCT01172639   Belgium
   People's Hospital, Peking University
      2009   -   ChiCTR-TRC-09000472   China
   Qilu Hospital of Shandong University
      2021   Phase 4   NCT05626348   China
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
   Sandoz
      2002   Phase 1   NCT00946686   -
   Sanofi
      2025   -   NCT06714461   France
      2018   Phase 4   NCT03449758   France
      2015   Phase 3   NCT02373202   Japan
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   NCT01709578   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
      2007   Phase 3   NCT00596206   Czech Republic;Italy;Korea, Republic of;Portugal;Romania
      2004   Phase 4   NCT00280644   Turkey
      2003   Phase 4   NCT00563849   Korea, Republic of
      2002   Phase 4   NCT00451971   Australia
   School of clinical medicine & the first affiliated hospital of chengdu Medical college
      2023   Phase 4   ChiCTR2300072896   China
   Shanxi Medical University
      2012   -   NCT01617590   China
   Singapore General Hospital
      2012   Phase 4   NCT01659242   Singapore
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2013   -   NCT01774877   China
   The First Affiliated Hospital of Yunnan University of Chinese Medicine
      2023   Phase 0   ChiCTR2300071123   China
   The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041819   China
   The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
      2009   Phase 1+Phase 2   ChiCTR-TRC-12003871   China
      2007   Phase 2 study   ChiCTR-TRC-11001755   China
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   University Hospitals Leuven
      2018   Phase 4   EUCTR2017-004054-41-BE   Belgium
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of Leeds
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   Wyeth is now a wholly owned subsidiary of Pfizer
      2007   Phase 4   NCT00422227   Hong Kong;India;Korea, Republic of;Malaysia;Philippines;Singapore;Taiwan;Thailand
   Yunnan Hospital of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041894   China
   Yunnan Hospital of Traditional Chinese Medicine /The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041777   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2023   Phase 0   ChiCTR2300067676   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041821   China
   Yunnan Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2100041909   China
   sanofi-aventis Groupe
      2008   -   EUCTR2007-000886-40-IT   Italy;Portugal
   sanofi-aventis groupe
      2007   -   EUCTR2007-000886-40-PT   Italy;Portugal
      2007   Phase 3   EUCTR2007-000886-40-CZ   Czech Republic;Italy;Portugal
Leflunomide 20MG TAB
   Assiut University
      2018   -   NCT04022525   Egypt
Leflunomide-sulfasalazine-hydroxychloroquine
   University of Nebraska
      2001   Phase 3   NCT00579878   United States
Leflunomidum
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00521924   Austria
Leucovorin
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
Levobupivacaine
   Daiyukai General Hospital
      2020   Phase 3   JPRN-UMIN000040054   Japan
      2019   Phase 3   JPRN-UMIN000037359   Japan
      2018   Phase 3   JPRN-UMIN000031890   Japan
Levofloxacin
   The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
      2020   Phase 1   ChiCTR2000034924   China
Licorice
   Affiliated Hospital of Zunyi Medical University
      2024   -   ChiCTR2400086304   China
Lidocaine
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Department of Pain, Guizhou Provincial People's Hospita
      2020   Phase 0   ChiCTR2000033004   China
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
Ligustrazine
   Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
      2012   -   ChiCTR-TRC-12001859   China
   Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
      2010   Phase 1 study   ChiCTR-TRC-10001014   China
Lingzhi and SEN miao SAN
   Chinese University of Hong Kong
      2005   Phase 2   NCT00432484   China
Lisinopril
   Research and Development Department, Addenbrookes NHS Foundation Trust
      2006   Phase 4   EUCTR2005-005295-32-GB   United Kingdom
LNK01001
   Lynk Pharmaceuticals Co., Ltd
      2023   Phase 3   NCT06276998   China
LNK01001 dose A
   Lynk Pharmaceuticals Co., Ltd
      2021   Phase 2   NCT06099535   China
LNK01001 dose B
   Lynk Pharmaceuticals Co., Ltd
      2021   Phase 2   NCT06099535   China
LNP1955
   Lupin Limited
      2017   Phase 2   EUCTR2016-001532-35-BG   Bulgaria;Hungary;Poland
      2016   Phase 2   EUCTR2016-001532-35-HU   Bulgaria;Hungary
LO4ab04
   R-Pharm
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
LONG-chain N-3 pufa
   University of Jena
      2013   -   NCT01742468   Germany
LONG-circulating liposomal prednisolone
   Radboud University
      2005   Phase 2   NCT00241982   Netherlands
Loratadine
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
Losartan
   MD, PhD, Annemarie Lyng Svensson
      2014   -   NCT02246257   Denmark
Losec
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Losec capsules 20 MG
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Lovastatin
   National Institute of Allergy and Infectious Diseases (NIAID)
      2007   Phase 2   NCT00302952   United States
LOW dose OF biil 284 BS tablets
   Boehringer Ingelheim
      2000   Phase 1   NCT02247375   -
LOW dose ORTD-1
   Oryn Therapeutics, LLC
      2021   Phase 1   NCT04286789   United States
LOW dose vehicle control
   Oryn Therapeutics, LLC
      2021   Phase 1   NCT04286789   United States
Loxoprofen
   Peking University People's Hospital
      2015   Phase 2   NCT02467504   China
LPX-TI641
   LAPIX Therapeutics Inc.
      2024   Phase 1   NCT06628206   Jordan
LTS 0.25MG
   Shanghai Pharmaceuticals Holding Co., Ltd
      2014   Phase 1/Phase 2   NCT02202395   China
LTS 0.5MG
   Shanghai Pharmaceuticals Holding Co., Ltd
      2014   Phase 1/Phase 2   NCT02202395   China
LTS 1.0MG
   Shanghai Pharmaceuticals Holding Co., Ltd
      2014   Phase 1/Phase 2   NCT02202395   China
Lumiracoxib
   Novartis
      2004   Phase 3   NCT00170872   -
LUO-FU-shan plaster
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2021   -   NCT04884880   China
Lutikizumab
   AbbVie
      2025   Phase 2   NCT06972446   -
LW402
   Shanghai Longwood Biopharmaceuticals Co., Ltd.
      2023   Phase 2   NCT06800157   China
LX3305
   Lexicon Pharmaceuticals
      2009   Phase 1   NCT00847886   United States
LX3305 dihydrate
   Lexicon Pharmaceuticals, Inc.
      2009   -   EUCTR2009-012705-19-HU   Bulgaria;Czech Republic;Hungary
      2009   -   EUCTR2009-012705-19-CZ   Bulgaria;Czech Republic;Hungary
      2009   -   EUCTR2009-012705-19-BG   Bulgaria;Czech Republic;Hungary
LX3305 high dose
   Lexicon Pharmaceuticals
      2009   Phase 2   NCT00903383   Bulgaria;Czech Republic;Hungary;Poland;Serbia;United States
LX3305 LOW dose
   Lexicon Pharmaceuticals
      2009   Phase 2   NCT00903383   Bulgaria;Czech Republic;Hungary;Poland;Serbia;United States
LX3305 MID dose
   Lexicon Pharmaceuticals
      2009   Phase 2   NCT00903383   Bulgaria;Czech Republic;Hungary;Poland;Serbia;United States
LY2127399
   Eli Lilly and Company
      2013   -   EUCTR2012-001618-40-PL   Argentina;Czech Republic;Poland;Russian Federation;United States
      2012   Phase 2   NCT01576549   United States
      2012   -   EUCTR2012-001618-40-CZ   Argentina;Czech Republic;Poland;Russian Federation;United States
      2011   Phase 3   NCT01215942   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sri Lanka;Taiwan;Ukraine;United States
      2011   Phase 3   NCT01202773   Argentina;Australia;Brazil;Colombia;France;Germany;Greece;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   Phase 3   NCT01202760   Argentina;Australia;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022208-36-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022208-36-LT   Bulgaria;Germany;Greece;Hungary;Italy;Lithuania;Poland;Spain
      2011   -   EUCTR2010-022208-36-IT   Bulgaria;Germany;Greece;Hungary;Italy;Lithuania;Poland;Spain
      2011   -   EUCTR2010-022208-36-HU   Bulgaria;Germany;Greece;Hungary;Italy;Lithuania;Poland;Spain
      2011   -   EUCTR2010-022208-36-GR   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Russian Federation;South Africa;Spain;Sri Lanka;Taiwan;Ukraine;United States
      2011   Phase 3   EUCTR2010-022208-36-ES   Bulgaria;Germany;Greece;Hungary;Italy;Lithuania;Poland;Spain
      2011   -   EUCTR2010-022208-36-DE   Bulgaria;Germany;Greece;Hungary;Italy;Lithuania;Poland;Spain
      2011   -   EUCTR2010-022208-36-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;France;Germany;Greece;Hungary;India;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022207-22-PL   Argentina;Australia;Brazil;Colombia;Germany;Greece;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;United States
      2011   -   EUCTR2010-022207-22-IT   Germany;Greece;Italy;Poland;Spain
      2011   -   EUCTR2010-022207-22-GR   Germany;Greece;Italy;Poland;Spain
      2011   -   EUCTR2010-022207-22-ES   Germany;Greece;Italy;Poland;Spain
      2011   -   EUCTR2010-022207-22-DE   Argentina;Australia;Brazil;Colombia;Germany;Greece;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;United States
      2011   -   EUCTR2010-022206-40-PL   Argentina;Australia;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022206-40-LT   Argentina;Australia;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022206-40-HU   Bulgaria;Hungary;Lithuania;Poland
      2011   -   EUCTR2010-022206-40-BG   Argentina;Australia;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-LT   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-HU   Bulgaria;Hungary;Lithuania;Poland
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2010   Phase 1   NCT01253291   Japan
      2010   Phase 3   NCT01198002   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2010   Phase 3   EUCTR2010-022206-40-SK   Argentina;Australia;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2009   Phase 1   NCT01253226   Japan
      2009   Phase 2   NCT00837811   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Czech Republic;France;Germany;Hungary;India;Mexico;Poland;Puerto Rico;Romania;Slovakia;Ukraine;United States
      2009   -   EUCTR2008-004875-23-PL   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-HU   Austria;Belgium;France;Germany;Hungary;Poland
      2009   Phase 2   EUCTR2008-004875-23-FR   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-DE   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-BE   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-004875-23-AT   Austria;Belgium;France;Germany;Hungary;Poland
      2009   -   EUCTR2008-001105-42-PL   Austria;Belgium;France;Germany;Poland
      2008   Phase 2   NCT00785928   Argentina;Australia;Brazil;Canada;Chile;Czech Republic;Germany;Hungary;India;Mexico;Poland;Romania;Slovakia;Ukraine;United States
      2008   Phase 2   NCT00689728   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Mexico;Poland;Puerto Rico;United States
      2008   Phase 2   EUCTR2008-001105-42-FR   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-DE   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-BE   Austria;Belgium;France;Germany;Poland
      2008   -   EUCTR2008-001105-42-AT   Austria;Belgium;France;Germany;Poland
      2006   Phase 2   NCT00308282   Romania
   Eli Lilly and Company limited
      2009   -   EUCTR2008-004894-16-PL   Czech Republic;Germany;Hungary;Poland
      2009   Phase 2   EUCTR2008-004894-16-HU   Czech Republic;Germany;Hungary;Poland
      2009   -   EUCTR2008-004894-16-DE   Czech Republic;Germany;Hungary;Poland
      2009   -   EUCTR2008-004894-16-CZ   Czech Republic;Germany;Hungary;Poland
LY2189102
   Eli Lilly and Company
      2005   Phase 1/Phase 2   NCT00380744   Argentina;Hungary;Poland;Spain;United States
   Eli Lilly and Company Limited
      2007   -   EUCTR2005-002660-29-HU   Hungary;Spain
LY2439821
   Eli Lilly and Company
      2010   Phase 1   NCT01253265   Japan
      2010   Phase 1   NCT01236118   Japan
      2009   Phase 2   NCT00966875   Argentina;Chile;Germany;Hungary;India;Korea, Republic of;Peru;Poland;Romania;Russian Federation;Taiwan;United States
      2009   -   EUCTR2009-009696-34-DE   Argentina;Chile;Germany;India;Korea, Republic of;Peru;Poland;Romania;Russian Federation;Taiwan
LY3009104
   ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP)
      2021   Phase 4   EUCTR2020-005773-27-FR   France
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   ELI LILLY AND COMPANY
      2013   -   EUCTR2012-002339-27-IT   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Portugal;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002324-32-IT   Argentina;Austria;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002323-15-IT   Argentina;Australia;Austria;Belgium;Canada;Croatia;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Turkey;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2012-003686-17-SI   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2012-003686-17-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-HU   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-FR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002339-27-SK   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-PT   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-HU   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   Phase 3   EUCTR2012-002339-27-GB   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-DE   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-CZ   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002339-27-BE   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002324-32-SE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-PT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-GR   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-GB   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-DE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-BE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-AT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-PL   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-NL   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-HR   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-GR   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-GB   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-DK   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002323-15-BE   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002323-15-AT   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-SK   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-SI   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-PT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-NL   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LV   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-LT   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-HU   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-GB   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002322-73-DE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-CZ   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-BE   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2011   -   EUCTR2010-022504-42-HU   Argentina;Croatia;Czech Republic;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-022504-42-GB   Hungary;United Kingdom
      2010   Phase 2   NCT01185353   Argentina;Croatia;Czech Republic;Czechia;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Lilly S.A.
      2013   Phase 3   EUCTR2012-003686-17-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002339-27-ES   Argentina;Belgium;Canada;Croatia;Czech Republic;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;United Kingdom
      2013   -   EUCTR2012-002323-15-ES   Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;France;Germany;Greece;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-ES   Argentina;Australia;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
LY3090106 - IV
   Eli Lilly and Company
      2013   Phase 1   NCT01925157   Bulgaria;Hungary;Moldova, Republic of;Poland;Romania;United States
LY3090106 - SQ
   Eli Lilly and Company
      2013   Phase 1   NCT01925157   Bulgaria;Hungary;Moldova, Republic of;Poland;Romania;United States
LY3337641
   Eli Lilly and Company
      2016   Phase 2   NCT02628028   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Puerto Rico;Slovakia;South Africa;Spain;United States
LY3337641 20 MG
   Eli Lilly and Company
      2017   Phase 2   EUCTR2015-003289-97-DE   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-SK   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-PL   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-AT   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
   Lilly S.A.
      2017   Phase 2   EUCTR2015-003289-97-ES   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
LY3337641 5 MG
   Eli Lilly and Company
      2017   Phase 2   EUCTR2015-003289-97-DE   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-SK   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-PL   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
      2016   Phase 2   EUCTR2015-003289-97-AT   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
   Lilly S.A.
      2017   Phase 2   EUCTR2015-003289-97-ES   Argentina;Australia;Austria;Germany;Italy;Japan;Korea, Republic of;Mexico;Poland;Slovakia;South Africa;Spain;United States
LY3462817
   Eli Lilly and Company
      2021   Phase 2   EUCTR2020-002673-10-PL   Czech Republic;Czechia;Hungary;Mexico;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2020-002673-10-HU   Czech Republic;Czechia;Hungary;Mexico;Poland;United Kingdom;United States
      2021   Phase 2   EUCTR2020-002673-10-CZ   Czech Republic;Czechia;Hungary;Mexico;Poland;United Kingdom;United States
LY3541860
   Eli Lilly and Company
      2025   Phase 2   NCT06859294   United States
LY3871801
   Eli Lilly and Company
      2023   Phase 2   NCT05848258   Argentina;Czechia;France;Germany;Hungary;India;Mexico;Poland;Slovakia;United Kingdom;United States
Lymphoseek
   Navidea Biopharmaceuticals Ltd
      2020   Phase 2   EUCTR2018-003418-41-GB   European Union;United Kingdom;United States
M2591 25 MG QD
   EMD Serono Research & Development Institute, Inc.
      2017   Phase 2   NCT03233230   Argentina;Brazil;Bulgaria;Chile;Colombia;Czechia;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
M281
   Janssen-Cilag International NV
      2021   Phase 2   EUCTR2021-000510-42-ES   Germany;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000510-42-DE   Germany;Poland;Spain;United Kingdom;United States
M2951
   EMD Serono Research & Development Institute, Inc.
      2016   Phase 2   NCT02784106   Germany;United States
   Merck KGaA
      2017   Phase 2   EUCTR2017-000384-32-CZ   Argentina;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Germany;Japan;Mexico;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2017   Phase 2   EUCTR2017-000384-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Germany;Japan;Mexico;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2016   Phase 2   EUCTR2016-000064-42-SK   Bulgaria;Czech Republic;Estonia;Hungary;Poland;Romania;Slovakia;South Africa;Ukraine
      2016   Phase 2   EUCTR2016-000064-42-HU   Bulgaria;Czech Republic;Estonia;Hungary;Poland;Romania;Slovakia;South Africa;Ukraine
      2016   Phase 2   EUCTR2016-000064-42-CZ   Bulgaria;Czech Republic;Estonia;Hungary;Poland;Romania;Slovakia;South Africa;Ukraine
      2016   Phase 2   EUCTR2016-000064-42-BG   Bulgaria;Czech Republic;Estonia;Hungary;Poland;Romania;Slovakia;Ukraine;United States
M2951 50 MG BID
   EMD Serono Research & Development Institute, Inc.
      2017   Phase 2   NCT03233230   Argentina;Brazil;Bulgaria;Chile;Colombia;Czechia;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
M2951 75 MG QD
   EMD Serono Research & Development Institute, Inc.
      2017   Phase 2   NCT03233230   Argentina;Brazil;Bulgaria;Chile;Colombia;Czechia;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
M923
   Momenta Pharmaceuticals, Inc.
      2016   Phase 3   NCT02722044   United States
Mabioncd20
   Mabion S.A.
      2021   Phase 3   EUCTR2020-002765-34-BE   Belgium;Bulgaria;Georgia;Poland;Serbia;Ukraine
      2014   Phase 3   EUCTR2012-003194-25-HR   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003194-25-LT   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
   Mabion SA
      2023   Phase 3   NCT04680962   -
Mabthera
   ARCHIGEN BIOTECH LIMITED
      2017   Phase 1;Phase 3   EUCTR2014-005368-13-IT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA
      2018   Phase 3   EUCTR2017-004079-30-IT   Belgium;Italy;Portugal;Spain
   Amgen Inc
      2017   Phase 1;Phase 3   EUCTR2013-005543-90-EE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2015   Phase 1;Phase 3   EUCTR2013-005543-90-BG   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-PL   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-HU   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-DE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Archigen Biotech Limited
      2016   Phase 1   NCT02819726   Bosnia and Herzegovina;Bulgaria;Czechia;Germany;Hungary;India;Korea, Republic of;Mexico;Poland;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-HU   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-ES   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-DE   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Biointegrator LLC
      2016   Phase 1   NCT03061838   Russian Federation
   Boehringer Ingelheim
      2012   Phase 3   NCT01682512   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   CELLTRION, Inc.
      2014   Phase 3   EUCTR2013-004555-21-SK   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-PT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-LV   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-HU   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-GR   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-DE   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
   CHRU de TOURS
      2014   Phase 4   EUCTR2014-000859-91-FR   France
   CHU Amiens-Picardie
      2015   Phase 4   EUCTR2015-000833-64-FR   France
   Celltrion
      2014   Phase 3   NCT02149121   Austria;Korea, Republic of
   Cliniques Universitaires Saint-Luc
      2006   Phase 4   EUCTR2006-005386-19-BE   Belgium
   Dr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona
      2008   -   EUCTR2007-003623-20-ES   Spain
   Dr. Reddy's Laboratories Limited
      2020   Phase 3   NCT04268771   United States
      2014   Phase 1/Phase 2   NCT02296775   India;Ukraine
   F Hoffmann-La Roche Ltd
      2009   Phase 2   EUCTR2008-005525-11-FR   France;Germany;Greece;Netherlands;Spain;United Kingdom
   F. Hoffmann - La Roche Ltd.
      2005   -   EUCTR2005-002395-15-IT   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
   F. Hoffmann- La Roche Ltd.
      2005   -   EUCTR2005-002396-33-IT   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2006   Phase 2   EUCTR2005-003632-22-ES   Spain
      2006   -   EUCTR2005-002396-33-SK   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-HU   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-002396-33-GB   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-DE   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002395-15-SE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DK   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-CZ   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002396-33-BE   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   -   EUCTR2005-002395-15-BE   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SI   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-GB   Germany;Ireland;Slovenia;Sweden;United Kingdom
   Gedeon Richter Plc
      2015   Phase 1;Phase 3   EUCTR2014-003255-54-CZ   Austria;Belgium;Czech Republic;Estonia;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Spain;Ukraine
   Gedeon Richter Plc.
      2015   Phase 1   NCT02371096   -
   Hexal AG
      2012   Phase 2   EUCTR2010-021184-32-EE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2011   Phase 2   EUCTR2010-021184-32-IT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2011   Phase 2   EUCTR2010-021184-32-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-FR   Austria;Belgium;Bulgaria;Estonia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-DE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
   Hexal AG (a Sandoz company)
      2015   Phase 3   EUCTR2012-003876-38-PL   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-HU   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-DE   Germany;Hungary;Poland;United States
   Hoffmann-La Roche
      2006   Phase 3   NCT02079532   Germany
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   JHL Biotech, Inc.
      2017   Phase 1   NCT03161457   Bosnia and Herzegovina;Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;Russian Federation;Taiwan;Ukraine;United Kingdom
   Johann Wolfgang Goethe-Universität Frankfurt/M.
      2010   -   EUCTR2009-015950-39-DE   Germany
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2016   Phase 4   EUCTR2012-002535-28-NL   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2015   Phase 4   EUCTR2012-002535-28-ES   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-BE   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2013   Phase 4   EUCTR2012-002535-28-GB   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London
      2015   Phase 4   EUCTR2012-002535-28-IT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-PT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-ES   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-BE   Belgium;Italy;Portugal;Spain
      2014   Phase 3   EUCTR2014-003529-16-GB   United Kingdom
   Mabion S.A.
      2021   Phase 3   EUCTR2020-002765-34-BE   Belgium;Bulgaria;Georgia;Poland;Serbia;Ukraine
      2014   Phase 3   EUCTR2012-003194-25-HR   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003194-25-LT   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
   Mabion SA
      2023   Phase 3   NCT04680962   -
   Mabscale, LLC
      2023   Phase 1   NCT06175338   Russian Federation
   Medical University of Vienna
      2012   Phase 4   NCT01638715   Austria;Czech Republic;Czechia;Russian Federation;Saudi Arabia;Switzerland
      -   Phase 4   EUCTR2015-002156-27-AT   Austria
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Merck Serono International
      2008   Phase 2   EUCTR2007-003647-75-NL   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-FR   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-003647-75-FI   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
   NHS Greater Glasgow and Clyde
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   Pfizer
      2012   Phase 2   NCT01526057   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2012-003223-38-GB   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-003223-38-ES   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003223-38-DE   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2011-002896-40-PL   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2012   Phase 2   EUCTR2011-002896-40-GB   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      -   Phase 2   EUCTR2011-002896-40-ES   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US
      2012   -   EUCTR2011-002896-40-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   ROCHE
      2007   -   EUCTR2007-001754-11-IT   Italy
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Samsung Electronics Co. Ltd.
      2012   -   EUCTR2011-004171-36-PL   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-HU   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-GB   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-ES   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-CZ   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
   Sandoz
      2015   Phase 3   NCT02514772   Germany;Hungary;Poland;United States
      2011   Phase 1/Phase 2   NCT01274182   Argentina;Austria;Belgium;Brazil;Estonia;France;Germany;Hungary;India;Italy;Romania;Spain;Turkey;United States
   Sint Maartenskliniek
      2020   Phase 4   EUCTR2020-002507-19-NL   Netherlands
      2016   Phase 4   EUCTR2016-002908-15-NL   Netherlands
   South Tees Hospitals NHS Foundation Trust
      2011   Phase 4   EUCTR2010-020499-50-GB   United Kingdom
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
      2007   Phase 3   EUCTR2006-005640-81-GB   United Kingdom
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
      2005   Phase 4   EUCTR2005-000674-43-GB   United Kingdom
Mabthera 100MG
   Dr. Reddy’s Laboratories S.A.
      2020   Phase 3   EUCTR2019-002810-37-PL   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-LT   Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
Mabthera 500 MG
   Division of Clinically Immunology and Rheumatology, AMC
      2009   -   EUCTR2009-010955-29-NL   Netherlands
   F. Hoffmann-La Roche Ltd.
      2006   -   EUCTR2005-002396-33-FI   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-002395-15-GB   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-FI   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002392-32-DE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002396-33-ES   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   -   EUCTR2005-002395-15-ES   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-IE   Germany;Ireland;Slovenia;Sweden;United Kingdom
Mabthera 500 MG (10 MG/ML) concentrate FOR solution FOR infusion
   Merck Serono International
      2008   -   EUCTR2007-003647-75-SE   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Serono SA - Geneva
      2008   Phase 2   EUCTR2007-003647-75-GB   Finland;France;Netherlands;Sweden;United Kingdom
Mabthera 500 MG concentrado para solucióN para perfusióN
   F Hoffmann-La Roche Ltd
      2009   Phase 2   EUCTR2008-005525-11-ES   France;Germany;Greece;Netherlands;Spain;United Kingdom
   ROCHE FARMA, S.A.
      2009   -   EUCTR2008-002381-55-ES   Spain
Mabthera 500 MG concentrate FOR solution FOR infusion
   Boehringer Ingelheim International GmbH
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-NO   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-ES   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-DE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-BG   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-002894-48-PT   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-HU   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GR   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GB   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-EE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-BE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   Roche (Hungary) Ltd.
      2006   -   EUCTR2006-004673-98-HU   Hungary
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
Mabthera 500 MG konzentrat ZUR herstellung einer infusionslösung
   Roche Pharma AG
      2007   -   EUCTR2006-006746-33-DE   Germany
      2006   -   EUCTR2006-001000-37-DE   Germany
Mabthera 500MG
   Dr. Reddy’s Laboratories S.A.
      2020   Phase 3   EUCTR2019-002810-37-PL   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-LT   Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
   F Hoffmann-La Roche Ltd
      2009   -   EUCTR2008-005525-11-NL   France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-GR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-005525-11-DE   France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-005525-11-GB   France;Germany;Greece;Netherlands;Spain;United Kingdom
   F. Hoffman- La Roche Ltd.
      2008   -   EUCTR2007-001585-33-GR   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
   F. Hoffman-La Roche Ltd.
      2007   -   EUCTR2007-001585-33-NL   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-LV   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-LT   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   Phase 3   EUCTR2007-001585-33-FR   Czech Republic;Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-ES   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-EE   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-DK   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   Phase 3   EUCTR2007-001585-33-CZ   Czech Republic;Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
   F. Hoffmann-La Roche Ltd.
      2008   -   EUCTR2007-001585-33-DE   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
Mabthera infusions
   Teva Pharmaceutical Industries
      2010   Phase 1/Phase 2   NCT01123070   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
Mabthera*EV 1FL 50ML 500MG
   A.O. UNIVERSITARIA INTEGRATA DI VERONA
      2012   -   EUCTR2011-006001-10-IT   Italy
Mabthera/rituxan
   Hoffmann-La Roche
      2011   Phase 3   NCT01332994   Germany
      2010   Phase 4   NCT01117129   Spain
      2009   -   NCT01075477   Finland;United States
      2009   Phase 2   NCT00845832   Belgium;France;Germany;Greece;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom
      2008   Phase 4   NCT01000610   Tunisia
      2007   Phase 4   NCT00934648   Morocco
      2007   Phase 4   NCT00576433   Russian Federation
      2007   Phase 4   NCT00504777   Taiwan
      2007   Phase 4   NCT00502853   Italy
      2007   Phase 3   NCT00502840   Germany
      2007   Phase 4   NCT00424502   Hungary
      2006   Phase 3   NCT02006706   Serbia
      2006   Phase 3   NCT00502996   Argentina;Brazil;Chile;Colombia;Ecuador;El Salvador;Mexico;Peru;Uruguay;Venezuela
      2006   Phase 2   NCT00422942   Netherlands;Spain
      2006   Phase 3   NCT00422383   Australia;Belgium;Brazil;Canada;China;Finland;France;Germany;Hungary;Italy;Netherlands;New Zealand;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;United Kingdom;United States
      2005   Phase 3   NCT00503425   Israel
      2004   Phase 3   NCT02097745   Belgium;Canada;France;Germany;Ireland;Israel;Italy;Netherlands;Norway;United Kingdom;United States
      2003   Phase 3   NCT00468546   Belgium;Canada;France;Germany;Ireland;Israel;Italy;Netherlands;Norway;United Kingdom;United States
Mabthera®, 100 MG concentrado para solucióN para perfusióN
   Teva Pharmaceutical Industries
      2012   -   EUCTR2011-005021-48-ES   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
Mabthera®, 100 MG concentrate FOR solution FOR infusion
   Teva Pharmaceutical Industries
      2012   Phase 3   EUCTR2011-005021-48-PL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-NL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-HU   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-CZ   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-BG   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
Magnesium
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
   University of Guadalajara
      2025   Phase 2/Phase 3   NCT06915701   Mexico
Magnetic resonance imaging
   Rigshospitalet, Denmark
      2023   -   NCT05698563   Denmark
   University of California, San Francisco
      2013   -   NCT01773681   United States
Maraviroc
   PFIZER
      2007   -   EUCTR2007-001035-58-IT   Italy;Portugal;Spain
   Pfizer
      2007   Phase 2   NCT00427934   Australia;Germany;India;Italy;Mexico;Portugal;Spain;Ukraine;United States
   Pfizer Inc, 235 East 42nd Street,New York, NY 10017
      2007   -   EUCTR2007-001035-58-PT   Italy;Portugal;Spain
   Pfizer, S. A.
      2007   Phase 2   EUCTR2007-001035-58-ES   Italy;Portugal;Spain
Masitinib
   AB Science
      2007   Phase 2   NCT00913432   -
      2004   Phase 2   NCT00831922   -
Masitinib 3 MG
   AB Science
      2011   Phase 2/Phase 3   NCT01410695   Czech Republic;Czechia;France;United States
Masitinib 6.0 MG
   AB Science
      2011   Phase 2/Phase 3   NCT01410695   Czech Republic;Czechia;France;United States
Masitinib mesylate
   AB Science
      2014   -   EUCTR2010-020992-21-DE   Argentina;Bosnia and Herzegovina;Czech Republic;Germany;Greece;India;Mexico;Monaco;Morocco;Philippines;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Tunisia;Ukraine;United States
      2012   Phase 3   EUCTR2010-020992-21-GR   Czech Republic;Germany;Greece;India;Monaco;Poland;Romania;Slovakia;Spain;Thailand;Turkey;United States
      2011   Phase 3   EUCTR2010-020992-21-SK   Czech Republic;France;Germany;Greece;India;Poland;Romania;Slovakia;Spain;Thailand;Tunisia;Turkey;United States
      2011   -   EUCTR2010-020992-21-ES   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
      2011   -   EUCTR2010-020992-21-CZ   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
Mavrilimumab
   MedImmune Limited
      2013   Phase 2   EUCTR2011-005649-10-GB   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   MedImmune Ltd
      2013   -   EUCTR2011-005649-10-SK   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-PT   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-HU   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-DE   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-CZ   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   Phase 2   EUCTR2011-005648-93-SK   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2013   -   EUCTR2011-005648-93-PT   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2013   Phase 2   EUCTR2011-005648-93-GB   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005649-10-GR   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-ES   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005648-93-HU   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-GR   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-ES   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005648-93-EE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-DE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005648-93-CZ   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   EUCTR2011-005648-93-BG   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Greece;Hungary;Mexico;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   -   EUCTR2011-005634-19-PL   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-HU   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-ES   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-EE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-DE   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-CZ   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2012   -   EUCTR2011-005634-19-BG   Argentina;Bulgaria;Chile;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2010   -   EUCTR2009-014735-20-PL   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-LT   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2010   -   EUCTR2009-014735-20-CZ   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2009   -   EUCTR2009-014735-20-LV   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
      2009   -   EUCTR2009-014735-20-EE   Bulgaria;Czech Republic;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Ukraine
Mavrilimumab 10 MG
   MedImmune LLC
      2010   Phase 2   NCT01050998   Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
Mavrilimumab 100 MG
   MedImmune LLC
      2013   Phase 2   NCT01715896   Argentina;Colombia;Czech Republic;France;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Serbia;Slovakia;Spain;Turkey;United Kingdom
      2013   Phase 2   NCT01712399   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Israel;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom
      2012   Phase 2   NCT01706926   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2010   Phase 2   NCT01050998   Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
Mavrilimumab 150 MG
   MedImmune LLC
      2012   Phase 2   NCT01706926   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
Mavrilimumab 30 MG
   MedImmune LLC
      2012   Phase 2   NCT01706926   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Estonia;France;Germany;Hungary;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine
      2010   Phase 2   NCT01050998   Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
Mavrilimumab 50 MG
   MedImmune LLC
      2010   Phase 2   NCT01050998   Bulgaria;Czech Republic;Czechia;Estonia;Hungary;Japan;Latvia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
Maxtrex
   ELI LILLY AND COMPANY
      2013   -   EUCTR2012-002324-32-IT   Argentina;Austria;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
MBS2320
   Modern Biosciences Ltd.
      2023   Phase 2   EUCTR2020-005496-13-BG   Bulgaria;Chile;Czech Republic;Czechia;Mexico;Peru;Poland;Russian Federation;Ukraine
      2022   Phase 2   EUCTR2020-005496-13-PL   Bulgaria;Chile;Czech Republic;Czechia;Mexico;Peru;Poland
   Modern Biosciences plc
      2018   Phase 2   EUCTR2016-004038-24-RO   Georgia;Moldova, Republic of;Romania
      2017   Phase 2   NCT03139136   Georgia;Moldova, Republic of;Romania
      2015   Phase 1   NCT02480946   United Kingdom
MBS2320 20 MG
   Modern Biosciences Ltd
      2022   Phase 2   NCT05460832   Bosnia and Herzegovina;Bulgaria;Chile;Czechia;Guatemala;Mexico;Poland;Serbia
MBS2320 40 MG
   Modern Biosciences Ltd
      2022   Phase 2   NCT05460832   Bosnia and Herzegovina;Bulgaria;Chile;Czechia;Guatemala;Mexico;Poland;Serbia
MBS2320 5 MG
   Modern Biosciences Ltd
      2022   Phase 2   NCT05460832   Bosnia and Herzegovina;Bulgaria;Chile;Czechia;Guatemala;Mexico;Poland;Serbia
MDX-1100
   Bristol-Myers Squibb
      2008   Phase 2   NCT01017367   Romania;Ukraine
MDX-1342
   Bristol-Myers Squibb
      2008   Phase 1   NCT00639834   Germany;Hungary;Poland;Ukraine;United Kingdom;United States
Meat intake
   University of Leeds
      1995   -   NCT06670144   United Kingdom
MEDI-522
   MedImmune LLC
      2003   Phase 2   NCT00069017   Canada;United States
MEDI5117
   Novo Nordisk A/S
      2012   Phase 1   NCT01559103   Germany;United Kingdom;United States
Medium THC/medium CBD
   Brown University
      2022   Phase 2   NCT04269993   United States
Medrol
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
Medrol 4 MG tablets
   N.V. Roche S.A.
      2010   Phase 4   EUCTR2010-019694-15-BE   Belgium
Medrol A 16 MG tablets
   N.V. Roche S.A.
      2010   Phase 4   EUCTR2010-019694-15-BE   Belgium
Mefloquine
   Arakis Ltd.
      2005   -   EUCTR2005-002421-31-DE   Germany;United Kingdom
Melatonin
   Shunichi Shiozawa
      2013   -   JPRN-UMIN000018816   Japan
Meloxicam
   Boehringer Ingelheim
      2003   -   NCT02184052   -
      2002   Phase 3   NCT00042068   Argentina;Australia;Belgium;Brazil;Canada;France;Germany;Hungary;Italy;Korea, Republic of;Russian Federation;Taiwan;Ukraine;United States
      2001   -   NCT02180516   -
   Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University
      2019   Phase 1   ChiCTR1900027855   China
      2019   Phase 1   ChiCTR1900025021   China
Meloxicam 0.125 MG/KG
   Boehringer Ingelheim
      2000   Phase 3   NCT00279747   Austria;Belgium;France;Germany;Italy;Russian Federation;United Kingdom
Meloxicam 0.25 MG/KG
   Boehringer Ingelheim
      2000   Phase 3   NCT00279747   Austria;Belgium;France;Germany;Italy;Russian Federation;United Kingdom
Meloxicam ampoule
   Boehringer Ingelheim
      2004   Phase 3   NCT00239382   China
Meloxicam oral suspension
   Boehringer Ingelheim
      2000   Phase 3   NCT00034853   Argentina;Brazil;Mexico;Ukraine;United States
Meloxicam tablet
   Boehringer Ingelheim
      2004   Phase 3   NCT00239382   China
Melphalan
   Paul Szabolcs
      2014   Phase 2   NCT01962415   United States
Meriva
   University of Arizona
      2015   Phase 1   NCT02543931   United States
Mesalazine
   Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
      2011   -   JPRN-UMIN000005362   Japan
Mesenchymal cell transplantation
   Royan Institute
      2009   Phase 2/Phase 3   NCT01873625   Iran, Islamic Republic of
Mesenchymal stem cells
   Alliancells Bioscience Corporation Limited
      2013   Phase 1/Phase 2   NCT01547091   China
   National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
      2025   Phase 1/Phase 2   NCT06888973   Pakistan
Messenchymal stem cell secretome
   Universitas Sebelas Maret
      2022   Phase 1/Phase 2   NCT05925647   Indonesia
Metal ON polyethylene articulation
   Zimmer Biomet
      2013   -   NCT02036931   France;Germany;Ireland;Netherlands;Spain;United States
Metex
   Abbott GmbH & Co. KG
      2008   -   EUCTR2006-004139-31-NO   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-SK   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-SE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-NL   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-HU   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-GB   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-FR   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-ES   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-DE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-CZ   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-BE   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-AT   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
   Charité-Universitätsmedizin Berlin; Department of Rheumatology and Clinical Immunology
      2007   -   EUCTR2006-003146-41-DE   Germany
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
Metex 10 MG/ML injektionslösung, fertigspritze
   medac Gesellschaft für klinische Spezialpräparate mbH
      -   -   EUCTR2007-003591-19-DE   Germany
Metex 10MG tabletten
   4SC AG
      2009   -   EUCTR2009-012953-39-PL   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-CZ   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
Metex 2,5MG tabletten
   4SC AG
      2009   -   EUCTR2009-012953-39-PL   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-CZ   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
Metex 50 MG/ML injeksjonsvæSKE, oppløsning I ferdigfylt SPRøYTE
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Metex 7,5MG tabletten
   4SC AG
      2009   -   EUCTR2009-012953-39-PL   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-CZ   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
Metex PEN
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
Metex® 50 MG/ML injektionslösung, fertigspritze
   medac Gesellschaft für klinische Spezialpräparate mbH
      2012   -   EUCTR2012-000222-21-DE   Germany
Metformin
   Ain Shams University
      2019   Phase 2   NCT03863405   Egypt
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
   Inner Mongolia University of Science and Technology Baotou Medical College First Affiliated Hospital
      2017   -   ChiCTR-INR-17011772   China
   MD, PhD, Annemarie Lyng Svensson
      2014   -   NCT02246257   Denmark
   Queen Mary University of London
      2010   Phase 2   EUCTR2008-005708-18-GB   United Kingdom
   Sadat City University
      2019   Phase 1/Phase 2   NCT04068246   Egypt
   the Second Hospital of Shanxi Medical University
      2017   -   ChiCTR-IPR-17010325   China
Metformin treatment
   University Hospital, Bordeaux
      2020   Phase 2   NCT04196868   France
Metformin/CP-690,550
   Pfizer
      2011   Phase 1   NCT01405118   Belgium
Metformine arrow 500MG
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
Methorexate
   University Hospitals Birmingham NHS Foundation Trust
      2006   Phase 4   EUCTR2006-001428-38-GB   United Kingdom
Methotrexaat
   Leiden University medical Centre
      2015   Phase 2   EUCTR2014-004472-35-NL   Netherlands
Methotrexat
   Biocad
      2019   Phase 3   NCT04227366   Russian Federation
   GlaxoSmithKline Research & Development Ltd
      -   -   EUCTR2005-002969-37-DE   Germany;Spain;Sweden
Methotrexat 2,5 MG tabletten medac
   Novartis Pharma Services AG
      2007   -   EUCTR2006-001553-10-DE   Germany;Italy;Netherlands
Methotrexat hexal® 2,5 MG tabletten
   Eli Lilly and Company
      2013   -   EUCTR2012-002324-32-SE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-PT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-GB   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-DE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-BE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-AT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
Methotrexat lederle - tabletten
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
Methotrexat lederle 2.5MG tablets
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
Methotrexate
      2010   -   EUCTR2009-015653-20-NL   Netherlands
   4SC AG
      2009   Phase 2   NCT01010581   Bulgaria;Czech Republic;Poland;Romania
      2009   -   EUCTR2009-012953-39-PL   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-CZ   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
   AB Science
      2014   -   EUCTR2010-020992-21-DE   Argentina;Bosnia and Herzegovina;Czech Republic;Germany;Greece;India;Mexico;Monaco;Morocco;Philippines;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Tunisia;Ukraine;United States
      2012   Phase 3   EUCTR2010-020992-21-GR   Czech Republic;Germany;Greece;India;Monaco;Poland;Romania;Slovakia;Spain;Thailand;Turkey;United States
      2011   Phase 2/Phase 3   NCT01410695   Czech Republic;Czechia;France;United States
      2011   Phase 3   EUCTR2010-020992-21-SK   Czech Republic;France;Germany;Greece;India;Poland;Romania;Slovakia;Spain;Thailand;Tunisia;Turkey;United States
      2011   -   EUCTR2010-020992-21-ES   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
      2011   -   EUCTR2010-020992-21-CZ   Czech Republic;Germany;Greece;India;Slovakia;Spain;Thailand;Turkey;United States
   AMGEN INC.
      2016   Phase 3   EUCTR2014-004868-38-IT   Bulgaria;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
   AbbVie
      2016   Phase 3   NCT02706873   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
   AbbVie (prior sponsor, Abbott)
      2010   Phase 3   NCT01185301   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Poland;Puerto Rico;Spain;United States
      2010   Phase 4   NCT01185288   Puerto Rico;United States
      2010   Phase 4   NCT01162421   Canada
      2009   Phase 4   NCT00808509   Sweden
      2000   Phase 3   NCT00195663   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003376-75-GR   Argentina;Australia;Austria;Belgium;Chile;Colombia;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-ES   Argentina;Australia;Austria;Chile;Colombia;European Union;Israel;Japan;Mexico;New Zealand;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-SI   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LV   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-IE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-HU   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Greece;Hong Kong;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-HR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-GR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-FI   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-ES   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Colombia;Croatia;Egypt;European Union;Greece;Hong Kong;Hungary;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BG   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003334-27-SK   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abbott
      2006   Phase 4   NCT00420927   Argentina;Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Mexico;Netherlands;New Zealand;Norway;Poland;Puerto Rico;Slovakia;South Africa;Spain;Sweden;United Kingdom;United States
      2005   Phase 4   NCT00233558   United States
      2003   Phase 3   NCT00235859   -
      2003   Phase 3   NCT00234936   -
      2003   Phase 3   NCT00234845   United States
   Abbott GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-ES   Austria;Czech Republic;Germany;Spain
      2011   -   EUCTR2010-019514-24-DE   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   Phase 3   EUCTR2010-019514-24-BE   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   -   EUCTR2010-019514-24-AT   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abivax S.A.
      2019   Phase 2   NCT03813199   Belgium;Czechia;France;Hungary;Poland
   Ablynx
      2015   Phase 2   NCT02309359   Belgium;Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;North Macedonia;Poland;Romania;Serbia;Spain;United States
      2009   Phase 1/Phase 2   NCT00959036   Belgium;Canada;Germany;Hungary;Russian Federation;Serbia;South Africa;Switzerland;United States
   Aclaris Therapeutics, Inc.
      2022   Phase 2   NCT05279417   Bulgaria;Czechia;Poland;United States
      2020   Phase 2   NCT04247815   United States
   All India Institute of Medical Sciences, New Delhi
      2009   Phase 3   NCT01870128   India
   Amgen
      2013   Phase 4   NCT01927757   Canada;Puerto Rico;United States
      2008   Phase 4   NCT00654368   Canada
      2000   Phase 3   NCT03781375   -
   Amgen Inc.
      2017   Phase 3   EUCTR2014-004868-38-DE   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-PT   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-HU   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-GR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-FR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-ES   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-BG   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2015   Phase 3   EUCTR2014-004868-38-CZ   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
   Anhui Provincial Hospital Department of Rheumatism
      2011   -   ChiCTR-TRC-11001789   China
   Antares Pharma Inc.
      2011   Phase 1/Phase 2   NCT01737944   United States
   Astellas Pharma Global Development, Inc.
      2016   Phase 1   NCT02867306   Moldova, Republic of
   Astellas Pharma Inc
      2016   Phase 2   NCT02884635   Japan
      2014   Phase 3   NCT02305849   Japan
      2012   Phase 2   NCT01554696   Belgium;Bulgaria;Colombia;Czech Republic;Czechia;Hungary;Mexico;Poland;United States
      2011   Phase 3   NCT01451203   Japan
      2010   Phase 1   NCT01754805   United States
      2009   Phase 3   NCT00851318   Japan
      2002   Phase 3   NCT00036153   Canada;United States
   Astellas Pharma Korea, Inc.
      2019   Phase 4   NCT03737708   Korea, Republic of
   AstraZeneca
      2009   Phase 1   NCT00920608   -
   BRISTOL-M.SQUIBB
      2011   -   EUCTR2010-023956-99-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;South Africa;Spain;Taiwan;United States
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Bio Logic Mate Study Group
      2012   -   JPRN-UMIN000009088   Japan
   Biocad
      2016   Phase 3   NCT02762838   Belarus;India;Russian Federation
      2015   Phase 3   NCT02744196   -
   Biogen
      2006   Phase 2   NCT00298272   United States
   Bird Rock Bio, Inc.
      2018   Phase 2   NCT02795299   -
   Brigham and Women's Hospital
      2020   -   NCT04691505   United States
   Bristol-Myers K.K.
      2011   Phase 2   JPRN-jRCT2080221588   -
   Bristol-Myers Squibb
      2021   Phase 3   NCT04909801   Argentina;Australia;Czechia;France;Germany;Italy;Japan;Mexico;Poland;Spain;Switzerland;Taiwan;United Kingdom;United States
      2017   Phase 1   NCT03131973   United States
      2016   Phase 2   NCT02638948   Argentina;Austria;Belgium;Brazil;Canada;France;Germany;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
      2015   Phase 4   NCT02557100   Algeria;Canada;Mexico;United States
      2015   Phase 3   NCT02504268   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Monaco;Netherlands;Peru;Poland;Puerto Rico;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom;United States
      2013   Phase 4   NCT01758198   Japan
      2010   Phase 3   NCT01142726   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Norway;Poland;Russian Federation;South Africa;Sweden;United States
      2008   Phase 3   NCT00767325   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2007   Phase 3   NCT00547521   Australia;Brazil;Canada;Mexico;Peru;South Africa;United States
      2007   Phase 3   NCT00409838   Korea, Republic of
      2005   Phase 3   NCT00122382   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;France;Germany;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;South Africa;Spain;United Kingdom;United States
      2005   Phase 3   NCT00095147   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Russian Federation;South Africa;Spain;Sweden;Switzerland;United States
      2002   Phase 3   NCT00048568   United States
   Bristol-Myers Squibb International Corporation
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   Bristol-Myers Squibb K.K.
      2016   Phase 2   JPRN-jRCT2080223262   Asia except Japan;Europe;Japan;North America;Oceania;South America
      2015   Phase 3   JPRN-jRCT2080223027   Africa;Asia except Japan;Europe;Japan;North America;Oceania;South America
   CENTOCOR
      2006   Phase 3   EUCTR2004-003295-10-IT   Austria;Hungary;Italy;Spain;United Kingdom
   CHU Saint-Etienne
      2018   Phase 4   EUCTR2017-004348-39-FR   France
   CHU de Bordeaux
      2019   Phase 2   EUCTR2018-004287-56-FR   France
   CSL Behring
      2011   Phase 2   NCT01373151   Argentina;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United States
   Can-Fite BioPharma, Ltd.
      2019   Phase 3   EUCTR2016-003682-26-PL   Bosnia and Herzegovina;Bulgaria;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
   Centocor, Inc.
      2010   Phase 3   NCT01248780   China
      2009   Phase 3   NCT00973479   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
      2008   Phase 2   NCT00718718   Argentina;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Taiwan;Ukraine;United States
      2006   Phase 3   NCT00361335   Argentina;Australia;Belgium;Colombia;Germany;Hungary;Latvia;Lithuania;Malaysia;Malta;Mexico;New Zealand;Peru;Poland;Russian Federation;Ukraine;United States
      2005   Phase 3   NCT00264550   Argentina;Australia;Brazil;Canada;Chile;Germany;Hungary;India;Korea, Republic of;Mexico;New Zealand;Poland;Taiwan;Turkey;United States
   Central Hospital of Jinhua
      2014   Phase 4   ChiCTR1900026116   China
   Chelsea Therapeutics
      2010   Phase 2   NCT01116141   -
      2008   Phase 2   NCT00658047   Canada
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-CZ   Bulgaria;Czech Republic
   China-Japan Friendship Hospital
      2022   Phase 1   ChiCTR2200063205   China
   Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
      2010   Phase 4   ChiCTR1900024107   China
   Chinese Academy of Sciences
      2012   -   NCT01619176   China
   Chinese SLE Treatment And Research Group
      2015   Phase 4   NCT02764515   China
   Chinese University of Hong Kong
      2008   -   NCT00901550   China
   Chugai Pharma Taiwan
      2011   Phase 3   NCT01347983   Taiwan
      2010   Phase 3   NCT01258712   Taiwan
   Chugai Pharmaceutical
      2008   Phase 2   NCT00779220   Japan
   Cinnagen
      2015   Phase 3   NCT03172325   Iran, Islamic Republic of
   Cui xuejun
      2018   Phase 2/Phase 3   NCT02885597   China
   Dazhou Central Hospital
      2023   -   ChiCTR2400081970   China
   Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University
      2013   -   JPRN-UMIN000010126   Japan
   Department of Medical Pharmaceutics , Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama
      2015   -   JPRN-UMIN000015433   Japan
   Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka City University Medical School
      2013   Phase 4   JPRN-UMIN000012073   Japan
   Dr. Mohammad Mamun Khan
      2019   Phase 4   NCT04464642   Bangladesh
   ELI LILLY AND COMPANY
      2013   -   EUCTR2012-002324-32-IT   Argentina;Austria;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
   Eli Lilly Japan K.K.
      2013   Phase 3   JPRN-jRCT2080222088   -
   Eli Lilly and Company
      2013   -   EUCTR2012-002324-32-GR   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002322-73-GR   Argentina;Belgium;Canada;China;Croatia;Czech Republic;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2012   Phase 3   NCT01711359   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2012   Phase 3   NCT01710358   Argentina;Belgium;Canada;China;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;United Kingdom;United States
      2011   Phase 2   NCT01469013   Japan
      2010   Phase 3   NCT01198002   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2010   Phase 2   NCT01185353   Argentina;Croatia;Czech Republic;Czechia;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2006   -   EUCTR2005-002396-33-FI   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002395-15-FI   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
   Fen Li
      2016   Phase 4   NCT02878161   -
   Flinders University
      2017   Phase 4   NCT03254589   Australia
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Gema Biotech S.A.
      2016   Phase 3   NCT03332719   Argentina
   Genentech, Inc.
      2010   Phase 2   NCT01225393   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Poland;Romania;Spain;United States
      2010   Phase 4   NCT01163747   United States
      2009   Phase 2   NCT00808210   United States
      2008   Phase 3   NCT00673920   United States
      2007   Phase 3   NCT00485589   United States
      2007   Phase 3   NCT00476996   Argentina;Australia;Belgium;Brazil;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Mexico;Netherlands;New Zealand;Panama;Peru;Poland;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;United States
      2006   Phase 3   NCT00406419   United States
      2006   Phase 3   NCT00299104   United States
      2006   Phase 2   NCT00282308   United States
      2006   Phase 3   NCT00266227   United States
      2005   Phase 3   NCT00299130   United States
      2005   Phase 2   NCT00243412   United States
      2003   Phase 2   NCT00074438   United States
   General Hospital of Chengdu Military Region
      2014   Phase 1 study   ChiCTR-TRC-14004520   China
   Gilead Sciences
      2016   Phase 2   NCT02885181   Bulgaria;Czech Republic;Czechia;Georgia;Hungary;Moldova, Republic of;Poland;Ukraine;United States
      2016   Phase 2   NCT02862574   Australia;Hungary;Taiwan;United States
   GlaxoSmithKline
      2017   Phase 1/Phase 2   NCT03028467   Japan
   Goupe d'Etudes et de Recherche Clinique En Rhumatologie
      2004   Phase 4   NCT00291915   France
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2019   Phase 2/Phase 3   NCT04170504   China
      2019   Phase 2/Phase 3   NCT04136262   China
   Guang'anmen Hospital, China Academy of Traditional Chinese Medicine
      2022   Phase 4   ChiCTR2200060763   China
   Guangdong Provincial Hospital of Chinese Medicine
      2024   Phase 0   ChiCTR2300079206   China
      2015   -   ChiCTR-IPR-15007368   China
   Hoffmann-La Roche
      2016   Phase 2   NCT03001219   Argentina;Austria;Colombia;Czech Republic;Czechia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
      2015   -   NCT02608112   France
      2014   Phase 3   NCT02046616   Denmark;Finland;Norway;Sweden
      2014   Phase 3   NCT02046603   United Kingdom
      2014   Phase 3   NCT02001987   France
      2014   Phase 3   NCT01987479   Netherlands
      2013   Phase 3   NCT01995201   Ireland;Portugal;Spain
      2013   Phase 3   NCT01941095   Greece
      2013   Phase 4   NCT01878318   Venezuela
      2013   Phase 3   NCT01855789   United States
      2012   Phase 4   NCT01661140   United Kingdom
      2012   Phase 3   NCT01587989   Austria
      2011   Phase 4   NCT01399697   Spain
      2011   Phase 4   NCT01382940   United States
      2011   Phase 3   NCT01353859   Greece;Indonesia
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   NCT01235507   Bosnia and Herzegovina
      2010   Phase 4   NCT01117129   Spain
      2010   Phase 3   NCT01063062   Egypt
      2010   Phase 3   NCT01034137   Netherlands
      2009   Phase 3   NCT01007435   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Czech Republic;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, The Former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Puerto Rico;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   Phase 1   NCT00965653   Canada;New Zealand;Spain;United Kingdom
      2009   Phase 3   NCT00810199   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Monaco;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00754572   Argentina;Brazil;Chile;Colombia;Costa Rica;Ecuador;Mexico;Peru;Uruguay;Venezuela
      2008   Phase 4   NCT01000610   Tunisia
      2007   Phase 4   NCT00934648   Morocco
      2007   Phase 3   NCT00578305   Argentina;Brazil;Canada;Czech Republic;Denmark;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Latvia;Lithuania;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;United Kingdom
      2007   Phase 4   NCT00576433   Russian Federation
      2007   Phase 3   NCT00535782   Canada;Puerto Rico;United Kingdom;United States
      2007   Phase 4   NCT00504777   Taiwan
      2007   Phase 4   NCT00502853   Italy
      2007   Phase 4   NCT00462345   Korea, Republic of
      2007   Phase 4   NCT00424502   Hungary
      2006   Phase 3   NCT02006706   Serbia
      2006   Phase 3   NCT00502996   Argentina;Brazil;Chile;Colombia;Ecuador;El Salvador;Mexico;Peru;Uruguay;Venezuela
      2006   Phase 2   NCT00422942   Netherlands;Spain
      2005   Phase 1   NCT00365001   New Zealand;United States
      2005   Phase 3   NCT00109408   Argentina;Australia;Canada;China;Croatia;Denmark;Former Serbia and Montenegro;France;Israel;Italy;Lithuania;Mexico;Norway;Peru;Portugal;Serbia;Slovenia;South Africa;Spain;United States
      2005   Phase 3   NCT00106548   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;France;Germany;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Spain;Switzerland;Thailand
      2005   Phase 3   NCT00106535   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;Puerto Rico;South Africa;Spain;Switzerland;United States
      2005   Phase 3   NCT00106522   Australia;Belgium;Canada;France;Germany;Iceland;Italy;Mexico;Netherlands;Puerto Rico;Sweden;Switzerland;United Kingdom;United States
      2004   Phase 3   NCT02097745   Belgium;Canada;France;Germany;Ireland;Israel;Italy;Netherlands;Norway;United Kingdom;United States
      2003   Phase 3   NCT00468546   Belgium;Canada;France;Germany;Ireland;Israel;Italy;Netherlands;Norway;United Kingdom;United States
      2002   Phase 2   NCT02093026   Australia;Belgium;Brazil;Canada;Czech Republic;Finland;Germany;Israel;Italy;Mexico;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2001   Phase 2   NCT02693210   Australia;Belgium;Canada;Czech Republic;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   Huashan Hospital, Fudan University / Peking University, Reople’s Hospital
      2019   Phase 3   ChiCTR2300067652   China
   Hvidovre University Hospital
      1998   Phase 4   NCT00209859   Denmark
   ILAb Co., Ltd.
      2022   Phase 1   NCT05533372   United States
   Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine
      2013   -   ChiCTR-TRC-13003948   China
   Janssen Biotech, Inc.
      2009   Phase 3   NCT01004432   Austria;Belgium;Canada;France;Germany;Greece;Spain;Sweden;United Kingdom;United States
   Janssen Korea, Ltd., Korea
      2007   -   NCT00760669   Korea, Republic of
   Janssen Pharmaceutical K.K.
      2008   Phase 3   NCT00727987   Japan
   Janssen Research & Development, LLC
      2012   Phase 2   NCT01679951   Argentina;Chile;Colombia;Czech Republic;Czechia;Hungary;Japan;Korea, Republic of;Latvia;Mexico;Poland;Romania;Russian Federation;Taiwan;Thailand;Ukraine;United States
      2012   Phase 2   NCT01645280   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Republic of;Mexico;Peru;Poland;Russian Federation;Singapore;Turkey;Ukraine;United States
   Japan Association of Rheumatologists in Private Practice
      2010   -   JPRN-UMIN000003807   Japan
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
      2015   Phase 4   NCT02644499   India
   Jiangsu Alphamab Biopharmaceuticals Co., Ltd
      2019   Phase 2   NCT04038970   China
   Jiangsu Simcere Pharmaceutical Co., Ltd.
      2016   Phase 3   NCT02722694   China
      2013   Phase 4   NCT02275299   China
      2012   Phase 4   NCT01548001   China
   Johoku Biological Summit
      2006   Phase 4   JPRN-C000000452   Japan
   Juan Carlos Nieto
      2018   -   NCT03535519   Spain
   KONAMON Study Group
      2013   -   JPRN-UMIN000007404   Japan
   Kaneko Yuko
      2018   Phase 4   JPRN-jRCT1031180088   Japan;South Korea;Taiwan
   Karolinska Institutet
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Keio University
      2025   Phase 4   NCT06913907   Japan
      2018   Phase 4   NCT03505008   Japan;Korea, Republic of;Taiwan
      2012   -   JPRN-UMIN000007432   Japan
   Keio University Hospital
      2015   -   JPRN-UMIN000018848   Japan
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   Kinki University Faculty of Medicine, Division of Hematology and Rheumatology
      2012   -   JPRN-UMIN000007380   Japan
   Konkuk University Medical Center
      2024   -   NCT06574594   Korea, Republic of
   Korea Otsuka Pharmaceutical Co., Ltd.
      2009   Phase 3   NCT00993317   Korea, Republic of
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Leiden University medical Centre
      2015   Phase 2   EUCTR2014-004472-35-NL   Netherlands
   Lexicon Pharmaceuticals
      2009   Phase 1   NCT00847886   United States
   Ludwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation
      2008   -   EUCTR2007-006288-56-AT   Austria
   Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation
      2008   Phase 4   NCT00695188   Austria
   Maoxiang Group Jilin Pharmaceutical Co., Ltd.
      2014   Phase 2   NCT02029599   China
   Maria Stoenoiu
      2015   Phase 3   NCT02837146   Belgium
   Medical University of Vienna
      2024   Phase 4   NCT06649136   Austria
   Merck Sharp & Dohme Corp.
      2012   Phase 2   NCT01651936   Australia;Colombia;Denmark;France;Greece;Hungary;Italy;Korea, Republic of;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
      2012   Phase 2   NCT01569152   Canada;Chile;Denmark;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Moldova, Republic of;Peru;Poland;South Africa;Taiwan;United Kingdom;United States
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
      2010   -   NCT01313858   Germany
      2006   Phase 3   NCT00732875   -
   Modern Biosciences plc
      2015   Phase 1   NCT02480946   United Kingdom
   Mostafa Bahaa
      2024   Phase 3   NCT06231745   Egypt
   Mycenax Biotech Inc.
      2012   Phase 3   NCT01709760   Taiwan
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      1998   Phase 2   NCT00001677   United States
   Nordic Pharma SAS
      2015   Phase 3   NCT02553018   France
   North Glasgow NHS Trust
      2004   -   EUCTR2004-002006-30-GB   United Kingdom
   Novartis
      2007   Phase 2   NCT00487825   Belgium;Germany;Italy;Netherlands;Spain;United States
   Novartis Pharma Services AG
      2007   -   EUCTR2006-001553-10-DE   Germany;Italy;Netherlands
   Novartis Pharmaceuticals
      2004   Phase 2   NCT00154336   Austria;Canada;Finland;United Kingdom
   Nuon Therapeutics, Inc.
      2009   -   EUCTR2008-006917-25-GB   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   -   EUCTR2008-006917-25-DE   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   -   EUCTR2008-006917-25-BG   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
   P. Verschueren
      2009   Phase 4   NCT01172639   Belgium
   Patrick Durez
      2010   -   NCT01245452   Belgium
   Peking Union Medical College Hospital
      2019   Phase 4   NCT03589833   China
      2012   Phase 2/Phase 3   NCT01613079   China
   Peking Union Medical college Hospital
      2022   Phase 3   ChiCTR2200066425   China
   Peking University First Hospital
      2021   Phase 4   ChiCTR2100048185   China
   Peking University People's Hospital
      2024   Phase 2   ChiCTR2400085087   China
      2022   Phase 4   ChiCTR2200055292   China
   Pfizer
      2016   Phase 4   NCT02831855   Australia;Belgium;Bulgaria;Czechia;Germany;Hungary;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2013   -   NCT01558089   Greece
      2011   -   NCT01557322   -
      2008   Phase 4   NCT00565409   Australia;Austria;Belgium;Brazil;Chile;Colombia;Czech Republic;Former Serbia and Montenegro;France;Germany;Hungary;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Taiwan;United Kingdom
      2007   Phase 1   NCT00446784   United States
      2006   Phase 3   NCT00445770   Japan
      2006   Phase 2   NCT00424294   United States
      2005   Phase 1   NCT01745055   United States
   Philogen S.p.A.
      2011   Phase 1   NCT02076659   Italy
   Postgraduate Institute of Medical Education and Research
      2011   Phase 4   NCT01404429   India
   Qilu Hospital of Shandong University
      2021   Phase 4   NCT05626348   China
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
   ROCHE
      2006   -   EUCTR2005-003694-25-IT   Czech Republic;Italy;Spain
   Region Västerbotten
      2022   Phase 4   NCT05353829   Sweden
   Rheumatosurgery, Osaka City University Medical School
      2006   -   JPRN-UMIN000000512   Japan
   Rottapharm Biotech
      2017   Phase 2   NCT03163966   Czechia
   Saitama Medical Center. Saitama Medical University
      2012   -   JPRN-UMIN000007786   Japan
   Saitama Medical University
      2007   Phase 4   NCT00716248   Japan
   Sanofi
      2018   Phase 4   NCT03449758   France
      2014   Phase 3   NCT02293902   Japan
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2013   Phase 1   NCT01850680   Japan
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   NCT01764997   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Czechia;Ecuador;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2012   Phase 3   NCT01709578   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
      2010   Phase 2   NCT01217814   Brazil;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;Italy;Mexico;Norway;Spain;United States
      2010   Phase 2/Phase 3   NCT01061736   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
   Seoul National University Hospital
      2016   -   NCT02897011   Korea, Republic of
      2015   Phase 4   NCT02748785   Korea, Republic of
   Shanghai Guanghua Integrated traditional Chinese and Western Medicine Hospital
      2021   Phase 0   ChiCTR2100046373   China
   Shanghai Henlius Biotech
      2018   Phase 3   NCT03522415   China
   Shanghai Traditional Chinese Medicine Hospital
      2020   Phase 0   ChiCTR2000037675   China
   Shanxi Medical University
      2012   -   NCT01617590   China
   SinoMab Pty Ltd
      2014   Phase 2   NCT04192617   China
   St Luke's International Hospital
      2010   -   JPRN-UMIN000003615   Japan
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2015   Phase 2   JPRN-jRCT2080222927   -
   TIPharma
      2007   -   EUCTR2007-002976-32-NL   Netherlands
   Takarazuka city hospital
      2014   -   JPRN-UMIN000013362   Japan
   Takeda
      2015   Phase 2   NCT02393378   Czech Republic;Czechia;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   NCT02379091   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Germany;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom
   Tanta University
      2022   Phase 3   NCT05594680   Egypt
   The Affiliated ZhuZhou Hospital Of XiangYa School Of Medicine CSU.
      2019   Phase 4   ChiCTR2000032534   China
   The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
      2019   -   ChiCTR1900024902   China
   The First Affiliated Hospital of Third Military Medical University
      2016   -   ChiCTR-IPR-16008793   China
   The First Affiliated Hospital of Yunnan University of Chinese Medicine
      2023   Phase 0   ChiCTR2300071123   China
   The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041819   China
   The First Hospital, Jilin University, Changchun
      2014   -   ChiCTR-BOC-16008925   China
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   The Second Hospital of Shanxi Medical University
      2019   Phase 4   ChiCTR1900024261   China
   The people's hospital, Yichun City
      2014   -   ChiCTR-RNC-14004887   China
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-001729-25-IT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   UCB Pharma
      2012   Phase 3   NCT01521923   Argentina;Australia;Austria;Belgium;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Mexico;Monaco;Netherlands;Poland;Romania;Spain;Sweden;Switzerland;United Kingdom;United States
      2009   Phase 1/Phase 2   NCT01009242   Germany;United States
   UCB Pharma SA
      2012   Phase 3   NCT01519791   Argentina;Australia;Austria;Belgium;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Mexico;Monaco;Netherlands;Poland;Romania;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2011   Phase 4   NCT01500278   Australia;Austria;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Monaco;Poland;Portugal;Romania;Spain;Switzerland;United Kingdom;United States
   UCB Pharma SA, Belgium
      2014   Phase 3   NCT02151851   China
   Ueno Masanobu
      2023   Phase 4   JPRN-jRCTs051220168   -
   University Medical Center Utrecht (UMCU)
      2016   Phase 4   EUCTR2015-004858-17-NL   Netherlands
   University of Alabama at Birmingham
      2004   Phase 4   NCT00259610   United States
      1996   Phase 2   NCT00000395   United States
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of Leeds
      2019   Phase 4   NCT03813771   United Kingdom
      2013   Phase 4   NCT04157010   United Kingdom
      2011   Phase 4   NCT02433184   United Kingdom
      2006   Phase 4   NCT01308255   United Kingdom
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
      2001   Phase 3   NCT00579644   United States
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02633332   Italy
   VA Office of Research and Development
      2007   -   NCT00405275   Canada;United States
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
   Vastra Gotaland Region
      2020   Phase 4   NCT04311567   Sweden
      2017   -   NCT03440892   Sweden
   Västerbotten county
      2021   Phase 4   EUCTR2020-000462-41-SE   Sweden
   Watanabe Ryu
      2022   Phase 4   JPRN-jRCTs051220105   -
   Wyeth Pharmaceuticals France
      2008   -   EUCTR2007-000896-41-HU   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-FR   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-ES   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2007-000896-41-NL   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Pharmaceuticals France, Wyeth Research Division
      2008   -   EUCTR2007-000896-41-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2008   -   EUCTR2007-000896-41-SE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2010   -   EUCTR2007-000896-41-AT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2007-000896-41-GB   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-000896-41-CZ   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 4   EUCTR2007-000896-41-BE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth is now a wholly owned subsidiary of Pfizer
      2008   Phase 4   NCT00706797   Austria;Croatia;Czech Republic;France;Germany;Hungary;Italy;Poland;Spain;Turkey;United Kingdom;United States
      2004   Phase 4   NCT00252668   -
      2004   Phase 4   NCT00195494   United States
   XBiotech, Inc.
      2025   Phase 2   NCT06590090   -
   Xian-Janssen Pharmaceutical Ltd.
      2007   Phase 4   NCT00896168   -
   Yunnan Hospital of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100053999   China
      2021   Phase 0   ChiCTR2100041894   China
   Yunnan Hospital of Traditional Chinese Medicine (The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine)
      2021   Phase 0   ChiCTR2100042328   China
   Yunnan Hospital of Traditional Chinese Medicine /The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041777   China
   Yunnan Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100042440   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2023   Phase 0   ChiCTR2300067676   China
   Yunnan Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2100041909   China
   Zhejiang Chinese Medical University
      2021   -   ChiCTR2100048795   China
   Zhejiang Provincial People's Hospital
      2023   -   ChiCTR2300075010   China
   medac GmbH
      2019   Phase 3   JPRN-jRCT2080224844   Japan
      2012   Phase 1   NCT01871961   United States
Methotrexate 'lederle' 2,5MG tablets
   Roche Nederland B.V.
      2009   -   EUCTR2009-013316-12-NL   Netherlands
Methotrexate 'lederle' 2.5MG tablets
   F Hoffmann-La Roche Ltd
      2008   -   EUCTR2008-001847-20-NL   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-001847-20-FR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-GR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-EE   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   Phase 3   EUCTR2009-012759-12-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   Roche Farma, S.A.
      -   -   EUCTR2011-001626-15-ES   Spain
   Roche Products Limited
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
Methotrexate 'lederle' tablets
   F. Hoffmann-La Roche Ltd.
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
Methotrexate (MTX)
   Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences
      2013   -   ChiCTR-TRC-13002981   -
Methotrexate + infliximab
   Université Catholique de Louvain
      2003   Phase 4   NCT00396747   Belgium
Methotrexate + methylprednisolone
   Université Catholique de Louvain
      2003   Phase 4   NCT00396747   Belgium
Methotrexate + targeted therapy administration
   University Hospital, Strasbourg, France
      2016   Phase 4   NCT02714634   France
Methotrexate - amneal
   Amneal Pharmaceuticals, LLC
      2016   Phase 1   NCT02940561   India
Methotrexate - dava
   Amneal Pharmaceuticals, LLC
      2016   Phase 1   NCT02940561   India
Methotrexate - delay
   University Hospital, Montpellier
      2013   Phase 3   NCT01942174   France;Monaco
Methotrexate - etanercept - prednisolone ARM
   Seattle Children's Hospital
      2007   Phase 4   NCT00443430   United States
Methotrexate - immediate
   University Hospital, Montpellier
      2013   Phase 3   NCT01942174   France;Monaco
Methotrexate 10 MG
   King Edward Medical University
      2017   Phase 4   NCT04177173   Pakistan
Methotrexate 10 MG tablets
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
Methotrexate 2.5 MG tablets
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2016   Phase 3   EUCTR2015-003376-75-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003376-75-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PL   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-GB   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-CZ   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2013   -   EUCTR2012-002324-32-SE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-PT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-DE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-BE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-AT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-PL   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-GB   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-DK   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-CZ   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-BG   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
Methotrexate 2.5MG tablets
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2016   Phase 3   EUCTR2015-003334-27-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003376-75-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003334-27-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Eli Lilly and Company
      2013   -   EUCTR2012-002324-32-SE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-PT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-GB   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-DE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-002324-32-BE   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002324-32-AT   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Russian Federation;South Africa;Sweden;United Kingdom;United States
   Roche Products Limited
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
   Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company)
      2009   Phase 4   EUCTR2008-002623-85-GB   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2010   Phase 4   EUCTR2008-002623-85-SE   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2009   -   EUCTR2008-002623-85-IE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   -   EUCTR2008-002623-85-DE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-NL   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2008-002623-85-FR   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
      2009   Phase 4   EUCTR2008-002623-85-ES   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Methotrexate 2.5MG tablets BP
   PFIZER INC
      2017   Phase 3   EUCTR2016-001825-15-IT   Bulgaria;Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;Spain
   Pfizer Inc.
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-SK   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-CZ   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, New York
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-PL   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-GB   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BG   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BE   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
Methotrexate 50MG/ML solution FOR injection, PRE-filled syringe
   medac Gesellschaft für klinische Spezialpräparate mbH
      -   -   EUCTR2007-003591-19-DE   Germany
Methotrexate ``lederle`` 2.5MG tablets
   F. Hoffmann-La Roche Ltd.
      2009   Phase 3   EUCTR2009-012759-12-IT   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
Methotrexate AS methotrexate disodium
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
   Roche Products Limited
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
Methotrexate capsules
   Centocor, Inc.
      2005   Phase 3   NCT00264537   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Philippines;Poland;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
Methotrexate combined with tofacitinib
   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      2024   -   NCT06301373   -
Methotrexate disodium
   Abbott GmbH & Co. KG
      2008   -   EUCTR2006-004139-31-NO   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2008   -   EUCTR2006-004139-31-GR   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-SK   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-SE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-NL   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-HU   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-GB   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 4   EUCTR2006-004139-31-FR   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-ES   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-DE   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-CZ   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-BE   Austria;Belgium;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Norway;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004139-31-AT   Austria;Czech Republic;France;Germany;Greece;Hungary;Netherlands;Spain;Sweden;United Kingdom
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      -   -   EUCTR2005-002969-37-DE   Germany;Spain;Sweden
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Roche Farma, S.A.
      -   -   EUCTR2011-001626-15-ES   Spain
   University Hospitals Leuven
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
   medac Gesellschaft für klinische Spezialpräparate mbH
      2012   -   EUCTR2012-000222-21-DE   Germany
      -   -   EUCTR2007-003591-19-DE   Germany
Methotrexate ebewe
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2015   Phase 3   EUCTR2015-001275-50-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
   Bristol-Myers Squibb International Corporation
      2016   Phase 3   EUCTR2015-001275-50-RO   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-NL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-SE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-GB   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FI   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
Methotrexate hospira 2,5 MG tablety
   Bristol Myers Squibb International Corporation
      2010   -   EUCTR2010-018674-20-SE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-FR   Belgium;Denmark;Finland;France;Germany;Italy;Sweden
      2010   -   EUCTR2010-018674-20-FI   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DK   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-BE   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;South Africa;Sweden;United States
Methotrexate hospira 2.5 MG tablety
   Bristol Myers Squibb International Corporation
      2010   -   EUCTR2010-018674-20-IT   Denmark;Finland;France;Germany;Italy;Sweden
Methotrexate lederle 2.5 MG tablets
   ROCHE
      2009   -   EUCTR2008-001847-20-IT   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
Methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
   University Hospital, Strasbourg, France
      2016   Phase 4   NCT02714634   France
Methotrexate pfizer 2,5 MG tabletter
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Methotrexate plus enbrel or enbrel alone
   Wyeth is now a wholly owned subsidiary of Pfizer
      2003   Phase 4   NCT00244556   -
Methotrexate plus ERB-041 FOR 12 weeks
   Wyeth is now a wholly owned subsidiary of Pfizer
      2005   Phase 2   NCT00141830   Canada;Hungary;Italy;Mexico;Spain;United States
Methotrexate plus sulfasalazine
   Singapore General Hospital
      2012   Phase 4   NCT01659242   Singapore
Methotrexate PRE-filled PEN
   medac Gesellschaft für klinische Spezialpräparate mbH
      2012   -   EUCTR2012-000222-21-DE   Germany
Methotrexate prefilled PEN
   medac GmbH
      2012   Phase 3   NCT01793259   Germany
Methotrexate prefilled syringe
   medac GmbH
      2012   Phase 3   NCT01793259   Germany
Methotrexate sodium
   F Hoffmann-La Roche Ltd
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   F. Hoffmann La-Roche AG
      2005   -   EUCTR2005-001138-33-LT   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
   PFIZER
      2010   Phase 3   EUCTR2009-016987-34-ES   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Poland;Slovakia;Spain;Sweden
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2010   -   EUCTR2009-016987-34-SE   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-PL   Bulgaria;Czech Republic;Germany;Hungary;Poland;Spain;Sweden
      2010   -   EUCTR2009-016987-34-HU   Bulgaria;Czech Republic;Germany;Hungary;Poland;Spain;Sweden
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2010   Phase 3   EUCTR2009-016987-34-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   -   EUCTR2009-016987-34-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
      2010   Phase 3   EUCTR2009-016987-34-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Methotrexate sodium 2.5MG tablets
   F. Hoffmann-La Roche Ltd
      2006   Phase 2   EUCTR2005-003694-25-ES   Czech Republic;Italy;Spain
      2006   -   EUCTR2005-003694-25-CZ   Czech Republic;Italy;Spain
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Methotrexate sodium tablets 2.5 MG
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   F. Hoffmann La-Roche AG
      2005   -   EUCTR2005-001138-33-PT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-NO   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-ES   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-DK   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      -   -   EUCTR2005-001138-33-SI   Denmark;Italy;Norway;Portugal;Slovenia;Spain
   Pfizer Inc.
      2011   -   EUCTR2010-020890-18-CZ   Czech Republic;Hungary
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-020890-18-HU   Czech Republic;Hungary
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA
      2008   -   EUCTR2007-000896-41-DE   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Methotrexate sodium tablets 2.5MG
   Wyeth Pharmaceuticals
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
   Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company)
      2009   Phase 4   EUCTR2008-002623-85-GB   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company, Philadelphia,PA-19101,USA
      2010   Phase 4   EUCTR2008-002623-85-SE   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA
      2009   -   EUCTR2008-002623-85-IE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2009   -   EUCTR2008-002623-85-DE   France;Germany;Ireland;Italy;Netherlands;Poland;Qatar;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   Phase 4   EUCTR2008-002623-85-FR   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Methotrexate tablets
   Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
      2022   Phase 1   NCT05380934   China
   China Academy of Chinese Medical Science Guang'an Men Hospital
      2007   -   ChiCTR-TRC-09000377   China
   Dongzhimen Hospital, Beijing University of Chinese Medicine
      2024   Phase 0   ChiCTR2400088173   China
   Guang'anmen Hospital, China Academy of Chinese Medical Sciences
      2021   Phase 4   ChiCTR2100048769   china
   Hospital of Chengdu Military Area Command PLA
      2008   -   ChiCTR-TCC-12002824   China
   Jiangxi Provincial People's Hospital
      2022   Phase 1   ChiCTR2300077294   China
   Longhua Hospital Shanghai University of Traditional Chinese Medicine
      2018   Phase 4   ChiCTR1900026079   China
   Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
      2024   Phase 4   ChiCTR2400090996   China
   The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2022   Phase 0   ChiCTR2300067710   China
      2021   Phase 0   ChiCTR2100042659   China
   The Ministry of Science and Technology of the People's Republic of China
      2010   -   ChiCTR-TRC-10000989   China
   The Second Affiliated Hospital of Anhui Medical University
      2023   Phase 1   ChiCTR2300070165   China
   The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
      2020   Phase 4   ChiCTR2100050865   China
   Wangjing Hospital, China Academy of Traditional Chinese Medicine
      2024   -   ChiCTR2400087722   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100054305   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine/The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041821   China
Methotrexate tablets 2.5 MG
   Gilead Sciences, Inc.
      2017   Phase 3   EUCTR2016-000570-37-PL   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-ES   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000570-37-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-SK   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000570-37-GB   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Methotrexate therapy
   Astellas Pharma Inc
      2017   Phase 2   NCT03257852   Japan
   School of clinical medicine & the first affiliated hospital of chengdu Medical college
      2023   Phase 4   ChiCTR2300072896   China
Methotrexate treatment
   University Hospital, Bordeaux
      2020   Phase 2   NCT04196868   France
Methotrexate ® 2.5MG tablets
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-GB   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
Methotrexate*100CPR 2,5MG
   F. Hoffmann - La Roche Ltd.
      2005   -   EUCTR2005-002395-15-IT   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
   OSPEDALE POLICLINICO S. MATTEO
      2006   -   EUCTR2006-003843-22-IT   Italy
Methotrexate*10MG/1,33ML 4S
   ROCHE
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
Methotrexate*15MG/2ML 4SIR
   ROCHE
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
Methotrexate*2,5MG 25CPR
   ROCHE
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
Methotrexate*20MG/2,66ML 4S
   ROCHE
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
Methotrexate*25CPR 2,5MG
   F. Hoffmann - La Roche Ltd.
      2005   -   EUCTR2005-002395-15-IT   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
   ROCHE
      2005   -   EUCTR2005-001138-33-IT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
   Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
      2009   -   EUCTR2008-002623-85-IT   France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;United Kingdom
Methotrexate, leucovorin and BMS-986142
   Bristol-Myers Squibb
      2015   Phase 1   NCT02456844   -
Methotrexate-lachema
   Wyeth Pharmaceuticals
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
Methotrexate-sulfasalazine-hydroxychloroquine
   University of Nebraska
      2001   Phase 3   NCT00579878   United States
Methotrexate® 2.5 MG tablets
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-PL   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-DK   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-CZ   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-BG   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
Methotrextate
   Chelsea Therapeutics, Inc
      2010   -   EUCTR2010-019134-27-CZ   Bulgaria;Czech Republic
      2010   -   EUCTR2010-019134-27-BG   Argentina;Bulgaria;Czech Republic;Mexico;Poland;United States
Methoxsalen
   Mallinckrodt
      2003   Phase 2   NCT00221000   Australia;Austria;Belgium;Canada;France;Germany;Italy;Mexico;Slovakia;South Africa;United States
   THERAKOS
      2005   -   EUCTR2004-001825-69-IT   Italy
Methyl 1-[N6-(3-iodobenzyl)-adenin-9-YL]-ß-dribofuronamide
   Can-Fite BioPharma Ltd.
      2008   -   EUCTR2007-006527-13-BG   Bulgaria
Methylaminopterin
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
Methylprednisolone
   Biogen
      2006   Phase 2   NCT00298272   United States
   Fairview University Medical Center
      2000   -   NCT00006055   United States
   Genentech, Inc.
      2009   Phase 2   NCT00808210   United States
      2006   Phase 3   NCT00299104   United States
      2005   Phase 3   NCT00299130   United States
      2005   Phase 2   NCT00243412   United States
   Hoffmann-La Roche
      2011   Phase 4   NCT01382940   United States
      2011   Phase 4   NCT01219933   Belgium
      2008   Phase 4   NCT01000610   Tunisia
      2007   Phase 3   NCT00578305   Argentina;Brazil;Canada;Czech Republic;Denmark;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Latvia;Lithuania;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;United Kingdom
      2006   Phase 3   NCT02006706   Serbia
      2002   Phase 2   NCT02093026   Australia;Belgium;Brazil;Canada;Czech Republic;Finland;Germany;Israel;Italy;Mexico;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000033059   Japan
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
   N.V. Roche S.A.
      2010   Phase 4   EUCTR2010-019694-15-BE   Belgium
   Nekoyama Miyao Hospital
      2017   -   JPRN-UMIN000029759   Japan
      2017   -   JPRN-UMIN000029003   Japan
      2013   -   JPRN-UMIN000012257   Japan
   Nekoyama miyao hospital
      2012   -   JPRN-UMIN000011181   Japan
      2012   -   JPRN-UMIN000010902   Japan
   Pfizer
      2008   Phase 2   NCT00634933   Austria;Belgium;Canada;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia;United States
   University of Leeds
      2007   Phase 3   EUCTR2006-005640-81-GB   United Kingdom
      2006   Phase 4   NCT01308255   United Kingdom
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
Methylprednisolone acetate
   Leiden University medical Centre
      2015   Phase 2   EUCTR2014-004472-35-NL   Netherlands
Methylprednisolone sodium succinate
   Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc.
      2009   -   EUCTR2007-006150-25-DE   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
      2008   -   EUCTR2007-006150-25-HU   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-006150-25-NL   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-FR   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-BE   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   -   EUCTR2007-006150-25-AT   Austria;Belgium;France;Germany;Hungary;Netherlands
Methylprednisone
   Genentech, Inc.
      2006   Phase 2   NCT00282308   United States
Metoject
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   The Karolinska Institute, ClinTRID
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   The Karolinska Instutute, ClinTRID
      2013   Phase 4   EUCTR2011-004720-35-IS   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   medac GmbH
      2012   Phase 1   NCT01871961   United States
Metotressato sale sodico
   GILEAD SCIENCES INCORPORATED
      2017   Phase 3   EUCTR2016-000568-41-IT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;Ukraine;United Kingdom;United States
Metotrexat orion
   Västra Götalandsregionen
      2020   Phase 4   EUCTR2019-004179-38-SE   Sweden
Metotrexato
   AMGEN INC.
      2016   Phase 3   EUCTR2014-004868-38-IT   Bulgaria;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom
   Abbott GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-ES   Austria;Czech Republic;Germany;Spain
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2015   Phase 3   EUCTR2015-001275-50-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Democratic People's Republic of;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
   Wyeth Pharmaceuticals France, Wyeth Research Division
      2008   -   EUCTR2007-000896-41-IT   Austria;Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom
Metotrexato sodico
   PFIZER
      2010   Phase 3   EUCTR2009-016987-34-ES   Belgium;Bulgaria;Czech Republic;Germany;Hungary;Poland;Slovakia;Spain;Sweden
Metotrexato sodio
   F Hoffmann-La Roche Ltd
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
Metotrexato-lederle 2,5 MG comprimidos
   Wyeth Pharmaceuticals
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
Metronidazol
   Dra Beatriz Lozano-Hospital Universitario de Canarias
      2018   Phase 4   EUCTR2017-003259-40-ES   Spain
Metronidazole
   Dra Beatriz Lozano-Hospital Universitario de Canarias
      2018   Phase 4   EUCTR2017-003259-40-ES   Spain
Mextrex
   University of Leeds
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
Micellar paclitaxel FOR injection
   Angiotech Pharmaceuticals
      2002   Phase 2   NCT00055133   United States
Midazolam
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02762123   United States
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
   R-Pharm International, LLC
      2021   Phase 1   NCT04246762   Bulgaria;Moldova, Republic of
Midazolam maleate tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Milnacipran
   Brigham and Women's Hospital
      2011   Phase 4   NCT01207453   United States
   University of California, Los Angeles
      2010   Phase 4   NCT01225991   United States
Minocycline
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
Minodronate
   Department of Orthopaedic Surgery Shinshu University School of Medicine
      2016   -   JPRN-UMIN000022364   Japan
Minodronic acid
   Osaka University Graduate School of Medicine
      2012   -   JPRN-UMIN000011087   Japan
Misoprostol
   Korea Otsuka Pharmaceutical Co.,Ltd.
      2007   Phase 3   NCT00576706   Korea, Republic of
Mizoribine
   Sanofi
      2015   Phase 3   NCT02373202   Japan
MK-0663
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2011   Phase 3   EUCTR2010-019871-31-SK   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2011   -   EUCTR2010-019871-31-CZ   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019871-31-BE   Austria;Belgium;Czech Republic;Finland;Germany;Lithuania;Slovakia;United Kingdom
      2010   -   EUCTR2010-019871-31-LT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-FI   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-DE   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
      2010   -   EUCTR2010-019871-31-AT   Argentina;Austria;Belgium;Canada;Colombia;Czech Republic;Finland;Germany;India;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;South Africa;Taiwan;United Kingdom;United States
MK-0873
   Merck Sharp & Dohme Corp.
      2005   Phase 2   NCT00132769   Belgium;Canada;Czech Republic;Finland;Germany;Italy;Norway;Spain;Switzerland
MK-8457
   MERCK SHARP & DOHME CORP.
      2013   -   EUCTR2012-000439-17-LV   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
      2012   -   EUCTR2012-000439-17-LT   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2013   -   EUCTR2012-002181-12-IT   Australia;Austria;Brazil;Colombia;Denmark;Greece;Hungary;Italy;New Zealand;Peru;South Africa;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-002181-12-HU   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002181-12-GR   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002181-12-GB   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002181-12-ES   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000439-17-DE   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as
      2013   -   EUCTR2012-002181-12-SE   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2012   -   EUCTR2012-002181-12-DK   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)
      2013   -   EUCTR2012-002181-12-AT   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc.
      2013   -   EUCTR2012-000439-17-HU   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2013   -   EUCTR2012-000439-17-PL   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Merck, Sharpe & Dohme Corp., a subsidiary of Merck & Co. Inc (hereafter referred to as Merck)
      2012   -   EUCTR2012-000439-17-GB   Brazil;Canada;Chile;Denmark;Germany;Hungary;India;Japan;Korea, Democratic People's Republic of;Latvia;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Russian Federation;South Africa;Taiwan;United Kingdom;United States
MK-8457 100 MG
   Merck Sharp & Dohme Corp.
      2012   Phase 2   NCT01651936   Australia;Colombia;Denmark;France;Greece;Hungary;Italy;Korea, Republic of;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
      2012   Phase 2   NCT01569152   Canada;Chile;Denmark;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Moldova, Republic of;Peru;Poland;South Africa;Taiwan;United Kingdom;United States
MK-8808
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
MK0359
   Merck Sharp & Dohme Corp.
      2002   Phase 2   NCT00482417   -
MK0663, etoricoxib
   Organon and Co
      2003   Phase 3   NCT00250445   -
      2003   Phase 3   NCT00092742   United States
MK0812 / duration OF treatment: 12 weeks
   Merck Sharp & Dohme Corp.
      2004   Phase 2   NCT00542022   -
MK0966
   Merck Sharp & Dohme Corp.
      2004   Phase 4   NCT00157872   China
MK8457
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2012   -   EUCTR2012-002181-12-ES   Australia;Austria;Brazil;Colombia;Denmark;France;Greece;Hungary;Italy;New Zealand;Peru;Poland;South Africa;Spain;Sweden;United Kingdom;United States
MLTA3698A
   GENENTECH, Inc
      2011   -   EUCTR2010-021577-37-ES   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-DE   Bulgaria;Germany;Hungary;Spain
      2011   -   EUCTR2010-021577-37-BG   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Spain;United States
      2010   -   EUCTR2010-021577-37-HU   Bulgaria;Germany;Hungary;Spain
   Genentech, Inc.
      2010   Phase 2   NCT01225393   Bulgaria;Chile;Germany;Hungary;Mexico;Peru;Poland;Romania;Spain;United States
MM-093
   Merrimack Pharmaceuticals
      2007   Phase 2   NCT00458146   United States
      2005   Phase 2   NCT00105976   United States
MMF
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
MMF discontinuation
   University of Sao Paulo General Hospital
      2023   Phase 4   NCT05879419   Brazil
MMF maintain
   University of Sao Paulo General Hospital
      2023   Phase 4   NCT05879419   Brazil
Moderna covid-19 vaccine
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2021   Phase 3   NCT04806113   Canada
Moderna MRNA-1273, bivalent
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
Modified BIP
   Revolo Biotherapeutics Ltd
      2023   Phase 2   EUCTR2021-005771-39-HU   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
      2023   Phase 2   EUCTR2021-005771-39-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
      2022   Phase 2   EUCTR2021-005771-39-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Latvia;Poland;Spain;United Kingdom
Modified zhiwang decoction combined with methotrexate
   Beijing University of Chinese Medicine
      2023   Early Phase 1   NCT05508815   China
Monovalent [B.1.351] COV2 pres DTM-AS03
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
Montelukast
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02762123   United States
   Noha Mansour
      2021   Phase 2   NCT05447520   Egypt
   Sherief Abd-Elsalam
      2018   Phase 3   NCT03770923   Egypt
Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and BMS-986142
   Bristol-Myers Squibb
      2015   Phase 1   NCT02456844   -
MOR103
   MorphoSys AG
      2010   -   EUCTR2007-006129-29-PL   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2010   -   EUCTR2007-006129-29-NL   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2010   -   EUCTR2007-006129-29-BG   Belarus;Bulgaria;Germany;Netherlands;Poland;Ukraine
      2009   Phase 1/Phase 2   NCT01023256   Bulgaria;Germany;Netherlands;Poland;Ukraine
      2009   -   EUCTR2007-006129-29-DE   Bulgaria;Germany;Netherlands;Poland;Ukraine
Morab-022
   Morphotek
      2013   Phase 1   NCT01357759   Netherlands;United States
Moringa oleifera
   Universitas Sebelas Maret
      2020   Phase 1/Phase 2   NCT05665985   Indonesia
Morphine
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000033059   Japan
   Nekoyama Miyao Hospital
      2013   -   JPRN-UMIN000012257   Japan
   Nekoyama miyao hospital
      2012   -   JPRN-UMIN000011181   Japan
      2012   -   JPRN-UMIN000010902   Japan
Morphine hexal
   Charité University medicine Berlin
      2015   Phase 2   EUCTR2015-000538-31-DE   Germany
Morphine sulfate
   Charité University medicine Berlin
      2015   Phase 2   EUCTR2015-000538-31-DE   Germany
Morphinsulfat
   Charité University medicine Berlin
      2015   Phase 2   EUCTR2015-000538-31-DE   Germany
Moxifloxacin
   AstraZeneca
      2009   Phase 1   NCT00887770   United Kingdom
MP-435(DOSE1) + methotrexate
   Mitsubishi Tanabe Pharma Corporation
      2010   Phase 2   NCT01143337   Japan
MPA
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
MR prednisone
   Horizon Pharma Ireland, Ltd., Dublin Ireland
      2008   Phase 3   NCT00650078   Canada;Germany;Hungary;Poland;United Kingdom;United States
   Merck KGaA, Darmstadt, Germany
      2004   Phase 3   NCT00146640   Germany;Poland
MRA
   Chugai Pharmaceutical
      2006   Phase 3   NCT00380601   Japan
      2005   Phase 3   NCT00144586   -
      2005   -   NCT00144573   -
      2005   -   NCT00144560   -
      2004   Phase 3   NCT00144547   -
      2004   Phase 3   NCT00144534   -
      2004   Phase 3   NCT00144521   -
      2003   Phase 3   NCT00144508   -
      2001   Phase 2   NCT00144651   -
   Chugai Pharmaceutical Co., Ltd.
      2014   Phase 3   JPRN-jRCT2080222455   -
      2005   Phase 3   JPRN-jRCT2080220018   -
      2005   Phase 3   JPRN-jRCT2080220016   -
   F Hoffmann La-Roche AG
      2007   -   EUCTR2005-002909-23-PT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-SI   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-NO   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-IS   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-002909-23-GB   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-FI   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002909-23-ES   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche AG
      2006   -   EUCTR2005-002909-23-DE   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F. Hoffmann La-Roche AG
      2005   -   EUCTR2005-001138-33-PT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-NO   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-LT   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-ES   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-DK   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2004-005210-37-SE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-FI   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-005210-37-ES   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-DE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-CZ   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-003741-40-SK   Austria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2004-003741-40-HU   Germany;Hungary;Italy
      2005   -   EUCTR2004-003741-40-DE   Germany;Hungary;Italy
      2005   -   EUCTR2004-003733-14-ES   Denmark;Finland;Italy;Spain
      2004   -   EUCTR2004-003741-40-AT   Austria;Germany;Hungary;Italy
      -   -   EUCTR2005-001138-33-SI   Denmark;Italy;Norway;Portugal;Slovenia;Spain
   F. Hoffmann La-Roche Ltd
      2005   -   EUCTR2005-002423-13-SK   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-HU   Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-AT   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann-La Roche AG
      2005   -   EUCTR2005-000884-25-SE   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-IS   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-GB   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   -   EUCTR2005-000884-25-DE   Germany;Iceland;Italy;Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd
      2005   -   EUCTR2005-002423-13-DE   Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-GR   Bulgaria;Greece;Hungary;Spain
      2011   Phase 3   EUCTR2010-019912-18-ES   Bulgaria;Greece;Hungary;Spain
MRA, actemra
   F Hoffmann La-Roche Ltd.
      2005   -   EUCTR2004-003733-14-DK   Denmark;Finland;Italy;Spain
MRC375 150MG
   Molecular Research Center, Inc.
      2011   Phase 2   NCT01408602   United States
MSB11022
   Fresenius Kabi SwissBioSim GmbH
      2017   Phase 3   NCT03052322   Bulgaria;Czech Republic;Czechia;Germany;Hungary;Poland;United Kingdom
   Merck KGaA
      2017   Phase 3   EUCTR2016-002852-26-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002852-26-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2017   Phase 3   EUCTR2016-002852-26-BG   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2016   Phase 3   EUCTR2016-002852-26-LT   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-HU   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-CZ   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
MSB11456
   Fresenius Kabi SwissBioSim GmbH
      2021   Phase 3   EUCTR2019-004369-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2020   Phase 3   NCT04512001   Bulgaria;Czechia;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-SK   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-PL   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-HU   Bulgaria;Czech Republic;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2020   Phase 3   EUCTR2019-004369-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
MT203
   Takeda
      2011   Phase 1   NCT01317797   Bulgaria;Netherlands
   Takeda Development Centre Europe Ltd.
      2015   Phase 2   EUCTR2014-002945-23-GB   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-ES   Czech Republic;Estonia;Latvia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-CZ   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2013-002805-76-BG   Bulgaria;Czech Republic;Japan;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2014-002945-23-EE   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-GB   Bulgaria;Czech Republic;Germany;Japan;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-ES   Argentina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002805-76-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-CZ   Bulgaria;Czech Republic;Japan;Poland;Russian Federation;Spain;United Kingdom
MTRX1011A
   Genentech, Inc.
      2008   Phase 1   NCT00718588   United States
MTX
   Anhui Provincial Hospital Department of Rheumatism
      2011   -   ChiCTR-TRC-11001789   China
   Antares Pharma Inc.
      2012   Phase 2   NCT01618968   United States
      2011   Phase 1/Phase 2   NCT01737944   United States
   Asai Shuji
      2021   -   JPRN-jRCTs041200048   -
      2020   -   JPRN-jRCT1041190125   -
   Astellas Pharma Global Development, Inc.
      2016   Phase 1   NCT02867306   Moldova, Republic of
   Astellas Pharma Inc
      2011   Phase 3   NCT01451203   Japan
   Bristol Myers Squibb International Corporation
      2010   -   EUCTR2010-018674-20-SE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-FR   Belgium;Denmark;Finland;France;Germany;Italy;Sweden
      2010   -   EUCTR2010-018674-20-FI   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DK   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   -   EUCTR2010-018674-20-DE   Australia;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Russian Federation;South Africa;Sweden;United States
      2010   Phase 3   EUCTR2010-018674-20-BE   Australia;Belgium;Canada;Denmark;Finland;France;Germany;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;South Africa;Sweden;United States
   Bristol-Myers Squibb
      2007   Phase 3   NCT00547521   Australia;Brazil;Canada;Mexico;Peru;South Africa;United States
   CHU Saint-Etienne
      2020   Phase 4   EUCTR2019-003700-12-FR   France
   Can-Fite BioPharma
      2017   Phase 3   NCT02647762   Bosnia and Herzegovina;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
   Centocor, Inc.
      2010   Phase 3   NCT01248780   China
      2009   Phase 3   NCT00973479   Argentina;Australia;Colombia;Hungary;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Poland;Russian Federation;Ukraine;United States
      2003   Phase 2   NCT00207714   -
   Chelsea Therapeutics
      2010   Phase 2   NCT01116141   -
      2008   Phase 2   NCT00658047   Canada
   China Academy of Chinese Medical Science Guang'an Men Hospital
      2007   -   ChiCTR-TRC-09000377   China
   Chugai Pharma Taiwan
      2011   Phase 3   NCT01347983   Taiwan
      2010   Phase 3   NCT01258712   Taiwan
   Chugai Pharmaceutical
      2004   Phase 3   NCT00144521   -
   Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka City University Medical School
      2013   Phase 4   JPRN-UMIN000012073   Japan
   Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
      2011   -   JPRN-UMIN000005590   Japan
   Eli Lilly Japan K.K.
      2013   Phase 3   JPRN-jRCT2080222088   -
   Eli Lilly and Company
      2012   Phase 3   NCT01711359   Argentina;Austria;Belgium;Brazil;Canada;Germany;Greece;India;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Russian Federation;South Africa;Sweden;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   NCT02833350   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
   Gilead Sciences
      2016   Phase 3   NCT02889796   Argentina;Australia;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2016   Phase 3   NCT02886728   Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Czech Republic;Czechia;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Malaysia;Mexico;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
   GlaxoSmithKline
      2016   Phase 2   NCT02799472   Germany;Poland;United States
      2015   Phase 2   NCT02504671   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom
   Guangdong Provincial Hospital of Chinese Medicine
      2015   -   ChiCTR-IPR-15007415   China
   Guangdong Provincial Hospital of Chinese Medicine
      2016   -   ChiCTR-IPR-16009029   China
      2015   -   ChiCTR-IPR-15007368   China
   Hoffmann-La Roche
      2017   Phase 3   NCT03155347   China
      2010   Phase 3   NCT01034137   Netherlands
   Janssen Biotech, Inc.
      2009   Phase 3   NCT01004432   Austria;Belgium;Canada;France;Germany;Greece;Spain;Sweden;United Kingdom;United States
   Janssen Pharmaceutical K.K.
      2008   Phase 3   NCT00727987   Japan
   Janssen Research & Development, LLC
      2012   Phase 2   NCT01645280   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Republic of;Mexico;Peru;Poland;Russian Federation;Singapore;Turkey;Ukraine;United States
   Kawakami Atsushi
      2021   Phase 4   JPRN-jRCTs071200079   -
   Keio University
      2025   Phase 4   NCT06913907   Japan
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Maldonado A Michael
      2021   Phase 3   JPRN-jRCT2071210068   Australia;France;Germany;Japan;Taiwan;USA
   Maria Stoenoiu
      2015   Phase 3   NCT02837146   Belgium
   Merck Sharp & Dohme Corp.
      2006   Phase 3   NCT00732875   -
      2005   Phase 3   NCT00202852   Korea, Republic of
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT05000216   United States
   Novartis
      2007   Phase 2   NCT00487825   Belgium;Germany;Italy;Netherlands;Spain;United States
   Novartis Pharma Services AG
      2007   -   EUCTR2006-001553-10-DE   Germany;Italy;Netherlands
   Osaka City University Medical School
      2012   Phase 4   JPRN-UMIN000009425   Japan
      2010   -   JPRN-UMIN000003880   Japan
   Osaka Medical College
      2017   -   JPRN-UMIN000027719   Japan
   Peking University First Hospital
      2015   -   NCT02320630   China
   Peking University People's Hospital
      2015   Phase 2   NCT02467504   China
   People's Hospital, Peking University
      2009   -   ChiCTR-TRC-09000473   China
   Pfizer
      2011   -   NCT01557322   -
      2005   Phase 1   NCT01745055   United States
   Philogen S.p.A.
      2014   Phase 2   NCT02270632   Germany;Italy;Switzerland
   Qiang Shu
      2015   Phase 4   NCT02837978   China
   Qilu Hospital of Shandong University
      2016   Phase 4   NCT03855007   China
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
   Sanofi
      2010   Phase 2   NCT01217814   Brazil;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;Italy;Mexico;Norway;Spain;United States
   Seoul National University Hospital
      2021   Phase 3   NCT05313061   Korea, Republic of
   Shanghai Biomabs Pharmaceutical Co., Ltd.
      2018   Phase 3   NCT03478111   China
   Shanghai Henlius Biotech
      2018   Phase 3   NCT03522415   China
   Shanghai Traditional Medicine University Affiliated Guanghua Hospital
      2018   -   ChiCTR1800019277   China
   SinoMab Pty Ltd
      2017   Phase 3   NCT04312815   China
   Sun Yat-sen University
      2018   Phase 4   NCT04066803   China
   The Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100042329   China
   Tokyo Medical and Dental University
      2012   -   JPRN-UMIN000006702   Japan
   UCB Pharma
      2012   Phase 3   NCT01521923   Argentina;Australia;Austria;Belgium;Canada;Colombia;Czech Republic;Czechia;France;Germany;Hungary;Ireland;Italy;Mexico;Monaco;Netherlands;Poland;Romania;Spain;Sweden;Switzerland;United Kingdom;United States
   UCB Pharma SA
      2011   Phase 4   NCT01500278   Australia;Austria;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Monaco;Poland;Portugal;Romania;Spain;Switzerland;United Kingdom;United States
   University Hospital Macau
      2022   Phase 0   ChiCTR2200063782   China
   University Medical Center Utrecht (UMCU)
      2016   Phase 4   EUCTR2015-004858-17-NL   Netherlands
   University of Occupational and Environmental Health, Japan
      2010   -   JPRN-UMIN000008756   Japan
   Watanabe Ryu
      2022   Phase 4   JPRN-jRCTs051220105   -
   XBiotech, Inc.
      2025   Phase 2   NCT06590090   -
      2022   Phase 2   NCT05363917   -
   Yunnan Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Chinese Medicine
      2023   Phase 0   ChiCTR2300070837   China
   medac GmbH
      2019   Phase 3   JPRN-jRCT2080224844   Japan
MTX discontinuation
   School of Medicine, University of Occupational and Environmental Health, Japan
      2014   -   JPRN-UMIN000015462   Japan
   Ueno Masanobu
      2023   Phase 4   JPRN-jRCTs051220168   -
   University of Sao Paulo General Hospital
      2023   Phase 4   NCT05879419   Brazil
MTX goldshield tablets
   AbbVie Deutschland GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
MTX hexal 2,5 MG tabletten
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2016   Phase 3   EUCTR2015-003376-75-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003376-75-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
MTX hexal 2,5MG tabletten
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2016   Phase 3   EUCTR2015-003334-27-IT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Italy;Japan;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2016   Phase 3   EUCTR2015-003334-27-RO   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
MTX hexal tablets
   AbbVie Deutschland GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-CZ   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
   Abbott GmbH & Co. KG
      2011   -   EUCTR2010-019514-24-ES   Austria;Czech Republic;Germany;Spain
      2011   -   EUCTR2010-019514-24-DE   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   Phase 3   EUCTR2010-019514-24-BE   Argentina;Austria;Belgium;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
      2011   -   EUCTR2010-019514-24-AT   Argentina;Austria;Canada;Czech Republic;Germany;Puerto Rico;Spain;United States
MTX maintain
   University of Sao Paulo General Hospital
      2023   Phase 4   NCT05879419   Brazil
MTX plus ANTI-TNF
   Karolinska Institutet
      2002   Phase 4   NCT00764725   -
MTX S.C or IM and silymarin 140 MG TAB
   Tanta University
      2024   Phase 4   NCT06724952   Egypt
MTX SC or IM
   Tanta University
      2024   Phase 4   NCT06641128   Egypt
MTX start
   Region Skane
      2016   -   NCT03775824   -
MTX therapy
   Kaneko Yuko
      2018   Phase 4   JPRN-jRCT1031180088   Japan;South Korea;Taiwan
   NYU Langone Health
      2016   Phase 4   NCT02874092   United States
   People's Hospital, Beijing University; Shanghai Changzheng Hospital
      2008   Phase 3 study   ChiCTR-TRC-10001060   China
   Xi-jing Hospital, the 4th Military Medical University, Shanghai Changzheng Hospital
      2008   Phase 3 study   ChiCTR-TRC-09000383   China
MTX-hold
   Seoul National University Hospital
      2021   Phase 3   NCT05069714   Korea, Republic of
Multispectral imaging system
   University of Rochester
      2021   Phase 1   NCT05197530   United States
      2019   Phase 1   NCT04046146   United States
      2015   Phase 1   NCT02680067   United States
Mushroom extract
   Egil Johnson
      2016   -   NCT01815411   Norway
Mussel OIL capsules
   Zhejiang University
      2014   -   NCT02173587   China
Mycophenolate mofetil
   Peking University People's Hospital
      2024   Phase 2   ChiCTR2400085240   China
N''-[(E)-[(2E)-3-[1-(2-nitrophenyl)-1H-pyrrol-2-YL]PROP-2-EN-1-ylidene]amino]guanidinium acetate
   SynAct Pharma ApS
      2022   Phase 2   EUCTR2022-001828-15-BG   Bulgaria;Moldova, Republic of
N-3 LC-pufa
   University of Jena
      2004   -   NCT00638950   Germany
Namilumab
   TAKEDA PHARMACEUTICAL COMPANY LTD.
      2015   Phase 2   JPRN-jRCT2080222927   -
   Takeda
      2015   Phase 2   NCT02393378   Czech Republic;Czechia;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   NCT02379091   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Germany;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom
      2011   Phase 1   NCT01317797   Bulgaria;Netherlands
   Takeda Development Centre Europe Ltd.
      2015   Phase 2   EUCTR2014-002945-23-GB   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-ES   Czech Republic;Estonia;Latvia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2014-002945-23-CZ   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2015   Phase 2   EUCTR2013-002805-76-BG   Bulgaria;Czech Republic;Japan;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2014-002945-23-EE   Czech Republic;Estonia;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-GB   Bulgaria;Czech Republic;Germany;Japan;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-ES   Argentina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 2   EUCTR2013-002805-76-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Germany;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-002805-76-CZ   Bulgaria;Czech Republic;Japan;Poland;Russian Federation;Spain;United Kingdom
Nanobubble drink
   University of Oxford
      2021   -   NCT04844008   United Kingdom
Nanocort
   Sun Pharma Global FZE
      2016   Phase 3   EUCTR2015-002924-17-BE   Belgium;Netherlands
      2015   Phase 3   EUCTR2015-002924-17-NL   Belgium;Netherlands
Nanoparticulated rebamipide
   Cairo University
      2020   Phase 3   NCT04649697   Egypt
Naprosyn 500 MG
   Asahi Kasei Pharma Corporation
      2011   -   EUCTR2010-021558-21-SK   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-HU   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2011   -   EUCTR2010-021558-21-GB   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-DE   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2010   -   EUCTR2010-021558-21-CZ   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2009   -   EUCTR2008-006075-75-HU   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-GB   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-DE   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-CZ   Czech Republic;Germany;Hungary;United Kingdom
Naproxen
   Asahi Kasei Pharma Corporation
      2011   -   EUCTR2010-021558-21-SK   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-HU   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2011   -   EUCTR2010-021558-21-GB   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2011   -   EUCTR2010-021558-21-DE   Czech Republic;Germany;Hungary;Slovakia;United Kingdom
      2010   -   EUCTR2010-021558-21-CZ   Czech Republic;Germany;Hungary;Slovakia;Ukraine;United Kingdom
      2009   -   EUCTR2008-006075-75-HU   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-GB   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-DE   Czech Republic;Germany;Hungary;United Kingdom
      2009   -   EUCTR2008-006075-75-CZ   Czech Republic;Germany;Hungary;United Kingdom
   Cubist Pharmaceuticals LLC
      2007   Phase 2   NCT00626275   United States
   POZEN
      2006   Phase 3   NCT00367211   United States
   Pfizer
      2003   Phase 4   NCT00650455   Canada;United States
   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
      2006   Phase 4   NCT00346216   Australia;Brazil;Canada;Colombia;Costa Rica;Hong Kong;Mexico;Panama;Peru;Philippines;Taiwan;Ukraine;United States
   Rheumatology clinic at Al-Kindy Teaching Hospital /Baghdad/Iraq
      2020   -   JPRN-UMIN000042632   Asia(except Japan)
   Sandoz
      2002   Phase 1   NCT00959439   -
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
Naproxen 10 MG/KG
   Boehringer Ingelheim
      2000   Phase 3   NCT00279747   Austria;Belgium;France;Germany;Italy;Russian Federation;United Kingdom
Naproxen oral suspension
   Boehringer Ingelheim
      2000   Phase 3   NCT00034853   Argentina;Brazil;Mexico;Ukraine;United States
Naproxen sodium 550MG tablet
   Inova Health Care Services
      2018   Phase 4   NCT03699293   United States
Naproxen tablet 500 MG
   Merck Sharp & Dohme Corp.
      2004   Phase 4   NCT00157872   China
Nasopharyngeal swabs
   Assistance Publique - Hôpitaux de Paris
      2020   -   NCT04584541   France
Natalizumab
   Biogen
      2004   Phase 2   NCT00831649   -
      2004   Phase 2   NCT00083759   Canada;United States
Natriumklorid 9MG/ML
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
Natrunix
   XBiotech, Inc.
      2023   Phase 2   NCT05363891   United States
      2022   Phase 2   NCT05363917   -
Natrunix 400 MG
   XBiotech, Inc.
      2025   Phase 2   NCT06590090   -
Nerve block
   Daiyukai General Hospital
      2020   Phase 3   JPRN-UMIN000040054   Japan
   First Affiliated Hospital of Gannan Medical University
      2025   Phase 0   ChiCTR2500100098   China
   Sohag University
      2019   -   NCT04130178   Egypt
NEW formulation adalimumab
   AbbVie (prior sponsor, Abbott)
      2012   Phase 2   NCT01752855   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
NEW formulation etanercept
   Amgen
      2016   Phase 3   NCT02986139   Puerto Rico;United States
NI-0101
   NovImmune S.A.
      2017   Phase 2   EUCTR2016-005017-45-PL   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-HU   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-GB   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
      2017   Phase 2   EUCTR2016-005017-45-BG   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United Kingdom
   NovImmune SA
      2017   Phase 2   NCT03241108   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia
NI-071
   Nichi-Iko Pharmaceutical Co., Ltd.
      2017   Phase 3   NCT02990806   Czechia;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-PL   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-GB   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-ES   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-CZ   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Nichi-Iko Pharmaceutical Co.,Ltd.
      2013   Phase 3   NCT01927263   Japan
Niclosamide
   Faiq Gorial
      2017   Phase 1/Phase 2   NCT03160001   Iraq
Nicotinamide tablet
   Ain Shams University
      2023   Phase 2   NCT06640309   Egypt
Nimesulide
   Anhui Medical University
      2008   Phase 3 study   ChiCTR-TRC-10000850   China
Nipocalimab
   Janssen Research & Development, LLC
      2023   Phase 2   NCT06028438   Argentina;Germany;Hungary;Poland;United Kingdom;United States
      2021   Phase 2   NCT04991753   Germany;Poland;Spain;United Kingdom;United States
   Janssen-Cilag International NV
      2021   Phase 2   EUCTR2021-000510-42-ES   Germany;Poland;Spain;United Kingdom;United States
      2021   Phase 2   EUCTR2021-000510-42-DE   Germany;Poland;Spain;United Kingdom;United States
Nitazoxanide 500MG oral tablet
   Tanta University
      2022   Phase 3   NCT05480878   Egypt
Niubangzi pill
   Cui xuejun
      2018   Phase 2/Phase 3   NCT03173040   China
Nivolumab
   Alliance Foundation Trials, LLC.
      2019   Phase 1   NCT03656627   United States
   National Cancer Institute (NCI)
      2019   Phase 1   NCT03816345   Canada;United States
NNC 0109-0000-0012
   NOVO NORDISK
      2011   -   EUCTR2010-021283-14-IT   Hungary;Italy;Portugal;Spain;United Kingdom
   Novo Nordisk A/S
      2011   Phase 2   EUCTR2010-021283-14-PT   Czech Republic;Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-HU   Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-GB   Hungary;Italy;Portugal;Spain;United Kingdom
      2011   -   EUCTR2010-021283-14-ES   Hungary;Italy;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-021283-14-CZ   Czech Republic;Hungary;Italy;Portugal;Spain;United Kingdom
NNC 0141-0000-0100
   Innate Pharma
      2011   Phase 1   NCT01370902   Germany
NNC 0142-0000-0002
   Novo Nordisk A/S
      2010   -   EUCTR2010-019261-28-DE   Germany
NNC 0151-0000-0000
   Novo Nordisk A/S
      2011   Phase 2   NCT01223911   Czech Republic;Denmark;Hungary;Poland;Romania;United Kingdom
      2008   Phase 1   NCT02151409   Netherlands
NNC 142-0002
   Novo Nordisk A/S
      2010   -   EUCTR2010-019261-28-DE   Germany
NNC0109-0012
   NOVO NORDISK
      2013   -   EUCTR2012-000610-11-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-IT   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Novo Nordisk A/S
      2014   Phase 2   NCT02097264   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-PT   Ireland;Portugal;Spain;United Kingdom
      2014   Phase 2   EUCTR2013-001492-20-ES   Ireland;Portugal;Spain;United Kingdom
      2013   Phase 2   EUCTR2013-001492-20-GB   Belgium;Czech Republic;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2013   -   EUCTR2012-000610-11-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000610-11-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2013   -   EUCTR2012-000609-58-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-000609-58-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   Phase 2   NCT01636843   Argentina;Belgium;Brazil;Czech Republic;Czechia;France;Germany;Hungary;Italy;Mexico;Poland;Russian Federation;Spain;Ukraine;United States
      2012   Phase 2   NCT01636817   Argentina;Belgium;Brazil;Czech Republic;Czechia;France;Germany;Hungary;Italy;Mexico;Poland;Spain;United Kingdom;United States
      2012   -   EUCTR2012-000610-11-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000610-11-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United States
      2012   -   EUCTR2012-000609-58-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   Phase 2   EUCTR2012-000609-58-GB   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2012   -   EUCTR2012-000609-58-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      -   -   EUCTR2012-000609-58-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;European Union;Germany;Hungary;Italy;Mexico;Russian Federation;Spain;Ukraine;United Kingdom;United States
NNC0114-0000-0005
   Novo Nordisk A/S
      2010   Phase 1   NCT01208506   Germany
NNC0114-0006
   Novo Nordisk A/S
      2012   Phase 2   NCT01647451   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   Phase 1   NCT01565408   Germany;Russian Federation
      2012   -   EUCTR2011-005376-42-LV   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   -   EUCTR2011-005376-42-HU   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   Phase 2   EUCTR2011-005376-42-ES   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
      2012   -   EUCTR2011-005376-42-BG   Bulgaria;Hungary;Latvia;Poland;Russian Federation;Serbia;Spain
NNC0142-0002
   Janssen Research & Development, LLC
      2010   Phase 2   NCT01181050   Germany;Russian Federation;Ukraine
      2009   Phase 1   NCT00927927   Germany
NNC0151-0000-0000
   Novo Nordisk A/S
      2012   -   EUCTR2009-011791-30-HU   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   Phase 2   EUCTR2009-011791-30-GB   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-DK   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-CZ   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
NNC0215-0384
   Novo Nordisk A/S
      2013   Phase 1   NCT01955603   Germany;Hungary;Poland;Russian Federation
      2012   Phase 1   NCT01611688   Germany
NNC109-0012
   Novo Nordisk A/S
      2011   Phase 2   NCT01282255   Czech Republic;Germany;Italy;Poland;Portugal;Romania;Spain;United Kingdom
NNC151-0000
   Novo Nordisk A/S
      2012   -   EUCTR2009-011791-30-HU   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   Phase 2   EUCTR2009-011791-30-GB   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-DK   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
      2010   -   EUCTR2009-011791-30-CZ   Czech Republic;Denmark;Germany;Hungary;Poland;Romania;Russian Federation;Ukraine;United Kingdom
NON-active stimulation
   SetPoint Medical Corporation
      2021   Phase 3   NCT04539964   United States
NON-ANTI-TNF biologics
   Janssen Biotech, Inc.
      2009   -   NCT01081717   United States
NON-biologic ANTI-rheumatic drugs
   Pfizer
      2012   -   NCT01646385   -
NON-biologic dmards
   Hoffmann-La Roche
      2014   Phase 3   NCT02046616   Denmark;Finland;Norway;Sweden
      2014   Phase 3   NCT01987479   Netherlands
NON-biological dmards
   Hoffmann-La Roche
      2010   Phase 4   NCT01034397   Portugal
NON-steroidal ANTI-inflammatory drug
   Chinese Academy of Sciences
      2012   -   NCT01619176   China
   Sucampo Pharma Americas, LLC
      2007   Phase 2   NCT00597818   United States
NON-steroidal ANTI-inflammatory drugs
   Hoffmann-La Roche
      2005   Phase 3   NCT00720798   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Puerto Rico;Russian Federation;Serbia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
NON-TNFI-biologic class
   University of Alabama at Birmingham
      2021   Phase 3   NCT04692493   Canada;United States
Nonbiologic dmards OF investigator'S choice
   Hoffmann-La Roche
      2009   Phase 3   NCT00891020   Puerto Rico;United Kingdom;United States
None AS OF YET
   Lexicon Pharmaceuticals, Inc.
      2009   -   EUCTR2009-012705-19-HU   Bulgaria;Czech Republic;Hungary
      2009   -   EUCTR2009-012705-19-CZ   Bulgaria;Czech Republic;Hungary
      2009   -   EUCTR2009-012705-19-BG   Bulgaria;Czech Republic;Hungary
Nordimet 7,5 MG solution injectable EN stylo PRérempli
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
Norethindrone
   Bristol-Myers Squibb
      2017   Phase 1   NCT03262740   United States
Normal saline
   Biogen Idec
      2008   Phase 1   NCT00771329   Russian Federation;Ukraine;United States
   First Affiliated Hospital of Gannan Medical University
      2025   Phase 0   ChiCTR2500100098   China
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000030237   Japan
      2017   -   JPRN-UMIN000029797   Japan
      2017   -   JPRN-UMIN000026137   Japan
   Mesoblast, Ltd.
      2013   Phase 2   NCT01851070   Australia;United States
   Nekoyama Miyao Hospital
      2016   -   JPRN-UMIN000018931   Japan
   Peking Union Medical College Hospital
      2018   -   ChiCTR1800014872   China
   Quanzhou First Hospital Affiliated to Fujian Medical University
      2019   -   ChiCTR2200057200   China
Nsaids
   Department of Pain, Guizhou Provincial People's Hospita
      2020   Phase 0   ChiCTR2000033004   China
   Fen Li
      2016   Phase 4   NCT02878161   -
   General Hospital of Chengdu Military Region
      2014   Phase 1 study   ChiCTR-TRC-14004520   China
   Hoffmann-La Roche
      2017   -   NCT03112213   Germany
   Hoshigaoka Koseinenkin Hospital
      2009   -   JPRN-UMIN000004271   Japan
Nulojix
   Bristol-Myers Squibb
      2014   -   NCT02500498   -
Numerical rating scale
   GlaxoSmithKline
      2017   -   NCT03285191   United Kingdom
OAT
   Shenzhen People's Hospital
      2022   -   NCT06322784   China
Observational study
   Janssen Korea, Ltd., Korea
      2007   -   NCT00760669   Korea, Republic of
Ocrelizumab
   Chugai Pharmaceutical Co., Ltd.
      2009   Phase 3   JPRN-jRCT2080220736   -
      2008   Phase 2   JPRN-jRCT2080220627   -
   F. Hoffmann-La Roche Ltd
      2010   Phase 3   EUCTR2006-005330-20-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2008   Phase 3   EUCTR2007-005759-41-GB   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005759-41-FR   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005759-41-ES   France;Germany;Italy;Spain;United Kingdom
      2008   -   EUCTR2007-005759-41-DE   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-005353-30-GB   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   -   EUCTR2006-005353-30-LT   Argentina;Australia;Austria;Brazil;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Thailand;United Kingdom;United States
      2007   -   EUCTR2006-005353-30-AT   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005330-20-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SI   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-NL   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-HU   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-DE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005147-28-GR   Austria;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-GB   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-FR   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-DE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-BE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-AT   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
   Genentech, Inc.
      2009   Phase 2   NCT00808210   United States
      2008   Phase 3   NCT00673920   United States
      2007   Phase 3   NCT00485589   United States
      2007   Phase 3   NCT00476996   Argentina;Australia;Belgium;Brazil;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Japan;Mexico;Netherlands;New Zealand;Panama;Peru;Poland;Slovakia;Slovenia;Spain;Sweden;Switzerland;Taiwan;United States
      2006   Phase 3   NCT00406419   United States
      2004   Phase 1/Phase 2   NCT00077870   United States
   Hoffmann-La Roche
      2005   Phase 1/Phase 2   NCT02720120   Australia;Belgium;Canada;Netherlands;New Zealand;Russian Federation;Spain;United Kingdom
   ROCHE
      2008   -   EUCTR2007-005759-41-IT   France;Germany;Italy;Spain;United Kingdom
      2007   -   EUCTR2006-005353-30-IT   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   -   EUCTR2006-005330-20-IT   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
Ocrelizumab / rhumab 2h7
   F. Hoffmann-La Roche Limited
      2008   Phase 1;Phase 2   EUCTR2004-002132-26-GB   Spain;United Kingdom
Ocrelizumab 500MG
   Chugai Pharmaceutical
      2008   Phase 2   NCT00779220   Japan
   Chugai Pharmaceutical Co., Ltd.
      2007   Phase 3   JPRN-jRCT2080220469   -
Ocrelizumabu 200MG
   Chugai Pharmaceutical
      2008   Phase 2   NCT00779220   Japan
Ocrelizumabu 50MG
   Chugai Pharmaceutical
      2008   Phase 2   NCT00779220   Japan
Ofatumumab
   GENMAB A/S
      2007   -   EUCTR2007-002945-18-IT   Czech Republic;Italy
   Genmab A/S
      2008   -   EUCTR2007-002951-18-SE   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2007-002951-18-FR   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002951-18-DK   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002950-42-BE   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002951-18-NL   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2007-002951-18-IT   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   Phase 3   EUCTR2007-002951-18-ES   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2007-002950-42-LT   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-HU   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-ES   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002945-18-CZ   Czech Republic
   GlaxoSmithKline
      2008   Phase 1   NCT00686868   Australia;Belgium;Canada;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Russian Federation;Spain;United States
      2008   Phase 2   NCT00655824   Denmark;Hungary;Poland;United Kingdom;United States
      2008   Phase 3   NCT00611455   Argentina;Australia;Belgium;Chile;Czech Republic;Czechia;Hungary;Peru;Poland;Romania;Russian Federation;South Africa;Spain;United Kingdom
      2008   Phase 3   NCT00603525   Argentina;Denmark;France;Germany;Italy;Korea, Republic of;Netherlands;Norway;Peru;Spain;Sweden;United Kingdom
   GlaxoSmithKline Research & Development
      2008   Phase 3   EUCTR2007-002951-18-GB   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002951-18-DE   Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2007-002950-42-GB   Belgium;Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      2008   Phase 1;Phase 2   EUCTR2008-002046-27-FR   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-DE   Belgium;France;Germany;Spain
      2008   -   EUCTR2008-002046-27-BE   Belgium;France;Germany;Spain
      2007   Phase 2   EUCTR2007-004878-31-GB   Denmark;Hungary;United Kingdom
      2007   -   EUCTR2007-004878-31-DK   Denmark;Hungary;United Kingdom
   GlaxoSmithKline Research & Development Ltd.
      2008   -   EUCTR2007-004878-31-HU   Denmark;Hungary;United Kingdom
   GlaxoSmithKline Research and Development
      2008   -   EUCTR2007-002950-42-PL   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
      2007   -   EUCTR2007-002950-42-CZ   Czech Republic;Hungary;Lithuania;Poland;Spain;United Kingdom
   GlaxoSmithKline S.A.
      2008   -   EUCTR2008-002046-27-ES   Belgium;France;Germany;Spain
Olikizumab
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
Olokizumab
   R-Pharm
      2017   Phase 3   EUCTR2015-005309-35-LV   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-HU   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-GB   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-RO   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005307-83-LV   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005308-27-HU   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;United States
      2016   Phase 3   EUCTR2015-005308-27-DE   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United States
      2016   Phase 3   EUCTR2015-005307-83-PL   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-LT   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-HU   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-DE   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2014-004719-36-BG   Belarus;Bulgaria;Russian Federation;Turkey
   R-Pharm International LLC
      2017   Phase 3   EUCTR2015-005309-35-PL   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-LT   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-DE   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2017   Phase 3   EUCTR2015-005309-35-CZ   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005308-27-CZ   Argentina;Brazil;Colombia;Czech Republic;Germany;Hungary;Korea, Republic of;Mexico;Poland;United States
      2016   Phase 3   EUCTR2015-005307-83-CZ   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Georgia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-005307-83-BG   Argentina;Brazil;Bulgaria;Colombia;Czech Republic;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
   R-Pharm International, LLC
      2021   Phase 1   NCT04246762   Bulgaria;Moldova, Republic of
      2017   Phase 3   NCT02760433   Argentina;Brazil;Colombia;Czech Republic;Czechia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United States
      2016   Phase 3   NCT02760368   Belarus;Bulgaria;Russian Federation;Turkey
   R-Pharm International, LLC.
      2017   Phase 3   EUCTR2015-005309-35-BG   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;Turkey;United Kingdom;United States
   UCB BIOSCIENCES, Inc.
      2012   Phase 2   NCT01533714   Japan;Korea, Republic of;Taiwan
   UCB Biosciences Inc
      2011   -   EUCTR2010-022224-77-GB   Belgium;United Kingdom;United States
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
   UCB Biosciences, Inc.
      2011   Phase 2   EUCTR2010-022224-77-BE   Belgium;United Kingdom;United States
Olokizumab 120 MG
   UCB Japan Co. Ltd.
      2011   Phase 2   NCT01463059   Japan;Korea, Republic of;Taiwan
Olokizumab 240 MG
   UCB Japan Co. Ltd.
      2011   Phase 2   NCT01463059   Japan;Korea, Republic of;Taiwan
Olokizumab 60 MG
   UCB Japan Co. Ltd.
      2011   Phase 2   NCT01463059   Japan;Korea, Republic of;Taiwan
Olokizumab 64 MG SC Q2W
   R-Pharm International, LLC
      2017   Phase 3   NCT03120949   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
Olokizumab 64 MG SC Q4W
   R-Pharm International, LLC
      2017   Phase 3   NCT03120949   Argentina;Belarus;Brazil;Bulgaria;Colombia;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
Olokizumab 64MG Q2W
   R-Pharm International, LLC
      2016   Phase 3   NCT02760407   Argentina;Brazil;Bulgaria;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
Olokizumab 64MG Q4W
   R-Pharm International, LLC
      2016   Phase 3   NCT02760407   Argentina;Brazil;Bulgaria;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Hungary;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Romania;Russian Federation;Taiwan;United Kingdom;United States
Olumiant
   Assistance Publique - Hôpitaux de Paris
      2022   Phase 4   NCT05238896   France
   ELI LILLY & COMPANY, LILLY CORPORATE CENTER
      2019   Phase 4   EUCTR2018-003351-37-IT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2012-003686-17-SI   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2014   Phase 3   EUCTR2012-003686-17-GR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-SE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-PL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LV   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-HR   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DK   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-CZ   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003686-17-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Taiwan;Turkey;United Kingdom;United States
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2021   Phase 4   EUCTR2018-004558-30-BE   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
      2020   Phase 4   EUCTR2018-004558-30-DK   Belgium;Denmark;Portugal;Spain
      2019   Phase 4   EUCTR2018-004558-30-ES   Spain
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   NHS Greater Glasgow and Clyde
      2021   -   NCT05112120   United Kingdom
   Shinshu University
      2018   Phase 2   NCT03755466   Japan
   Transparency in Healthcare
      2019   Phase 4   EUCTR2019-000505-72-NL   Netherlands
Olumiant 2 MG/4 MG filmtabletten
   Universitätsklinikum Erlangen
      2022   Phase 2   EUCTR2021-006562-20-DE   Germany
Olumiant 4 MG
   ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP)
      2021   Phase 4   EUCTR2020-005773-27-FR   France
Olumiant 4MG
   ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP)
      2021   Phase 4   EUCTR2020-005773-27-FR   France
   CHU de Bordeaux
      2021   Phase 3   EUCTR2020-004345-37-FR   France;Monaco
Omalizumab
   Leiden University Medical Center, Department of Rheumatology
      2010   -   EUCTR2009-017306-36-NL   Netherlands
Omega-3
   Haukeland University Hospital
      2020   -   NCT04586933   Norway
   Instituto de Ciencias de la Salud, Universidad de O'Higgins
      2022   -   NCT05945693   Chile
Omega-3 and vitamin E supplementation
   Shahid Beheshti Medical University
      2006   Phase 1   NCT00399282   Iran, Islamic Republic of
Omega-3 fatty acid
   Hanyang University
      2010   -   NCT01618019   Korea, Republic of
Omega-3 supplementation
   Hopital Charles Nicolle
      2025   -   NCT06881966   Tunisia
Omegaven (10% FISH-OIL emulsion
   Humanis Klinikum Niederosterreich
      2004   Phase 3   NCT00412256   Austria
Omeprazole
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
      2016   Phase 1   NCT02762123   United States
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   POZEN
      2006   Phase 3   NCT00367211   United States
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Qingdao Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2400085746   China
   R-Pharm International, LLC
      2021   Phase 1   NCT04246762   Bulgaria;Moldova, Republic of
Omeprazole enteric capsules
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Oncoxin + viusid
   Catalysis SL
      2009   Phase 3   NCT00969527   Cuba
OPEN-label abatacept
   Bristol-Myers Squibb
      2002   Phase 3   NCT00048932   United States
OPEN-label adalimumab
   Abbott
      2009   Phase 3   NCT00870467   Japan
OPEN-labeladalimumabrescue
   Abbott
      2009   Phase 3   NCT00870467   Japan
Oral bovine type II collagen
   University of Tennessee
      1999   Phase 2   NCT00000401   United States
Oral corticosteroids
   Hoffmann-La Roche
      2014   Phase 3   NCT02046603   United Kingdom
      2005   Phase 3   NCT00720798   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Puerto Rico;Russian Federation;Serbia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
Oral methotrexate
   Amgen
      2015   Phase 3   NCT02373813   Argentina;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;South Africa;Spain;United States
   Shanghai Guanghua Integrated traditional Chinese and Western Medicine Hospital
      2023   Phase 0   ChiCTR2300072849   China
   The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2024   Phase 0   ChiCTR2400084989   China
   Traditional Chinese Medicine Hospital of Dianjiang Chongqing
      2023   Phase 1   ChiCTR2300075439   China
Oral SCIO-469 capsule
   Scios, Inc.
      2005   Phase 1   NCT00508768   -
Orencia
   Academisch Medisch Centrum Amsterdam
      2010   -   EUCTR2010-021435-14-NL   Netherlands
   Bristol Myers Squibb International Corporation
      2011   Phase 3   EUCTR2008-001523-57-NO   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2008-001523-57-HU   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2010   -   EUCTR2008-001523-57-DE   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-GB   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-001523-57-ES   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2009   -   EUCTR2008-001523-57-DK   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-001523-57-FR   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   -   EUCTR2007-005434-37-NL   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-IE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-HU   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-GR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-FR   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-DE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-BE   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-005434-37-AT   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-GB   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-000784-26-DE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
      2005   -   EUCTR2005-000784-26-BE   Austria;Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
   Bristol-Myers Squibb
      2018   -   NCT01694693   -
      2013   -   NCT02600468   -
      2013   -   NCT02600455   Japan
      2010   -   NCT01583244   Korea, Republic of
   Bristol-Myers Squibb Company
      -   Phase 2   EUCTR2015-005450-36-Outside-EU/EEA   United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2008   -   EUCTR2008-001523-57-IT   Denmark;France;Germany;Hungary;Italy;Norway;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005434-37-GB   Austria;Belgium;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;United Kingdom
      2008   -   EUCTR2007-004241-15-IT   Belgium;France;Germany;Italy;Netherlands;Spain;United Kingdom
      2007   -   EUCTR2006-003768-67-SE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-DE   Austria;Germany;Netherlands;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-003768-67-BE   Austria;Belgium;Germany;Netherlands;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005102-68-BE   Belgium;Czech Republic;Germany;Ireland;Italy;Spain;United Kingdom
   CHU Amiens-Picardie
      2015   Phase 4   EUCTR2015-000833-64-FR   France
   Cambridge University Hospitals NHS Foundation Trust
      2018   Phase 2   EUCTR2016-002569-68-GB   United Kingdom
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fundació Clínic per a la Recerca Biomèdica
      2019   Phase 4   EUCTR2017-004543-20-ES   Spain
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Medical University of Vienna
      2012   Phase 4   NCT01638715   Austria;Czech Republic;Czechia;Russian Federation;Saudi Arabia;Switzerland
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Novartis Pharma AG
      2011   -   EUCTR2011-000102-21-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma Services AG
      2011   -   EUCTR2011-000102-21-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   The Karolinska Instutute, ClinTRID
      2013   Phase 4   EUCTR2011-004720-35-IS   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
   Universitätsklinikum Erlangen
      2019   Phase 2   EUCTR2018-003877-91-DE   Germany
      2017   Phase 3   EUCTR2014-000555-93-ES   Brazil;Czech Republic;Germany;Spain
Orencia 125 MG
   Leiden University Medical Center
      2018   Phase 4   EUCTR2017-002878-38-NL   Netherlands
Orencia 125 MG injektionslösung IM fertigpen
   Universitätsklinikum Erlangen
      2023   Phase 1;Phase 2   EUCTR2021-006669-40-DE   Germany
Orencia 125 MG solution FOR injection
   King’s College London
      2014   Phase 2   EUCTR2013-003413-18-GB   Netherlands;United Kingdom
   Leiden University Medical Center
      2017   Phase 2   EUCTR2013-003413-18-NL   Netherlands;United Kingdom
Orencia 125 MG solution FOR injection IN PRE-filled syringe
   Bristol-Myers Squibb International Corporation
      2021   Phase 2   EUCTR2019-002205-22-NL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-PL   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-GB   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-FR   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-ES   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-DE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
      2020   Phase 2   EUCTR2019-002205-22-BE   Argentina;Belgium;France;Germany;Mexico;Netherlands;Poland;Spain;United Kingdom;United States
Orencia 125 MG, solution injectable EN seringue PRéremplie
   Groupement des Hôpitaux de l’Institut Catholique de Lille
      2017   Phase 4   EUCTR2017-000947-41-FR   France
Orencia 250 MG polvo para concentrado para SOL. para perfusióN
   Novartis Farmacéutica S.A.
      2011   -   EUCTR2011-000102-21-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
Orencia 250MG powder FOR concentrate FOR solution FOR infusion
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2017   Phase 3   EUCTR2016-000933-37-IT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;European Union;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2018   Phase 3   EUCTR2016-000933-37-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SK   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-DE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-BE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-LV   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-ES   Argentina;Australia;Belarus;Brazil;Canada;Chile;Colombia;European Union;Hungary;Israel;Korea, Democratic People's Republic of;Latvia;Mexico;New Zealand;Norway;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;United States
Orencia abatacept
   Policlinico Gemelli-CIC- UCSC
      2015   Phase 4   EUCTR2015-000089-72-IT   Italy
Orencia injektionslösung IN einer fertigspritze
   Universitätsklinikum Erlangen
      2023   Phase 1;Phase 2   EUCTR2021-006669-40-DE   Germany
Orencia subcutaneous injection
   Bristol-Myers Squibb
      2016   -   NCT02758769   Japan
Orencia*IV 2FL 250MG+2SIR
   NOVARTIS FARMA
      2011   -   EUCTR2011-000102-21-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
Originator
   Opal Rheumatology Ltd.
      2018   -   NCT03470688   Australia
   Sandoz
      2015   Phase 3   NCT02514772   Germany;Hungary;Poland;United States
Originator (legacy) drug
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2018   -   NCT03729674   Canada
Orncia
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
Ortho-novum® 1/35
   Hoffmann-La Roche
      2009   Phase 3   NCT01044498   United States
Otelixizumab
   GlaxoSmithKline
      2010   Phase 1   NCT01077531   Russian Federation;Spain;United Kingdom
Other biological agent
   University of Athens
      2017   -   NCT03288584   Greece
Other biologics
   Department of Rheumatosurgery, Osaka City University Medical School
      2009   Phase 4   JPRN-UMIN000002340   Japan
   Hoffmann-La Roche
      2016   -   NCT02797769   -
Other dmards
   Flinders University
      2017   Phase 4   NCT03254589   Australia
   Osaka City University Medical School
      2012   Phase 4   JPRN-UMIN000009425   Japan
      2010   -   JPRN-UMIN000003880   Japan
Other NON steroidal ANTI-inflammatory drugs (nsaids) except etodolac
   Boehringer Ingelheim
      2001   -   NCT02180516   -
Otilimab
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-IT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   GlaxoSmithKline
      2020   Phase 3   NCT04333147   Argentina;Australia;Belgium;Bulgaria;Canada;China;Colombia;Czechia;Estonia;Germany;Hungary;India;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT04134728   Argentina;Belgium;Canada;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   NCT03980483   Argentina;Canada;China;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   NCT03970837   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
   GlaxoSmithKline K.K.
      2020   Phase 3   JPRN-jRCT2080225238   Argentina;Australia;Belgium;Bulgaria;Canada;China;Colombia;Czechia;Estonia;Germany;Hungary;India;Korea;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2019   Phase 3   JPRN-jRCT2080224948   Argentina;Australia;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Korea;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2021   Phase 3   EUCTR2019-000878-30-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-HU   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-ES   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-CZ   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-ES   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-ES   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-CZ   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-000878-30-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
   Yamada Masanori
      2022   Phase 1   JPRN-jRCT2071210132   -
Outpatient rheumatology department
   MD, PhD, Annemarie Lyng Svensson
      2014   -   NCT02246257   Denmark
Overencapsulated prednisolone tablets
   GlaxoSmithKline R&D Ltd
      2005   -   EUCTR2004-005115-29-DE   Germany;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      2005   Phase 2   EUCTR2004-005115-29-GB   Germany;United Kingdom
Oxiklorin
   Karolinska Institutet
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
OXY-001
   Cyxone AB
      2022   Phase 2   EUCTR2021-006665-38-PL   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United States
      2022   Phase 2   EUCTR2021-006665-38-HU   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United States
Oxycodone
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
Ozoralizumab
   Hashimoto Motomu
      2024   Phase 4   JPRN-jRCTs051240053   -
   Kawakami Atsushi
      2023   Phase 4   JPRN-jRCTs071230067   -
   Taisho Pharmaceutical Co.Ltd
      2019   Phase 3   JPRN-jRCT2080224848   Japan
   Taisho Pharmaceutical co., LTD
      2018   Phase 3   JPRN-jRCT2080223973   Japan
      2018   Phase 2-3   JPRN-jRCT2080223971   Japan
P38 (4) MAP kinase inhibitor
   F. Hoffmann-La Roche Ltd
      2006   Phase 2   EUCTR2005-003694-25-ES   Czech Republic;Italy;Spain
      2006   -   EUCTR2005-003694-25-CZ   Czech Republic;Italy;Spain
      2006   Phase 2   EUCTR2005-003495-38-GR   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-IE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-GB   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-ES   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-EE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-DE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
P38 inhibitor (4) 150MG
   Hoffmann-La Roche
      2005   Phase 2   NCT00316771   Australia;Brazil;Canada;Estonia;Germany;Greece;Ireland;Mexico;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
P38 inhibitor (4) 25MG
   Hoffmann-La Roche
      2005   Phase 2   NCT00316771   Australia;Brazil;Canada;Estonia;Germany;Greece;Ireland;Mexico;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
P38 inhibitor (4) 300MG
   Hoffmann-La Roche
      2005   Phase 2   NCT00316771   Australia;Brazil;Canada;Estonia;Germany;Greece;Ireland;Mexico;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
P38 inhibitor (4) 50MG
   Hoffmann-La Roche
      2005   Phase 2   NCT00316771   Australia;Brazil;Canada;Estonia;Germany;Greece;Ireland;Mexico;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
P38 inhibitor (4) 75MG
   Hoffmann-La Roche
      2005   Phase 2   NCT00316771   Australia;Brazil;Canada;Estonia;Germany;Greece;Ireland;Mexico;New Zealand;Poland;South Africa;Spain;United Kingdom;United States
P38 MAP kinase inhibitor
   ROCHE
      2006   -   EUCTR2005-003694-25-IT   Czech Republic;Italy;Spain
P38(4) MAP kinase inhibitor
   F. Hoffmann-La Roche Ltd
      2006   Phase 2   EUCTR2005-003694-25-ES   Czech Republic;Italy;Spain
      2006   -   EUCTR2005-003694-25-CZ   Czech Republic;Italy;Spain
      2006   Phase 2   EUCTR2005-003495-38-GR   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-IE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-GB   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-ES   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-EE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-DE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
Panax quinquefolius
   Zhejiang Provincal Hospital of TCM
      2019   Phase 2   ChiCTR1900026257   China
Paracetamol
   Merck & Co. Inc.
      2005   Phase 2   EUCTR2004-004302-24-ES   Czech Republic;Finland;Germany;Italy;Spain
   Merck & Co., Inc.
      2005   Phase 2   EUCTR2004-004302-24-CZ   Czech Republic;Finland;Germany;Italy;Spain
   Merck Sharp & Dohme (Sweden) AB
      2004   -   EUCTR2004-000074-31-SE   Sweden
   Merck Sharp & Dohme BV
      2005   Phase 2   EUCTR2004-000074-31-BE   Belgium;Sweden
   Rheumazentrum Ruhrgebiet
      2011   -   EUCTR2011-002633-19-DE   Germany
   Suomen MSD Oy
      2005   -   EUCTR2004-004302-24-FI   Czech Republic;Finland;Germany;Italy;Spain
Paralen 500
   Merck & Co., Inc.
      2005   Phase 2   EUCTR2004-004302-24-CZ   Czech Republic;Finland;Germany;Italy;Spain
Parecoxib
   Peking Union Medical College Hospital
      2018   -   ChiCTR1800014872   China
      2014   -   ChiCTR1800014846   China
Paroxetine
   COMBINATORX, INC
      2005   Phase 2   EUCTR2004-004995-35-IT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
   CombinatoRx, Inc.
      2005   -   EUCTR2004-004995-35-DE   Czech Republic;Denmark;Germany;Italy;United Kingdom
   Mostafa Bahaa
      2024   Phase 3   NCT06231745   Egypt
   Sadat City University
      2021   Phase 1/Phase 2   NCT04757571   Egypt
Paroxetine & prednisolone
   CombinatoRx, Inc.
      2006   Phase 2   EUCTR2004-004995-35-GB   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
      2006   -   EUCTR2004-004995-35-DK   Czech Republic;Denmark;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-004995-35-CZ   Czech Republic;Denmark;Germany;Italy;United Kingdom
      2005   -   EUCTR2004-004995-35-AT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
Paroxetine hydrochloride 10 & 20 MG and prednisolone 1 MG BP
   CombinatoRx, Inc.
      2006   Phase 2   EUCTR2004-004995-35-GB   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
Paroxetine hydrochloride tablets 10 & 20 MG and prednisolone 1 MG BP
   CombinatoRx, Inc.
      2005   -   EUCTR2004-004995-35-AT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
Part A
   GlaxoSmithKline
      2005   Phase 2   NCT00291928   Denmark;Finland;France;Hungary;Poland;United Kingdom;United States
Part B
   Galapagos NV
      2010   Phase 2   NCT01211249   Belgium;Netherlands;Poland;Russian Federation;Ukraine
   GlaxoSmithKline
      2005   Phase 2   NCT00291928   Denmark;Finland;France;Hungary;Poland;United Kingdom;United States
Patient current care
   University Hospital, Grenoble
      2021   -   NCT04117165   France
Patient treated with dmard
   University Hospital, Toulouse
      2018   -   NCT03980639   France
Patients' existing NON-steroidal ANTI-inflammatory drug (nsaid) AT approved doses
   University of Dundee
      2011   -   EUCTR2007-000012-90-NL   Denmark;Netherlands;United Kingdom
      2008   Phase 4   EUCTR2007-000012-90-GB   Denmark;Netherlands;United Kingdom
      2007   Phase 4   EUCTR2007-000012-90-DK   Denmark;Netherlands;United Kingdom
PCA
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
PCR polymorphism
   Sohag University
      2022   -   NCT05588817   Egypt
PD 0360324
   Pfizer
      2007   Phase 1   NCT00550355   Argentina;Bulgaria;Czech Republic;Mexico;Poland;Slovakia;Spain;United States
PDA001
   Celularity Incorporated
      2010   Phase 2   NCT01261403   United States
Peficitinib
   Astellas Pharma China, Inc.
      2018   Phase 3   NCT03660059   China;Korea, Republic of;Taiwan
   Astellas Pharma Global Development, Inc.
      2012   Phase 2   NCT01711814   Belgium;Bulgaria;Colombia;Czech Republic;Czechia;Hungary;Mexico;Poland;United States
      2012   Phase 2   NCT01565655   Bulgaria;Czech Republic;Czechia;Hungary;Mexico;Poland;United States
   Astellas Pharma Inc
      2019   -   NCT03971253   Japan
      2014   Phase 3   NCT02308163   Japan;Korea, Republic of;Taiwan
      2014   Phase 3   NCT02305849   Japan
      2012   Phase 2   NCT01649999   Japan
      2012   Phase 3   NCT01638013   Japan;Korea, Republic of;Taiwan
      2012   Phase 2   NCT01554696   Belgium;Bulgaria;Colombia;Czech Republic;Czechia;Hungary;Mexico;Poland;United States
      2010   Phase 1   NCT01754805   United States
   Hashimoto Motomu
      2022   -   JPRN-jRCTs051220027   -
PEG
   Amgen
      2002   Phase 2   NCT00111423   -
   VU Medical Center, department of Rheumatology
      2020   Phase 4   EUCTR2018-004429-94-NL   Netherlands
      2018   Phase 4   EUCTR2018-001114-15-NL   Netherlands
Pegsunercept
   Amgen
      2002   Phase 2   NCT00111423   -
      2001   Phase 2   NCT00037700   United States
Pelubiprofen 30 MG
   Daewon Pharmaceutical Co., Ltd.
      2010   Phase 3   NCT01781702   -
Peresolimab
   Eli Lilly and Company
      2022   Phase 2   NCT05516758   Argentina;Canada;China;Greece;Hungary;Italy;Japan;Mexico;Poland;Puerto Rico;Spain;United States
   Masaki Takeshi
      2023   Phase 2   JPRN-jRCT2031220628   Argentina;Canada;China;Greece;Hungary;Italy;Japan;Mexico;Poland;Puerto Rico;Spain;United States
PERI-neural dexamethasone 1 MG
   University of Calgary
      2016   -   NCT02666443   Canada
Periodontitis-associated bacteria presence
   University of Copenhagen
      2017   -   NCT03225950   Denmark
Permitted dmards
   Hoffmann-La Roche
      2007   Phase 3   NCT00531817   Puerto Rico;United States
Persantin 100 MG and
   CombinatoRx, Inc
      2006   -   EUCTR2004-001930-18-EE   Estonia
Personalized ayurveda treatment protocol
   Ayurai Private Limited
      2021   -   NCT06167226   India
Pertussis filamentous haemagglutinin adsorbed ON aluminium hydroxide
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
Pertussis pertactin adsorbed ON aluminium hydroxide
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
Pertussis toxoid adsorbed ON aluminium hydroxide
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
Pertussis vaccine
   Tel-Aviv Sourasky Medical Center
      2011   Phase 4   NCT01301703   Israel
PF-04171327
   Pfizer
      2011   Phase 2   NCT01393639   Bulgaria;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer Inc.
      2009   Phase 2   EUCTR2009-013223-37-CZ   Czech Republic;Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-023782-22-CZ   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2009   -   EUCTR2009-013223-37-HU   Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2011   -   EUCTR2010-023782-22-DE   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2012   -   EUCTR2010-023782-22-SK   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-HU   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-BG   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer S.A.
      2009   Phase 2   EUCTR2009-013223-37-ES   Czech Republic;Hungary;Spain
   Pfizer, S.L.U.
      2011   -   EUCTR2010-023782-22-ES   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
PF-04171327 10 MG
   Pfizer
      2009   Phase 2   NCT00938587   Czech Republic;Czechia;Hong Kong;Hungary;Korea, Republic of;Russian Federation;Serbia;Singapore;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
PF-04171327 25 MG
   Pfizer
      2009   Phase 2   NCT00938587   Czech Republic;Czechia;Hong Kong;Hungary;Korea, Republic of;Russian Federation;Serbia;Singapore;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
PF-05280586
   Pfizer
      2012   Phase 2   NCT01526057   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2012-003223-38-GB   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-003223-38-ES   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003223-38-DE   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2011-002896-40-PL   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2012   Phase 2   EUCTR2011-002896-40-GB   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      -   Phase 2   EUCTR2011-002896-40-ES   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US
      2012   -   EUCTR2011-002896-40-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
PF-06410293
   Pfizer
      2020   Phase 3   NCT04230213   Bosnia and Herzegovina;Bulgaria;Czechia;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2015   Phase 3   NCT02480153   Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
   Pfizer Inc
      2020   Phase 4   EUCTR2019-000284-24-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2019   Phase 3   EUCTR2019-000284-24-LT   Argentina;Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Mexico;Peru;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
PF-06438179
   Pfizer
      2014   Phase 3   NCT02222493   Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Czechia;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Jordan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2013-004148-49-FR   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-PL   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-HU   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-GB   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-DE   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-CZ   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
PF-06650833
   Pfizer
      2020   Phase 2   NCT04413617   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czechia;Georgia;Hungary;Poland;Slovakia;Spain;Sweden;Ukraine
      2016   Phase 2   NCT02996500   Australia;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
PF-06650833 100 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-002337-30-CZ   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-002337-30-HU   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-HR   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-ES   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-DE   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-BG   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
PF-06650833 20 MG
   Pfizer Inc.
      2017   Phase 2   EUCTR2016-002337-30-CZ   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-002337-30-HU   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-HR   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-ES   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-DE   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-BG   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
PF-06651600
   Pfizer
      2020   Phase 2   NCT04413617   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czechia;Georgia;Hungary;Poland;Slovakia;Spain;Sweden;Ukraine
      2016   Phase 2   NCT02969044   Bulgaria;Czechia;Georgia;Germany;Hungary;Poland;Serbia;Slovakia;United States
   Pfizer Inc 235 East 42nd Street, New York, NY10017 US
      2017   Phase 2   EUCTR2016-002862-30-SK   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 2   EUCTR2016-002862-30-HU   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 2   EUCTR2016-002862-30-DE   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 2   EUCTR2016-002862-30-CZ   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
      2017   Phase 2   EUCTR2016-002862-30-BG   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-002862-30-PL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Poland;Romania;Serbia;Slovakia;United States
PF-06835375
   Pfizer
      2017   Phase 1   NCT03334851   Puerto Rico;United States
PG-760564
   Procter & Gamble Pharmaceuticals
      2007   -   EUCTR2006-002216-10-NL   Czech Republic;Hungary;Netherlands;United Kingdom
      2007   -   EUCTR2006-002216-10-HU   Czech Republic;Hungary;Netherlands;United Kingdom
      2007   Phase 2   EUCTR2006-002216-10-GB   Czech Republic;Hungary;Netherlands;United Kingdom
      2006   -   EUCTR2006-002216-10-CZ   Czech Republic;Hungary;Netherlands;United Kingdom
   Procter and Gamble
      2006   Phase 2   NCT00369928   Czech Republic;Hungary;Netherlands;Poland;United Kingdom;United States
PH-797804
   Pfizer
      2008   Phase 2   NCT00620685   United States
      2006   Phase 2   NCT00383188   Australia;Brazil;Chile;Czech Republic;Estonia;India;Korea, Republic of;Peru;Poland;Russian Federation;South Africa;Spain
   Pfizer Ltd
      2006   -   EUCTR2006-003577-27-CZ   Czech Republic;Estonia;Spain
   Pfizer Luxembourg SARL Branch Office Estonia
      2006   -   EUCTR2006-003577-27-EE   Czech Republic;Estonia;Spain
   Pfizer S.A.
      2007   Phase 2   EUCTR2006-003577-27-ES   Czech Republic;Estonia;Spain
Pharmacokinetics OF certolizumab pegol
   UCB Biopharma SRL
      2020   Phase 1   NCT04163016   Canada;France;Germany;Netherlands;Spain;Switzerland;United States
Phase 1: conventiaonal dmard
   Pfizer
      2009   Phase 4   NCT00848354   Argentina;Brazil;Chile;Colombia;Ecuador;Mexico;Panama;Spain;Venezuela
Phase 1: etanercept
   Pfizer
      2009   Phase 4   NCT00848354   Argentina;Brazil;Chile;Colombia;Ecuador;Mexico;Panama;Spain;Venezuela
Phase 1: methotrexate
   Pfizer
      2009   Phase 4   NCT00848354   Argentina;Brazil;Chile;Colombia;Ecuador;Mexico;Panama;Spain;Venezuela
Phase 2: optional ETN, SSZ, HCQ, MTX
   Pfizer
      2009   Phase 4   NCT00848354   Argentina;Brazil;Chile;Colombia;Ecuador;Mexico;Panama;Spain;Venezuela
Phosphate
   Eli Lilly and Company
      2011   -   EUCTR2010-022504-42-HU   Argentina;Croatia;Czech Republic;Hungary;India;Mexico;Peru;Poland;Romania;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-022504-42-GB   Hungary;United Kingdom
Piclidenoson
   Can-Fite BioPharma, Ltd.
      2019   Phase 3   EUCTR2016-003682-26-PL   Bosnia and Herzegovina;Bulgaria;Canada;Israel;Moldova, Republic of;Poland;Romania;Serbia
Picture OF THE feet
   Rigshospitalet, Denmark
      2023   -   NCT05698563   Denmark
PIG whipworm eggs
   Immanuel Krankenhaus Berlin
      2013   Phase 2   EUCTR2011-006344-71-DE   Germany
Pioglitazone
   AstraZeneca
      2011   Phase 1   NCT01309854   United States
   Ohio State University
      2015   Phase 1   NCT02535832   United States
   University of Michigan
      2007   Phase 3   NCT00554853   United States
   Vanderbilt University
      2009   -   NCT00763139   United States
Pirfenidone
   Brigham and Women's Hospital
      2017   Phase 2   NCT02808871   Australia;Canada;United Kingdom;United States
   The First Affiliated Hospital of DaLian Medical University
      2021   Phase 4   ChiCTR2100046283   China
   University Hospitals of Leicester NHS Trust
      2017   Phase 2   EUCTR2017-000149-30-GB   Australia;Canada;United Kingdom;United States
PL 00095/5079R
   F. Hoffmann-La Roche Ltd
      2006   Phase 2   EUCTR2005-003694-25-ES   Czech Republic;Italy;Spain
      2006   -   EUCTR2005-003694-25-CZ   Czech Republic;Italy;Spain
PLA + MTX switched TO ABA+ MTX, DB
   Bristol-Myers Squibb
      2005   Phase 3   NCT00095147   Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Russian Federation;South Africa;Spain;Sweden;Switzerland;United States
PLA-695
   Wyeth is now a wholly owned subsidiary of Pfizer
      2006   Phase 1   NCT00440492   Canada;United States
Plaebo
   Astellas Pharma China, Inc.
      2018   Phase 3   NCT03660059   China;Korea, Republic of;Taiwan
Planar image with both hands IN field OF view
   Navidea Biopharmaceuticals
      2017   Phase 1/Phase 2   NCT02865434   United States
Plant-based diet
   Physicians Committee for Responsible Medicine
      2018   -   NCT03580681   United States
Plaquenil
   Christine Bengtsson
      2015   Phase 2   EUCTR2014-005418-45-SE   Sweden
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
   North Glasgow NHS Trust
      2004   -   EUCTR2004-002006-30-GB   United Kingdom
   University Hospitals Birmingham NHS Foundation Trust
      2006   Phase 4   EUCTR2006-001428-38-GB   United Kingdom
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
Plaquenil 200 MG filmdrasjerte tabletter
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Plasma analysis FOR bacterial translocation
   Centre Hospitalier Universitaire de Nimes
      2016   -   NCT01961310   France
Platelet rich plasma
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-005391-40-IT   Italy
PLX3397
   Plexxikon
      2010   Phase 1   NCT01090570   United States
PLX5622
   Plexxikon
      2011   Phase 1   NCT01329991   United States
Pneumo23 / pneumovax
   University Hospital, Montpellier
      2013   Phase 3   NCT01942174   France;Monaco
Pneumococcal conjugate vaccine
   University Hospital, Montpellier
      2016   -   NCT02547493   France;Monaco
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated TO CRM197 carrier protein and adsorbed ON aluminium phosphate
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
Pneumococcal polysaccharide vaccine
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
   University Hospital, Montpellier
      2016   -   NCT02547493   France;Monaco
Pneumococcal serotypes
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
Pneumovax
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
Pneumovax 23
   Radboud University Nijmegen Medical Centre
      2008   -   EUCTR2008-001282-28-NL   Netherlands
Pneumovax® 23
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
POLY-L-D-lactic acid implant (regjoint) interposition arthroplasty
   Helsinki University Central Hospital
      2019   -   NCT06804356   Finland
Positron emission tomography
   Jonsson Comprehensive Cancer Center
      2016   Early Phase 1   NCT02925351   United States
Potassium supplement
   Shahid Beheshti Medical University
      2007   Phase 1   NCT00461448   Iran, Islamic Republic of
Power doppler ultrasonography
   GlaxoSmithKline
      2004   -   NCT00242853   United Kingdom
PR-06410293
   Pfizer Inc.
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
Pravastatin
   Bristol-Myers Squibb
      2017   Phase 1   NCT03131973   United States
   Gilead Sciences
      2020   Phase 1   NCT04608344   United States
PRD4862257
   Tampere University Hospital
      2018   Phase 4   EUCTR2017-002753-11-FI   Finland
PRE-filled syringe
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2021   Phase 2   EUCTR2020-005303-39-IT   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   AbbVie Deutschland GmbH & Co. KG
      2021   Phase 2   EUCTR2020-005303-39-SK   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-PL   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-NL   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-GR   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-ES   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-DE   Australia;Canada;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2021   Phase 2   EUCTR2020-005303-39-CZ   Australia;Canada;Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Italy;Japan;Korea, Republic of;Netherlands;New Zealand;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2019   Phase 2   EUCTR2018-003053-21-PL   Israel;Poland;Puerto Rico;United States
      2015   Phase 2   EUCTR2014-001471-31-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2015   Phase 2   EUCTR2014-001471-31-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;New Zealand;Poland;Romania
      2013   Phase 2   EUCTR2012-003881-42-SK   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   -   EUCTR2012-003881-42-RO   Germany;Puerto Rico;Romania;United States
      2013   -   EUCTR2012-003881-42-DE   Belgium;Czech Republic;Germany;Puerto Rico;Romania;Slovakia;United States
      2013   Phase 2   EUCTR2012-003881-42-BE   Belgium;Germany;Puerto Rico;Romania;Slovakia;United States
   Alvotech Swiss AG
      2023   Phase 3   EUCTR2022-001825-63-LT   Bulgaria;Czechia;Georgia;Lithuania;Poland;Serbia
      2023   Phase 3   EUCTR2022-001825-63-BG   Bulgaria;Georgia;Lithuania;Poland
   Amgen Inc
      2014   -   EUCTR2013-000525-31-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-000525-31-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2013   -   EUCTR2013-000525-31-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   Amgen Inc.
      2017   Phase 3   EUCTR2014-004868-38-DE   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-PT   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-HU   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-GR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-FR   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-ES   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2016   Phase 3   EUCTR2014-004868-38-BG   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Portugal;Spain;United States
      2015   Phase 3   EUCTR2014-004868-38-CZ   Argentina;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Portugal;Spain;United States
      2014   Phase 3   EUCTR2013-004654-13-RO   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-PL   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   -   EUCTR2013-004654-13-HU   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-GB   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-ES   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-DE   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-CZ   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004654-13-BG   Argentina;Bulgaria;Canada;Czech Republic;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Spain;United Kingdom;United States
   BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION
      2021   Phase 3   EUCTR2020-000350-96-IT   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2016   Phase 3   EUCTR2015-002634-41-PL   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-HU   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-DE   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2016   Phase 3   EUCTR2015-002634-41-BG   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
      2015   Phase 3   EUCTR2015-002634-41-ES   Bulgaria;Chile;Estonia;Germany;Hungary;Korea, Republic of;Malaysia;Poland;Russian Federation;Serbia;Spain;Thailand;Ukraine;United States
   Bristol-Myers Squibb International Corporation
      2022   Phase 3   EUCTR2020-000350-96-DE   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-PL   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-FR   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-ES   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2021   Phase 3   EUCTR2020-000350-96-CZ   Argentina;Australia;Czech Republic;Czechia;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Switzerland;Taiwan;United Kingdom;United States
      2016   Phase 3   EUCTR2015-001275-50-RO   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-NL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2016   Phase 3   EUCTR2015-001275-50-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-SE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-GB   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-FI   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2015   Phase 3   EUCTR2015-001275-50-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Qatar;Romania;Russian Federation;Saudi Arabia;Singapore;South Africa;Spain;Sweden;Taiwan;United Arab Emirates;United Kingdom
      2014   -   EUCTR2013-003780-65-IT   Argentina;Australia;Canada;Czech Republic;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2014   -   EUCTR2013-003780-65-HU   Argentina;Australia;Canada;France;Hungary;Italy;Japan;Mexico;South Africa;United States
      2011   -   EUCTR2010-023956-99-NL   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-HU   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-ES   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-DE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-CZ   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
      2011   -   EUCTR2010-023956-99-BE   Argentina;Belgium;Brazil;Canada;Czech Republic;France;Germany;Hungary;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Peru;Russian Federation;South Africa;Spain;Taiwan;United States
   Celltrion, Inc
      2019   Phase 3   EUCTR2018-001690-25-LT   Bulgaria;Hungary;Lithuania;Peru;Poland;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-PL   Bosnia and Herzegovina;Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-HU   Bosnia and Herzegovina;Bulgaria;Hungary;Lithuania;Peru;Poland;Russian Federation;Ukraine
      2018   Phase 3   EUCTR2018-001690-25-BG   Bulgaria;Hungary;Korea, Republic of;Lithuania;Peru;Poland;Ukraine
      2017   Phase 1;Phase 3   EUCTR2016-002125-11-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-LV   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-HU   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-EE   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
   Cliniques Universitaires Saint-Luc, Université catholique de Louvain
      2015   Phase 4   EUCTR2015-001246-28-BE   Belgium
   Cliniques universitaires Saint-Luc
      2020   Phase 4   EUCTR2019-003138-17-BE   Belgium
   Coherus BioSciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-PL   Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-GB   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Coherus BioSciences, Inc.
      2015   Phase 3   EUCTR2015-000665-30-GB   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-ES   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
      2015   Phase 3   EUCTR2015-000665-30-DE   Australia;Canada;France;Germany;Israel;Italy;Japan;South Africa;Spain;United Kingdom
   Coherus Biosciences, Inc
      2014   Phase 3   EUCTR2014-000443-33-IT   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-HU   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-ES   Argentina;Belarus;Brazil;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000443-33-DE   Argentina;Belarus;France;Germany;Hungary;Israel;Italy;Japan;Poland;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Eli Lilly and Company
      2020   Phase 3;Phase 4   EUCTR2018-003351-37-FR   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-RO   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-PL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-NL   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-LT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-HU   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GR   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-GB   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DK   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-DE   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-CZ   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-BE   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-AT   Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fresenius Kabi SwissBioSim GmbH
      2021   Phase 3   EUCTR2019-004369-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2020   Phase 3   EUCTR2019-004369-42-SK   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-PL   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-HU   Bulgaria;Czech Republic;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2020   Phase 3   EUCTR2019-004369-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
   Fujifilm Kyowa Kirin Biologics Co., Ltd.
      2015   Phase 3   EUCTR2014-000110-61-ES   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-DE   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2015   Phase 3   EUCTR2014-000110-61-CZ   Bulgaria;Canada;Chile;Czech Republic;Germany;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
   Fundación Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
      2020   Phase 4   EUCTR2018-004558-30-PT   Belgium;Denmark;Portugal;Spain
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   Genentech, Inc.
      2016   Phase 2   EUCTR2016-000335-40-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Korea, Republic of;Mexico;Poland;Russian Federation;Serbia;Ukraine;United States
   Ghent University Hospital
      2012   Phase 3   EUCTR2009-017998-37-BE   Belgium
   Gilead Sciences, Inc.
      2017   Phase 2   EUCTR2016-000897-39-HU   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
      2017   Phase 2   EUCTR2016-000897-39-DE   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
      2017   Phase 2   EUCTR2016-000897-39-BE   Australia;Belgium;Germany;Hungary;Mexico;Taiwan;United States
   GlaxoSmithKline Research & Development Limited
      2021   Phase 3   EUCTR2019-000878-30-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LV   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-LT   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-CZ   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BG   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000878-30-BE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      -   Phase 3   EUCTR2019-000878-30-EE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;France;Germany;Hungary;India;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Thailand;Ukraine;United Kingdom;United States
   Groupement des Hôpitaux de l’Institut Catholique de Lille
      2017   Phase 4   EUCTR2017-000947-41-FR   France
   Hexal, AG
      2016   Phase 3   EUCTR2015-003433-10-RO   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-HU   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-GB   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-ES   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-DE   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003433-10-CZ   Czech Republic;France;Germany;Hungary;Italy;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;United Kingdom;United States
   Janssen-Cilag International N.V.
      2015   Phase 3   EUCTR2012-001176-10-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2012-001176-10-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2010-022243-38-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2010-022242-24-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
      2012   -   EUCTR2010-022243-38-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022243-38-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Serbia;Spain;Sweden;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022242-24-LT   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   King’s College London
      2014   Phase 2   EUCTR2013-003413-18-GB   Netherlands;United Kingdom
   Leiden University Medical Center
      2018   Phase 4   EUCTR2017-002878-38-NL   Netherlands
      2017   Phase 2   EUCTR2013-003413-18-NL   Netherlands;United Kingdom
   Lilly S.A
      2019   Phase 3;Phase 4   EUCTR2018-003351-37-ES   Australia;Austria;Belgium;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   MedImmune Limited
      2013   Phase 2   EUCTR2011-005649-10-GB   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   MedImmune Ltd
      2013   -   EUCTR2011-005649-10-SK   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-PT   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-HU   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-DE   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-CZ   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-GR   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-ES   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   Merck KGaA
      2017   Phase 3   EUCTR2016-002852-26-GB   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-002852-26-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2017   Phase 3   EUCTR2016-002852-26-BG   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
      2016   Phase 3   EUCTR2016-002852-26-LT   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-HU   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom;United States
      2016   Phase 3   EUCTR2016-002852-26-CZ   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United Kingdom
   NHS Greater Glasgow and Clyde
      2015   Phase 4   EUCTR2014-004419-35-GB   United Kingdom
   Novartis Farma S.p.A.
      2013   -   EUCTR2013-000944-25-IT   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
   Novartis Farmaceutica, S.A.
      2012   -   EUCTR2012-002760-27-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma AG
      2012   -   EUCTR2012-002760-27-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-PT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2011-006058-94-GR   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
   Novartis Pharma Services AG
      2013   -   EUCTR2012-002760-27-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma Services AG
      2013   -   EUCTR2013-000944-25-HU   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
      2013   -   EUCTR2011-006058-94-DE   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2012-002760-27-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-CZ   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
   Pfizer Inc
      2020   Phase 4   EUCTR2019-000284-24-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
      2019   Phase 3   EUCTR2019-000284-24-LT   Argentina;Bosnia and Herzegovina;Bulgaria;Czech Republic;Lithuania;Mexico;Peru;Poland;Russian Federation;Serbia;South Africa;Ukraine;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2014-000352-29-HR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-FR   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-EE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2015   Phase 3   EUCTR2014-000352-29-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2014-000352-29-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-ES   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2014-000352-29-CZ   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom
      2013   -   EUCTR2012-003644-71-ES   Australia;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Israel;Netherlands;Russian Federation;Spain
      2013   Phase 4   EUCTR2012-003644-71-BE   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;New Zealand;Poland;Russian Federation;Spain
   Pfizer Inc., 235 EAst 42nd Street, New York, NY 10017, United States
      2013   -   EUCTR2012-003644-71-NL   Australia;Belgium;Chile;Colombia;France;Hong Kong;Israel;Netherlands;Russian Federation;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2015   Phase 3   EUCTR2013-004569-16-SK   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-HU   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-HR   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-GR   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
      2015   Phase 3   EUCTR2013-004569-16-BG   Bulgaria;Colombia;Croatia;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;Slovakia;South Africa
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-PL   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-LT   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005026-30-HU   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-CZ   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-BG   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
   Sanofi
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   UCB Pharma SA
      2015   -   EUCTR2011-002067-20-FR   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;Turkey;United Kingdom;United States
      2013   -   EUCTR2011-002067-20-GR   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-PT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-IE   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-HU   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-GB   Australia;Austria;Bulgaria;Canada;Czech Republic;European Union;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-ES   Australia;Austria;Bulgaria;Canada;Czech Republic;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-DE   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-CZ   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 4   EUCTR2011-002067-20-BG   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-002067-20-AT   Australia;Austria;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Ireland;Italy;Mexico;Portugal;Spain;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
   University Hospitals Leuven
      2013   Phase 4   EUCTR2012-004631-22-BE   Belgium
   University Medical Center Utrecht
      2021   Phase 1;Phase 2   EUCTR2019-003620-20-NL   Netherlands
      2019   Phase 4   EUCTR2017-003037-28-NL   Netherlands
   University Medical Center Utrecht (UMCU)
      2016   Phase 4   EUCTR2015-004858-17-NL   Netherlands
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
   University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine
      2015   Phase 4   EUCTR2013-002777-22-IT   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-HU   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-ES   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2014   Phase 4   EUCTR2013-002777-22-DK   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-GB   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
      2013   Phase 4   EUCTR2013-002777-22-DE   Denmark;France;Germany;Hungary;Italy;Japan;Spain;United Kingdom
   University of Southern Denmark
      2021   Phase 1;Phase 2   EUCTR2020-005998-27-DK   Denmark
   Universitätsklinikum Erlangen
      2023   Phase 1;Phase 2   EUCTR2021-006669-40-DE   Germany
      2019   Phase 2   EUCTR2018-003877-91-DE   Germany
      2017   Phase 3   EUCTR2014-000555-93-ES   Brazil;Czech Republic;Germany;Spain
      2015   Phase 3   EUCTR2013-000337-13-PT   Germany;Portugal;Serbia;United States
      2013   Phase 3   EUCTR2013-000337-13-DE   Germany;Portugal;Serbia
   Wyeth Pharmaceuticals France
      2008   -   EUCTR2006-006591-37-GR   Austria;Greece
      2008   -   EUCTR2006-006591-37-AT   Austria;Greece
      2007   -   EUCTR2006-006591-37-BE   Austria;Belgium;Greece
      2007   -   EUCTR2006-005137-38-SE   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   Phase 3   EUCTR2006-005137-38-GB   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-FI   Denmark;Finland;France;Germany;Sweden;United Kingdom
      2007   -   EUCTR2006-005137-38-DK   Denmark;Finland;France;Germany;Sweden;United Kingdom
   YL Biologics Ltd
      2016   Phase 3   EUCTR2015-002809-12-BG   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-LV   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-HU   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-ES   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-CZ   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
   medac Gesellschaft für klinische Spezialpräparate mbH
      2012   -   EUCTR2012-000222-21-DE   Germany
   sanofi-aventis Recherche & Développement
      2014   Phase 3   EUCTR2012-004339-21-PL   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2014   Phase 3   EUCTR2010-019262-86-SE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-NO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-AT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-LT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-FI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2014   -   EUCTR2013-002790-22-HU   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   -   EUCTR2013-002790-22-EE   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2013-002790-22-CZ   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2011-003538-16-SK   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-LT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-GR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2011   -   EUCTR2009-016266-90-PT   Argentina;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   Phase 2;Phase 3   EUCTR2009-016266-90-BE   Argentina;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   -   EUCTR2009-016266-90-AT   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-HU   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-FI   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-DE   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
Pred
   Qilu Hospital of Shandong University
      2020   Phase 4   NCT04928066   China
      2016   Phase 4   NCT03855007   China
Pred + meth
   Hamad Medical Corporation
      2012   Phase 3   NCT01724268   Qatar
Prednihexal
   AstraZeneca AB
      2017   Phase 2   EUCTR2017-000838-64-SE   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-NL   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-DK   Denmark;Netherlands;Sweden
Prednihexal® 5MG tabletten, prednihexal® 10MG tabletten
   Ruhr-Universität Bochum
      2013   Phase 3   EUCTR2012-004074-25-DE   Germany
Prednihexal® 5MG tabletten, prednihexal® 20MG tabletten
   Ruhr-Universität Bochum
      2013   Phase 3   EUCTR2012-004074-25-DE   Germany
Predniso
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
Prednisolene tablets BP 1 MG
   COMBINATORX, INC
      2005   Phase 2   EUCTR2004-004995-35-IT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
Prednisolon
   Ruhr-Universität Bochum
      2013   Phase 3   EUCTR2012-004074-25-DE   Germany
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Prednisolon pfizer
   Karolinska Universitetssjukhuset
      2021   Phase 4   EUCTR2020-005096-12-SE   Sweden
Prednisolone
   Amsterdam UMC, location VUmc
      2016   Phase 4   NCT02585258   Finland;Germany;Hungary;Italy;Netherlands;Portugal;Romania;Slovakia
   AstraZeneca
      2018   Phase 2   NCT03368235   Denmark;Netherlands;Sweden
      2015   Phase 1   NCT02512575   Germany
   AstraZeneca AB
      2017   Phase 2   EUCTR2017-000838-64-SE   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-NL   Denmark;Netherlands;Sweden
      2017   Phase 2   EUCTR2017-000838-64-DK   Denmark;Netherlands;Sweden
   COMBINATORX, INC
      2005   Phase 2   EUCTR2004-004995-35-IT   Austria;Czech Republic;Denmark;Germany;Italy;United Kingdom
   Cinnagen
      2015   Phase 3   NCT03172325   Iran, Islamic Republic of
   CombinatoRx, Inc.
      2005   -   EUCTR2004-004995-35-DE   Czech Republic;Denmark;Germany;Italy;United Kingdom
   CombinatoRx, Incorporated
      2008   -   EUCTR2007-004399-38-LT   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-GB   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-004399-38-EE   Estonia;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-LT   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-HU   Estonia;Hungary;Lithuania;United Kingdom
      2008   -   EUCTR2007-003069-42-GB   Estonia;Hungary;Lithuania;United Kingdom
      2007   -   EUCTR2007-003069-42-EE   Estonia;Hungary;Lithuania;United Kingdom
   Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University
      2013   -   JPRN-UMIN000010126   Japan
   GlaxoSmithKline
      2006   Phase 2   NCT00379990   Serbia;United Kingdom
      2005   Phase 2   NCT00134693   Australia;France;Germany;Russian Federation;United Kingdom
   GlaxoSmithKline Research & Development Limited
      2005   Phase 2   EUCTR2005-001977-82-GB   United Kingdom
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
      2015   Phase 4   NCT02644499   India
   Karolinska Universitetssjukhuset
      2021   Phase 4   EUCTR2020-005096-12-SE   Sweden
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   Prof. Dr. rer. nat. H.J. Trampisch
      2014   Phase 3   NCT02000336   Germany
   Rheumazentrum Ruhrgebiet
      2012   Phase 2/Phase 3   NCT01395251   Germany
      2011   -   EUCTR2011-002633-19-DE   Germany
   Ruhr-Universität Bochum
      2013   Phase 3   EUCTR2012-004074-25-DE   Germany
   Sun Pharma Global FZE
      2016   Phase 3   EUCTR2015-002924-17-BE   Belgium;Netherlands
      2015   Phase 3   EUCTR2015-002924-17-NL   Belgium;Netherlands
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Trafford NHS Trust
      2008   -   EUCTR2007-006729-28-GB   United Kingdom
   University Medical Center Utrecht
      2019   Phase 4   EUCTR2017-003037-28-NL   Netherlands
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
   Zalicus
      2011   Phase 2   NCT01369745   United States
      2007   Phase 2   NCT00551707   Argentina;Canada;Estonia;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Serbia;South Africa;United States
   Zalicus, Inc.
      2012   -   EUCTR2011-002392-41-HU   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2012   -   EUCTR2011-002392-41-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-PL   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-HU   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-BG   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
Prednisolone & dipyridamole
   CombinatoRx, Inc
      2006   -   EUCTR2004-001930-18-EE   Estonia
Prednisolone 20 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
Prednisolone 40 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
Prednisolone 5 MG
   AstraZeneca
      2016   Phase 1   NCT02760316   Germany;United Kingdom
Prednisolone labesfal
   VU University Medical Center
      2016   Phase 4   EUCTR2015-002729-21-SK   Finland;Germany;Hungary;Portugal;Slovakia
      2016   Phase 4   EUCTR2015-002729-21-PT   Finland;Germany;Hungary;Portugal;Slovakia
      2016   Phase 4   EUCTR2015-002729-21-HU   Finland;Germany;Hungary;Portugal;Slovakia
      2016   Phase 4   EUCTR2015-002729-21-FI   Finland;Germany;Hungary;Portugal;Slovakia
      2016   Phase 4   EUCTR2015-002729-21-DE   Finland;Germany;Hungary;Portugal;Slovakia
Prednisolone tablets BP
   GlaxoSmithKline Research & Development Ltd
      2005   Phase 2   EUCTR2004-005115-29-GB   Germany;United Kingdom
Prednisolone tablets BP 1 MG
   CombinatoRx, Inc.
      2005   -   EUCTR2004-004995-35-CZ   Czech Republic;Denmark;Germany;Italy;United Kingdom
Prednisolone tablets USP 5 MG
   GlaxoSmithKline Research & Development Limited
      2005   Phase 4   EUCTR2005-000902-30-GB   United Kingdom
Prednisolone-dipyridamole
   Zalicus
      2012   Phase 2   NCT01612377   Serbia
Prednison
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
Prednisone
   CHU de Bordeaux
      2021   Phase 3   EUCTR2020-004345-37-FR   France;Monaco
      2019   Phase 2   EUCTR2018-004287-56-FR   France
   Central Hospital of Jinhua
      2014   Phase 4   ChiCTR1900026116   China
   Fairview University Medical Center
      2000   -   NCT00006055   United States
   Hoffmann-La Roche
      2016   Phase 4   NCT02573012   Egypt;France;Germany;Italy;Russian Federation;Serbia;Switzerland;Tunisia;Turkey
   Horizon Pharma Ireland, Ltd., Dublin Ireland
      2014   -   NCT02287610   -
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Merck KGaA
      2009   -   NCT01075711   Germany
   Narrows Institute for Biomedical Research
      2011   Phase 4   NCT04169100   United States
   Nitec Pharma AG
      2008   -   EUCTR2007-003508-36-HU   Germany;Hungary;United Kingdom
      2008   Phase 3   EUCTR2007-003508-36-GB   Germany;Hungary;United Kingdom
      2008   -   EUCTR2007-003508-36-DE   Germany;Hungary;United Kingdom
   OSPEDALE POLICLINICO S. MATTEO
      2006   -   EUCTR2006-003843-22-IT   Italy
   P. Verschueren
      2009   Phase 4   NCT01172639   Belgium
   Pfizer
      2011   Phase 2   NCT01393639   Bulgaria;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2008   Phase 2   NCT00634933   Austria;Belgium;Canada;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia;United States
   Pfizer Inc.
      2009   Phase 2   EUCTR2009-013223-37-CZ   Czech Republic;Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-023782-22-CZ   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2009   -   EUCTR2009-013223-37-HU   Hungary;Spain
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2011   -   EUCTR2010-023782-22-DE   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer Inc.235 East 42nd Street, New York, NY 10017
      2012   -   EUCTR2010-023782-22-SK   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-HU   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
      2011   -   EUCTR2010-023782-22-BG   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Pfizer S.A.
      2009   Phase 2   EUCTR2009-013223-37-ES   Czech Republic;Hungary;Spain
   Pfizer, S.L.U.
      2011   -   EUCTR2010-023782-22-ES   Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United States
   Qilu Hospital of Shandong University
      2021   -   NCT05651373   China
   RenJi Hospital
      2020   -   NCT04569890   China
   TIPharma
      2007   -   EUCTR2007-002976-32-NL   Netherlands
   United Bristol Healthcare NHS Trust
      2006   Phase 2   EUCTR2005-004385-16-GB   United Kingdom
   University Medical Center Utrecht
      2019   Phase 4   EUCTR2017-003037-28-NL   Netherlands
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of South Florida
      2007   Phase 2/Phase 3   NCT00580229   United States
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
   Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc.
      2009   -   EUCTR2007-006150-25-DE   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
      2008   -   EUCTR2007-006150-25-HU   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-006150-25-NL   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-FR   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-BE   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   -   EUCTR2007-006150-25-AT   Austria;Belgium;France;Germany;Hungary;Netherlands
   Zalicus
      2012   Phase 2   NCT01612377   Serbia
      2011   Phase 2   NCT01369745   United States
   Zalicus, Inc.
      2012   -   EUCTR2011-002392-41-HU   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2012   -   EUCTR2011-002392-41-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-PL   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-HU   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-BG   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
   Zhejiang Chinese Medical University
      2021   -   ChiCTR2100048802   China
Prednisone 1 MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
Prednisone 15 MG
   Merck Sharp & Dohme Corp.
      2008   Phase 1   NCT00746512   United Kingdom
Prednisone 2 MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
Prednisone 3 MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
Prednisone 4 MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
Prednisone 5 MG
   CHU Toulouse
      2016   Phase 4   EUCTR2016-001618-18-FR   France
   Pfizer
      2009   Phase 2   NCT00938587   Czech Republic;Czechia;Hong Kong;Hungary;Korea, Republic of;Russian Federation;Serbia;Singapore;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
Prednisone 7.5 MG
   Merck Sharp & Dohme Corp.
      2008   Phase 1   NCT00746512   United Kingdom
Prednisone acetate
   The First Affiliated Hospital of Yunnan University of Chinese Medicine
      2023   Phase 0   ChiCTR2300071123   China
   Yunnan Hospital of Traditional Chinese Medicine /The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2021   Phase 0   ChiCTR2100041777   China
   Yunnan Provincial Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
      2023   Phase 0   ChiCTR2300067676   China
   Yunnan Traditional Chinese Medicine Hospital
      2021   Phase 0   ChiCTR2100041909   China
Prednisone tablets USP, 1 MG
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
Prednisone tablets USP, 5 MG
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
Pregabalin
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
Prevenar 13
   Department of Infectious Diseases, Odense University Hospital
      2014   Phase 3   EUCTR2014-001299-79-DK   Denmark
   University Hospital, Montpellier
      2013   Phase 3   NCT01942174   France;Monaco
Prevenar vaccination
   Region Skane
      2008   Phase 4   NCT00828997   Sweden
Prevenar vaccine
   Dept of Rheumatology, Lund University Hospital, Lund, Sweden
      2008   -   EUCTR2007-006539-29-SE   Sweden
Previously known AS R935788
   AstraZeneca AB
      2011   Phase 2   EUCTR2010-023692-26-SK   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-HU   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   Phase 2   EUCTR2010-023692-26-GB   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-CZ   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      2011   -   EUCTR2010-023692-26-BG   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
      -   -   EUCTR2010-023692-26-DE   Bulgaria;Canada;Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Ukraine;United Kingdom;United States
Primus
   Tornier, Inc.
      2013   -   NCT02350881   Italy
PRO283698
   Genentech, Inc.
      2009   Phase 1   NCT00888745   Hungary;United Kingdom;United States
Probiotic capsules containing lactobacillus rhamnosus GR-1 and L. reuteri RC-14
   Lawson Health Research Institute
      2008   -   NCT00664820   Canada
Progressive spacing OF TNF-blocker injections
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 4   NCT00780793   France
Propofol
   Helsinki University Central Hospital
      2016   Phase 4   EUCTR2016-002035-15-FI   Finland
Propolipid
   Helsinki University Central Hospital
      2016   Phase 4   EUCTR2016-002035-15-FI   Finland
Proposed INN - filgotinib
   Galapagos NV
      2017   Phase 2   EUCTR2012-003655-11-FR   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
Propsoed INN - filgotinib
   Galapagos NV
      2014   -   EUCTR2012-003654-86-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2014   -   EUCTR2012-003654-86-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003654-86-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-LV   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-ES   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-DE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
      2013   -   EUCTR2012-003635-31-BE   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;France;Germany;Guatemala;Hungary;Israel;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States
Protein
   Affiliated Hospital of North Sichuan Medical College
      2018   -   ChiCTR1800018637   China
   FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA (VHIR)
      2018   Phase 4   EUCTR2018-002368-18-ES   Spain
   Johns Hopkins University
      2014   -   NCT02078375   United States
   Zhongda Hospital Southeast University
      2023   -   ChiCTR2400082686   China
Proximod
   Longevity Inc.
      2021   Phase 1   NCT06361199   China
      2017   Phase 1   NCT06361186   China
PRTX-100
   Protalex, Inc.
      2015   Phase 1/Phase 2   NCT02330445   United States
PRTX-100 AT 1.5 MCG/KG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
PRTX-100 AT 12.0 MCG/KG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
PRTX-100 AT 240 MCG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
PRTX-100 AT 3.0 MCG/KG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
PRTX-100 AT 420 MCG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
PRTX-100 AT 6.0 MCG/KG
   Protalex, Inc.
      2012   Phase 1   NCT01749787   United States
Psyllium husks
   Wuerzburg University Hospital
      2024   -   NCT06492200   Germany
Puerarin injection 400 MG
   Chengdu PLA General Hospital
      2014   -   NCT02264301   China
      2013   Phase 2   NCT02254655   China
Puerarin tablet 50 MG
   Chengdu PLA General Hospital
      2014   -   NCT02219191   China
QAL964
   Novartis Pharma Services AG
      2014   -   EUCTR2013-003493-27-HU   Hungary;Russian Federation;Ukraine
      2014   -   EUCTR2013-003493-27-GR   Greece;Hungary;Romania;Russian Federation;Ukraine
Qalcimum questionnaire
   Centre Hospitalier Universitaire de Nimes
      2016   -   NCT02636829   France
Qing RE HUO XUE (qrhx) granule
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2019   Phase 2/Phase 3   NCT04170504   China
Qingkailing injection 40 ML
   Chengdu PLA General Hospital
      2014   -   NCT02264301   China
QLS12010
   Shanghai Qilu Pharmaceutical Research and Development Center LTD
      2025   Phase 1   NCT06946641   China
Quantiferon-TB gold assay
   Ospedale L. Sacco – Polo Universitario
      2007   -   NCT00491933   Italy
Quensyl
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
R-2487
   Rise Therapeutics LLC
      2023   Phase 1   NCT05961592   United States
R788
   Rigel Pharmaceuticals
      2006   Phase 2   NCT00326339   Mexico;United States
R788 sodium hexahydrate, RIG2-01, RIG-G
   AstraZeneca AB
      2012   -   EUCTR2011-006070-73-DE   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-CZ   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-BG   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
R788 sodium, R788 NA, R788
   AstraZeneca AB
      2009   -   EUCTR2008-000744-13-BG   Belgium;Bulgaria;Colombia;France;Germany;Italy;Mexico;Peru;Poland;Romania;United States
      2008   Phase 2   EUCTR2008-000744-13-BE   Belgium;Bulgaria;France;Germany;Italy
      -   -   EUCTR2008-000744-13-DE   Belgium;Bulgaria;France;Germany;Italy
   Rigel Pharmaceuticals, Inc
      2009   -   EUCTR2008-000744-13-FR   Bulgaria;France;Germany;Italy
   Rigel Pharmaceuticals, Inc.
      2008   Phase 2   EUCTR2008-000743-34-FR   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000743-34-DE   France;Germany;Italy
      2008   -   EUCTR2008-000743-34-BE   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000742-30-PL   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-HU   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-BG   Bulgaria;Hungary;Poland
R935788
   AstraZeneca
      2008   Phase 2   NCT00805467   Belgium;Bulgaria;Colombia;France;Germany;Italy;Mexico;Peru;Poland;Romania;United States
   AstraZeneca AB
      2012   -   EUCTR2011-006070-73-DE   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-CZ   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2012   -   EUCTR2011-006070-73-BG   Argentina;Brazil;Bulgaria;Czech Republic;Germany;Mexico;Peru;Poland;South Africa;Ukraine;United States
      2009   -   EUCTR2008-000744-13-BG   Belgium;Bulgaria;Colombia;France;Germany;Italy;Mexico;Peru;Poland;Romania;United States
      2008   Phase 2   EUCTR2008-000744-13-BE   Belgium;Bulgaria;France;Germany;Italy
      -   -   EUCTR2008-000744-13-DE   Belgium;Bulgaria;France;Germany;Italy
   RIGEL PHARMACEUTICALS INC
      2009   -   EUCTR2008-000744-13-IT   Bulgaria;France;Germany;Italy
      2008   -   EUCTR2008-000743-34-IT   France;Germany;Italy
   Rigel Pharmaceuticals
      2008   Phase 2   NCT00665925   Bulgaria;Colombia;Israel;Mexico;Poland;Romania;United States
      2008   Phase 2   NCT00665626   Belgium;Brazil;Colombia;France;Germany;Italy;Peru;United States
   Rigel Pharmaceuticals, Inc
      2009   -   EUCTR2008-000744-13-FR   Bulgaria;France;Germany;Italy
   Rigel Pharmaceuticals, Inc.
      2008   Phase 2   EUCTR2008-000743-34-FR   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000743-34-DE   France;Germany;Italy
      2008   -   EUCTR2008-000743-34-BE   Belgium;France;Germany;Italy
      2008   -   EUCTR2008-000742-30-PL   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-HU   Bulgaria;Hungary;Poland
      2008   -   EUCTR2008-000742-30-BG   Bulgaria;Hungary;Poland
Rabeximod
   Cyxone AB
      2022   Phase 2   EUCTR2021-006665-38-PL   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United States
      2022   Phase 2   EUCTR2021-006665-38-HU   Bosnia and Herzegovina;Bulgaria;Georgia;Hungary;Moldova, Republic of;Poland;Serbia;United States
Radiofrequency
   Assiut University
      2019   -   NCT03852355   Egypt
Raloxifene hydrochloride
   Sara Saeidi Shahri
      2016   -   NCT02982083   -
Ramelteon
   Shunichi Shiozawa
      2013   -   JPRN-UMIN000018816   Japan
Ramipril
   University of Zurich
      2004   Phase 2/Phase 3   NCT00273533   Switzerland
Rapamycin
   the Second Hospital of Shanxi Medical University
      2017   -   ChiCTR-IPR-17010307   China
Raptiva 100 MG/ML powder and solvent FOR solution FOR injection
   Merck Serono International S.A.
      2009   -   EUCTR2007-001377-28-PT   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-NL   Austria;France;Germany;Netherlands;Portugal
      2008   Phase 4   EUCTR2007-001377-28-FR   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-DE   Austria;France;Germany;Netherlands;Portugal
      2008   -   EUCTR2007-001377-28-AT   Austria;France;Germany;Netherlands;Portugal
Ravagalimab
   AbbVie
      2025   Phase 2   NCT06972446   -
RC18 160 MG plus MTX
   RemeGen
      2015   Phase 2   NCT02882087   China
   RemeGen Co., Ltd.
      2017   Phase 3   NCT03016013   China
REAL-time data capture APP
   GlaxoSmithKline
      2017   -   NCT03285191   United Kingdom
Rebamipide
   Korea Otsuka Pharmaceutical Co.,Ltd.
      2007   Phase 3   NCT00576706   Korea, Republic of
   October 6 University
      2024   Phase 1/Phase 2   NCT05166304   Egypt
   Seoul National University Boramae Hospital
      2021   Phase 4   NCT04885751   -
Recombinant factor FC fusion protein
   Amgen Inc
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-ES   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
      2018   Phase 1;Phase 2   EUCTR2017-001944-36-BG   Australia;Bulgaria;Czech Republic;Germany;Mexico;New Zealand;Poland;Romania;Spain;United Kingdom;United States
Recombinant human anti IL-22 monoclonal antibody IGG1
   Wyeth Pharmaceuticals Inc., acting through its division Wyeth Research, a Pfizer company
      2009   -   EUCTR2008-006936-37-DE   Belgium;Germany;Hungary;Netherlands
   Wyeth Research Division of Wyeth Pharmaceuticals Inc, Clinical Research and Development
      2009   -   EUCTR2008-006936-37-NL   Belgium;Germany;Hungary;Netherlands
      2009   -   EUCTR2008-006936-37-HU   Belgium;Germany;Hungary;Netherlands
      2009   Phase 2   EUCTR2008-006936-37-BE   Belgium;Germany;Hungary;Netherlands
Recombinant human MAB OF IGG4 subtype
   UCB Biosciences Inc
      2011   -   EUCTR2010-022224-77-GB   Belgium;United Kingdom;United States
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
   UCB Biosciences, Inc.
      2011   Phase 2   EUCTR2010-022224-77-BE   Belgium;United Kingdom;United States
   UCB Biosciences, Inc. A Member of the UCB Group of Companies
      2011   Phase 2   EUCTR2010-020839-39-BE   Belgium;United Kingdom;United States
   UCB Celltech
      2009   -   EUCTR2009-010813-57-DE   Germany
Recombinant human monoclonal antibody
   Newcastle-upon-Tyne Hospitals NHS Foundation Trust
      2007   Phase 4   EUCTR2006-006127-40-GB   United Kingdom
Recombinant human monoclonal antibody TO inerleukin-1beta OF THE IGG1-K-class
   Novartis Farmacéutica S.A.
      2009   Phase 2   EUCTR2008-005320-81-ES   Austria;Belgium;Germany;Spain
   Novartis Pharma Services AG
      2009   -   EUCTR2008-005320-81-BE   Austria;Belgium;Germany;Spain
      2008   -   EUCTR2008-005320-81-AT   Austria;Germany;Spain
Recombinant human monoclonal antibody TO interleukin-1beta OF THE IGG1-kappa-class
   Novartis Pharma Services AG
      2009   -   EUCTR2008-005320-81-DE   Austria;Germany;Spain
Recombinant humanised ANTI-human monoclonal antibody directed against THE IL-6R
   Roche Products Limited
      2013   Phase 3   EUCTR2013-000054-22-GB   United Kingdom
Recombinant humanized ANTI-human interleukin 6-receptor (IL-6R) monoclonal
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
Recombinant humanized ANTI-human interleukin 6-receptor (IL-6R) monoclonal antibody
   F. Hoffmann-La Roche Ltd.
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
Recombinant humanized ANTI-human interleukin-6
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-GR   Bulgaria;Greece;Hungary;Spain
      2011   Phase 3   EUCTR2010-019912-18-ES   Bulgaria;Greece;Hungary;Spain
Recombinant humanized ANTI-human interleukin-6 receptor (IL-6R) monoclonal antibody
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
Recombinant humanized ANTI-human monoclonal antibody directed against THE IL-6R
   Roche a/s
      2014   Phase 3   EUCTR2013-002007-34-SE   Denmark;Finland;Sweden
      2014   Phase 3   EUCTR2013-002007-34-FI   Denmark;Finland;Sweden
      2013   Phase 3   EUCTR2013-002007-34-DK   Denmark;Finland;Sweden
Recombinant humanized ANTI-interleukin-6 receptor monoclonal antibody injection
   Beijing VDJBio Co., LTD.
      2025   Phase 3   NCT06726096   China
   Xiaoming Gong
      2022   Phase 2   NCT05957107   China
Recombinant humanized monoclonal antibody TO IL-6R
   CELLTRION, Inc.
      2023   Phase 3   EUCTR2022-002928-12-PL   Poland
      2022   Phase 3   EUCTR2022-001066-36-PL   Poland
Recombinant TNF-A receptor: IGG FC fusion protein
   Zhejiang Hisun Pharmaceutical Co. Ltd.
      2018   -   NCT03636984   -
Reditux
   Dr. Reddy’s Laboratories S.A.
      2020   Phase 3   EUCTR2019-002810-37-PL   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-LT   Bulgaria;Czechia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-HU   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-DE   Bulgaria;Czech Republic;Germany;Hungary;Lithuania;Poland;United States
      2020   Phase 3   EUCTR2019-002810-37-BG   Bulgaria;Czech Republic;Estonia;Germany;Hungary;Lithuania;Poland;United States
Reduction group 1
   University of Erlangen-Nürnberg Medical School
      2009   Phase 3   NCT02779114   Germany
Reduction group 2
   University of Erlangen-Nürnberg Medical School
      2009   Phase 3   NCT02779114   Germany
Refered TO general practice
   MD, PhD, Annemarie Lyng Svensson
      2014   -   NCT02246257   Denmark
Reference medicinal product
   Dr. Reddy's Laboratories Limited
      2023   Phase 1   NCT06126042   United States
Reference product
   Dr. Reddy's Laboratories Limited
      2023   Phase 1   NCT06126042   United States
REGN88
   Regeneron Pharmaceuticals
      2008   Phase 1   NCT01055899   United States
      2008   Phase 1   NCT01026519   Russian Federation
      2008   Phase 1   NCT01011959   United States
   Sanofi
      2018   -   NCT03378219   Canada;United States
      2015   Phase 1   NCT02404558   Japan
      2014   Phase 3   NCT02293902   Japan
      2014   Phase 3   NCT02121210   Chile;Czech Republic;Czechia;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 1   NCT02017639   Korea, Republic of;Moldova, Republic of;United States
      2013   Phase 1   NCT01850680   Japan
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 1   NCT01328522   United States
      2010   Phase 3   NCT01146652   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   sanofi-aventis Recherche & Développement
      2014   Phase 3   EUCTR2012-004339-21-PL   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2014   Phase 3   EUCTR2010-019262-86-SE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-NO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-AT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-LT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-FI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002790-22-HU   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   -   EUCTR2013-002790-22-EE   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2013-002790-22-CZ   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   -   EUCTR2009-016266-90-AT   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-HU   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-FI   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-DE   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
Remicade
   AESCA Pharma Ges.m.b.H
      2005   -   EUCTR2005-004530-40-AT   Austria
   Amgen Inc.
      2016   Phase 3   EUCTR2014-004704-29-PL   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-HU   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-ES   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-DE   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-CZ   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
      2016   Phase 3   EUCTR2014-004704-29-BG   Australia;Bulgaria;Canada;Czech Republic;Germany;Hungary;Poland;Romania;Spain;United States
   Biocad
      2016   Phase 3   NCT02762838   Belarus;India;Russian Federation
   Bristol Myers Squibb International Corporation
      2005   -   EUCTR2004-000922-59-DK   Czech Republic;Denmark;Spain;Sweden
      2005   -   EUCTR2004-000922-59-CZ   Czech Republic;Denmark;Spain;Sweden
      2004   -   EUCTR2004-000922-59-SE   Czech Republic;Denmark;Spain;Sweden
      2004   Phase 3   EUCTR2004-000922-59-ES   Czech Republic;Denmark;Spain;Sweden
   CELLTRION, Inc
      2010   Phase 3   EUCTR2010-018646-31-SK   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-PT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LV   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-LT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Indonesia;Italy;Jordan;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine;United Kingdom
      2010   -   EUCTR2010-018646-31-IT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-GB   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-BG   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
      2010   -   EUCTR2010-018646-31-AT   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Spain;United Kingdom
   CHRU de Tours
      2007   -   EUCTR2007-002752-42-FR   France
   CHU Saint-Etienne
      2008   Phase 4   EUCTR2008-006256-22-FR   France
   Celltrion
      2018   Phase 3   NCT03707535   China
   Centocor BV
      2009   Phase 4   EUCTR2007-003288-36-GB   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2007-003288-36-ES   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-NL   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 4   EUCTR2007-003288-36-FR   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-FI   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-DE   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2007-003288-36-AT   Austria;Finland;France;Germany;Netherlands;Spain;United Kingdom
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
   Epirus Biopharmaceuticals (Switzerland) GmbH
      2016   Phase 3   NCT02683564   -
   Greater Glasgow Health Board
      2006   Phase 4   EUCTR2006-000363-28-GB   United Kingdom
   Hvidovre Hospital, Dept. Rheumatology
      2006   -   EUCTR2005-001633-14-SE   Denmark;Sweden
      2005   -   EUCTR2005-001633-14-DK   Denmark;Sweden
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Integrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp.
      2006   Phase 3   EUCTR2005-001889-13-NL   Austria;Belgium;Denmark;France;Germany;Netherlands;Portugal;Sweden
      2006   Phase 3   EUCTR2005-001889-13-GR   Austria;Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
      2006   Phase 3   EUCTR2005-001889-13-FR   Austria;Belgium;Denmark;France;Germany;Netherlands;Portugal;Sweden
      2006   -   EUCTR2005-001889-13-DK   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
      2005   -   EUCTR2005-001889-13-AT   Austria;Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
   Karolinska Institute
      2008   -   EUCTR2008-005212-40-SE   Sweden
   Kawakami Atsushi
      2020   Phase 4   JPRN-jRCTs071190030   -
   Kings College London
      2008   Phase 4   EUCTR2007-005464-26-GB   United Kingdom
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medical University of Vienna
      2012   Phase 4   NCT01638715   Austria;Czech Republic;Czechia;Russian Federation;Saudi Arabia;Switzerland
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Merck Sharp & Dohme Corp.
      2003   Phase 4   NCT00794898   -
   Nichi-Iko Pharmaceutical Co., Ltd.
      2017   Phase 3   NCT02990806   Czechia;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-PL   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-GB   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-ES   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001064-11-CZ   Czech Republic;Poland;Puerto Rico;Russian Federation;Spain;Ukraine;United Kingdom;United States
   Pfizer Inc.
      2015   Phase 3   EUCTR2013-004148-49-FR   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-PL   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-LT   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-HU   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-GB   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-DE   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-CZ   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-004148-49-BG   Argentina;Australia;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Czech Republic;European Union;France;Georgia;Germany;Guatemala;Hungary;Israel;Japan;Korea, Republic of;Lithuania;Mexico;Morocco;Peru;Philippines;Poland;Russian Federation;Serbia;South Africa;Tunisia;Ukraine;United Kingdom;United States
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Saint-Luc Universitary Hospital
      2007   Phase 3   EUCTR2007-004694-26-BE   Belgium
   Samsung Bioepis Co., Ltd.
      2013   Phase 3   NCT01936181   Bulgaria;Lithuania
      2013   -   EUCTR2012-005733-37-LV   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   -   EUCTR2012-005733-37-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-GB   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
   Schering Plough Research Institute, a Division of Schering Corporation
      2006   -   EUCTR2005-001889-13-PT   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
      2006   Phase 3   EUCTR2005-001889-13-BE   Austria;Belgium;Denmark;France;Germany;Netherlands;Portugal;Sweden
   Schering-Plough Research Institute (SPRI)
      2007   -   EUCTR2005-001889-13-DE   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
   Schering-Plough Research Institute, a division of Schering Corporation
      2005   -   EUCTR2005-001889-13-SE   Belgium;Denmark;France;Germany;Greece;Netherlands;Portugal;Sweden
   Shanghai Biomabs Pharmaceutical Co., Ltd.
      2018   Phase 3   NCT03478111   China
   University of California, Los Angeles
      2008   -   NCT00948610   United States
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
   Universitätsklinkum Erlangen
      2010   Phase 3   EUCTR2009-015740-42-DE   Germany
Remicade - 100 MG polvere PER concentrato PER infusione endovenosa 1 flacone vetro 20 ML USO EV
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
Remicade 100 MG polvo para concentrado para solucióN para perfusióN
   CELLTRION, Inc
      2010   Phase 3   EUCTR2010-018646-31-ES   Austria;Bulgaria;Italy;Latvia;Lithuania;Portugal;Slovakia;Spain;United Kingdom
Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Remicade*EV F 100MG+F 2ML
   POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
      2004   -   EUCTR2005-000492-18-IT   Italy
Remsima
   Celltrion, Inc
      2017   Phase 1;Phase 3   EUCTR2016-002125-11-ES   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-LV   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-HU   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-EE   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Estonia;Hungary;Korea, Republic of;Latvia;Lithuania;Poland;Russian Federation;South Africa;Spain;Ukraine
      2016   Phase 1;Phase 3   EUCTR2016-002125-11-BG   Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Czech Republic;Estonia;Hungary;Italy;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine
   Department of Clinical Biochemestry, Aarhus University Hospital
      2015   Phase 4   EUCTR2015-004173-32-DK   Denmark
   Mundipharma Pharmaceuticals B.V.
      2016   Phase 4   EUCTR2014-004904-31-BE   Belgium;Netherlands
      2015   Phase 4   EUCTR2014-004904-31-NL   Netherlands
   UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
      2016   Phase 4   EUCTR2016-002061-54-IT   Italy
Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning
   Diakonhjemmet Hospital AS
      2014   Phase 4   EUCTR2014-002056-40-NO   Norway
Remsima IV
   Celltrion
      2023   -   NCT05866614   France
Remsima SC
   Celltrion
      2023   -   NCT05866614   France
Repaglinide tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Repository corticotropin injection
   Arthritis Treatment Center, Maryland
      2013   Phase 4   NCT01966718   United States
Research testing performed
   University of Colorado, Denver
      2024   -   NCT06397677   United States
Resistance exercise program
   Johns Hopkins University
      2014   -   NCT02078375   United States
Response TO anakinra associated with methotrexate
   University Hospital, Rouen
      2003   -   NCT00213538   France
Response TO infliximab associated with methotrexate
   University Hospital, Rouen
      2003   -   NCT00213564   France
Revamilast
   Glenmark Pharmaceuticals Ltd. India
      2011   Phase 2   NCT01430507   India;Philippines;Poland;Sri Lanka;United Kingdom
   Glenmark Pharmaceuticals SA
      2011   -   EUCTR2011-000107-40-GB   India;Philippines;Poland;Sri Lanka;United Kingdom
RGB-03
   Gedeon Richter Plc
      2015   Phase 1;Phase 3   EUCTR2014-003255-54-CZ   Austria;Belgium;Czech Republic;Estonia;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Spain;Ukraine
   Gedeon Richter Plc.
      2015   Phase 1   NCT02371096   -
Rhumab 2h7
   F Hoffmann-La Roche Limited
      2005   Phase 1;Phase 2   EUCTR2004-002132-26-ES   Spain;United Kingdom
   F. Hoffmann-La Roche Ltd
      2010   Phase 3   EUCTR2006-005330-20-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2008   Phase 3   EUCTR2007-005759-41-GB   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005759-41-FR   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005759-41-ES   France;Germany;Italy;Spain;United Kingdom
      2008   -   EUCTR2007-005759-41-DE   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-005353-30-GB   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   -   EUCTR2006-005353-30-LT   Argentina;Australia;Austria;Brazil;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Thailand;United Kingdom;United States
      2007   -   EUCTR2006-005353-30-AT   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005330-20-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SI   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-NL   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-HU   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-DE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005147-28-GR   Austria;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-GB   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-FR   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-DE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-BE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-AT   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
Rhustoxicodendron 30
   Healthcare Homoeo Charitable Society
      2013   Phase 2   NCT01905735   India
Rhutnfr:FC
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
Ribazen
   Nuon Therapeutics, Inc.
      2009   -   EUCTR2008-006917-25-DE   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
Riboflavin
   Joseph B. Ciolino, MD
      2012   Phase 1/Phase 2   NCT01582880   United States
Rifampicin
   AstraZeneca
      2011   Phase 1   NCT01336218   United States
Rimacalib
   Dainippon Sumitomo Pharma Europe Ltd
      2005   -   EUCTR2005-003436-21-GB   Czech Republic;Germany;Hungary;United Kingdom
   Dainippon Sumitomo Pharma Europe Ltd.
      2006   -   EUCTR2005-003436-21-DE   Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-003436-21-CZ   Czech Republic;Germany;Hungary;United Kingdom
Risedronate
   Division of rheumatology, endcrinology and nephrology, Hokkaido University Graduate School of Medicine
      2014   Phase 4   JPRN-UMIN000015794   Japan
Ritlecitinib/JAK 3
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
Rituxan
   ARCHIGEN BIOTECH LIMITED
      2017   Phase 1;Phase 3   EUCTR2014-005368-13-IT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Amgen Inc
      2017   Phase 1;Phase 3   EUCTR2013-005543-90-EE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2015   Phase 1;Phase 3   EUCTR2013-005543-90-BG   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-PL   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-HU   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-DE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Archigen Biotech Limited
      2016   Phase 1   NCT02819726   Bosnia and Herzegovina;Bulgaria;Czechia;Germany;Hungary;India;Korea, Republic of;Mexico;Poland;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-HU   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-ES   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-DE   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Boehringer Ingelheim
      2012   Phase 3   NCT01682512   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   Boehringer Ingelheim International GmbH
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-NO   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-ES   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-DE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-BG   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-002894-48-PT   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-HU   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GR   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GB   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-EE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-BE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   CELLTRION, Inc.
      2014   Phase 3   EUCTR2013-004555-21-SK   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-PT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-LV   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-HU   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-GR   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-DE   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
   Celltrion
      2014   Phase 3   NCT02149121   Austria;Korea, Republic of
   Dr. Reddy's Laboratories Limited
      2020   Phase 3   NCT04268771   United States
      2014   Phase 1/Phase 2   NCT02296775   India;Ukraine
   Mabion S.A.
      2021   Phase 3   EUCTR2020-002765-34-BE   Belgium;Bulgaria;Georgia;Poland;Serbia;Ukraine
   Mabion SA
      2023   Phase 3   NCT04680962   -
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
   Pfizer
      2012   Phase 2   NCT01526057   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2012-003223-38-GB   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-003223-38-ES   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003223-38-DE   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2011-002896-40-PL   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2012   Phase 2   EUCTR2011-002896-40-GB   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      -   Phase 2   EUCTR2011-002896-40-ES   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US
      2012   -   EUCTR2011-002896-40-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Sandoz
      2015   Phase 3   NCT02514772   Germany;Hungary;Poland;United States
      2011   Phase 1/Phase 2   NCT01274182   Argentina;Austria;Belgium;Brazil;Estonia;France;Germany;Hungary;India;Italy;Romania;Spain;Turkey;United States
   University of California, San Francisco
      2009   -   NCT00844714   United States
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
Rituxan (INN: rituximab), brand name IN THE united states
   Hexal AG
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-PL   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-HU   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-GB   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2015   Phase 1;Phase 2   EUCTR2010-021184-32-BG   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Russian Federation;Spain;Turkey;United Kingdom;United States
      2012   Phase 2   EUCTR2010-021184-32-EE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2011   Phase 2   EUCTR2010-021184-32-IT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-DE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
Rituxan (INN: rituximab), brand name IN THE US
   Hexal AG
      2011   Phase 2   EUCTR2010-021184-32-BE   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
Rituximab
   A.O. UNIVERSITARIA INTEGRATA DI VERONA
      2012   -   EUCTR2011-006001-10-IT   Italy
   ARCHIGEN BIOTECH LIMITED
      2017   Phase 1;Phase 3   EUCTR2014-005368-13-IT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Amgen
      2016   Phase 3   NCT02792699   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Amgen Inc
      2015   Phase 1;Phase 3   EUCTR2013-005543-90-BG   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-PL   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-HU   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
      2014   Phase 1;Phase 3   EUCTR2013-005543-90-DE   Bulgaria;Canada;Estonia;Germany;Hungary;Poland;United States
   Archigen Biotech Limited
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-HU   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-ES   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-DE   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Biocad
      2012   Phase 3   NCT01759030   Belarus;Colombia;India;Russian Federation;Ukraine
   Biogen
      2006   Phase 2   NCT00298272   United States
   Boehringer Ingelheim International GmbH
      2014   -   EUCTR2013-002622-23-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-NO   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-ES   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   -   EUCTR2011-002894-48-DE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2013   Phase 1;Phase 3   EUCTR2011-002894-48-BG   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2011-002894-48-PT   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-NL   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   -   EUCTR2011-002894-48-HU   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GR   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-GB   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-EE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2012   Phase 1;Phase 3   EUCTR2011-002894-48-BE   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;Estonia;France;Germany;Greece;Guatemala;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   CELLTRION, Inc.
      2014   Phase 3   EUCTR2013-004555-21-SK   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-PT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-LV   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-HU   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-GR   Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-DE   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
      2014   Phase 3   EUCTR2013-004555-21-AT   Austria;Bosnia and Herzegovina;Bulgaria;Chile;Colombia;Germany;Greece;Hungary;Israel;Korea, Republic of;Latvia;Mexico;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Ukraine
   CHRU de TOURS
      2014   Phase 4   EUCTR2014-000859-91-FR   France
   Celltrion
      2012   Phase 1   NCT01534884   Korea, Republic of
   Charite University, Berlin, Germany
      2024   Phase 1/Phase 2   NCT06475495   -
   Chinese University of Hong Kong
      2006   Phase 2   NCT00555542   China
   Division of Clinically Immunology and Rheumatology, AMC
      2009   -   EUCTR2009-010955-29-NL   Netherlands
   Dr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona
      2008   -   EUCTR2007-003623-20-ES   Spain
   Eric Matteson
      2007   Phase 3   NCT00578565   United States
   F Hoffmann-La Roche Ltd
      2009   -   EUCTR2008-005525-11-NL   France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-GR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-FR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-ES   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-005525-11-DE   France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-005525-11-GB   France;Germany;Greece;Netherlands;Spain;United Kingdom
   F. Hoffman- La Roche Ltd.
      2008   -   EUCTR2007-001585-33-GR   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
   F. Hoffman-La Roche Ltd.
      2007   -   EUCTR2007-001585-33-NL   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-LV   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-LT   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   Phase 3   EUCTR2007-001585-33-FR   Czech Republic;Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-ES   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-EE   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   -   EUCTR2007-001585-33-DK   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2007   Phase 3   EUCTR2007-001585-33-CZ   Czech Republic;Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
   F. Hoffmann - La Roche Ltd.
      2005   -   EUCTR2005-002395-15-IT   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
   F. Hoffmann- La Roche Ltd.
      2005   -   EUCTR2005-002396-33-IT   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2008   -   EUCTR2007-001585-33-DE   Denmark;Estonia;France;Germany;Greece;Latvia;Lithuania;Netherlands;Spain
      2006   Phase 2   EUCTR2005-003632-22-ES   Spain
      2006   -   EUCTR2005-002396-33-SK   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-HU   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-002396-33-GB   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-FI   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-DE   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002395-15-SE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-002395-15-GB   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-FI   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DK   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-CZ   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002392-32-DE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002396-33-ES   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-002396-33-BE   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   -   EUCTR2005-002395-15-ES   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002395-15-BE   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SI   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-IE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-GB   Germany;Ireland;Slovenia;Sweden;United Kingdom
   Frank Behrens
      2010   Phase 3   NCT01244958   Germany
   Gaylis, Norman B., M.D.
      2007   Phase 2   NCT00425932   United States
   Gedeon Richter Plc
      2015   Phase 1;Phase 3   EUCTR2014-003255-54-CZ   Austria;Belgium;Czech Republic;Estonia;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Spain;Ukraine
   Gedeon Richter Plc.
      2015   Phase 1   NCT02371096   -
   Genentech, Inc.
      2007   Phase 3   NCT00443651   United States
      2006   Phase 3   NCT00299104   United States
      2006   Phase 2   NCT00282308   United States
      2006   Phase 3   NCT00266227   United States
      2005   Phase 3   NCT00299130   United States
      2005   Phase 2   NCT00243412   United States
      2003   Phase 2   NCT00074438   United States
   Hexal AG
      2010   Phase 2   EUCTR2010-021184-32-FR   Austria;Belgium;Bulgaria;Estonia;France;Germany;Hungary;Italy;Poland;Spain;United Kingdom
      2010   Phase 2   EUCTR2010-021184-32-AT   Argentina;Austria;Belgium;Brazil;Bulgaria;Estonia;France;Germany;Hungary;India;Italy;Poland;Romania;Spain;Turkey;United Kingdom
   Hexal AG (a Sandoz company)
      2015   Phase 3   EUCTR2012-003876-38-PL   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-HU   Germany;Hungary;Poland;United States
      2015   Phase 3   EUCTR2012-003876-38-DE   Germany;Hungary;Poland;United States
   Hoffmann-La Roche
      2012   -   NCT01613027   Greece
      2011   -   NCT01641952   Romania
      2011   -   NCT01592292   Korea, Republic of
      2011   Phase 4   NCT01382940   United States
      2011   Phase 3   NCT01332994   Germany
      2010   Phase 4   NCT01117129   Spain
      2010   -   NCT01071798   Germany;United States
      2009   -   NCT01075477   Finland;United States
      2009   Phase 2   NCT00845832   Belgium;France;Germany;Greece;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom
      2008   -   NCT02622503   Finland
      2008   Phase 4   NCT01000610   Tunisia
      2007   -   NCT02699892   Serbia
      2007   Phase 4   NCT00934648   Morocco
      2007   Phase 3   NCT00578305   Argentina;Brazil;Canada;Czech Republic;Denmark;Estonia;Former Serbia and Montenegro;France;Germany;Greece;Latvia;Lithuania;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;United Kingdom
      2007   Phase 4   NCT00576433   Russian Federation
      2007   Phase 4   NCT00504777   Taiwan
      2007   Phase 4   NCT00502853   Italy
      2007   Phase 3   NCT00502840   Germany
      2007   Phase 4   NCT00462345   Korea, Republic of
      2007   Phase 4   NCT00424502   Hungary
      2006   Phase 3   NCT02079532   Germany
      2006   Phase 3   NCT02006706   Serbia
      2006   Phase 3   NCT01272908   Canada;Sweden
      2006   Phase 3   NCT01126541   France
      2006   Phase 3   NCT00502996   Argentina;Brazil;Chile;Colombia;Ecuador;El Salvador;Mexico;Peru;Uruguay;Venezuela
      2006   Phase 2   NCT00422942   Netherlands;Spain
      2006   Phase 3   NCT00422383   Australia;Belgium;Brazil;Canada;China;Finland;France;Germany;Hungary;Italy;Netherlands;New Zealand;Slovakia;South Africa;Spain;Switzerland;Taiwan;Thailand;United Kingdom;United States
      2005   Phase 3   NCT00503425   Israel
      2004   Phase 3   NCT02097745   Belgium;Canada;France;Germany;Ireland;Israel;Italy;Netherlands;Norway;United Kingdom;United States
      2004   Phase 3   NCT00468377   United States
      2002   Phase 2   NCT02093026   Australia;Belgium;Brazil;Canada;Czech Republic;Finland;Germany;Israel;Italy;Mexico;New Zealand;Poland;Spain;Sweden;United Kingdom;United States
      2001   Phase 2   NCT02693210   Australia;Belgium;Canada;Czech Republic;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom
   IRIS Research and Development, LLC
      2024   Phase 1   NCT06581562   United States
   Johann Wolfgang Goethe-Universität Frankfurt/M.
      2010   -   EUCTR2009-015950-39-DE   Germany
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2015   Phase 4   EUCTR2012-002535-28-ES   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London
      2015   Phase 4   EUCTR2012-002535-28-IT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-PT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-ES   Belgium;Italy;Portugal;Spain
   Julia Brown
      2011   Phase 4   NCT01295151   United Kingdom
   Mabion S.A.
      2021   Phase 3   EUCTR2020-002765-34-BE   Belgium;Bulgaria;Georgia;Poland;Serbia;Ukraine
      2014   Phase 3   EUCTR2012-003194-25-HR   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2012-003194-25-LT   Croatia;Georgia;Lithuania;Poland;Romania;Russian Federation;Serbia;Ukraine
   Mabion SA
      2023   Phase 3   NCT04680962   -
      2013   Phase 3   NCT02468791   Bosnia and Herzegovina;Georgia;Poland;Serbia;Ukraine
   Mabscale, LLC
      2023   Phase 1   NCT06175338   Russian Federation
   Mashhad University of Medical Sciences
      2010   Phase 4   NCT01593332   Iran, Islamic Republic of
   Medical University of Vienna
      -   Phase 4   EUCTR2015-002156-27-AT   Austria
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Merck KGaA
      2008   Phase 2   NCT00664521   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Serono International
      2008   -   EUCTR2007-003647-75-SE   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-NL   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-FR   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-003647-75-FI   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Serono SA - Geneva
      2008   Phase 2   EUCTR2007-003647-75-GB   Finland;France;Netherlands;Sweden;United Kingdom
   Merck Sharp & Dohme Corp.
      2011   Phase 1   NCT01390441   Belarus;Bulgaria;Colombia;Georgia;Hungary;Italy;Philippines;Poland;Russian Federation;Singapore;Spain;Ukraine;United Kingdom;United States
   NHS Greater Glasgow and Clyde
      2009   -   EUCTR2009-011268-13-GB   United Kingdom
   National Institute of Allergy and Infectious Diseases (NIAID)
      2006   Phase 1/Phase 2   NCT00396812   United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2012   Phase 2   EUCTR2011-002896-40-GB   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      -   Phase 2   EUCTR2011-002896-40-ES   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Korea, Democratic People's Republic of;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Prof. Abid Z. Farooqi
      2010   Phase 4   NCT02731560   -
   ROCHE
      2007   -   EUCTR2007-001754-11-IT   Italy
   ROCHE FARMA, S.A.
      2009   -   EUCTR2008-002381-55-ES   Spain
   Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases
      2009   Phase 4   EUCTR2008-005450-20-BE   Belgium
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
      2007   -   EUCTR2006-006746-33-DE   Germany
      2006   -   EUCTR2006-001000-37-DE   Germany
   Samsung Electronics Co. Ltd.
      2012   -   EUCTR2011-004171-36-PL   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-HU   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-GB   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-ES   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-CZ   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
   Sint Maartenskliniek
      2020   Phase 4   EUCTR2020-002507-19-NL   Netherlands
      2016   Phase 4   EUCTR2016-002908-15-NL   Netherlands
   South Tees Hospitals NHS Foundation Trust
      2011   Phase 4   EUCTR2010-020499-50-GB   United Kingdom
   Teva Pharmaceutical Industries
      2012   Phase 3   EUCTR2011-005021-48-PL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-NL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-HU   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-ES   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-CZ   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-BG   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
   Universitaire Ziekenhuizen KU Leuven
      2024   Phase 4   NCT06003283   Belgium
   University Hospital, Rouen
      2011   Phase 4   NCT01765374   France
   University Hospital, Tours
      2015   Phase 3   NCT02304354   France
   University of California, San Diego
      2008   Phase 2   NCT00147966   United States
   University of Glasgow
      2010   Phase 4   NCT01021735   United Kingdom
   University of Leeds
      2011   Phase 4   EUCTR2010-023880-17-GB   United Kingdom
      2007   Phase 3   EUCTR2006-005640-81-GB   United Kingdom
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
   University of Manitoba
      2007   -   NCT00963703   Canada
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   Universitätsklinikum Erlangen
      2019   Phase 2   EUCTR2018-003877-91-DE   Germany
Rituximab - mabthera
   Vienna Medical University
      2006   -   EUCTR2006-000854-32-AT   Austria
Rituximab 1G/6months
   University Hospital, Strasbourg, France
      2025   Phase 4   NCT06906549   -
Rituximab 200MG/6months
   University Hospital, Strasbourg, France
      2025   Phase 4   NCT06906549   -
Rituximab mabthera
   Vienna Medical University
      2006   -   EUCTR2006-000854-32-AT   Austria
Rituximab, MTX, folic acid
   Celltrion
      2013   Phase 1   NCT01873443   Korea, Republic of
Rituximab, observational study amon patients with active RA
   Kuopio University Hospital
      2004   -   NCT00854321   Finland
Rituximab-EU+ rituximab-pfizer X 2 courses
   Pfizer
      2012   -   NCT01643928   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Switzerland;Ukraine;United Kingdom;United States
Rituximab-pfizer
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2013   Phase 2   EUCTR2012-003223-38-GB   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   -   EUCTR2012-003223-38-ES   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2012-003223-38-DE   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
      2013   Phase 2   EUCTR2011-002896-40-PL   Argentina;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US
      2012   -   EUCTR2011-002896-40-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Israel;Italy;Mexico;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;United Kingdom;United States
Rituximab-pfizer (PF-05280586) X 3 courses
   Pfizer
      2012   -   NCT01643928   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Switzerland;Ukraine;United Kingdom;United States
Rituximab-US + rituximab-pfizer X 2 courses
   Pfizer
      2012   -   NCT01643928   Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;Switzerland;Ukraine;United Kingdom;United States
Rivaroxaban
   Department of Orthopaedics, West China Hospital, Sichuan University
      2018   -   ChiCTR1800014584   China
   Department of Orthopedics, the First Affliated Hospital of Xinjiang Medical University
      2024   Phase 4   ChiCTR2400092488   China
Rixathon
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
   Sint Maartenskliniek
      2020   Phase 4   EUCTR2020-002507-19-NL   Netherlands
RO 001-9265/F02-01
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
RO 002-9893/F02
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   Phase 3   EUCTR2009-012759-12-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   Roche Farma, S.A.
      -   -   EUCTR2011-001626-15-ES   Spain
RO 45-2294
   F Hoffmann-La Roche Ltd
      2009   -   EUCTR2008-005525-11-NL   France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-GR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-ES   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-005525-11-DE   France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-005525-11-GB   France;Germany;Greece;Netherlands;Spain;United Kingdom
   F. Hoffmann-La Roche Ltd.
      2006   -   EUCTR2005-002396-33-SK   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-HU   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-002396-33-GB   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-FI   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002396-33-DE   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2006   -   EUCTR2005-002395-15-SE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-002395-15-GB   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-FI   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DK   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-DE   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002395-15-CZ   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002392-32-DE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002396-33-ES   Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   Phase 3   EUCTR2005-002396-33-BE   Belgium;Finland;Germany;Hungary;Italy;Slovakia;Spain;United Kingdom
      2005   -   EUCTR2005-002395-15-ES   Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002395-15-BE   Belgium;Czech Republic;Denmark;Finland;Germany;Italy;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SI   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   -   EUCTR2005-002392-32-SE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-IE   Germany;Ireland;Slovenia;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-002392-32-GB   Germany;Ireland;Slovenia;Sweden;United Kingdom
   Roche Pharma AG
      2007   -   EUCTR2006-006746-33-DE   Germany
      2006   -   EUCTR2006-001000-37-DE   Germany
RO 48-77533
   ROCHE
      2005   -   EUCTR2005-001138-33-IT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
RO 487-7533
   F. Hoffmann - La Roche Ltd
      2006   -   EUCTR2005-002909-23-IT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
   ROCHE
      2009   -   EUCTR2009-011105-17-IT   Italy
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
RO 487-7533/F01
   F. Hoffmann-La Roche Ltd
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018331-18-GB   United Kingdom
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   Roche Oy
      2010   -   EUCTR2010-019935-37-FI   Finland
RO 487-7533/F10
   F. Hoffmann-La Roche Ltd
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-GR   Bulgaria;Greece;Hungary;Spain
      2011   Phase 3   EUCTR2010-019912-18-ES   Bulgaria;Greece;Hungary;Spain
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2010   -   EUCTR2010-018375-22-IT   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018375-22-ES   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
RO 487-7533/F10-02
   N.V. Roche S.A.
      2013   Phase 3   EUCTR2013-002150-79-BE   Belgium
RO 487-7533/F10-04
   ROCHE HELLAS S.A.
      2013   Phase 3   EUCTR2013-000359-42-GR   Greece
   Roche Farma S.A
      2013   Phase 3   EUCTR2013-002429-52-IE   Ireland;Portugal;Spain
      2013   Phase 3   EUCTR2013-002429-52-ES   Ireland;Portugal;Spain
   Roche Farma S.A.
      2013   Phase 3   EUCTR2013-002429-52-PT   Ireland;Portugal;Spain
   Roche Nederland B.V.
      2013   Phase 3   EUCTR2013-000342-19-NL   Netherlands
   Roche Products Limited
      2013   Phase 3   EUCTR2013-000054-22-GB   United Kingdom
   Roche S.p.A.
      2013   Phase 3   EUCTR2013-001569-17-IT   Italy
   Roche a/s
      2014   Phase 3   EUCTR2013-002007-34-SE   Denmark;Finland;Sweden
      2014   Phase 3   EUCTR2013-002007-34-FI   Denmark;Finland;Sweden
      2013   Phase 3   EUCTR2013-002007-34-DK   Denmark;Finland;Sweden
RO 496-4913
   F Hoffmann-La Roche Limited
      2005   Phase 1;Phase 2   EUCTR2004-002132-26-ES   Spain;United Kingdom
   F. Hoffmann-La Roche Limited
      2008   Phase 1;Phase 2   EUCTR2004-002132-26-GB   Spain;United Kingdom
   F. Hoffmann-La Roche Ltd
      2010   Phase 3   EUCTR2006-005330-20-CZ   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2008   Phase 3   EUCTR2007-005759-41-GB   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2007-005759-41-ES   France;Germany;Italy;Spain;United Kingdom
      2008   -   EUCTR2007-005759-41-DE   France;Germany;Italy;Spain;United Kingdom
      2008   Phase 3   EUCTR2006-005353-30-GB   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   -   EUCTR2006-005353-30-LT   Argentina;Australia;Austria;Brazil;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Thailand;United Kingdom;United States
      2007   -   EUCTR2006-005353-30-AT   Austria;Italy;Lithuania;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005330-20-SK   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SI   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-SE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-NL   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-HU   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-FR   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005330-20-DE   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
      2007   Phase 3   EUCTR2006-005330-20-BE   Belgium;Czech Republic;France;Germany;Hungary;Italy;Netherlands;Slovakia;Slovenia;Spain;Sweden
      2007   -   EUCTR2006-005147-28-GR   Austria;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-GB   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-DE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-BE   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-AT   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
   ROCHE
      2007   -   EUCTR2006-005330-20-IT   Belgium;France;Germany;Hungary;Italy;Netherlands;Slovenia;Spain;Sweden
RO 496-4913/F03
   F. Hoffmann-La Roche Ltd
      2008   Phase 3   EUCTR2007-005759-41-FR   France;Germany;Italy;Spain;United Kingdom
      2007   Phase 3   EUCTR2006-005147-28-FR   Austria;Belgium;France;Germany;Greece;Spain;United Kingdom
RO 551-6922
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
RO actemra
   F. Hoffmann - La Roche Ltd
      2006   -   EUCTR2005-002909-23-IT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
RO-496-4913
   ROCHE
      2008   -   EUCTR2007-005759-41-IT   France;Germany;Italy;Spain;United Kingdom
RO-actemra
   Medical University of Vienna
      2012   Phase 4   NCT01638715   Austria;Czech Republic;Czechia;Russian Federation;Saudi Arabia;Switzerland
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
RO001-9265/F04
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
RO0029893
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
RO045-2294
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
RO04877533
   F Hoffmann-La Roche Ltd
      2008   -   EUCTR2008-001847-20-NL   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   ROCHE
      2009   -   EUCTR2008-001847-20-IT   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   Roche Farma, S.A.
      2009   -   EUCTR2008-006443-39-ES   Spain
RO04877533/F05/F04
   F Hoffmann-La Roche Ltd
      2008   Phase 3   EUCTR2008-001847-20-FR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
RO0506997
   F.Hoffmann - La Roche Ltd
      2005   -   EUCTR2004-004022-27-ES   Spain
RO4402257
   F. Hoffmann-La Roche Ltd
      2006   Phase 2   EUCTR2005-003694-25-ES   Czech Republic;Italy;Spain
      2006   -   EUCTR2005-003694-25-CZ   Czech Republic;Italy;Spain
      2006   Phase 2   EUCTR2005-003495-38-GR   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-IE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-GB   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   Phase 2   EUCTR2005-003495-38-ES   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-EE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
      2005   -   EUCTR2005-003495-38-DE   Estonia;Germany;Greece;Ireland;Spain;United Kingdom
RO452294/V02
   F Hoffmann-La Roche Ltd
      2009   Phase 2   EUCTR2008-005525-11-FR   France;Germany;Greece;Netherlands;Spain;United Kingdom
RO487-7533
   ROCHE
      2009   -   EUCTR2009-012185-32-IT   Italy
RO487-7533/F01-F05
   ROCHE
      2009   Phase 4   EUCTR2008-008309-23-FR   France
RO487-7533/F10-04
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
RO4877533
   F Hoffmann La-Roche AG
      2007   -   EUCTR2005-002909-23-PT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-SI   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-NO   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-IS   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-002909-23-GB   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-FI   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-DK   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002909-23-ES   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann La-Roche Ltd.
      2006   -   EUCTR2005-002909-23-SE   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-LT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2005   -   EUCTR2004-003733-14-DK   Denmark;Finland;Italy;Spain
   F Hoffmann-La Roche AG
      2006   -   EUCTR2005-002909-23-DE   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd
      2009   -   EUCTR2008-005525-11-NL   France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-GR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-ES   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-005525-11-DE   France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-005525-11-GB   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-001847-20-FR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-GR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-EE   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. Hoffmann La-Roche AG
      2005   -   EUCTR2005-001138-33-PT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-NO   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-LT   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-ES   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-DK   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2004-005210-37-SE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-FI   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-005210-37-ES   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-DE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-CZ   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-003741-40-SK   Austria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2004-003741-40-HU   Germany;Hungary;Italy
      2005   -   EUCTR2004-003741-40-DE   Germany;Hungary;Italy
      2005   -   EUCTR2004-003733-14-ES   Denmark;Finland;Italy;Spain
      2004   -   EUCTR2004-003741-40-AT   Austria;Germany;Hungary;Italy
      -   -   EUCTR2005-001138-33-SI   Denmark;Italy;Norway;Portugal;Slovenia;Spain
   F. Hoffmann La-Roche Ltd
      2005   -   EUCTR2005-002423-13-SK   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-HU   Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-AT   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann La-Roche Ltd.
      2005   Phase 3   EUCTR2004-003733-14-FI   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;South Africa;Spain;United States
   F. Hoffmann- La Roche Ltd
      2009   -   EUCTR2008-000587-17-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   F. Hoffmann-La Roche
      2009   -   EUCTR2008-006924-68-IT   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
   F. Hoffmann-La Roche AG
      2005   -   EUCTR2005-000884-25-SE   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-IS   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-GB   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   -   EUCTR2005-000884-25-DE   Germany;Iceland;Italy;Sweden;United Kingdom
   F. Hoffmann-La Roche Limited
      2007   -   EUCTR2007-001114-17-GB   United Kingdom
   F. Hoffmann-La Roche Ltd
      2013   -   EUCTR2013-002341-11-GB   United Kingdom
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2008-006924-68-AT   Austria;Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-PT   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-NL   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-HU   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GB   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-ES   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-CZ   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-000587-17-HU   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-000587-17-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-SE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-IE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-ES   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002423-13-DE   Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-ES   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-GR   Bulgaria;Greece;Hungary;Spain
      2011   Phase 3   EUCTR2010-019912-18-ES   Bulgaria;Greece;Hungary;Spain
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2010   -   EUCTR2010-018375-22-IT   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   Phase 3   EUCTR2010-018375-22-ES   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   FUNDACIÓN ESPAÑOLA DE REUMATOLOGIA
      2014   Phase 4   EUCTR2013-004051-20-ES   Spain
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
      2009   Phase 4   EUCTR2008-008309-23-FR   France
      2009   -   EUCTR2008-000587-17-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Roche (Magyarország) Kft.
      2012   -   EUCTR2011-006125-14-HU   Hungary
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
   Roche Farma S.A
      2013   Phase 3   EUCTR2013-002429-52-IE   Ireland;Portugal;Spain
      2013   Phase 3   EUCTR2013-002429-52-ES   Ireland;Portugal;Spain
   Roche Farma S.A.
      2013   Phase 3   EUCTR2013-002429-52-PT   Ireland;Portugal;Spain
   Roche Farma, S.A.
      2009   -   EUCTR2008-006443-39-ES   Spain
   Roche Nederland B.V.
      2013   Phase 3   EUCTR2013-000342-19-NL   Netherlands
   Roche Oy
      2010   -   EUCTR2010-019935-37-FI   Finland
      2008   -   EUCTR2008-004126-16-FI   Finland
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
      2008   -   EUCTR2008-000105-11-DE   Germany
   Roche Products Limited
      2013   Phase 3   EUCTR2013-000054-22-GB   United Kingdom
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
   Roche S.p.A.
      2013   Phase 3   EUCTR2013-001569-17-IT   Italy
   Roche a/s
      2014   Phase 3   EUCTR2013-002007-34-SE   Denmark;Finland;Sweden
      2014   Phase 3   EUCTR2013-002007-34-FI   Denmark;Finland;Sweden
      2013   Phase 3   EUCTR2013-002007-34-DK   Denmark;Finland;Sweden
      2011   -   EUCTR2011-002363-15-DK   Denmark;Iceland
   University of Leeds
      2009   Phase 2   EUCTR2008-003011-12-GB   United Kingdom
RO4877533/F01
   F Hoffmann-La Roche Ltd
      2009   Phase 2   EUCTR2008-005525-11-FR   France;Germany;Greece;Netherlands;Spain;United Kingdom
RO4877533/F04-F05
   F. Hoffmann-La Roche Ltd
      2009   Phase 3   EUCTR2008-006924-68-FR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
RO496-4913
   ROCHE
      2007   -   EUCTR2006-005353-30-IT   Austria;Italy;Lithuania;Spain;United Kingdom
RO7123520
   Hoffmann-La Roche
      2016   Phase 2   NCT03001219   Argentina;Austria;Colombia;Czech Republic;Czechia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
RO7123520/F03-01
   F. Hoffmann - Roche Ltd
      2017   Phase 2   EUCTR2016-002126-36-IT   Argentina;Austria;Colombia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
   F. Hoffmann-La Roche Ltd
      2017   Phase 2   EUCTR2016-002126-36-ES   Argentina;Austria;Colombia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002126-36-DE   Argentina;Austria;Colombia;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
      2017   Phase 2   EUCTR2016-002126-36-AT   Argentina;Austria;Brazil;Chile;Colombia;Czech Republic;Germany;Guatemala;Italy;Mexico;Peru;Poland;Spain;United Kingdom;United States
Roactemra
   Aarhus University Hospital, Department of Rheumatology U
      2012   Phase 4   EUCTR2011-006040-79-DK   Denmark
   Ablynx NV
      2015   Phase 2   EUCTR2014-003012-36-HU   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-ES   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-DE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-CZ   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BG   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
   Bio-Thera Solutions, Ltd.
      2019   Phase 3   EUCTR2018-002202-31-BG   Bulgaria;China;Georgia;Poland;Ukraine
   CHU Amiens-Picardie
      2015   Phase 4   EUCTR2015-000833-64-FR   France
   CHU DIJON
      2010   -   EUCTR2010-018696-21-FR   France
   CHU de Clermont Ferrand
      2011   Phase 3   EUCTR2011-000215-79-FR   France
   Cliniques Universitaires Saint-Luc, Université catholique de Louvain
      2015   Phase 4   EUCTR2015-001246-28-BE   Belgium
   F Hoffmann La-Roche AG
      2006   -   EUCTR2005-002909-23-SI   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-DK   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann La-Roche Ltd.
      2006   -   EUCTR2005-002909-23-SE   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-LT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2005   -   EUCTR2004-003733-14-DK   Denmark;Finland;Italy;Spain
   F Hoffmann-La Roche AG
      2006   -   EUCTR2005-002909-23-DE   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-GR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-EE   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. Hoffmann - La Roche Ltd
      2006   -   EUCTR2005-002909-23-IT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F. Hoffmann La-Roche Ltd
      2005   -   EUCTR2005-002423-13-AT   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
      -   -   EUCTR2005-002423-13-BG   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;France;Germany;Hong Kong;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Switzerland;Thailand
   F. Hoffmann La-Roche Ltd.
      2005   Phase 3   EUCTR2004-003733-14-FI   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;South Africa;Spain;United States
   F. Hoffmann-La Roche Ltd
      2013   -   EUCTR2013-002341-11-GB   United Kingdom
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-006924-68-PT   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-HU   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GB   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-FR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-CZ   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-000587-17-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002423-13-DE   Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-ES   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-IT   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018331-18-GB   United Kingdom
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-IT   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   F.Hoffmann La Roche Ltd
      2005   -   EUCTR2005-002423-13-IT   Bulgaria;Germany;Hungary;Italy;Slovakia
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Fresenius Kabi SwissBioSim GmbH
      2021   Phase 3   EUCTR2019-004369-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2020   Phase 3   EUCTR2019-004369-42-SK   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-PL   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-HU   Bulgaria;Czech Republic;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2020   Phase 3   EUCTR2019-004369-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
   Hoffmann-La Roche
      2014   Phase 3   NCT02011334   Argentina;Brazil;Colombia;Dominican Republic;Ecuador;Mexico;Uruguay;Venezuela
      2013   Phase 3   NCT01995201   Ireland;Portugal;Spain
      2013   Phase 4   NCT01878318   Venezuela
      2012   Phase 3   NCT01730456   Macedonia, The Former Yugoslav Republic of
      2012   Phase 3   NCT01664598   Russian Federation
      2012   Phase 3   NCT01649804   Hungary
      2012   Phase 3   NCT01587989   Austria
      2011   Phase 4   NCT01399697   Spain
      2011   Phase 3   NCT01353859   Greece;Indonesia
      2011   Phase 3   NCT01332994   Germany
      2011   Phase 3   NCT01326962   Saudi Arabia
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   NCT01254331   Tunisia
      2011   Phase 4   NCT01251120   Finland
      2011   Phase 3   NCT01245439   Turkey
      2011   Phase 3   NCT01235507   Bosnia and Herzegovina
      2011   Phase 4   NCT01219933   Belgium
      2010   Phase 4   NCT02010216   Kazakhstan
      2010   Phase 3   NCT01610791   Morocco
      2010   Phase 3   NCT01214733   South Africa
      2010   Phase 4   NCT01195272   United Kingdom
      2010   Phase 4   NCT01149057   Israel
      2010   Phase 4   NCT01089023   Bahrain;Iran, Islamic Republic of;Kuwait;Qatar;United Arab Emirates
      2010   Phase 3   NCT01063062   Egypt
      2010   Phase 4   NCT01034397   Portugal
      2010   Phase 3   NCT01034137   Netherlands
      2009   Phase 4   NCT01010503   Slovakia
      2009   Phase 4   NCT00996203   Russian Federation
      2009   Phase 3   NCT00977106   France
      2009   Phase 1   NCT00965653   Canada;New Zealand;Spain;United Kingdom
      2009   Phase 3   NCT00951275   Italy
      2009   Phase 3   NCT00891020   Puerto Rico;United Kingdom;United States
      2009   Phase 2   NCT00887341   Spain
      2009   Phase 3   NCT00883753   Australia;Austria;Canada;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Turkey;United Kingdom
      2009   Phase 2   NCT00845832   Belgium;France;Germany;Greece;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom
      2009   Phase 3   NCT00810199   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Monaco;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00754572   Argentina;Brazil;Chile;Colombia;Costa Rica;Ecuador;Mexico;Peru;Uruguay;Venezuela
      2008   Phase 3   NCT00848120   Philippines
      2008   Phase 3   NCT00810277   Finland
      2008   Phase 3   NCT00773461   China
      2008   Phase 3   NCT00750880   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Luxembourg;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2005   Phase 1   NCT00365001   New Zealand;United States
      2005   Phase 3   NCT00109408   Argentina;Australia;Canada;China;Croatia;Denmark;Former Serbia and Montenegro;France;Israel;Italy;Lithuania;Mexico;Norway;Peru;Portugal;Serbia;Slovenia;South Africa;Spain;United States
      2005   Phase 3   NCT00106574   Argentina;Australia;Brazil;Canada;China;Costa Rica;Czech Republic;Finland;France;Germany;Hong Kong;Mexico;Panama;Russian Federation;South Africa;Spain;Sweden;Thailand;United States
      2005   Phase 3   NCT00106548   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;France;Germany;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Spain;Switzerland;Thailand
      2005   Phase 3   NCT00106535   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;Puerto Rico;South Africa;Spain;Switzerland;United States
      2005   Phase 3   NCT00106522   Australia;Belgium;Canada;France;Germany;Iceland;Italy;Mexico;Netherlands;Puerto Rico;Sweden;Switzerland;United Kingdom;United States
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2016   Phase 4   EUCTR2012-002535-28-NL   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2015   Phase 4   EUCTR2012-002535-28-ES   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-BE   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2013   Phase 4   EUCTR2012-002535-28-GB   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London
      2015   Phase 4   EUCTR2012-002535-28-IT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-PT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-DK   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   N.V. Roche S.A.
      2013   Phase 3   EUCTR2013-002150-79-BE   Belgium
   OSSERVATORIO EPIDEMIOLOGICO GISEA
      2012   Phase 4   EUCTR2012-001760-30-IT   Italy
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012185-32-IT   Italy
      2009   -   EUCTR2009-011105-17-IT   Italy
      2009   Phase 4   EUCTR2008-008309-23-FR   France
   Reade
      2019   Phase 4   EUCTR2019-001754-25-NL   Netherlands
      2019   Phase 1;Phase 4   EUCTR2018-004605-57-NL   Netherlands
   Roche (Magyarország) Kft.
      2012   -   EUCTR2011-006125-14-HU   Hungary
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
   Roche Farma S.A
      2013   Phase 3   EUCTR2013-002429-52-IE   Ireland;Portugal;Spain
      2013   Phase 3   EUCTR2013-002429-52-ES   Ireland;Portugal;Spain
   Roche Farma, S.A.
      2009   -   EUCTR2008-006443-39-ES   Spain
   Roche Farmacêutica Química, Lda.
      2009   -   EUCTR2009-012218-30-PT   Portugal
   Roche Nederland B.V.
      2009   -   EUCTR2009-013316-12-NL   Netherlands
   Roche Oy
      2010   -   EUCTR2010-019935-37-FI   Finland
   Roche Pharma AG
      2008   -   EUCTR2008-000105-11-DE   Germany
   Roche Products Limited
      2013   Phase 3   EUCTR2013-000054-22-GB   United Kingdom
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
   Roche Slovensko s.r.o.
      2009   -   EUCTR2009-011520-53-SK   Slovakia
   Roche a/s
      2014   Phase 3   EUCTR2013-002007-34-SE   Denmark;Finland;Sweden
      2013   Phase 3   EUCTR2013-002007-34-DK   Denmark;Finland;Sweden
      2011   -   EUCTR2011-002363-15-IS   Denmark;Iceland
      2011   -   EUCTR2011-002363-15-DK   Denmark;Iceland
   The Karolinska Institute, ClinTRID
      2017   Phase 4   EUCTR2011-004720-35-NL   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
      2012   -   EUCTR2011-004720-35-SE   Sweden
   The Karolinska Institutet, ClinTRID
      2014   Phase 4   EUCTR2014-002374-36-SE   Sweden
   The Karolinska Instutute, ClinTRID
      2013   Phase 4   EUCTR2011-004720-35-IS   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   The University of Leeds
      2013   Phase 4   EUCTR2011-004017-17-GB   United Kingdom
   UCB Pharma
      2010   Phase 2   NCT01242488   Belgium;United Kingdom;United States
   UCL Cliniques Universitaires Saint Luc
      2010   Phase 2   EUCTR2010-019873-13-BE   Belgium
   University Medical Center Utrecht
      2019   Phase 4   EUCTR2017-003037-28-NL   Netherlands
   University of Southern Denmark
      2021   Phase 1;Phase 2   EUCTR2020-005998-27-DK   Denmark
Roactemra - 162 MG - soluzione iniettabile - USO sottocutaneo - siringa preriempita 0,9ML (vetro) - 4 siringhe preriempite
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
Roactemra - 20 MG/ML concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 4ML 1 flaconcino
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
Roactemra 162 MG
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
Roactemra 162 MG solution injectable EN seringue PRéremplie
   Groupement des Hôpitaux de l’Institut Catholique de Lille
      2017   Phase 4   EUCTR2017-000947-41-FR   France
Roactemra 20 MG/ML concentrado para solucióN para perfusióN
   FUNDACIÓN ESPAÑOLA DE REUMATOLOGIA
      2014   Phase 4   EUCTR2013-004051-20-ES   Spain
Roactemra 20 MG/ML concentrate FOR solution FOR infusion
   CELLTRION, Inc.
      2022   Phase 3   EUCTR2022-001066-36-PL   Poland
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
   UCB Biosciences, Inc. A Member of the UCB Group of Companies
      2011   Phase 2   EUCTR2010-020839-39-BE   Belgium;United Kingdom;United States
   sanofi-aventis recherche & développement
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
Roactemra 20 MG/ML, concentrado para solucióN para perfusióN
   F. Hoffmann-La Roche Ltd.
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2010   Phase 3   EUCTR2010-018375-22-ES   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2009   Phase 3   EUCTR2009-012759-12-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
   Roche Farma, S.A.
      -   -   EUCTR2011-001626-15-ES   Spain
Roactemra®EV
   University of Leeds
      2009   Phase 2   EUCTR2008-003011-12-GB   United Kingdom
Roacterma
   Bio-Thera Solutions, Ltd.
      2019   Phase 3   EUCTR2018-002202-31-BG   Bulgaria;China;Georgia;Poland;Ukraine
Roactmera
   AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA
      2018   Phase 3   EUCTR2017-004079-30-IT   Belgium;Italy;Portugal;Spain
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-ES   Belgium;Italy;Portugal;Spain
      2018   Phase 3   EUCTR2017-004079-30-BE   Belgium;Italy;Portugal;Spain
      2014   Phase 3   EUCTR2014-003529-16-GB   United Kingdom
ROB 803
   OxyPharma
      2007   Phase 2   NCT00525213   Belgium;Bulgaria;Former Serbia and Montenegro;Georgia;Latvia;Lithuania;Poland;Romania;Serbia;Sweden;United Kingdom
ROB 803 (9-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-B] quinoxali
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-BG   Bulgaria;Latvia;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-LV   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-LT   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
ROB 803 12.5MG capsule
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-PL   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-LT   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-GB   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-BE   Belgium;Bulgaria;Latvia;Poland;United Kingdom
ROB 803 15MG capsule
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-PL   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-LT   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-GB   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-BE   Belgium;Bulgaria;Latvia;Poland;United Kingdom
ROB 803 25MG capsule
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-PL   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-LT   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-GB   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-BE   Belgium;Bulgaria;Latvia;Poland;United Kingdom
ROB 803 6.25MG capsule
   OxyPharma AB
      2008   -   EUCTR2006-004834-33-PL   Bulgaria;Latvia;Poland;United Kingdom
      2007   Phase 2   EUCTR2006-004834-33-LT   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
ROB 803 6.5MG capsule
   OxyPharma AB
      2007   Phase 2   EUCTR2006-004834-33-GB   Belgium;Bulgaria;Latvia;Lithuania;Poland;United Kingdom
      2007   -   EUCTR2006-004834-33-BE   Belgium;Bulgaria;Latvia;Poland;United Kingdom
Rofecoxib
   Merck Sharp & Dohme Corp.
      2004   Phase 4   NCT00157872   China
Romosozumab
   Tokyo Metropolitan Tama medical center
      2022   -   JPRN-UMIN000049741   Japan
Ropivacaine
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000033059   Japan
   Nekoyama Miyao Hospital
      2017   -   JPRN-UMIN000029759   Japan
      2017   -   JPRN-UMIN000029003   Japan
      2013   -   JPRN-UMIN000012257   Japan
   Nekoyama miyao hospital
      2012   -   JPRN-UMIN000011181   Japan
      2012   -   JPRN-UMIN000010902   Japan
   Quanzhou First Hospital Affiliated to Fujian Medical University
      2019   -   ChiCTR2200057200   China
   West China Hospital, Sichuan University
      2021   Phase 0   ChiCTR2000036316   China
      2021   Phase 0   ChiCTR2000036164   china
      2020   -   ChiCTR2000035179   China
      2020   -   ChiCTR2000035146   China
Rosiglitazone extended release tablets
   GlaxoSmithKline Research & Development Ltd.
      2005   -   EUCTR2004-000482-35-LT   Lithuania;United Kingdom
      2004   Phase 2   EUCTR2004-000482-35-GB   Lithuania;United Kingdom
Rosiglitazone maleate
   GlaxoSmithKline Research & Development Ltd.
      2005   -   EUCTR2004-000482-35-LT   Lithuania;United Kingdom
      2004   Phase 2   EUCTR2004-000482-35-GB   Lithuania;United Kingdom
Rosiglitazone XR
   GlaxoSmithKline
      2004   Phase 2   NCT00379600   Lithuania;United Kingdom
Rosnilimab
   AnaptysBio, Inc.
      2023   Phase 2   NCT06041269   Argentina;Belgium;Canada;Estonia;France;Georgia;Germany;Hungary;Italy;Mexico;Moldova, Republic of;Peru;Poland;Slovakia;Spain;Ukraine;United Kingdom;United States
Rosuvastatin
   AstraZeneca
      2012   Phase 1   NCT01725230   United States
   Chinese University of Hong Kong
      2007   Phase 2   NCT00555230   China
   Diakonhjemmet Hospital
      2013   -   NCT01389388   Norway
   Gilead Sciences
      2020   Phase 1   NCT04608344   United States
   University of Dundee
      2005   -   EUCTR2004-001909-10-GB   United Kingdom
      2004   Phase 2/Phase 3   NCT00679510   United Kingdom
Roxithromycin
   Nazilli State Hospital
      2006   Phase 4   NCT00439062   Turkey
Rozibafusp alfa
   Amgen
      2017   Phase 1   NCT03156023   Germany;United States
RTNV148B IGG
   Centocor B.V.
      2006   -   EUCTR2005-003232-21-MT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LV   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-LT   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-HU   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-003232-21-DE   Germany;Hungary;Latvia;Lithuania;Malta
      2006   -   EUCTR2005-001742-16-NL   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   Phase 3   EUCTR2005-001742-16-GB   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-ES   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2004-003296-36-HU   Germany;Hungary
      2006   -   EUCTR2004-003296-36-DE   Germany;Hungary
   Centocor BV
      2006   -   EUCTR2004-003295-10-HU   Hungary;Italy;Spain;United Kingdom
      2006   Phase 3   EUCTR2004-003295-10-GB   Austria;Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-ES   Hungary;Italy;Spain;United Kingdom
      2006   -   EUCTR2004-003295-10-AT   Austria;Hungary;Italy;Spain;United Kingdom
   Janssen Biologics B.V.
      2006   -   EUCTR2005-001742-16-FI   Austria;Finland;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-DE   Austria;Germany;Netherlands;Spain;United Kingdom
      2006   -   EUCTR2005-001742-16-AT   Austria;Germany;Netherlands;Spain;United Kingdom
Rupatadine
   Sherief Abd-Elsalam
      2018   Phase 3   NCT03770923   Egypt
RWJ-445380 100 MG
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2006   Phase 2   NCT00425321   Argentina;Brazil;Czech Republic;Germany;Mexico;Poland;United States
RWJ-445380 200 MG
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2006   Phase 2   NCT00425321   Argentina;Brazil;Czech Republic;Germany;Mexico;Poland;United States
RWJ-445380 300 MG
   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
      2006   Phase 2   NCT00425321   Argentina;Brazil;Czech Republic;Germany;Mexico;Poland;United States
RWJ-445380 capsule 100 MG
   Janssen-Cilag International N.V.
      2007   -   EUCTR2006-003983-73-CZ   Czech Republic;Germany
   Janssen-Cliag International N.V.
      -   -   EUCTR2006-003983-73-DE   Czech Republic;Germany
RWJ-445380 capsules 150 MG
   Janssen-Cilag International N.V.
      2007   -   EUCTR2006-003983-73-CZ   Czech Republic;Germany
   Janssen-Cliag International N.V.
      -   -   EUCTR2006-003983-73-DE   Czech Republic;Germany
RWJ-445380 capsules 50 MG
   Janssen-Cilag International N.V.
      2007   -   EUCTR2006-003983-73-CZ   Czech Republic;Germany
   Janssen-Cliag International N.V.
      -   -   EUCTR2006-003983-73-DE   Czech Republic;Germany
RWJ-445380-002
   Janssen-Cilag International N.V.
      2007   -   EUCTR2006-003983-73-CZ   Czech Republic;Germany
   Janssen-Cliag International N.V.
      -   -   EUCTR2006-003983-73-DE   Czech Republic;Germany
RYR
   Chengdu PLA General Hospital
      2014   -   NCT02257047   China
S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)OXY]-6-methyl-2-oxopyridin-1(2H)-YL]-N,4-dimethylbenzamide
   Pfizer Ltd
      2006   -   EUCTR2006-003577-27-CZ   Czech Republic;Estonia;Spain
   Pfizer Luxembourg SARL Branch Office Estonia
      2006   -   EUCTR2006-003577-27-EE   Czech Republic;Estonia;Spain
   Pfizer S.A.
      2007   Phase 2   EUCTR2006-003577-27-ES   Czech Republic;Estonia;Spain
S.C. injections OF bovine intestinal alkaline phosphatase
   Alloksys Life Sciences B.V.
      2011   Phase 1/Phase 2   NCT01416493   United Kingdom
SAIT101
   ARCHIGEN BIOTECH LIMITED
      2017   Phase 1;Phase 3   EUCTR2014-005368-13-IT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Archigen Biotech Limited
      2016   Phase 1   NCT02819726   Bosnia and Herzegovina;Bulgaria;Czechia;Germany;Hungary;India;Korea, Republic of;Mexico;Poland;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-HU   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-ES   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-DE   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
      2016   Phase 1;Phase 3   EUCTR2014-005368-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Germany;Hungary;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;United States
   Samsung Electronics Co. Ltd.
      2012   -   EUCTR2011-004171-36-PL   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-HU   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-GB   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-ES   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
      2012   -   EUCTR2011-004171-36-CZ   Argentina;Brazil;Canada;Czech Republic;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom
Salazopyrin EN
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
Salazopyrin EN 500 MG enterotabletter
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
Salazopyrin EN-tabs
   North Glasgow NHS Trust
      2004   -   EUCTR2004-002006-30-GB   United Kingdom
   University Hospitals Birmingham NHS Foundation Trust
      2006   Phase 4   EUCTR2006-001428-38-GB   United Kingdom
Salazopyrine
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   University Hospitals Leuven
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
Salazosulfapyridine
   Higashi-Hiroshima Memorial Hospital
      2009   Phase 4   JPRN-UMIN000002169   Japan
   St Luke's International Hospital
      2010   -   JPRN-UMIN000003615   Japan
Saline
   Assiut University
      2017   -   NCT03394131   Egypt
   Peking Union Medical College Hospital
      2014   -   ChiCTR1800014846   China
Saline solution
   Instituto Mexicano del Seguro Social
      2021   Phase 1/Phase 2   NCT06656169   Mexico
Salirumab
   Shinshu University
      2018   Phase 2   NCT03784261   Japan
SAN-300 0.5 MG/KG QW
   Bausch Health Americas, Inc.
      2013   Phase 2   NCT02047604   United States
SAN-300 1.0 MG/KG QW
   Bausch Health Americas, Inc.
      2013   Phase 2   NCT02047604   United States
SAN-300 2.0 MG/KG QOW
   Bausch Health Americas, Inc.
      2013   Phase 2   NCT02047604   United States
SAN-300 4.0 MG/KG QOW
   Bausch Health Americas, Inc.
      2013   Phase 2   NCT02047604   United States
SAN-300 4.0 MG/KG QW
   Bausch Health Americas, Inc.
      2013   Phase 2   NCT02047604   United States
Sandimmun neoral*30CPS 100MG
   PFIZER
      2007   -   EUCTR2007-001984-31-IT   Belgium;Czech Republic;France;Germany;Italy;Netherlands;Portugal;Spain
Sandimmun neoral*50CPS 25MG
   PFIZER
      2007   -   EUCTR2007-001984-31-IT   Belgium;Czech Republic;France;Germany;Italy;Netherlands;Portugal;Spain
SAR
   sanofi-aventis recherche & développement
      2010   -   EUCTR2009-016266-90-FI   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
SAR153191
   SANOFI- AVENTIS RECHERCHE ET DÉVELOPPEMENT
      2013   -   EUCTR2011-003538-16-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
   SANOFI-AVENTIS S.P.A
      2011   Phase 3   EUCTR2010-019262-86-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Italy;Korea, Democratic People's Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Ukraine;United Kingdom;United States
   Sanofi
      2018   -   NCT03378219   Canada;United States
      2015   Phase 1   NCT02404558   Japan
      2014   Phase 3   NCT02293902   Japan
      2014   Phase 3   NCT02121210   Chile;Czech Republic;Czechia;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 1   NCT02017639   Korea, Republic of;Moldova, Republic of;United States
      2013   Phase 1   NCT01850680   Japan
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 1   NCT01328522   United States
      2010   Phase 3   NCT01146652   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   Sanofi-aventis Recherche & D?veloppement
      2010   -   EUCTR2010-021020-94-IT   Czech Republic;Germany;Hungary;Italy;Spain
   Sanofi-aventis Recherche & Développement
      2011   -   EUCTR2010-021020-94-HU   Czech Republic;Germany;Hungary;Italy;Spain
      2011   -   EUCTR2010-021020-94-DE   Czech Republic;Germany;Hungary;Italy;Spain
      2011   Phase 2   EUCTR2009-016266-90-ES   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
      2010   -   EUCTR2010-021020-94-ES   Czech Republic;Germany;Hungary;Italy;Spain
      2010   -   EUCTR2010-021020-94-CZ   Czech Republic;Germany;Hungary;Italy;Spain
      2010   Phase 2;Phase 3   EUCTR2009-016266-90-RO   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
      2010   Phase 2;Phase 3   EUCTR2009-016266-90-NL   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
      2010   -   EUCTR2009-016266-90-LT   Austria;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
      2010   -   EUCTR2009-016266-90-GR   Austria;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
      2010   -   EUCTR2009-016266-90-CZ   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Portugal;Romania;Spain
   sanofi-aventis Recherche & Développement
      2014   Phase 3   EUCTR2012-004339-21-PL   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2014   Phase 3   EUCTR2010-019262-86-SE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-NO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-AT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-ES   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2011   Phase 3   EUCTR2010-019262-86-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-LT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-GR   Austria;Belgium;Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2010-019262-86-FI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002790-22-HU   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   -   EUCTR2013-002790-22-EE   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2013-002790-22-CZ   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2011-003538-16-SK   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-LT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-GR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2011   -   EUCTR2009-016266-90-PT   Argentina;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   Phase 2;Phase 3   EUCTR2009-016266-90-BE   Argentina;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   -   EUCTR2009-016266-90-AT   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-HU   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-FI   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-DE   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
SAR153191-C1f3 drug product
   Sanofi
      2010   Phase 1   NCT06159452   -
SAR153191-P2 drug product
   Sanofi
      2010   Phase 1   NCT06159452   -
SAR153191-P3 drug product
   Sanofi
      2010   Phase 1   NCT06159452   -
SAR441566
   Sanofi
      2023   Phase 2   NCT06073093   Argentina;Brazil;Canada;Chile;China;Czechia;Georgia;Germany;Greece;India;Japan;Mauritius;Mexico;Poland;Puerto Rico;Slovakia;South Africa;Spain;United States
      2023   Phase 1   NCT05858788   United States
      2023   Phase 1   NCT05844735   United States
Sarilumab
   Cliniques universitaires Saint-Luc
      2020   Phase 4   EUCTR2019-003138-17-BE   Belgium
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000868-18-IT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Sweden;United Kingdom;United States
   Gaylis, Norman B., M.D.
      2018   Phase 3   NCT03535402   United States
   GlaxoSmithKline
      2019   Phase 3   NCT04134728   Argentina;Belgium;Canada;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2020   Phase 3   EUCTR2019-000868-18-DE   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-PL   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-LT   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-HU   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Lithuania;Poland;South Africa;Spain;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-GB   Argentina;Belgium;Canada;China;Czech Republic;Czechia;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-ES   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000868-18-CZ   Argentina;Belgium;Canada;China;Czech Republic;Germany;Hungary;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;South Africa;Spain;Ukraine;United Kingdom;United States
   IDIVAL
      2020   Phase 4   EUCTR2019-004078-24-ES   Spain
   Instituto de Investigación Marqués de Valdecilla
      2020   Phase 4   NCT04350216   -
   Kawahito Yutaka
      2022   -   JPRN-jRCTs031210665   -
   Ogasawara Michihiro
      2023   Phase 4   JPRN-jRCT1031230107   -
   Regeneron Pharmaceuticals
      2014   Phase 1   NCT02097524   United States
   SANOFI- AVENTIS RECHERCHE ET DÉVELOPPEMENT
      2013   -   EUCTR2011-003538-16-IT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
   Sanofi
      2018   Phase 4   NCT03449758   France
      2018   -   NCT03378219   Canada;United States
      2015   Phase 1   NCT02404558   Japan
      2015   Phase 3   NCT02373202   Japan
      2015   Phase 3   NCT02332590   Chile;Czech Republic;Czechia;France;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 3   NCT02293902   Japan
      2014   Phase 3   NCT02121210   Chile;Czech Republic;Czechia;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2014   Phase 1   NCT02017639   Korea, Republic of;Moldova, Republic of;United States
      2013   Phase 1   NCT01850680   Japan
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   NCT01764997   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Czechia;Ecuador;Finland;France;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United Kingdom;United States
      2012   Phase 3   NCT01709578   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
      2010   Phase 2   NCT01217814   Brazil;Canada;Colombia;Czech Republic;Czechia;Germany;Hungary;Italy;Mexico;Norway;Spain;United States
      2010   Phase 2/Phase 3   NCT01061736   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Philippines;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   University of Southern Denmark
      2021   Phase 1/Phase 2   NCT04842981   Denmark
      2021   Phase 1;Phase 2   EUCTR2020-005998-27-DK   Denmark
   sanofi-aventis Recherche & Développement
      2014   Phase 3   EUCTR2012-004339-21-PL   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2014   Phase 3   EUCTR2010-019262-86-SE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-NO   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-GB   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2010-019262-86-BE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-NO   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LV   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-LT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-IT   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-HU   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-GR   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001984-66-GB   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-FI   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-ES   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-DE   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2012-001984-66-CZ   Argentina;Australia;Brazil;Chile;Colombia;Czech Republic;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Peru;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-SK   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2010-019262-86-CZ   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-PT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2012   Phase 3   EUCTR2010-019262-86-AT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-NL   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2011   Phase 3   EUCTR2010-019262-86-DE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-LT   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-HU   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-FI   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
      2010   Phase 3   EUCTR2010-019262-86-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Norway;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States
   sanofi-aventis recherche & développement
      2015   Phase 3   EUCTR2014-002541-22-HU   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   -   EUCTR2014-002541-22-GB   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-ES   Argentina;Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Mexico;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-DE   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2014-002541-22-CZ   Chile;Czech Republic;Germany;Hungary;Israel;Korea, Republic of;Peru;Poland;Puerto Rico;Romania;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   -   EUCTR2013-002790-22-HU   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   -   EUCTR2013-002790-22-EE   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2014   Phase 3   EUCTR2013-002790-22-CZ   Argentina;Chile;Czech Republic;Estonia;Hungary;Poland;Russian Federation;United States
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2011-003538-16-SK   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-PL   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-LT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-HU   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-GR   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-ES   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   Phase 3   EUCTR2011-003538-16-DE   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-CZ   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2013   -   EUCTR2011-003538-16-AT   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Ecuador;Estonia;Germany;Greece;Guatemala;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Switzerland;Taiwan;Turkey;Ukraine;United States
      2011   -   EUCTR2009-016266-90-PT   Argentina;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   Phase 2;Phase 3   EUCTR2009-016266-90-BE   Argentina;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Ukraine;United States
      2011   -   EUCTR2009-016266-90-AT   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-HU   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-FI   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-EE   Argentina;Australia;Austria;Belarus;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
      2010   -   EUCTR2009-016266-90-DE   Argentina;Australia;Austria;Belarus;Brazil;Canada;Chile;Colombia;Czech Republic;Egypt;Estonia;Finland;Germany;Greece;Hungary;India;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Philippines;Portugal;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States
SB 681323
   GlaxoSmithKline
      2006   Phase 2   EUCTR2005-002219-26-HU   Denmark;Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
SB-681323
   GLAXO SMITHKLINE
      2005   -   EUCTR2005-002219-26-IT   Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
   GlaxoSmithKline
      2005   Phase 2   NCT00320450   Denmark;Germany;Hong Kong;Hungary;Italy;Norway;Poland;Spain;Sweden;United Kingdom
      2005   Phase 2   NCT00134693   Australia;France;Germany;Russian Federation;United Kingdom
SB-681323 oral tablets
   GlaxoSmithKline
      2005   Phase 1   NCT00419809   Australia
SB-681323 tablets
   GlaxoSmithKline R&D Ltd
      2006   Phase 2   EUCTR2005-002219-26-NO   Denmark;Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002219-26-SE   Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
      2005   Phase 2   EUCTR2005-002219-26-DK   Denmark;Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002219-26-DE   Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-005115-29-DE   Germany;United Kingdom
   GlaxoSmithKline Research & Development Ltd
      2006   Phase 2   EUCTR2005-002219-26-GB   Denmark;Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
      2005   Phase 2   EUCTR2004-005115-29-GB   Germany;United Kingdom
   GlaxoSmithKline S.A.
      2005   Phase 2   EUCTR2005-002219-26-ES   Denmark;Germany;Hungary;Italy;Norway;Spain;Sweden;United Kingdom
SB2
   Samsung Bioepis Co., Ltd.
      2013   Phase 3   NCT01936181   Bulgaria;Lithuania
      2013   -   EUCTR2012-005733-37-LV   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   -   EUCTR2012-005733-37-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-GB   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005733-37-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;India;Korea, Republic of;Latvia;Lithuania;Mexico;Philippines;Poland;Romania;Ukraine;United Kingdom
SB4
   Samsung Bioepis Co., Ltd.
      2013   Phase 3   NCT01895309   Poland;United Kingdom
      2013   -   EUCTR2012-005026-30-PL   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-LT   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005026-30-HU   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-CZ   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-BG   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
SB5
   Samsung Bioepis Co., Ltd
      2015   -   EUCTR2014-004887-39-PL   Poland
   Samsung Bioepis Co., Ltd.
      2014   Phase 3   NCT02167139   Lithuania;Poland
      2014   -   EUCTR2013-005013-13-PL   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Latvia;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-LT   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   -   EUCTR2013-005013-13-CZ   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
      2014   Phase 3   EUCTR2013-005013-13-BG   Bosnia and Herzegovina;Bulgaria;Czech Republic;Korea, Republic of;Lithuania;Mexico;Poland;Russian Federation;Ukraine;United Kingdom
SBI-087
   Pfizer
      2009   Phase 2   NCT01008852   Argentina;Canada;Chile;Greece;Hungary;Japan;Mexico;Poland;Serbia;Spain;Turkey;United States
      2008   Phase 1   NCT00815906   Japan
      2008   Phase 1   NCT00641225   Canada;United States
   Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company
      2010   -   EUCTR2009-010516-15-PL   Greece;Hungary;Poland;Spain
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2010   Phase 2   EUCTR2009-010516-15-GR   Greece;Hungary;Poland;Spain
      2010   Phase 2   EUCTR2009-010516-15-ES   Greece;Hungary;Poland;Spain
      2009   -   EUCTR2009-010516-15-HU   Greece;Hungary;Poland;Spain
SBT777101
   Sonoma Biotherapeutics, Inc.
      2024   Phase 1   NCT06201416   United States
SC golimumab
   Merck Sharp & Dohme Corp.
      2009   Phase 3   NCT00975130   Argentina;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Ecuador;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Mexico;Monaco;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom
SC12267
   4SC AG
      2009   Phase 2   NCT01010581   Bulgaria;Czech Republic;Poland;Romania
      2009   -   EUCTR2009-012953-39-PL   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-CZ   Bulgaria;Czech Republic;Poland
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
      2006   -   EUCTR2006-003142-42-DE   Germany
SCH 900259
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2010   -   EUCTR2009-011137-26-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Schering-Plough Research Institute, A Division of Schering Corporation
      2010   -   EUCTR2009-011137-26-PL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-011137-26-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-SK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-IE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-HU   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-ES   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Shering Plough Research Institute, A division of Schering Plough Corporation
      2010   -   EUCTR2009-011137-26-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
SCH900259
   Shering Plough Research Institute, A division of Schering Plough Corporation
      2010   -   EUCTR2009-011137-26-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
SCIO-469
   Scios, Inc.
      2004   Phase 2   NCT00089921   United States
      2002   Phase 2   NCT00043732   United States
SD-QIV
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2016   Phase 4   NCT02936180   Canada
Seal OIL
   Laval University
      2022   -   NCT04688398   Canada
Seasonal influenza vaccine
   Seoul National University Hospital
      2015   Phase 4   NCT02748785   Korea, Republic of
   Tel-Aviv Sourasky Medical Center
      2013   Phase 4   NCT01980836   Israel
Secukinmab
   Novartis Pharmaceuticals
      2009   Phase 2   NCT00928512   Belgium;Czech Republic;Germany;Hungary;Japan;Korea, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;Taiwan;United States
Secukinumab
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   NOVARTIS FARMA
      2012   -   EUCTR2012-002760-27-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-IT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   -   EUCTR2011-000275-13-IT   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-IT   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2010-024516-34-IT   Bulgaria;Canada;Hungary;Italy;United States
   Novartis Farma S.p.A.
      2013   -   EUCTR2013-000944-25-IT   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
   Novartis Farmaceutica, S.A.
      2012   -   EUCTR2012-002760-27-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Farmacéutica S.A.
      2011   -   EUCTR2011-000102-21-ES   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma AG
      2012   -   EUCTR2012-002760-27-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2012-002760-27-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-PT   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2011-006058-94-GR   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   -   EUCTR2011-000275-13-HU   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000275-13-GB   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000275-13-BE   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Thailand;Turkey;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-SK   Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Hungary;Italy;Mexico;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2010-024516-34-SK   Bulgaria;Canada;Hungary;Italy;Slovakia;United States
      2011   -   EUCTR2010-024516-34-HU   Bulgaria;Canada;Hungary;Italy;United States
      2011   -   EUCTR2010-024516-34-BG   Bulgaria;Canada;Hungary;Italy;Slovakia;United States
   Novartis Pharma K.K.
      2013   Phase 3   JPRN-jRCT2080222163   -
      2013   Phase 3   JPRN-jRCT2080222045   -
      2011   Phase 3   JPRN-jRCT2080221561   -
   Novartis Pharma Services AG
      2013   -   EUCTR2012-002760-27-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharma Services AG
      2013   -   EUCTR2013-000944-25-HU   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Thailand;United States
      2013   -   EUCTR2011-006058-94-DE   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2012   -   EUCTR2012-002760-27-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2012   -   EUCTR2011-006058-94-CZ   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;South Africa;United States
      2011   Phase 2   EUCTR2011-001220-38-GB   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   -   EUCTR2011-001220-38-DE   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   Phase 2   EUCTR2011-001220-38-BE   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   -   EUCTR2011-000102-21-HU   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-DE   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-CZ   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   -   EUCTR2011-000102-21-BG   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
   Novartis Pharmaceuticals
      2013   Phase 3   NCT01901900   Argentina;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Puerto Rico;Thailand;United States
      2012   Phase 3   NCT01770379   Argentina;Brazil;Colombia;Czech Republic;Dominican Republic;Ecuador;Germany;Greece;Guatemala;India;Italy;Japan;Korea, Republic of;Panama;Portugal;Puerto Rico;South Africa;United States
      2012   Phase 3   NCT01640938   Brazil;Bulgaria;Canada;Colombia;Czech Republic;France;Germany;Hungary;Italy;Mexico;Romania;Russian Federation;Slovakia;Spain;United States
      2011   Phase 2   NCT01426789   Belgium;Germany;Russian Federation;United Kingdom;United States
      2011   Phase 3   NCT01377012   Argentina;Belgium;Canada;Colombia;Guatemala;Hungary;India;Italy;Japan;Mexico;Panama;Peru;Puerto Rico;Romania;Thailand;Turkey;United Kingdom;United States
      2011   Phase 2   NCT01359943   Bulgaria;Canada;Hungary;Italy;Poland;Puerto Rico;Slovakia;United States
SEE D.3.9.3 'other descriptive name' below
   Rottapharm Biotech S.r.l.
      2017   Phase 2   EUCTR2016-004834-11-PL   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-DK   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-CZ   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
      2017   Phase 2   EUCTR2016-004834-11-BG   Argentina;Bulgaria;Czech Republic;Denmark;Moldova, Republic of;Poland;Romania;United Kingdom
Serum metal ION levels determined TO monitor changes IN chromium and cobalt levels
   Zimmer Biomet
      2009   -   NCT03681639   Germany
Sham stimulation
   Galvani Bioelectronics
      2021   -   NCT05003310   Netherlands;United States
Sham vagus nerve stimulation
   Xijing Hospital
      2019   -   NCT04037111   China
Shingrix
   Region Skane
      2019   Phase 4   NCT03886038   Sweden
   Watanabe Ryu
      2022   Phase 4   JPRN-jRCTs051220105   -
Short chain fatty acids (scfa) dietary supplement
   NYU Langone Health
      2021   -   NCT05152615   United States
SHR-3045 injection
   Guangdong Hengrui Pharmaceutical Co., Ltd
      2025   Phase 1   NCT06883695   China
SHR0302
   Jiangsu HengRui Medicine Co., Ltd.
      2020   Phase 3   NCT04333771   China
      2017   Phase 2   NCT03254966   China
      2016   Phase 1   NCT02892370   China
      2016   Phase 1   NCT02665910   China
      2015   Phase 1   NCT02423538   China
SHR0302 tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Sildenafil
   Kimberly Liang
      2017   Phase 2   NCT02908490   United States
Silymarin
   Phramongkutklao College of Medicine and Hospital
      2024   -   NCT06277635   Thailand
Simplejecttm
   Amgen
      2002   Phase 4   NCT00121043   -
Simplex® bone cement
   Zimmer Biomet
      2006   -   NCT00589485   United States
Simponi
   AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA
      2017   Phase 4   EUCTR2016-003129-40-IT   Italy
   Alvotech Swiss AG
      2023   Phase 3   NCT05842213   Bulgaria
      2023   Phase 3   EUCTR2022-001825-63-LT   Bulgaria;Czechia;Georgia;Lithuania;Poland;Serbia
      2023   Phase 3   EUCTR2022-001825-63-BG   Bulgaria;Georgia;Lithuania;Poland
   Diakonhjemmet Hospital AS
      2013   Phase 4   EUCTR2012-005275-14-NO   Norway
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   MD, PhD Salome Kristensen
      2017   Phase 4   EUCTR2017-001970-41-DK   Denmark
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   MedImmune Limited
      2013   Phase 2   EUCTR2011-005649-10-GB   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   MedImmune Ltd
      2013   -   EUCTR2011-005649-10-SK   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-PT   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-HU   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-DE   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2013   -   EUCTR2011-005649-10-CZ   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-GR   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
      2012   -   EUCTR2011-005649-10-ES   Argentina;Brazil;Czech Republic;France;Germany;Greece;Hungary;Israel;Mexico;Portugal;Russian Federation;Slovakia;Spain;United Kingdom
   Merck Sharp & Dohme Corp.
      2010   -   NCT01313858   Germany
   Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
      2010   -   EUCTR2009-011137-26-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   READE
      2015   Phase 4   EUCTR2015-002284-42-FI   Finland
   SCHERING PLOUGH RESEARCH INSTITUTE, A DIVISION OF SCHERING CORPORATION
      2012   -   EUCTR2011-000311-34-IT   Canada;Finland;Germany;Greece;Italy;Russian Federation;Spain;Turkey;United Kingdom;United States
   Sanofi-aventis Recherche & D?veloppement
      2010   -   EUCTR2010-021020-94-IT   Czech Republic;Germany;Hungary;Italy;Spain
   Sanofi-aventis Recherche & Développement
      2011   -   EUCTR2010-021020-94-HU   Czech Republic;Germany;Hungary;Italy;Spain
      2011   -   EUCTR2010-021020-94-DE   Czech Republic;Germany;Hungary;Italy;Spain
      2010   -   EUCTR2010-021020-94-CZ   Czech Republic;Germany;Hungary;Italy;Spain
   Schering-Plough Research Institute, A Division of Schering Corporation
      2010   -   EUCTR2009-011137-26-PL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2010   Phase 3   EUCTR2009-011137-26-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2010   -   EUCTR2009-011137-26-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2009-011137-26-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Slovakia;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
      2009   -   EUCTR2009-011137-26-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Poland;Portugal;Spain;United Kingdom
   Sint Maartenskliniek
      2020   Phase 4   EUCTR2019-004101-27-NL   Netherlands
Simponi 50 MG solucióN inyectable EN pluma precargada
   Sanofi-aventis Recherche & Développement
      2010   -   EUCTR2010-021020-94-ES   Czech Republic;Germany;Hungary;Italy;Spain
Simvastatin
   AstraZeneca
      2012   Phase 1   NCT01725230   United States
   Hoffmann-La Roche
      2005   Phase 1   NCT00365001   New Zealand;United States
   MD, PhD, Annemarie Lyng Svensson
      2014   -   NCT02246257   Denmark
   Sanofi
      2014   Phase 1   NCT02017639   Korea, Republic of;Moldova, Republic of;United States
Simvastatin 20 MG
   King Edward Medical University
      2017   Phase 4   NCT04177173   Pakistan
Sinomenine
   Guangdong Provincial Hospital of Chinese Medicine
      2015   -   ChiCTR-IPR-15007415   China
Sirolimus
   Children's Hospital of Philadelphia
      2006   Phase 1/Phase 2   NCT00392951   United States
   The Second Hospital of Shanxi Medical University
      2019   Phase 4   ChiCTR1900024261   China
   the Second Hospital of Shanxi Medical University
      2017   -   ChiCTR-IPR-17011566   China
Sirukumab
   JANSSEN-CILAG INTERNATIONAL N.V.
      2012   -   EUCTR2010-022243-38-IT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Portugal;Spain;Taiwan;United Kingdom;United States
   Janssen Pharmaceutical K.K.
      2015   Phase 3   JPRN-jRCT2080223019   -
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
      2012   Phase 3   NCT01606761   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   NCT01604343   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
   Janssen-Cilag International N.V.
      2015   Phase 3   EUCTR2012-001176-10-BG   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-LT   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-HU   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2013-001417-32-ES   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-DE   Argentina;Austria;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2013-001417-32-BG   Argentina;Brazil;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2014   Phase 3   EUCTR2012-001176-10-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-PL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-IT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-HR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2014   Phase 3   EUCTR2012-001176-10-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-LT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001176-10-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
      2013   -   EUCTR2010-022243-38-NL   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2013   Phase 3   EUCTR2010-022242-24-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
      2012   -   EUCTR2010-022243-38-PT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-LT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022243-38-GB   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-ES   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Netherlands;Poland;Portugal;Serbia;Spain;Sweden;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-DE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-BE   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   -   EUCTR2010-022243-38-AT   Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Croatia;France;Germany;Italy;Japan;Korea, Republic of;Lithuania;Mexico;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Serbia;Spain;Taiwan;United Kingdom;United States
      2012   Phase 3   EUCTR2010-022242-24-LT   Argentina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Taiwan;Ukraine;United States
Sirukumab 100 MG
   Janssen Pharmaceutical K.K.
      2012   Phase 3   NCT01689532   Japan
   Janssen Research & Development, LLC
      2014   Phase 3   NCT02019472   Argentina;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2013   Phase 3   NCT01856309   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;France;Germany;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
Sirukumab 50 MG
   Janssen Pharmaceutical K.K.
      2012   Phase 3   NCT01689532   Japan
   Janssen Research & Development, LLC
      2014   Phase 3   NCT02019472   Argentina;Bulgaria;Chile;Colombia;Germany;Hungary;Lithuania;Mexico;Moldova, Republic of;Peru;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Ukraine;United States
      2013   Phase 3   NCT01856309   Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;France;Germany;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States
SKI-O-703
   Oscotec Inc.
      2019   Phase 2   NCT04057118   Czechia;Poland;Russian Federation;Ukraine;United States
      2019   Phase 2   EUCTR2018-003330-32-PL   Czech Republic;Korea, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States
SKI-O-703 capsule
   Oscotec Inc.
      2015   Phase 1   NCT02717988   United States
SM03
   SinoMab Pty Ltd
      2017   Phase 3   NCT04312815   China
      2014   Phase 2   NCT04192617   China
SMP-114
   Dainippon Sumitomo Pharma Europe LTd.
      2006   Phase 2   NCT00296257   Czech Republic;Germany;Hungary;Netherlands;Poland;United Kingdom
   Dainippon Sumitomo Pharma Europe Ltd
      2005   -   EUCTR2005-003436-21-GB   Czech Republic;Germany;Hungary;United Kingdom
   Dainippon Sumitomo Pharma Europe Ltd.
      2006   -   EUCTR2005-003436-21-DE   Czech Republic;Germany;Hungary;United Kingdom
      2006   -   EUCTR2005-003436-21-CZ   Czech Republic;Germany;Hungary;United Kingdom
   Sumitomo Pharmaceuticals Europe Limited
      2005   -   EUCTR2005-003436-21-HU   Czech Republic;Germany;Hungary;United Kingdom
Sodium aurothiomalate
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
Sodium butyrate
   Peking University People's Hospital
      2022   Phase 2   NCT05576597   China
Sodium chloride
   AbbVie
      2017   Phase 3   NCT03086343   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   Knowledge Centre for Rheumatology and Back Diseases
      2013   -   EUCTR2013-003486-34-DK   Denmark
   Patrick Durez
      2007   -   NCT01245361   Belgium
Sodium-[O-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Sodium-[O-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Sofusa doseconnect
   Sorrento Therapeutics, Inc.
      2021   Phase 1   NCT04559412   United States
SOL-116
   Lipum AB
      2022   Phase 1   NCT05576012   Netherlands
SOLU-medrone 125MG
   Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc.
      2009   -   EUCTR2007-006150-25-DE   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
      2008   -   EUCTR2007-006150-25-HU   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-006150-25-NL   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-FR   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-BE   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   -   EUCTR2007-006150-25-AT   Austria;Belgium;France;Germany;Hungary;Netherlands
SOLU-medrone 2 gram
   University of Leeds
      2006   Phase 4   EUCTR2005-005013-37-GB   United Kingdom
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
SOLU-medrone 2MG
   University of Leeds
      2006   Phase 4   EUCTR2005-004582-41-GB   United Kingdom
Solumedrol
   Sohag University
      2024   Phase 3   NCT06456489   Egypt
Somatropin [rdna origin] FOR injection
   Nationwide Children's Hospital
      2007   Phase 2/Phase 3   NCT00511329   United States
Spinal anesthesia with tourniquet
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
Spinal anesthesia without tourniquet
   Riku Antero Palanne
      2016   -   NCT03364088   Finland
Spironolactone
   University Hospital, Strasbourg, France
      2022   Phase 3   NCT05092984   France
Spironolactone mylan 25 MG comprimé pelliculé Sécable
   Hopitaux Universitaires de Strasbourg
      2021   Phase 3   EUCTR2021-003958-23-FR   France;Switzerland
SSR150106
   Sanofi
      2007   Phase 2   NCT00545454   Bulgaria;Croatia;Czech Republic;Czechia;Former Serbia and Montenegro;Romania;Russian Federation;Slovakia;Ukraine
SSR150106XB
   sanofi-aventis recherche & développement
      2008   Phase 2   EUCTR2007-000760-24-SK   Czech Republic;Slovakia
      2007   Phase 2   EUCTR2007-000760-24-CZ   Czech Republic
ST36
   Traditional Chinese Medicine Hospital of Dianjiang Chongqing
      2023   Phase 1   ChiCTR2300075439   China
STA 5326 mesylate
   Synta Pharmaceuticals Corp.
      2005   Phase 2   NCT00642629   Netherlands
Stable weekly dose OF methotrexate
   Amgen
      2009   Phase 2   NCT00950989   Bulgaria;Canada;Czech Republic;Hungary;Latvia;Mexico;Poland;United Kingdom;United States
Statins
   Sherief Abd-Elsalam
      2018   Phase 3   NCT03770702   Egypt
Stem cell transplantation
   Stem Cells Arabia
      2016   Phase 1   NCT03067870   -
Stem cells
   Tigenix S.A.U.
      2011   Phase 1/Phase 2   NCT01663116   Spain
Sterile saline
   Kang Stem Biotech Co., Ltd.
      2018   Phase 1/Phase 2   NCT03618784   Korea, Republic of
Steroid drug
   Assiut University
      2019   Phase 3   NCT04344405   Egypt
Steroids
   Assiut University
      2019   -   NCT03852355   Egypt
Stool analysis
   Centre Hospitalier Universitaire de Nimes
      2016   -   NCT01961310   France
Stools
   Assistance Publique - Hôpitaux de Paris
      2020   -   NCT04584541   France
Stress myocardial perfusion PET
   Brigham and Women's Hospital
      2016   -   NCT02714881   United States
Subcutaneous (SC) abatacept
   Bristol-Myers Squibb
      2009   Phase 2/Phase 3   NCT01001832   Japan
      2008   Phase 3   NCT00559585   Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Turkey;United Kingdom;United States
Subcutaneous abatacept
   Orrin M Troum, M.D. and Medical Associates
      2011   Phase 2/Phase 3   NCT01333878   United States
   St.Marianna University School of Medicine
      2014   -   JPRN-UMIN000015175   Japan
Subcutaneous polyvidone collagen
   Instituto Mexicano del Seguro Social
      2021   Phase 1/Phase 2   NCT06656169   Mexico
Subcutaneous tocilizumab
   Centre Hospitalier Régional d'Orléans
      2016   Phase 4   NCT02765074   France
   St.Marianna University School of Medicine
      2014   -   JPRN-UMIN000015175   Japan
Subcutaneous tocilizumab 162MG/biweekly
   Atsushi Kawakami
      2021   Phase 3   NCT05090410   Japan
Subcutaneous(SC) abatacept
   Jiangsu Simcere Pharmaceutical Co., Ltd.
      2016   Phase 3   NCT02722694   China
Subcutanious administration
   GlaxoSmithKline
      2010   Phase 1   NCT01101555   Russian Federation
Sublingual nitroglycerine
   University of Michigan
      2007   Phase 3   NCT00554853   United States
Sulfasalazine
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Flinders University
      2017   Phase 4   NCT03254589   Australia
   Hoffmann-La Roche
      2013   Phase 3   NCT01941095   Greece
   Hôpitaux Universitaires de Strasbourg
      2015   Phase 4   EUCTR2015-000863-15-FR   France;Monaco
   Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences
      2013   -   ChiCTR-TRC-13002981   -
   Jawaharlal Institute of Postgraduate Medical Education & Research
      2016   Phase 3   NCT02930343   India
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   King's College London
      2007   Phase 4   EUCTR2007-001190-28-GB   United Kingdom
   Leiden University Medical Center, department of rheumatology
      2007   -   EUCTR2006-006186-16-NL   Netherlands
   Merck Sharp & Dohme Corp.
      2007   Phase 3   NCT00521924   Austria
   North Glasgow NHS Trust
      2004   -   EUCTR2004-002006-30-GB   United Kingdom
   P. Verschueren
      2009   Phase 4   NCT01172639   Belgium
   Sanofi
      2018   Phase 4   NCT03449758   France
      2015   Phase 3   NCT02373202   Japan
      2014   Phase 3   NCT02057250   Chile;France;Mexico;Poland;Russian Federation;South Africa;United States
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2012   Phase 3   NCT01709578   Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;Czech Republic;Czechia;Ecuador;Germany;Greece;Guatemala;Hong Kong;Hungary;Israel;Italy;Korea, Republic of;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Taiwan;Turkey;Ukraine;United States
   School of clinical medicine & the first affiliated hospital of chengdu Medical college
      2023   Phase 4   ChiCTR2300072896   China
   University Hospitals Leuven
      2009   Phase 4   EUCTR2008-007225-39-BE   Belgium
   University of Alabama at Birmingham
      2004   Phase 4   NCT00259610   United States
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
   University of Leeds
      2019   Phase 4   NCT03813771   United Kingdom
      2011   Phase 4   NCT02433184   United Kingdom
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   VA Office of Research and Development
      2007   -   NCT00405275   Canada;United States
   VU University Medical Center
      2013   Phase 4   EUCTR2013-003658-26-NL   Netherlands
   Vastra Gotaland Region
      2017   -   NCT03440892   Sweden
   Wyeth is now a wholly owned subsidiary of Pfizer
      2007   Phase 4   NCT00422227   Hong Kong;India;Korea, Republic of;Malaysia;Philippines;Singapore;Taiwan;Thailand
Sulfasalazine + hydroxychloroquine
   Karolinska Institutet
      2006   -   NCT05051137   Sweden
Sulfur pool & medicinal MUD
   Soroka University Medical Center
      2013   -   NCT01861782   Israel
Sulphasalazine
   TIPharma
      2007   -   EUCTR2007-002976-32-NL   Netherlands
Sunflower OIL
   University of Jena
      2013   -   NCT01742468   Germany
Suspension IR
   Pfizer
      2008   Phase 1   NCT00782600   United States
Synovial biopsy
   Barts & The London NHS Trust
      2010   -   NCT02528292   United Kingdom
   Odense University Hospital
      2016   -   NCT02652299   Denmark
Systane™ hydration lubricant EYE drops
   Chang Gung Memorial Hospital
      2024   Phase 4   NCT06209879   Taiwan
Systemic NON-biological treatments
   Janssen Biotech, Inc.
      2009   -   NCT01081717   United States
T cell injection targeting CD19 chimeric antigen receptor
   PersonGen BioTherapeutics (Suzhou) Co., Ltd.
      2024   Early Phase 1   NCT06417398   -
T-5224
   Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
      2010   Phase 2   JPRN-jRCT2080221322   -
T-614
   Eisai Co., Ltd.
      2009   Phase 3   NCT00965757   Japan
T0001
   Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
      2015   Phase 1   NCT02481180   China
TA-650 10 MG/KG
   Mitsubishi Tanabe Pharma Corporation
      2005   Phase 3   NCT00691028   -
TA-650 3 MG/KG
   Mitsubishi Tanabe Pharma Corporation
      2005   Phase 3   NCT00691028   -
TA-650 6 MG/KG
   Mitsubishi Tanabe Pharma Corporation
      2005   Phase 3   NCT00691028   -
TAB08
   Theramab LLC
      2013   Phase 1/Phase 2   NCT01990157   Russian Federation
Tabalumab
   Eli Lilly and Company
      2013   -   EUCTR2012-001618-40-PL   Argentina;Czech Republic;Poland;Russian Federation;United States
      2012   -   EUCTR2012-001618-40-CZ   Argentina;Czech Republic;Poland;Russian Federation;United States
      2009   Phase 1   NCT01253226   Japan
Tabalumab AUTO-injector
   Eli Lilly and Company
      2012   Phase 3   NCT01676701   Argentina;Czech Republic;Czechia;Poland;Puerto Rico;Russian Federation;United States
Tabalumab prefilled syringe
   Eli Lilly and Company
      2012   Phase 3   NCT01676701   Argentina;Czech Republic;Czechia;Poland;Puerto Rico;Russian Federation;United States
Taci - FC5
   SERONO INTERNATIONAL SA
      2007   -   EUCTR2006-004140-23-IT   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
TACI-FC5
   Merck Serono Int, a branch of Laboratoires Seron SA an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-DE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt, Germany
      2008   -   EUCTR2006-004140-23-GB   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   Phase 2   EUCTR2006-004140-23-SK   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-PT   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-CZ   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-BE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch of Laboratoires Serono SA, an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-FI   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany
      2007   -   EUCTR2006-004140-23-SE   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono Int.a branch of Laboratoires Serono SA an affiliate of Merck KgaA, Darmstadt, Germany
      2006   -   EUCTR2006-004140-23-NL   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono International
      2008   -   EUCTR2007-003647-75-SE   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-NL   Finland;France;Netherlands;Sweden;United Kingdom
      2008   Phase 2   EUCTR2007-003647-75-FR   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-003647-75-FI   Finland;France;Netherlands;Sweden;United Kingdom
      2008   -   EUCTR2007-002536-29-PT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-GR   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   Phase 2   EUCTR2007-002536-29-ES   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-DE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-CZ   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BG   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2008   -   EUCTR2007-002536-29-BE   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-SE   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   Phase 2   EUCTR2007-002536-29-FI   Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      2007   -   EUCTR2007-002536-29-AT   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
      -   -   EUCTR2007-002536-29-PL   Austria;Bulgaria;Czech Republic;Finland;France;Germany;Greece;Italy;Poland;Portugal;Spain;Sweden
   Merck Serono International S.A.
      2007   -   EUCTR2006-004140-23-GR   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   Merck Serono SA - Geneva
      2008   Phase 2   EUCTR2007-003647-75-GB   Finland;France;Netherlands;Sweden;United Kingdom
   Serono International S.A.
      2007   Phase 2   EUCTR2006-004140-23-ES   Belgium;Bulgaria;Czech Republic;Finland;Germany;Greece;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom
      2007   -   EUCTR2006-004140-23-BG   Belgium;Bulgaria;Finland;Germany;Greece;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
Tacrolimus
   Astellas Pharma Inc
      2012   -   NCT01870908   Japan
      2011   Phase 4   NCT01511003   Korea, Republic of
      2009   Phase 4   NCT01224041   Korea, Republic of
      2008   Phase 4   NCT01224418   Korea, Republic of
      2006   Phase 4   NCT00319917   Japan
      2002   Phase 3   NCT00036153   Canada;United States
   Astellas Pharma Korea, Inc.
      2019   Phase 4   NCT03737708   Korea, Republic of
   Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University
      2013   -   JPRN-UMIN000010126   Japan
   Department of Rheumatology and infectious disease, Kitasato university school of medicine
      2012   -   JPRN-UMIN000008572   Japan
   Juntendo University
      2012   -   JPRN-UMIN000007205   Japan
   National hospital organization Chiba east national hospital Clinical Research Center
      2013   -   JPRN-UMIN000012690   Japan
   Qiang Shu
      2015   Phase 4   NCT02837978   China
   Rheumatosurgery, Osaka City University Medical School
      2006   -   JPRN-UMIN000000512   Japan
   Sanofi
      2015   Phase 3   NCT02373202   Japan
   Tokyo Medical and Dental University
      2012   -   JPRN-UMIN000006702   Japan
Tacrolimus with methotrexate
   Chong Kun Dang Pharmaceutical
      2012   Phase 4   NCT01746680   Korea, Republic of
TAK-715
   Takeda Europe R&D Centre Ltd. (TEuR&D)
      2004   Phase 2   EUCTR2004-002157-30-SK   Denmark;Finland;Slovakia
      2004   -   EUCTR2004-002157-30-FI   Denmark;Finland
      2004   -   EUCTR2004-002157-30-DK   Denmark;Finland
TAK-715 and methotrexate
   Takeda
      2004   Phase 2   NCT00760864   -
TAK-783
   Takeda Global R&D (Europe) Ltd
      2008   -   EUCTR2006-003054-26-HU   Czech Republic;Hungary;Latvia
      2007   -   EUCTR2006-003054-26-LV   Czech Republic;Hungary;Latvia
      2007   -   EUCTR2006-003054-26-CZ   Czech Republic;Hungary;Latvia
TAK-783 and methotrexate
   Takeda
      2007   Phase 2   NCT00760968   Czech Republic;Latvia;Romania;Russian Federation;Slovakia;Ukraine
Targeted synthetic dmard class
   University of Alabama at Birmingham
      2021   Phase 3   NCT04692493   Canada;United States
TAS5315 high dose
   Taiho Pharmaceutical Co., Ltd.
      2018   Phase 2   NCT03605251   Japan
TAS5315 LOW dose
   Taiho Pharmaceutical Co., Ltd.
      2018   Phase 2   NCT03605251   Japan
Tasocitinib
   Pfizer
      2011   Phase 1   NCT01262118   Hungary;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2010   -   EUCTR2009-014296-40-AT   Austria;Belgium;France;Germany;Ireland;Italy;Spain;United Kingdom
Tasocitinib citrate
   Pfizer Inc.
      2011   -   EUCTR2010-020890-18-CZ   Czech Republic;Hungary
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-020890-18-HU   Czech Republic;Hungary
Tasocitinib plus methotrexate
   Pfizer
      2010   Phase 2   NCT01164579   Argentina;Chile;Croatia;Czech Republic;Hungary;Mexico;Poland;Puerto Rico;United States
TBE-vaccine
   Sormland County Council, Sweden
      2010   Phase 2   NCT01131910   Finland;Sweden
TC 99M tilmanocept
   Navidea Biopharmaceuticals
      2021   Phase 2   NCT04078191   United Kingdom;United States
      2019   Phase 2   NCT03938636   United States
TC99M tilmanocept
   Navidea Biopharmaceuticals
      2021   Phase 2   NCT04947137   United States
TC99M-tilmanocept
   Navidea Biopharmaceuticals
      2022   Phase 3   NCT05246280   United States
      2017   Phase 1/Phase 2   NCT02865434   United States
TCK-276
   Teijin America, Inc.
      2022   Phase 1   NCT05437419   United States
Tdmards
   Pfizer
      2012   -   NCT01438892   United States
TEA
   Chengdu PLA General Hospital
      2014   -   NCT02257047   China
TEA consumption
   University of Leeds
      1995   -   NCT06670144   United Kingdom
Technetium labelled glucosamine
   University of Sydney
      2012   -   NCT01789151   Australia
Technetium TC 99M tilmanocept
   Navidea Biopharmaceuticals Ltd
      2020   Phase 2   EUCTR2018-003418-41-GB   European Union;United Kingdom;United States
Telitacicept
   Affiliated Hospital of North Sichuan Medical College
      2025   -   ChiCTR2500101014   China
   Peking Union Medical College Hospital
      2025   Phase 1   ChiCTR2500102443   China
Telitacicept tofacitinib
   Zhejiang Provincial People's Hospital
      2025   -   NCT06979271   China
Telomere length
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
Tendon interposition arthroplasty
   Helsinki University Central Hospital
      2019   -   NCT06804356   Finland
Teriparatide
   Brigham and Women's Hospital
      2011   Phase 4   NCT01400516   United States
Test product
   Dr. Reddy's Laboratories Limited
      2023   Phase 1   NCT06126042   United States
Tetanus + pnemococcal vaccines alone
   Bristol-Myers Squibb
      2004   Phase 1   NCT00279734   United States
Tetanus toxoid
   Eli Lilly and Company
      2011   -   EUCTR2010-022205-17-PL   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
      2011   -   EUCTR2010-022205-17-BG   Argentina;Australia;Brazil;Bulgaria;Colombia;Croatia;Hungary;India;Japan;Korea, Republic of;Lithuania;Malaysia;Mexico;New Zealand;Peru;Poland;Romania;Russian Federation;Slovakia;South Africa;Sri Lanka;Taiwan;Ukraine;United States
   Tel-Aviv Sourasky Medical Center
      2011   Phase 4   NCT01301703   Israel
Tetanus toxoid adsorbed booster vaccine
   Genentech, Inc.
      2006   Phase 2   NCT00282308   United States
Tetanus toxoid adsorbed vaccine
   Genentech, Inc.
      2010   Phase 4   NCT01163747   United States
Tetraccycline-hydrochloride
   Hammersmith Hospitals NHS trust
      2005   Phase 3   EUCTR2004-004893-96-GB   United Kingdom
Tetracycline
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02633332   Italy
Tetrandrine
   Peking University People's Hospital
      2022   -   NCT05245448   China
   The First People's Hospital of Yancheng
      2020   Phase 0   ChiCTR2000030400   China
Tgaac94 gene therapy vector
   Targeted Genetics Corporation
      2004   Phase 1   NCT00617032   Canada;United States
THA
   Department of Orthopedics, the First Affliated Hospital of Xinjiang Medical University
      2024   Phase 4   ChiCTR2400092488   China
THE effectiveness OF xeljanz IN rheumatoid arthritis patients
   Shinshu University
      2014   Phase 4   NCT02157012   Japan
Therapeutic drug monitoring (TDM) OF adalimumab
   Diakonhjemmet Hospital
      2024   Phase 4   NCT06440629   Austria;Norway;Romania;Sweden;United Kingdom
Thiotepa
   Paul Szabolcs
      2014   Phase 2   NCT01962415   United States
Ticagrelor
   NYU Langone Health
      2016   Phase 4   NCT02874092   United States
Tilmanocept
   Navidea Biopharmaceuticals
      2017   Phase 1   NCT03241446   -
      2016   Phase 1   NCT02683421   United States
Tirabrutinib
   Gilead Sciences
      2016   Phase 1   NCT02626026   United States
TL011
   Teva Pharmaceutical Industries
      2012   Phase 3   EUCTR2011-005021-48-PL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-NL   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-HU   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-ES   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-CZ   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
      2012   -   EUCTR2011-005021-48-BG   Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine
TL011, anti CD20, FOR THE treatment OF rheumatoid arthritis
   Teva Pharmaceutical Industries
      2010   Phase 1/Phase 2   NCT01123070   Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom
TLL-018
   Hangzhou Highlightll Pharmaceutical Co., Ltd
      2025   Phase 3   NCT06887127   China
      2023   Phase 3   NCT06020144   China
      2022   Phase 2   NCT05133297   China
TMI-005
   WYETH LEDERLE
      2005   -   EUCTR2004-000012-13-IT   Czech Republic;Estonia;Italy
   Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development
      2005   Phase 2   EUCTR2004-002215-80-HU   Hungary
      2005   -   EUCTR2004-000012-13-EE   Czech Republic;Estonia;Italy
      2004   Phase 2   EUCTR2004-000012-13-CZ   Czech Republic;Estonia;Italy
   Wyeth is now a wholly owned subsidiary of Pfizer
      2003   Phase 2   NCT00095342   Canada;United States
TNF alpha blockers
   Centre Hospitalier Universitaire de Nimes
      2014   -   NCT02927509   -
TNF alpha inhibitors
   Prof. Roberto Giacomelli
      2013   Phase 4   NCT02236481   Italy
TNF antagonist
   Brigham and Women's Hospital
      2011   Phase 4   NCT01400516   United States
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
TNF blockers monotherapy
   Centre Hospitalier Universitaire de Nimes
      2015   -   NCT02927535   -
TNF inhibitor
   Brigham and Women's Hospital
      2021   -   NCT04798287   United States
      2021   -   NCT04772248   United States
   Eli Lilly and Company
      2020   Phase 4   NCT04086745   United States
      2019   Phase 4   NCT03915964   Australia;Austria;Belgium;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States
   Gilead Sciences
      2016   Phase 2   NCT02862574   Australia;Hungary;Taiwan;United States
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   University Hospital, Montpellier
      2022   Phase 3   NCT05428488   France;Monaco
TNF inhibitor/TCZ
   Hoffmann-La Roche
      2016   -   NCT02679001   Sweden
TNF inhibitors
   Columbia University
      2011   Phase 4   NCT01548768   United States
   Diakonhjemmet Hospital
      2013   Phase 4   NCT01881308   Norway
TNF kinoid
   Neovacs
      2009   Phase 2   NCT01040715   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania;Switzerland
TNF start
   Region Skane
      2016   -   NCT03775824   -
TNF-A antagonists, NON-tnfs, dmard NON-biologics
   Biologics & Biosimilars Collective Intelligence Consortium
      2012   -   NCT02922192   -
TNF-A inhibitor or JAK inhibitor
   Vastra Gotaland Region
      2020   -   NCT04378621   Sweden
TNF-alpha antagonist and other biotherapy
   Central Hospital, Nancy, France
      2007   -   NCT02886689   France
TNF-alpha antagonists
   Assistance Publique - Hôpitaux de Paris
      2004   -   NCT00224562   France
TNF-alpha inhibitor
   University of Erlangen-Nürnberg Medical School
      2015   -   NCT02778789   Germany
TNF-blockers suspension IN patients with rheumatoid arthritis
   University Hospital of Ferrara
      2013   -   NCT03736044   -
TNF-K
   Neovacs SA
      2013   -   EUCTR2013-001999-38-PL   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   Phase 2   EUCTR2013-001999-38-HU   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   Phase 2   EUCTR2013-001999-38-CZ   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2013-001999-38-BE   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2010   -   EUCTR2009-012041-35-BG   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania
      2010   Phase 2   EUCTR2009-012041-35-BE   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania
      2009   -   EUCTR2009-012041-35-FR   Bulgaria;France
TNF-kinoid
   Neovacs
      2013   Phase 2   NCT01911234   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, The Former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
   Neovacs SA
      2013   -   EUCTR2013-001999-38-PL   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   Phase 2   EUCTR2013-001999-38-HU   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   Phase 2   EUCTR2013-001999-38-CZ   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2013   -   EUCTR2013-001999-38-BE   Belgium;Czech Republic;Georgia;Hungary;Lebanon;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine
      2010   -   EUCTR2009-012041-35-BG   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania
      2010   Phase 2   EUCTR2009-012041-35-BE   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania
      2009   -   EUCTR2009-012041-35-FR   Bulgaria;France
Tnfa kinoid
   Neovacs
      2009   Phase 2   NCT01040715   Argentina;Belgium;Bulgaria;Chile;Croatia;France;Romania;Switzerland
Tnfi
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Marie Hudson, MD
      2023   -   NCT05305066   Canada
   Pfizer
      2024   -   NCT06418529   United States
Tnfr:FC
   National Eye Institute (NEI)
      1999   Phase 3   NCT00012506   United States
   Samsung Bioepis Co., Ltd.
      2013   -   EUCTR2012-005026-30-PL   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-LT   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   Phase 3   EUCTR2012-005026-30-HU   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-CZ   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
      2013   -   EUCTR2012-005026-30-BG   Bulgaria;Colombia;Czech Republic;Hungary;India;Korea, Republic of;Lithuania;Mexico;Poland;Ukraine;United Kingdom
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
TNR-001
   Wyeth Pharmaceuticals
      2005   -   EUCTR2004-000563-96-FI   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2005   -   EUCTR2004-000563-96-AT   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-SE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-IE   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-HU   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-ES   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      2004   -   EUCTR2004-000563-96-DK   Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
      -   Phase 4   EUCTR2004-000563-96-NO   Austria;Denmark;Finland;Hungary;Ireland;Italy;Norway;Spain;Sweden
TO BE confirmed
   Kowa Research Europe Ltd
      2004   -   EUCTR2004-000362-12-CZ   Czech Republic
Tocilizmab
   Shinshu University
      2018   Phase 2   NCT03784261   Japan
Tocilizumab
   AA amyloidosis clinical research conference
      2008   -   JPRN-UMIN000002421   Japan
   Ablynx
      2015   Phase 2   NCT02287922   Belgium;Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;North Macedonia;Poland;Romania;Serbia;Spain;United States
   Ablynx NV
      2015   Phase 2   EUCTR2014-003012-36-HU   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-ES   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-DE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-CZ   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BG   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
      2015   Phase 2   EUCTR2014-003012-36-BE   Argentina;Belgium;Bulgaria;Czech Republic;Georgia;Germany;Hungary;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Romania;Serbia;Spain;United States
   Astellas Pharma Korea, Inc.
      2019   Phase 4   NCT03737708   Korea, Republic of
   Bio-Thera Solutions, Ltd.
      2019   Phase 3   EUCTR2018-002202-31-BG   Bulgaria;China;Georgia;Poland;Ukraine
   Brigham and Women's Hospital
      2020   -   NCT04529863   United States
   CELLTRION, Inc.
      2023   Phase 3   EUCTR2022-002928-12-PL   Poland
      2022   Phase 3   EUCTR2022-001066-36-PL   Poland
   CHU DIJON
      2010   -   EUCTR2010-018696-21-FR   France
   CHU de Clermont Ferrand
      2011   Phase 3   EUCTR2011-000215-79-FR   France
   Celltrion
      2023   Phase 3   NCT05725434   -
   Centre Hospitalier Universitaire de Besancon
      2013   Phase 4   NCT02843789   France
   Chugai Pharma Taiwan
      2011   Phase 3   NCT01347983   Taiwan
      2010   Phase 3   NCT01258712   Taiwan
   Chugai Pharmaceutical
      2006   Phase 3   NCT00380601   Japan
      2005   Phase 3   NCT00144586   -
      2005   -   NCT00144573   -
      2005   -   NCT00144560   -
      2004   Phase 3   NCT00144547   -
      2004   Phase 3   NCT00144534   -
      2004   Phase 3   NCT00144521   -
      2003   Phase 3   NCT00144508   -
      2001   Phase 2   NCT00144651   -
   Chugai Pharmaceutical Co., Ltd.
      2014   Phase 3   JPRN-jRCT2080222455   -
      2005   Phase 3   JPRN-jRCT2080220018   -
      2005   Phase 3   JPRN-jRCT2080220016   -
   Daihei Kida
      2013   -   JPRN-UMIN000010033   Japan
   Department of Orthopaedic Surgery, Graduate School of Medicine, Osaka City University Medical School
      2013   Phase 4   JPRN-UMIN000012073   Japan
   Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity
      2012   -   JPRN-UMIN000008812   Japan
   Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity
      2012   -   JPRN-UMIN000007019   Japan
   Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
      2011   -   JPRN-UMIN000005590   Japan
   Department of Rheumatosurgery, Osaka City University Medical School
      2009   Phase 4   JPRN-UMIN000002340   Japan
   Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences
      2011   -   JPRN-UMIN000013750   Japan
   Division of Rheumatology & Clinical Immunology, Jichi Medical University
      2008   -   JPRN-UMIN000001240   Japan
   Dr. Larry W. Moreland
      2015   Phase 4   NCT02353780   United States
   F Hoffmann La-Roche AG
      2007   -   EUCTR2005-002909-23-PT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-SI   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-NO   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-IS   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   Phase 3   EUCTR2005-002909-23-GB   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-FI   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-DK   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Norway;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002909-23-ES   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann La-Roche Ltd.
      2006   -   EUCTR2005-002909-23-SE   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2006   -   EUCTR2005-002909-23-LT   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Lithuania;Portugal;Slovenia;Spain;Sweden;United Kingdom
      2006   -   EUCTR2005-002909-23-CZ   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Russian Federation;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
   F Hoffmann-La Roche AG
      2006   -   EUCTR2005-002909-23-DE   Czech Republic;Denmark;Finland;Germany;Iceland;Italy;Portugal;Slovenia;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd
      2009   -   EUCTR2008-005525-11-NL   France;Germany;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-GR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-FR   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   Phase 2   EUCTR2008-005525-11-ES   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2009   -   EUCTR2008-005525-11-DE   France;Germany;Netherlands;Spain;United Kingdom
      2008   Phase 2   EUCTR2008-005525-11-GB   France;Germany;Greece;Netherlands;Spain;United Kingdom
      2008   -   EUCTR2008-001847-20-NL   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-001847-20-FR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-ES   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
   F Hoffmann-La Roche Ltd.
      2009   -   EUCTR2008-001847-20-SE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   -   EUCTR2008-001847-20-GR   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-001847-20-DE   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-LV   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   Phase 3   EUCTR2008-001847-20-GB   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2008   -   EUCTR2008-001847-20-EE   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-001847-20-DK   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
   F. HOFFMANN - LA ROCHE LTD.
      2015   Phase 4   EUCTR2014-004673-16-IT   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
   F. Hoffmann La-Roche AG
      2005   -   EUCTR2005-001138-33-PT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-NO   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-LT   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   Phase 3   EUCTR2005-001138-33-ES   Denmark;Italy;Lithuania;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-001138-33-DK   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2004-005210-37-SE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-FI   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-005210-37-ES   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-DE   Czech Republic;Finland;Germany;Spain;Sweden
      2005   -   EUCTR2004-005210-37-CZ   Czech Republic;Finland;Germany;Spain;Sweden
      2005   Phase 3   EUCTR2004-003741-40-SK   Austria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2004-003741-40-HU   Germany;Hungary;Italy
      2005   -   EUCTR2004-003741-40-DE   Germany;Hungary;Italy
      2005   -   EUCTR2004-003733-14-ES   Denmark;Finland;Italy;Spain
      2004   -   EUCTR2004-003741-40-AT   Austria;Germany;Hungary;Italy
      -   -   EUCTR2005-001138-33-SI   Denmark;Italy;Norway;Portugal;Slovenia;Spain
   F. Hoffmann La-Roche Ltd
      2005   -   EUCTR2005-002423-13-SK   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-HU   Bulgaria;Germany;Hungary;Italy;Slovakia
      2005   -   EUCTR2005-002423-13-AT   Austria;Bulgaria;Germany;Hungary;Italy;Slovakia
      -   -   EUCTR2005-002423-13-BG   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;France;Germany;Hong Kong;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Switzerland;Thailand
   F. Hoffmann La-Roche Ltd.
      2005   Phase 3   EUCTR2004-003733-14-FI   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;South Africa;Spain;United States
   F. Hoffmann- La Roche Ltd
      2009   -   EUCTR2008-000587-17-GR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
   F. Hoffmann-La Roche
      2009   -   EUCTR2008-006924-68-IT   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
   F. Hoffmann-La Roche AG
      2005   -   EUCTR2005-000884-25-SE   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-IS   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   Phase 3   EUCTR2005-000884-25-GB   Germany;Iceland;Italy;Sweden;United Kingdom
      2005   -   EUCTR2005-000884-25-DE   Germany;Iceland;Italy;Sweden;United Kingdom
   F. Hoffmann-La Roche Ltd
      2016   Phase 4   EUCTR2014-004673-16-DE   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Switzerland;Turkey
      2015   Phase 4   EUCTR2014-004673-16-FR   Egypt;France;Germany;Italy;Lebanon;Russian Federation;Serbia;Slovenia;Switzerland;Tunisia;Turkey
      2013   -   EUCTR2013-002341-11-GB   United Kingdom
      2010   Phase 3   EUCTR2008-006924-68-AT   Austria;Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-PT   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-NL   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-HU   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-GB   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   Phase 3   EUCTR2008-006924-68-FR   Austria;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-ES   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-006924-68-CZ   Czech Republic;France;Hungary;Italy;Netherlands;Portugal;Spain;United Kingdom
      2009   -   EUCTR2008-000587-17-HU   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-000587-17-DE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-SE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-PT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-NL   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-IE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-GB   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   Phase 3   EUCTR2008-000587-17-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-FI   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-DK   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-CZ   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-BE   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2008   -   EUCTR2008-000587-17-AT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-002423-13-DE   Bulgaria;Germany;Hungary;Italy;Slovakia
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-023587-40-SE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-NL   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-IT   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   -   EUCTR2010-023587-40-GR   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-FI   Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-ES   Denmark;Finland;Germany;Greece;Italy;Netherlands;Spain;Sweden
      2011   Phase 4   EUCTR2010-023587-40-DK   Denmark;European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   -   EUCTR2010-023587-40-DE   European Union;Finland;Germany;Greece;Italy;Netherlands;Russian Federation;Spain;Sweden;United States
      2011   Phase 4   EUCTR2010-020065-24-NL   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-LV   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   -   EUCTR2010-020065-24-LT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-HU   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GR   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-GB   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-ES   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-DE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Denmark;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-CZ   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-BE   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 4   EUCTR2010-020065-24-AT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Canada;Chile;Croatia;Czech Republic;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2010   -   EUCTR2010-018331-18-GB   United Kingdom
      2010   -   EUCTR2009-015845-21-SE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-PT   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-GR   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-GB   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-FI   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-ES   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-015845-21-DE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-015845-21-CZ   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 4   EUCTR2009-015845-21-BE   Belgium;Czech Republic;Finland;Germany;Greece;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-SE   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-PT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2010   -   EUCTR2009-012759-12-IE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-HU   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   -   EUCTR2009-012759-12-GR   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2010   Phase 3   EUCTR2009-012759-12-CZ   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-IT   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-GB   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   Phase 3   EUCTR2009-012759-12-FR   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-FI   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   Phase 3   EUCTR2009-012759-12-ES   Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-DK   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012759-12-DE   Austria;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Portugal;Spain;Sweden;United Kingdom
      2009   -   EUCTR2009-012759-12-AT   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, the former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
   FRANCISCO J. BLANCO GARCÍA
      2013   -   EUCTR2012-004482-40-ES   Spain
   FUNDACIÓN ESPAÑOLA DE REUMATOLOGIA
      2014   Phase 4   EUCTR2013-004051-20-ES   Spain
   Fresenius Kabi SwissBioSim GmbH
      2021   Phase 3   EUCTR2019-004369-42-DE   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2020   Phase 3   EUCTR2019-004369-42-SK   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-PL   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-HU   Bulgaria;Czech Republic;Georgia;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia;Spain;United States
      2020   Phase 3   EUCTR2019-004369-42-CZ   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
      2020   Phase 3   EUCTR2019-004369-42-BG   Bulgaria;Czech Republic;Czechia;Georgia;Germany;Hungary;Moldova, Republic of;Poland;Russian Federation;Serbia;Slovakia
   Genentech, Inc.
      2012   Phase 3   NCT01662063   Puerto Rico;United States
      2010   Phase 4   NCT01163747   United States
   General Internal Medicine, Tenri Hospital
      2010   -   JPRN-UMIN000004412   Japan
   Hoffmann-La Roche
      2017   -   NCT03291457   Belgium
      2017   Phase 3   NCT03155347   China
      2017   -   NCT03112213   Germany
      2016   -   NCT02797769   -
      2016   Phase 4   NCT02682823   United States
      2016   -   NCT02648035   Greece
      2016   Phase 4   NCT02573012   Egypt;France;Germany;Italy;Russian Federation;Serbia;Switzerland;Tunisia;Turkey
      2015   -   NCT02608112   France
      2015   -   NCT02552940   Belgium;Luxembourg
      2015   -   NCT02534311   Slovakia
      2015   -   NCT02402686   Hungary
      2014   -   NCT02234960   Poland
      2014   Phase 3   NCT02046616   Denmark;Finland;Norway;Sweden
      2014   Phase 3   NCT02046603   United Kingdom
      2014   Phase 3   NCT02031471   Belgium;Luxembourg
      2014   Phase 3   NCT02011334   Argentina;Brazil;Colombia;Dominican Republic;Ecuador;Mexico;Uruguay;Venezuela
      2014   Phase 3   NCT02001987   France
      2014   Phase 3   NCT01988012   Israel
      2014   Phase 3   NCT01987479   Netherlands
      2013   Phase 3   NCT01995201   Ireland;Portugal;Spain
      2013   Phase 3   NCT01951170   Australia
      2013   Phase 3   NCT01941940   Italy
      2013   Phase 3   NCT01941095   Greece
      2013   Phase 4   NCT01878318   Venezuela
      2013   Phase 3   NCT01855789   United States
      2013   Phase 4   NCT01715831   Brazil
      2013   Phase 3   NCT01668966   Brazil
      2012   Phase 3   NCT01772316   Spain
      2012   -   NCT01741688   Peru
      2012   Phase 3   NCT01734993   France
      2012   Phase 3   NCT01730456   Macedonia, The Former Yugoslav Republic of
      2012   -   NCT01705730   Belgium
      2012   -   NCT01670045   Greece;Indonesia
      2012   Phase 3   NCT01665430   Poland
      2012   Phase 3   NCT01664598   Russian Federation
      2012   -   NCT01664104   Italy
      2012   Phase 4   NCT01661140   United Kingdom
      2012   Phase 3   NCT01655381   France
      2012   Phase 3   NCT01649804   Hungary
      2012   -   NCT01617005   Montenegro
      2012   Phase 3   NCT01587989   Austria
      2012   -   NCT01579006   Israel
      2012   -   NCT01562327   Argentina
      2012   -   NCT01474291   France;Monaco
      2011   Phase 2   NCT01468077   Denmark;Iceland
      2011   -   NCT01462162   Spain
      2011   Phase 4   NCT01399697   Spain
      2011   Phase 3   NCT01353859   Greece;Indonesia
      2011   Phase 3   NCT01332994   Germany
      2011   Phase 4   NCT01331837   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Croatia;Czech Republic;Czechia;Ecuador;France;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Turkey;United Kingdom;United States
      2011   Phase 3   NCT01326962   Saudi Arabia
      2011   Phase 4   NCT01283971   Denmark;Finland;France;Germany;Greece;Italy;Netherlands;Puerto Rico;Russian Federation;Spain;Sweden;United Kingdom;United States
      2011   Phase 3   NCT01254331   Tunisia
      2011   Phase 4   NCT01251120   Finland
      2011   Phase 3   NCT01245439   Turkey
      2011   Phase 3   NCT01235507   Bosnia and Herzegovina
      2011   Phase 4   NCT01219933   Belgium
      2010   Phase 4   NCT02010216   Kazakhstan
      2010   Phase 3   NCT01610791   Morocco
      2010   -   NCT01362062   India
      2010   Phase 3   NCT01214733   South Africa
      2010   Phase 4   NCT01195272   United Kingdom
      2010   Phase 4   NCT01149057   Israel
      2010   Phase 4   NCT01119859   Australia;Belgium;Brazil;Czech Republic;Finland;Germany;Greece;Mexico;Norway;Portugal;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2010   Phase 4   NCT01089023   Bahrain;Iran, Islamic Republic of;Kuwait;Qatar;United Arab Emirates
      2010   Phase 3   NCT01063062   Egypt
      2010   Phase 4   NCT01034397   Portugal
      2010   Phase 3   NCT01034137   Netherlands
      2009   -   NCT02809833   Germany
      2009   -   NCT02721004   Austria
      2009   Phase 3   NCT01044498   United States
      2009   Phase 4   NCT01010503   Slovakia
      2009   Phase 3   NCT01007435   Argentina;Australia;Austria;Brazil;Canada;China;Colombia;Czech Republic;Denmark;Finland;France;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Macedonia, The Former Yugoslav Republic of;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Portugal;Puerto Rico;Russian Federation;Singapore;South Africa;Spain;Sweden;Thailand;Turkey;United Kingdom;United States
      2009   Phase 3   NCT00996606   Italy
      2009   Phase 4   NCT00996203   Russian Federation
      2009   Phase 3   NCT00977106   France
      2009   Phase 1   NCT00965653   Canada;New Zealand;Spain;United Kingdom
      2009   Phase 3   NCT00951275   Italy
      2009   Phase 3   NCT00891020   Puerto Rico;United Kingdom;United States
      2009   Phase 2   NCT00887341   Spain
      2009   Phase 3   NCT00883753   Australia;Austria;Canada;Czech Republic;France;Greece;Hungary;Italy;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Turkey;United Kingdom
      2009   Phase 2   NCT00845832   Belgium;France;Germany;Greece;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom
      2009   Phase 3   NCT00810199   Brazil;Croatia;Denmark;Estonia;France;Germany;Greece;Israel;Italy;Latvia;Monaco;Netherlands;Norway;Romania;Russian Federation;Serbia;Spain;Sweden;Thailand;United Kingdom;United States
      2009   Phase 3   NCT00754572   Argentina;Brazil;Chile;Colombia;Costa Rica;Ecuador;Mexico;Peru;Uruguay;Venezuela
      2008   Phase 3   NCT00848120   Philippines
      2008   Phase 3   NCT00810277   Finland
      2008   Phase 3   NCT00773461   China
      2008   Phase 3   NCT00754559   Germany
      2008   Phase 3   NCT00750880   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Luxembourg;Netherlands;Poland;Portugal;Romania;Saudi Arabia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2007   Phase 3   NCT00535782   Canada;Puerto Rico;United Kingdom;United States
      2007   Phase 3   NCT00531817   Puerto Rico;United States
      2005   Phase 3   NCT00721123   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;France;Germany;Hong Kong;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Switzerland;Thailand
      2005   Phase 3   NCT00720798   Argentina;Australia;Belgium;Brazil;Canada;China;Costa Rica;Czech Republic;Denmark;Finland;France;Germany;Hong Kong;Iceland;Israel;Italy;Lithuania;Mexico;Netherlands;Norway;Panama;Peru;Portugal;Puerto Rico;Russian Federation;Serbia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;United Kingdom;United States
      2005   Phase 1   NCT00365001   New Zealand;United States
      2005   Phase 3   NCT00109408   Argentina;Australia;Canada;China;Croatia;Denmark;Former Serbia and Montenegro;France;Israel;Italy;Lithuania;Mexico;Norway;Peru;Portugal;Serbia;Slovenia;South Africa;Spain;United States
      2005   Phase 3   NCT00106574   Argentina;Australia;Brazil;Canada;China;Costa Rica;Czech Republic;Finland;France;Germany;Hong Kong;Mexico;Panama;Russian Federation;South Africa;Spain;Sweden;Thailand;United States
      2005   Phase 3   NCT00106548   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;China;France;Germany;Hungary;Israel;Italy;Mexico;Singapore;Slovakia;Spain;Switzerland;Thailand
      2005   Phase 3   NCT00106535   Australia;Brazil;China;Denmark;Finland;France;Greece;Italy;Mexico;Norway;Poland;Puerto Rico;South Africa;Spain;Switzerland;United States
      2005   Phase 3   NCT00106522   Australia;Belgium;Canada;France;Germany;Iceland;Italy;Mexico;Netherlands;Puerto Rico;Sweden;Switzerland;United Kingdom;United States
   Huashan Hospital, Fudan University / Peking University, Reople’s Hospital
      2019   Phase 3   ChiCTR2300067652   China
   JW Pharmaceutical
      2010   Phase 3   NCT01256736   Korea, Republic of
      2009   Phase 3   NCT01211834   Korea, Republic of
   Japan Labour Health and Welfare Organization, Yokohama Rosai Hospital
      2012   -   JPRN-UMIN000008404   Japan
   JiangSu Qyuns Therapeutics Co., Ltd
      2019   Phase 1   ChiCTR1900021808   China
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry)
      2015   Phase 4   EUCTR2012-002535-28-ES   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London
      2015   Phase 4   EUCTR2012-002535-28-IT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
      2014   Phase 4   EUCTR2012-002535-28-PT   Belgium;Italy;Netherlands;Portugal;Spain;United Kingdom
   Juntendo University, Juntendo Koshigaya Hospital
      2012   -   JPRN-UMIN000014484   Japan
   Karolinska Institutet
      2015   -   EUCTR2011-004720-35-NO   Denmark;Finland;Norway;Sweden
      2014   Phase 4   EUCTR2011-004720-35-FI   Denmark;Finland;Iceland;Netherlands;Norway;Sweden
   Kinki University Faculty of Medicine, Division of Hematology and Rheumatology
      2012   -   JPRN-UMIN000007380   Japan
   Kyushu University
      2012   -   JPRN-UMIN000017230   Japan
   Maria Stoenoiu
      2015   Phase 3   NCT02837146   Belgium
   Mario Negri Institute for Pharmacological Research
      2018   Phase 4   NCT03100253   Italy
   Massachusetts General Hospital
      2016   Phase 4   NCT02659150   -
   Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie
      2012   Phase 4   EUCTR2011-005204-15-AT   Austria
   Medizinische Universität Wien, Universitätsklinik für Innere Medizin III
      2012   Phase 4   EUCTR2012-000139-21-AT   Austria;Czech Republic;Russian Federation;Slovakia;Switzerland
   National hospital organization Chiba east national hospital Clinical Research Center
      2013   -   JPRN-UMIN000012690   Japan
   OSSERVATORIO EPIDEMIOLOGICO GISEA
      2012   Phase 4   EUCTR2012-001760-30-IT   Italy
   Patrick Durez
      2010   -   NCT01245452   Belgium
   ROCHE
      2011   Phase 4   EUCTR2010-020065-24-IT   Argentina;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Chile;China;Czech Republic;Ecuador;Germany;Greece;Hungary;India;Israel;Italy;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Philippines;Russian Federation;South Africa;Spain;Turkey;United Kingdom;United States
      2009   -   EUCTR2009-012185-32-IT   Italy
      2009   -   EUCTR2009-011105-17-IT   Italy
      2009   -   EUCTR2008-001847-20-IT   Denmark;Estonia;France;Germany;Greece;Italy;Latvia;Netherlands;Spain;Sweden;United Kingdom
      2009   -   EUCTR2008-000587-17-IT   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2005-001138-33-IT   Denmark;Italy;Norway;Portugal;Slovenia;Spain
      2005   -   EUCTR2005-000884-25-IT   Germany;Iceland;Italy;Sweden;United Kingdom
      2004   -   EUCTR2004-003741-40-IT   Germany;Hungary;Italy
      2004   -   EUCTR2004-003733-14-IT   Denmark;Finland;Italy;Spain
   Reade
      2019   Phase 1;Phase 4   EUCTR2018-004605-57-NL   Netherlands
   Reade Rheumatology Research Institute
      2020   Phase 4   NCT03895879   Netherlands
   Regeneron Pharmaceuticals
      2014   Phase 1   NCT02097524   United States
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
   Roche Austria GmbH
      2011   -   EUCTR2011-001863-39-AT   Austria
   Roche Farma, S.A.
      2009   -   EUCTR2008-006443-39-ES   Spain
      -   -   EUCTR2011-001626-15-ES   Spain
   Roche Oy
      2010   -   EUCTR2010-019935-37-FI   Finland
      2008   -   EUCTR2008-004126-16-FI   Finland
   Roche Pharma AG
      2011   -   EUCTR2010-022049-88-DE   Germany
      2008   -   EUCTR2008-000105-11-DE   Germany
   Roche Products Limited
      2012   Phase 4   EUCTR2011-005260-20-GB   United Kingdom
   Roche Slovensko s.r.o.
      2009   -   EUCTR2009-011520-53-SK   Slovakia
   Roche a/s
      2011   -   EUCTR2011-002363-15-DK   Denmark;Iceland
   SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
      2017   Phase 4   EUCTR2016-001987-12-IT   Italy
   Sanofi
      2015   Phase 1   NCT02404558   Japan
      2013   Phase 3   NCT01768572   Argentina;Belgium;Brazil;Czech Republic;Czechia;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
   Spanish Foundation of Rheumatology
      2014   Phase 4   NCT02087696   Spain
   Sungkyunkwan University
      2020   -   NCT04115423   Korea, Republic of
   Taizhou Hospital of Zhejiang Province
      2025   -   ChiCTR2500102023   China
   Tel-Aviv Sourasky Medical Center
      2018   Phase 4   NCT03781310   Israel
   The Second Hospital of Lanzhou University
      2024   Phase 4   ChiCTR2400087546   China
   The University of Leeds
      2013   Phase 4   EUCTR2011-004017-17-GB   United Kingdom
   Tufts Medical Center
      2025   -   NCT06016517   United States
   UCB Biosciences, Inc
      2011   -   EUCTR2010-020839-39-GB   United Kingdom;United States
   UCB Biosciences, Inc. A Member of the UCB Group of Companies
      2011   Phase 2   EUCTR2010-020839-39-BE   Belgium;United Kingdom;United States
   UCB Pharma
      2010   Phase 2   NCT01242488   Belgium;United Kingdom;United States
   UCL Cliniques Universitaires Saint Luc
      2010   Phase 2   EUCTR2010-019873-13-BE   Belgium
   University Medical Center Utrecht
      2019   Phase 4   EUCTR2017-003037-28-NL   Netherlands
   University of Athens
      2017   -   NCT03288584   Greece
   University of California, Los Angeles
      2014   Phase 4   NCT01717859   United States
   University of Erlangen-Nürnberg Medical School
      2015   -   NCT02778789   Germany
   University of Leeds
      2013   Phase 4   NCT04157010   United Kingdom
      2009   Phase 2   EUCTR2008-003011-12-GB   United Kingdom
   University of Southern Denmark
      2021   Phase 1/Phase 2   NCT04842981   Denmark
      2021   Phase 1;Phase 2   EUCTR2020-005998-27-DK   Denmark
   Vastra Gotaland Region
      2017   -   NCT03440892   Sweden
   Watanabe Manabu
      2023   Phase 3   JPRN-jRCT2031220512   -
   sanofi-aventis recherche & développement
      2013   -   EUCTR2012-003536-23-SE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-PL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-NO   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-NL   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-IT   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-HU   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-003536-23-GB   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-FI   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-ES   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-EE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-CZ   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
      2013   -   EUCTR2012-003536-23-BE   Argentina;Belgium;Brazil;Colombia;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Mexico;Netherlands;Norway;Poland;Romania;Russian Federation;Spain;Sweden;United Kingdom;United States
   the Second Hospital of Shanxi Medical University
      2016   -   ChiCTR-INR-16009546   China
Tocilizumab 162 MG
   Hoffmann-La Roche
      2011   Phase 3   NCT01232569   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Poland;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
Tocilizumab 162MG/0.9ML jeringa SC
   F. Hoffmann-La Roche Ltd.
      2010   Phase 3   EUCTR2010-018375-22-ES   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
Tocilizumab 162MG/0.9ML SC PFS SC
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-GR   Bulgaria;Greece;Hungary;Spain
      2011   Phase 3   EUCTR2010-019912-18-ES   Bulgaria;Greece;Hungary;Spain
Tocilizumab 162MG/0.9ML syringe SC
   F. Hoffmann-La Roche Ltd
      2010   -   EUCTR2010-018375-22-LT   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   Phase 3   EUCTR2010-018375-22-GB   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
      2010   -   EUCTR2010-018375-22-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2010   -   EUCTR2010-018375-22-IT   Bulgaria;Germany;Italy;Lithuania;Spain;United Kingdom
      2010   -   EUCTR2010-018375-22-DE   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
Tocilizumab injection 8MG/KG
   Beijing VDJBio Co., LTD.
      2021   Phase 1/Phase 2   NCT05232396   China
Tocilizumab IV
   Hoffmann-La Roche
      2010   Phase 3   NCT01194414   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
Tocilizumab or sarilumab
   Kawakami Atsushi
      2021   -   JPRN-jRCTs071200107   -
   Pfizer
      2024   -   NCT06418529   United States
Tocilizumab plus methotrexate
   Biologic Mate Study Group
      2014   -   JPRN-UMIN000015616   Japan
   Keio University
      2009   -   JPRN-UMIN000002744   Japan
   SURPRISE Study Group
      2009   Phase 4   NCT01120366   Japan
Tocilizumab prefilled syringe
   Lille Catholic University
      2018   Phase 4   NCT03227419   France
   Syneos Health
      2021   Phase 1   NCT04885829   Australia;India;New Zealand
Tocilizumab roche
   F Hoffmann La-Roche Ltd.
      2005   -   EUCTR2004-003733-14-DK   Denmark;Finland;Italy;Spain
   F. Hoffmann-La Roche Ltd
      2008   Phase 3   EUCTR2008-000587-17-ES   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
Tocilizumab SC
   F. Hoffmann-La Roche Ltd.
      2011   -   EUCTR2010-019912-18-HU   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
      2011   -   EUCTR2010-019912-18-BG   Argentina;Australia;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Dominican Republic;Greece;Guatemala;Hungary;Israel;Malaysia;Mexico;New Zealand;Panama;Peru;Philippines;Russian Federation;South Africa;Spain;Switzerland;Thailand;United States
   Hoffmann-La Roche
      2010   Phase 3   NCT01194414   Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;France;Germany;Guatemala;Hong Kong;Italy;Lithuania;Mexico;New Zealand;Peru;Philippines;Poland;Puerto Rico;Romania;Russian Federation;Singapore;South Africa;Spain;Thailand;United Kingdom;United States
   Joint Research & Development Office (QMUL)
      2018   Phase 3   EUCTR2017-004079-30-PT   Belgium;Italy;Portugal;Spain
   N.V. Roche S.A.
      2013   Phase 3   EUCTR2013-002150-79-BE   Belgium
   ROCHE HELLAS S.A.
      2013   Phase 3   EUCTR2013-000359-42-GR   Greece
   Roche Farma S.A
      2013   Phase 3   EUCTR2013-002429-52-IE   Ireland;Portugal;Spain
      2013   Phase 3   EUCTR2013-002429-52-ES   Ireland;Portugal;Spain
   Roche Farma S.A.
      2013   Phase 3   EUCTR2013-002429-52-PT   Ireland;Portugal;Spain
   Roche Nederland B.V.
      2013   Phase 3   EUCTR2013-000342-19-NL   Netherlands
   Roche Products Limited
      2013   Phase 3   EUCTR2013-000054-22-GB   United Kingdom
   Roche S.p.A.
      2013   Phase 3   EUCTR2013-001569-17-IT   Italy
   Roche a/s
      2014   Phase 3   EUCTR2013-002007-34-SE   Denmark;Finland;Sweden
      2014   Phase 3   EUCTR2013-002007-34-FI   Denmark;Finland;Sweden
      2013   Phase 3   EUCTR2013-002007-34-DK   Denmark;Finland;Sweden
Tocilizumabum
   Revmatologicky ustav Praha
      2015   Phase 4   EUCTR2015-000581-58-CZ   Czech Republic
Tofacitinb
   PFIZER INC
      2017   Phase 3   EUCTR2016-001825-15-IT   Bulgaria;Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;Spain
Tofacitinib
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2019   Phase 4   EUCTR2018-003162-13-IT   Italy
   AbbVie (prior sponsor, Abbott)
      2012   Phase 1   NCT01741493   United States
   Arthritis Alapítvány
      2016   Phase 4   EUCTR2015-002523-26-HU   Hungary
   Brigham and Women's Hospital
      2021   -   NCT04798287   United States
      2021   -   NCT04772248   United States
      2020   -   NCT04529876   United States
   Department of Rheumatology, Anqing Hospital Affiliated to Anhui Medical University
      2020   Phase 4   ChiCTR2000033214   -
   Division of rheumatology, hiroshima clinic
      2016   Phase 4   JPRN-UMIN000027242   Japan
   Dr. Frank Behrens
      2019   Phase 4   NCT04485325   Germany
   Dr. Mohammad Mamun Khan
      2019   Phase 4   NCT04464642   Bangladesh
   Ethics Committee of Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)
      2023   -   ChiCTR2300075535   China
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2021   Phase 4   EUCTR2021-001560-14-ES   Spain
   GlaxoSmithKline
      2019   Phase 3   NCT03970837   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
   GlaxoSmithKline K.K.
      2019   Phase 3   JPRN-jRCT2080224948   Argentina;Australia;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Korea;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
   Graduate School of Medicine and School of Medicine, Chiba University the department of allergy and clinical immunology
      2015   Phase 4   JPRN-UMIN000017440   Japan
   Hangzhou Highlightll Pharmaceutical Co., Ltd
      2023   Phase 3   NCT06020144   China
      2022   Phase 2   NCT05133297   China
   Hanyang University
      2016   -   NCT03011281   Korea, Republic of
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   Kyusyu University Hospital Medicine and biosystemic science
      2014   -   JPRN-UMIN000020663   Japan
   Lanzhou University Second Hospital
      2020   Phase 1   ChiCTR2400081609   China
   Lawson Health Research Institute
      2020   Phase 4   NCT03976245   Canada
   National Institute of Respiratory Diseases, Mexico
      2022   Phase 2   NCT05246293   Mexico
   Norman B. Gaylis, MD
      2015   Phase 3   NCT02566967   United States
   Peking University First Hospital
      2021   Phase 4   ChiCTR2100048185   China
   Pfizer
      2024   -   NCT06418529   United States
      2020   Phase 2   NCT04413617   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czechia;Georgia;Hungary;Poland;Slovakia;Spain;Sweden;Ukraine
      2019   -   NCT03981900   France
      2017   -   NCT03387423   Germany
      2016   Phase 2   NCT02996500   Australia;Bosnia and Herzegovina;Bulgaria;Croatia;Czechia;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2014   Phase 3   NCT02281552   Japan
      2014   Phase 2   NCT02147587   United Kingdom;United States
      2014   Phase 4   NCT02092467   Argentina;Australia;Austria;Brazil;Bulgaria;Canada;Chile;China;Colombia;Czech Republic;Czechia;Finland;Hong Kong;Israel;Jordan;Lebanon;Malaysia;Mexico;Netherlands;New Zealand;Peru;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Sweden;Taiwan;Thailand;Turkey;United Kingdom;United States
      2013   -   NCT01932372   Japan
      2010   Phase 2   NCT01164579   Argentina;Chile;Croatia;Czech Republic;Hungary;Mexico;Poland;Puerto Rico;United States
      2005   Phase 1   NCT01745055   United States
   Pfizer Inc.
      2011   -   EUCTR2010-020890-18-CZ   Czech Republic;Hungary
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2011   -   EUCTR2010-020890-18-HU   Czech Republic;Hungary
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA
      2010   -   EUCTR2009-016987-34-DE   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Costa Rica;Czech Republic;Denmark;Dominican Republic;Germany;Hungary;India;Korea, Republic of;Malaysia;Mexico;New Zealand;Peru;Philippines;Poland;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Ukraine;United States
   Qilu Hospital of Shandong University
      2022   Phase 4   ChiCTR2200062645   China
      2020   Phase 4   NCT04928066   China
   Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
      2019   Phase 4   ChiCTR2000039799   China
   School of Medicine, University of Occupational and Environmental Health, Japan
      2014   -   JPRN-UMIN000015462   Japan
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2022   Phase 4   NCT05606107   China
      2021   Phase 4   NCT04927000   China
   Taizhou Hospital of Zhejiang Province
      2025   -   ChiCTR2500102023   China
   The Second Affiliated Hospital of Guangzhou Medical University
      2022   Phase 0   ChiCTR2200066368   China
   University Hospital, Lille
      2020   -   NCT04175886   France
   University of Nebraska
      2007   Phase 3   NCT03414502   United States
   Vastra Gotaland Region
      2020   Phase 4   NCT04311567   Sweden
   Yantai Yuhuangding Hospital
      2021   Phase 4   ChiCTR2100054220   Chian
   hiroshima clinic
      2015   -   JPRN-UMIN000027241   Japan
Tofacitinib (xeljanz®) 11MG prolonged release tablet
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
Tofacitinib 5 MG
   Gilead Sciences
      2022   Phase 2   NCT05165771   -
   GlaxoSmithKline
      2019   Phase 3   NCT03980483   Argentina;Canada;China;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Shinshu University
      2018   Phase 2   NCT03755466   Japan
Tofacitinib 5 MG twice daily
   Kaneko Yuko
      2023   Phase 4   JPRN-jRCTs031230329   -
   University Hospital, Toulouse
      2025   Phase 4   NCT06687551   -
Tofacitinib 5MG PO BID
   University of California, Los Angeles
      2016   Phase 4   NCT02321930   United States
Tofacitinib citrate
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000797-39-IT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-ES   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-ES   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-CZ   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   PFIZER INC
      2017   Phase 3   EUCTR2016-001825-15-IT   Bulgaria;Czech Republic;Germany;Hungary;Italy;Poland;Slovakia;Spain
   Pfizer Inc, 235 East 42nd Street, New York 10017
      2013   -   EUCTR2011-005689-39-HU   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United States
   Pfizer Inc, 235 East 42nd Street, New York, NY 10017
      2010   Phase 2;Phase 3   EUCTR2006-005035-19-IE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-GB   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-FI   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2009   Phase 2;Phase 3   EUCTR2006-005035-19-DK   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2008   Phase 2;Phase 3   EUCTR2006-005035-19-DE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2008   Phase 2;Phase 3   EUCTR2006-005035-19-BG   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-SE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-BE   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-AT   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-SE   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-HU   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-CZ   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2020   Phase 2   EUCTR2019-002676-14-BG   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
      2017   Phase 2   EUCTR2016-002337-30-CZ   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-SK   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-CZ   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2014   Phase 2   EUCTR2011-005689-39-SK   Belgium;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2014   Phase 2   EUCTR2011-005689-39-NL   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2014   -   EUCTR2011-005689-39-DE   Belgium;Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2013   Phase 2   EUCTR2011-005689-39-ES   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Slovakia;Spain;Taiwan;United States
      2013   -   EUCTR2011-005689-39-CZ   Canada;Czech Republic;Germany;Hungary;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Taiwan;United States
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-HR   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2015   Phase 3;Phase 4   EUCTR2014-000358-13-ES   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   -   EUCTR2014-000706-34-GB   Germany;Hungary;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-RO   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LV   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-LT   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Hungary;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-GB   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-EE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-CZ   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-BG   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, NY 10017
      2017   Phase 2   EUCTR2016-002337-30-HU   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-HR   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-ES   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-DE   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2017   Phase 2   EUCTR2016-002337-30-BG   Australia;Bosnia and Herzegovina;Bulgaria;Colombia;Croatia;Czech Republic;Georgia;Germany;Hungary;Korea, Republic of;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United States
      2014   Phase 3;Phase 4   EUCTR2014-000358-13-PL   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
      2007   Phase 2;Phase 3   EUCTR2006-005035-19-CZ   Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Costa Rica;Croatia;Czech Republic;Denmark;Dominican Republic;Finland;France;Germany;Greece;Hungary;India;Ireland;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;New Zealand;Peru;Philippines;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of
   Pfizer Inc., 235 East 42nd Street, New York, New York
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-PL   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-HU   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-GB   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-ES   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-DE   Australia;Belgium;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Germany;Greece;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BG   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
      2017   Phase 3;Phase 4   EUCTR2016-001825-15-BE   Australia;Belgium;Bulgaria;Czech Republic;Germany;Hungary;Italy;Korea, Republic of;Mexico;Philippines;Poland;Russian Federation;Slovakia;South Africa;Spain;United Kingdom;United States
   Tampere University Hospital
      2018   Phase 4   EUCTR2017-002753-11-FI   Finland
Tofacitinib citrate CP-690550
   Pfizer Inc.
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
Tofacitinib or baricitinib
   Hanyang University
      2020   -   NCT04449224   Korea, Republic of
Tofacitinib with methotrexate
   Pfizer
      2014   Phase 4   NCT02187055   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Tofacitinib without methotrexate
   Pfizer
      2014   Phase 4   NCT02187055   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;Estonia;France;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Tofacitinib XR
   Erasmus Medical Center
      2022   Phase 4   EUCTR2021-004131-84-NL   Netherlands
   Pfizer
      2022   -   NCT04876781   Korea, Republic of
Tofacitinib/baricitinib
   Vastra Gotaland Region
      2017   -   NCT03440892   Sweden
Toldc
   Newcastle University
      2012   Phase 1   NCT01352858   United Kingdom
Toldcb29
   University Medical Center Utrecht
      2021   Phase 1;Phase 2   EUCTR2019-003620-20-NL   Netherlands
Tolerogenic dendritic cells
   Russian Academy of Medical Sciences
      2016   Phase 1   NCT03337165   Russian Federation
Tolicizumab
   ROCHE
      2009   Phase 4   EUCTR2008-008309-23-FR   France
Tolicizumab roche
   F. Hoffmann-La Roche Ltd
      2008   Phase 3   EUCTR2008-000587-17-FR   Austria;Belgium;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom
Tollb-001 tablets
   Toll Biotech Co. Ltd. (Beijing)
      2023   Phase 1   NCT06103773   China
Topical compound tripterygium
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2011   -   NCT01961505   -
Topical tripterygium GEL
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2012   -   NCT02818361   China
TQH3821 tablets
   Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
      2022   Phase 1   NCT05380934   China
TQH3821 tablets 200 MG
   Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
      2023   Phase 2   NCT05849727   China
Traditional antirheumatic drugs
   Sadat City University
      2020   -   NCT04434118   Egypt
Tramadol
   Kojima Toshihisa
      2016   -   JPRN-jRCTs041180071   -
   Osaka City University Medical School, Department of Orthopedic Surgery
      2014   -   JPRN-UMIN000012364   Japan
Tramadol hydrochloride + acetaminophen
   Janssen Korea, Ltd., Korea
      2005   Phase 4   NCT00246168   -
Tranexamic acid
   Guanghua Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine
      2019   Phase 4   ChiCTR1900025013   China
   Hokusuikai Kinen Hospital
      2018   -   JPRN-UMIN000030237   Japan
      2017   -   JPRN-UMIN000029797   Japan
      2017   -   JPRN-UMIN000026137   Japan
Tranilast
   Imperial College London
      2008   Phase 1   NCT00717808   United Kingdom
   Nuon Therapeutics, Inc.
      2009   Phase 2   NCT00882024   Argentina;Bulgaria;Czech Republic;Germany;Mexico;Serbia;United Kingdom;United States
      2009   -   EUCTR2008-006917-25-PL   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   -   EUCTR2008-006917-25-GB   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   -   EUCTR2008-006917-25-DE   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   Phase 2   EUCTR2008-006917-25-CZ   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
      2009   -   EUCTR2008-006917-25-BG   Bulgaria;Czech Republic;Germany;Poland;United Kingdom
Transcutaneous electrical vagus nerve stimulation
   Xijing Hospital
      2019   -   NCT04037111   China
Transthoracic echocardiographic
   Assistance Publique Hopitaux De Marseille
      2011   Phase 3   NCT01954381   France
Treat TO target
   Chinese University of Hong Kong
      2020   -   NCT04324892   Hong Kong
Treatment A
   Pfizer
      2010   Phase 1   NCT01184092   Singapore
      2010   Phase 1   NCT01184001   Singapore
Treatment B
   Pfizer
      2010   Phase 1   NCT01184092   Singapore
      2010   Phase 1   NCT01184001   Singapore
Treatment C
   Pfizer
      2010   Phase 1   NCT01184092   Singapore
Treatment I
   Sun Pharmaceutical Industries Limited
      2015   Phase 3   NCT02534896   Belgium;Netherlands
Treatment II
   Sun Pharmaceutical Industries Limited
      2015   Phase 3   NCT02534896   Belgium;Netherlands
Treatment III
   Sun Pharmaceutical Industries Limited
      2015   Phase 3   NCT02534896   Belgium;Netherlands
Treatment OF MTX and HCQ
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2014   Phase 2/Phase 3   NCT02551575   China
Treatment OF MTX and twhf
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2017   Phase 2/Phase 3   NCT03337815   China
      2017   Phase 2/Phase 3   NCT03324412   -
Treatment OF TCM
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2014   Phase 2/Phase 3   NCT02551575   China
Treatment OF twhf
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2017   Phase 2/Phase 3   NCT03337815   China
Tregalizumab
   Biotest
      2013   Phase 2   NCT01999192   Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
   Biotest AG
      2013   -   EUCTR2013-000114-38-SK   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-LT   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-HU   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-EE   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-DE   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   Phase 2   EUCTR2013-000114-38-CZ   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
      2013   -   EUCTR2013-000114-38-BG   Bulgaria;Canada;Czech Republic;Estonia;Germany;Hungary;Lithuania;Mexico;Poland;Russian Federation;Serbia;Slovakia;Sweden;Ukraine;United States
Trexan
   UCB PHARMA SA/NV.
      2012   -   EUCTR2011-001729-25-IT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
   UCB Pharma SA
      2012   Phase 3   EUCTR2011-001729-25-SE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-NL   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-IE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-HU   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-001729-25-GB   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;European Union;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-ES   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-DE   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-CZ   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   -   EUCTR2011-001729-25-AT   Argentina;Australia;Austria;Brazil;Canada;Colombia;Czech Republic;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;Spain;Sweden;Switzerland;United Kingdom;United States
Trexan+salazopyrin+oxiklorin+prednisolone + infliximab
   Helsinki University
      2003   Phase 4   NCT00908089   Finland
Triam 40 MG lichtenstein
   Charité University medicine Berlin
      2015   Phase 2   EUCTR2015-000538-31-DE   Germany
Triamcinolonacetonid EP
   Charité University medicine Berlin
      2015   Phase 2   EUCTR2015-000538-31-DE   Germany
Triamcinolone
   AZIENDA OSPEDALIERA SENESE
      2006   -   EUCTR2006-005391-40-IT   Italy
   Sohag University
      2020   Phase 4   NCT04361513   Egypt
   University of Illinois at Chicago
      2015   Phase 4   NCT02451748   United States
Triamcinolone acetonide
   Trafford NHS Trust
      2008   -   EUCTR2007-006729-28-GB   United Kingdom
Triamcinolone hexacetonide
   Center for Research and Development Uppsala University/County Council of Gävleborg
      2014   Phase 4   EUCTR2014-000993-20-SE   Sweden
   Federal University of São Paulo
      2013   -   NCT01851278   Brazil
Trichuris suis OVA
   Immanuel Krankenhaus Berlin
      2013   Phase 2   EUCTR2011-006344-71-DE   Germany
Tripterygium wilfordii
   Beijing Hospital
      2023   Phase 0   ChiCTR2300075871   China
   Dongzhimen Hospital, Beijing University of Chinese Medicine
      2024   Phase 0   ChiCTR2400088173   China
   Peking Union Medical College Hospital
      2019   Phase 4   NCT03589833   China
   Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
      2024   Phase 4   ChiCTR2400090996   China
   The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
      2020   Phase 4   ChiCTR2100050865   China
Tripterygium wilfordii hook F
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2019   Phase 2/Phase 3   NCT04136262   China
   Peking Union Medical College Hospital
      2012   Phase 2/Phase 3   NCT01613079   China
Trivalent chromium versus synthetic and/ or biological dmards
   Alexandria University
      2022   Phase 2/Phase 3   NCT05545020   Egypt
Trivalent inactivated influenza vaccine
   National Institute of Allergy and Infectious Diseases (NIAID)
      2011   Phase 2   NCT01436370   United States
TRP
   Dazhou Central Hospital
      2023   -   ChiCTR2400081970   China
TRU-015
   Pfizer
      2008   Phase 2   NCT00634933   Austria;Belgium;Canada;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia;United States
   Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc.
      2009   -   EUCTR2007-006150-25-DE   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
      2008   -   EUCTR2007-006150-25-HU   Austria;Belgium;France;Germany;Hungary;Mexico;Netherlands;Romania;Serbia
   Wyeth Research Division of Wyeth Pharmaceuticals Inc.
      2008   -   EUCTR2007-006150-25-NL   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-FR   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   Phase 2   EUCTR2007-006150-25-BE   Austria;Belgium;France;Germany;Hungary;Netherlands
      2008   -   EUCTR2007-006150-25-AT   Austria;Belgium;France;Germany;Hungary;Netherlands
Tryptophan
   Dazhou Central Hospital
      2024   -   ChiCTR2400094366   China
      2023   -   ChiCTR2400081970   China
TS-152
   Taisho Pharmaceutical Co., Ltd.
      2019   Phase 3   NCT04077567   Japan
   Taisho Pharmaceutical Co.Ltd
      2019   Phase 3   JPRN-jRCT2080224848   Japan
   Taisho Pharmaceutical co., LTD
      2018   Phase 3   JPRN-jRCT2080223973   Japan
      2018   Phase 2-3   JPRN-jRCT2080223971   Japan
TSO
   Immanuel Krankenhaus Berlin
      2013   Phase 2   EUCTR2011-006344-71-DE   Germany
Tuberculin skin test
   Ospedale L. Sacco – Polo Universitario
      2007   -   NCT00491933   Italy
Tumor necrosis factor inhibitors
   Brigham and Women's Hospital
      2020   -   NCT04529902   United States
   Pfizer
      2024   -   NCT06418529   United States
Twhf
   Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      2019   Phase 2/Phase 3   NCT04136262   China
   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
      2003   Phase 2   NCT00062465   United States
UC-MSC+dmards
   Alliancells Bioscience Corporation Limited
      2013   Phase 1/Phase 2   NCT01547091   China
UC-mscs
   Alliancells Bioscience Corporation Limited
      2013   Phase 1/Phase 2   NCT01547091   China
   Xijing Hospital
      2017   -   NCT03798028   China
UCB4940
   UCB Biopharma Sprl
      2016   Phase 2   EUCTR2016-000393-37-BG   Bulgaria;Georgia;Hungary;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;United Kingdom
   UCB Celltech, UK Registered Branch of UCB Pharma SA
      2015   Phase 2   EUCTR2014-003307-30-SK   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-HU   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-GB   Czech Republic;Hungary;Russian Federation;Slovakia;United Kingdom
      2015   Phase 2   EUCTR2014-003307-30-CZ   Czech Republic;Georgia;Hungary;Moldova, Republic of;Russian Federation;Slovakia;United Kingdom
UK-427,857
   PFIZER
      2007   -   EUCTR2007-001035-58-IT   Italy;Portugal;Spain
   Pfizer Inc, 235 East 42nd Street,New York, NY 10017
      2007   -   EUCTR2007-001035-58-PT   Italy;Portugal;Spain
   Pfizer, S. A.
      2007   Phase 2   EUCTR2007-001035-58-ES   Italy;Portugal;Spain
Ultrasound
   Assistance Publique Hopitaux De Marseille
      2011   Phase 3   NCT01954381   France
   Rigshospitalet, Denmark
      2023   -   NCT05698563   Denmark
   West China Hospital, Sichuan University
      2020   -   ChiCTR2000035146   China
   Zhejiang Provincial People's Hospital
      2023   -   ChiCTR2300075010   China
Umbilical cord mesenchymal stem cells
   Translational Biosciences
      2013   Phase 1/Phase 2   NCT01985464   Panama
Upadacitinib
   ABBVIE DEUTSCHLAND GMBH & CO. KG
      2016   Phase 3   EUCTR2015-003376-75-IT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Italy;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
   AbbVie
      2023   Phase 3   NCT05814627   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Greece;Hungary;Italy;Japan;Korea, Republic of;Mexico;Portugal;Puerto Rico;Romania;Serbia;South Africa;Spain;United Kingdom;United States
      2019   Phase 2   NCT03823378   Belgium;Canada;Czechia;Hungary;Poland;Spain;United Kingdom
      2018   Phase 2   NCT03682705   Belgium;Canada;Czechia;Germany;Hungary;Ireland;Poland;Puerto Rico;Spain;United Kingdom;United States
      2018   Phase 3   NCT02955212   Brazil;China;Korea, Republic of
      2017   Phase 3   NCT03086343   Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czechia;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 2/Phase 3   NCT02720523   Japan
      2016   Phase 3   NCT02706873   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Estonia;Finland;Germany;Greece;Guatemala;Hong Kong;Hungary;Ireland;Israel;Italy;Japan;Kazakhstan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Tunisia;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   NCT02706847   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2015   Phase 3   NCT02675426   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   NCT02629159   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 2   NCT02066389   Bulgaria;Chile;Czech Republic;Czechia;Hungary;Israel;Latvia;Mexico;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Turkey;Ukraine;United States
   AbbVie Deutschland GmbH & Co. KG
      2019   Phase 2   EUCTR2018-002306-31-HU   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-002306-31-BE   Belgium;Canada;Czech Republic;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-000666-10-HU   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
      2019   Phase 2   EUCTR2018-000666-10-ES   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2019   Phase 2   EUCTR2018-000666-10-BE   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Spain;United Kingdom
      2018   Phase 2   EUCTR2018-000666-10-GB   Belgium;Canada;Czech Republic;Germany;Hungary;Poland;Puerto Rico;Spain;United Kingdom;United States
      2018   Phase 3   EUCTR2016-000933-37-BG   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-SE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-PT   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-NL   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-DE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-CZ   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2017   Phase 3   EUCTR2016-000933-37-BE   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-LV   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2016-000933-37-HU   Argentina;Australia;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Mexico;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003376-75-PT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-PL   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-HU   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-CZ   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-BG   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003376-75-AT   Argentina;Australia;Austria;Belgium;Bulgaria;Chile;Colombia;Czech Republic;European Union;Greece;Hungary;Israel;Japan;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Spain;Turkey;Ukraine;United States
      2016   Phase 3   EUCTR2015-003335-35-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-PT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-LV   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-IE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-GR   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-DE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-BE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003335-35-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Korea, Republic of;Latvia;Mexico;New Zealand;Norway;Portugal;Puerto Rico;Russian Federation;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-SI   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-PL   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LV   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-LT   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-IE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-HR   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-GB   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-CZ   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BG   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003334-27-BE   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-DE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;France;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003333-95-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-PT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-PL   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-LV   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-LT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-IE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-HU   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-HR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-GR   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-GB   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-FI   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-CZ   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-BG   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-BE   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2016   Phase 3   EUCTR2015-003332-13-AT   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Norway;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003334-27-SK   Argentina;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Egypt;European Union;Finland;Greece;Hong Kong;Hungary;Ireland;Israel;Japan;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2015   Phase 3   EUCTR2015-003333-95-SK   Argentina;Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;European Union;Finland;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Kazakhstan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;New Zealand;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Serbia;Singapore;Slovakia;South Africa;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Jeffrey Curtis
      2021   Phase 4   NCT05080218   United States
   Otani Tetsuya
      2023   Phase 4   JPRN-jRCT2071230022   Argentina;Belgium;Brazil;Bulgaria;Canada;Chile;China;Colombia;Croatia;France;Germany;Greece;Hungary;Italy;Japan;Mexico;Portugal;Puerto Rico;Republic of Korea;Romania;Serbia;South Africa;Spain;United Kingdom;United States
   Ottawa Hospital Research Institute
      2022   Phase 4   NCT05153200   -
   Tufts Medical Center
      2025   -   NCT06016517   United States
   University Hospital, Montpellier
      2021   -   NCT04530305   France
Upadacitinib 12MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
Upadacitinib 15 MG
   I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
      2024   -   NCT06630715   Italy
   University Hospital, Toulouse
      2025   Phase 4   NCT06687551   -
   Watanabe Ryu
      2022   Phase 4   JPRN-jRCTs051220105   -
Upadacitinib 15MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
   Kawakami Atsushi
      2021   Phase 4   JPRN-jRCTs071200079   -
Upadacitinib 30MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
Upadacitinib 3MG
   AbbVie Deutschland GmbH & Co. KG
      2015   Phase 2   EUCTR2013-003530-33-GB   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BG   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2015   Phase 2   EUCTR2013-003530-33-BE   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-HU   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
      2014   Phase 2   EUCTR2013-003530-33-CZ   Belgium;Bulgaria;Chile;Czech Republic;European Union;Hungary;Israel;Latvia;Mexico;Netherlands;New Zealand;Puerto Rico;Russian Federation;South Africa;Spain;Ukraine;United Kingdom;United States
Urine samples taken TO measure methotrexate and ITS major metabolite 7-OH-methotrexate level
   CHU de Reims
      2018   -   NCT03852888   France
Ursodeoxycholic acid (udca) 500 MG
   Tanta University
      2023   Phase 2   NCT05973370   Egypt
      2021   Phase 2   NCT04834557   Egypt
Ustekinumab
   Janssen Research & Development, LLC
      2012   Phase 2   NCT01645280   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Republic of;Mexico;Peru;Poland;Russian Federation;Singapore;Turkey;Ukraine;United States
   Janssen-Cilag International NV
      2013   -   EUCTR2011-001122-18-BG   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   -   EUCTR2011-001122-18-HU   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
      2012   Phase 2   EUCTR2011-001122-18-CZ   Argentina;Bulgaria;Chile;Colombia;Czech Republic;Hungary;Korea, Democratic People's Republic of;Mexico;Peru;Russian Federation;Singapore;Turkey;United States
UTAA91 injection
   PersonGen BioTherapeutics (Suzhou) Co., Ltd.
      2025   Early Phase 1   NCT06982547   China
      2025   Early Phase 1   NCT06970951   China
Uvadex
   THERAKOS
      2005   -   EUCTR2004-001825-69-IT   Italy
Uvedose
   CHU de Clermont-Ferrand
      2011   -   EUCTR2009-012615-18-FR   France
Vaccination against TBE
   Sormland County Council, Sweden
      2010   Phase 2   NCT01131910   Finland;Sweden
Vaccine
   Tel-Aviv Sourasky Medical Center
      2009   Phase 2   NCT01006681   -
Valdecoxib
   Pfizer
      2003   Phase 4   NCT00650455   Canada;United States
Vancomycin
   New York University School of Medicine
      2010   -   NCT01198509   United States
Varicella zoster vaccine
   Kevin Winthrop
      2014   Phase 2   NCT03604406   United States
VAY736
   Novartis Pharmaceuticals
      2010   Phase 1   NCT02675803   Germany
VAY736 1ML PFS
   Novartis Pharmaceuticals
      2024   Phase 2   NCT06293365   Argentina;Canada;Czechia;Hungary;Italy;Poland;Spain;United States
VAY736 2 ML PFS
   Novartis Pharmaceuticals
      2024   Phase 2   NCT06293365   Argentina;Canada;Czechia;Hungary;Italy;Poland;Spain;United States
VAY736 2ML AI
   Novartis Pharmaceuticals
      2024   Phase 2   NCT06293365   Argentina;Canada;Czechia;Hungary;Italy;Poland;Spain;United States
VC005 tablets
   Jiangsu vcare pharmaceutical technology co., LTD
      2023   Phase 1   NCT05874622   China
Vectra mbda test
   Sequenom, Inc.
      2018   -   NCT03810144   United States
Vegan diet
   Physicians Committee for Responsible Medicine
      2011   -   NCT01544101   United States
Veltuzumab
   Takeda
      2011   Phase 2   NCT01390545   Argentina;Canada;Czech Republic;Germany;Hungary;Italy;Mexico;Poland;Spain;United Kingdom;United States
Veltuzumab solution 75MG/ML
   Nycomed GmbH
      2011   -   EUCTR2010-022378-15-HU   Czech Republic;Germany;Hungary;Spain;United Kingdom
      2011   -   EUCTR2010-022378-15-GB   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-ES   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-DE   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
      2011   -   EUCTR2010-022378-15-CZ   Argentina;Canada;Czech Republic;Germany;Hungary;Mexico;Spain;United Kingdom;United States
Venlafaxine hydrochloride
   Newcastle upon Tyne Hospitals NHS Trust
      2005   -   EUCTR2004-002482-20-GB   United Kingdom
Venous blood sample
   Assistance Publique Hopitaux De Marseille
      2009   -   NCT00947492   France
VIB4920
   Amgen
      2019   Phase 2   NCT04163991   Poland;United States
      2016   Phase 1   NCT02780388   Poland;United States
VIB4920 with tnfi
   National Institute of Allergy and Infectious Diseases (NIAID)
      2023   Phase 2   NCT05306353   United States
VIB4920 without tnfi
   National Institute of Allergy and Infectious Diseases (NIAID)
      2023   Phase 2   NCT05306353   United States
Vidofludimus
   4SC AG
      2009   -   EUCTR2009-012953-39-BG   Bulgaria;Czech Republic;Poland
Viread - 245 MG 30 compresse rivestite CON film IN flacone USO orale
   DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA - UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II
      2016   Phase 3   EUCTR2015-000570-35-IT   Italy
Viread 30 CPR 245 MG
   DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA - UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II
      2016   Phase 3   EUCTR2015-000570-35-IT   Italy
Vitamin D
   Assiut University
      2019   Phase 3   NCT04344405   Egypt
   Brigham and Women's Hospital
      2011   Phase 4   NCT01400516   United States
      2011   -   NCT01351805   United States
   Department of Orthopaedic Surgery Shinshu University School of Medicine
      2016   -   JPRN-UMIN000022364   Japan
   UMC Utrecht
      2000   Phase 3   NCT00138983   Netherlands
   University of Aarhus
      2015   Phase 2   NCT02944799   Denmark
   University of Pristina
      2022   Phase 4   NCT06716476   Kosovo
   University of Wisconsin, Madison
      2005   -   NCT00423358   United States
   Yokohama City University Medical Center
      2014   -   JPRN-UMIN000014737   Japan
Vitamin D 2
   Rajavithi Hospital
      2021   -   NCT04909931   Thailand
Vitamin D IN ARM B
   Indiana University
      2009   Phase 2   NCT00279461   United States
Vitamin D intake
   University of Leeds
      1995   -   NCT06670144   United Kingdom
Vitamin D status
   University of Leeds
      2006   -   NCT06670183   -
Vitamin D3
   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
      2021   -   NCT05078502   Bangladesh
   Università Popolare Homo & Natura
      2015   Phase 1   NCT02633332   Italy
Vitamin K
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
Vitamin K1 tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Voltarol SR
      2007   -   EUCTR2004-001234-17-EE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Inc.
      2005   -   EUCTR2004-001234-17-LT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Pharma GmbH
      2006   -   EUCTR2004-001234-17-DE   Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer SA/NV
      2006   -   EUCTR2004-001234-17-BE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
Voltrarol SR
      2007   -   EUCTR2004-001234-17-GR   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2006   -   EUCTR2004-001234-17-LV   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Laboratórios Pfizer, Lda
      2006   -   EUCTR2004-001234-17-PT   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer AB
      2006   -   EUCTR2004-001234-17-SE   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Healthcare Ireland
      2006   Phase 4   EUCTR2004-001234-17-IE   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer Limited
      2006   Phase 4   EUCTR2004-001234-17-GB   Belgium;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
      2005   -   EUCTR2004-001234-17-CZ   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
   Pfizer, S.A.
      2005   -   EUCTR2004-001234-17-ES   Czech Republic;Estonia;Greece;Ireland;Latvia;Lithuania;Portugal;Spain;Sweden;United Kingdom
VX-509
   Vertex Pharmaceuticals Incorporated
      2013   Phase 2/Phase 3   NCT01830985   Estonia;Lithuania;South Africa;United States
      2013   Phase 2   NCT01754935   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-004342-14-LT   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-004342-14-EE   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   Phase 2;Phase 3   EUCTR2012-004342-14-DK   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-003439-41-NL   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-003439-41-LT   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-003439-41-EE   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2013   -   EUCTR2012-003439-41-DK   Denmark;Estonia;Lithuania;Netherlands;South Africa;United States
      2012   Phase 2   NCT01590459   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   -   EUCTR2011-004419-22-SK   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   -   EUCTR2011-004419-22-HU   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   -   EUCTR2011-004419-22-EE   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   -   EUCTR2011-004419-22-DE   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   -   EUCTR2011-004419-22-CZ   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2012   Phase 2   EUCTR2011-004419-22-BG   Argentina;Bulgaria;Czech Republic;Estonia;Germany;Hungary;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Ukraine;United States
      2010   Phase 2   NCT01052194   Belgium;Croatia;Germany;Hungary;Poland;Puerto Rico;Romania;Russian Federation;Serbia;United States
      2010   -   EUCTR2009-017438-32-PL   Germany;Hungary;Poland
      2010   -   EUCTR2009-017438-32-HU   Germany;Hungary;Poland
      2010   Phase 2   EUCTR2009-017438-32-BE   Belgium;Germany;Hungary;Poland
      -   -   EUCTR2009-017438-32-DE   Belgium;Croatia;Germany;Hungary;Poland;Romania;Russian Federation;Serbia;United States
VX-702
   Vertex Pharmaceuticals Incorporated
      2006   Phase 2   NCT00395577   Bulgaria;Croatia;Former Serbia and Montenegro;Poland;Russian Federation;Slovenia
      2006   -   EUCTR2006-004715-22-SI   Slovenia
      2005   Phase 2   NCT00205478   Bulgaria;Croatia;Czech Republic;Former Serbia and Montenegro;Poland;Russian Federation;Slovakia;Slovenia;Ukraine
      2005   Phase 2   EUCTR2005-000549-13-SK   Czech Republic;Slovakia
      2005   -   EUCTR2005-000549-13-CZ   Czech Republic
Wangbi granules simulant
   China-Japan Friendship Hospital
      2023   Phase 4   NCT05540938   China
Warfarin
   AstraZeneca
      2011   Phase 1   NCT01311622   United Kingdom
   Janssen Research & Development, LLC
      2012   Phase 1   NCT01636557   Germany;Korea, Republic of;Moldova, Republic of;South Africa
Warfarin sodium tablets
   Jiangsu HengRui Medicine Co., Ltd.
      2022   Phase 1   NCT05392127   China
Warfarin+ vitamin K
   R-Pharm International, LLC
      2021   Phase 1   NCT04246762   Bulgaria;Moldova, Republic of
Warm salt water bath
   Hacettepe University
      2022   -   NCT05888220   Turkey
Water
   Zhejiang Chinese Medical University
      2013   Phase 1 study   ChiCTR-ONRC-13003578   China
Water exercises
   Federal University of São Paulo
      2009   Phase 3   NCT01447264   Brazil
WAY-177005
   WYETH LEDERLE
      2005   -   EUCTR2004-000012-13-IT   Czech Republic;Estonia;Italy
   Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development
      2005   Phase 2   EUCTR2004-002215-80-HU   Hungary
      2005   -   EUCTR2004-000012-13-EE   Czech Republic;Estonia;Italy
      2004   Phase 2   EUCTR2004-000012-13-CZ   Czech Republic;Estonia;Italy
Whale blubber OIL
   National Institute of Nutrition and Seafood Research, Norway
      2008   -   NCT00805116   Norway
Whey protein&prebiotic supplement
   Veena Ranganath, MD, MS
      2016   -   NCT02881307   United States
Whole body protein turnover
   University of Texas Southwestern Medical Center
      2006   -   NCT00286689   United States
Whoqol-bref
   National Institute of Medical Sciences and Nutrition, Salvador Zubiran
      2024   -   NCT06386380   -
Will take vitamin E 800MG/DAY
   University of Guadalajara
      2025   Phase 2/Phase 3   NCT06915701   Mexico
Xeljanz
   FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE
      2021   Phase 4   EUCTR2021-001560-14-ES   Spain
   Fraunhofer-Institute for Translational Medicine and Pharmacology ITMP
      2019   Phase 4   EUCTR2018-004539-54-DE   Germany
   GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
      2019   Phase 3   EUCTR2019-000797-39-IT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States
   GlaxoSmithKline Research & Development Limited
      2020   Phase 3   EUCTR2019-000867-26-DE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-PL   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-HU   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-GB   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-ES   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-EE   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000867-26-BG   Argentina;Australia;Brazil;Bulgaria;China;Colombia;Estonia;France;Germany;Hungary;Japan;Korea, Republic of;Mexico;Poland;Russian Federation;Spain;Thailand;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-PL   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LV   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-LT   Argentina;Brazil;Canada;China;Czech Republic;Czechia;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-HU   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-GB   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-ES   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
      2019   Phase 3   EUCTR2019-000797-39-CZ   Argentina;Brazil;Canada;China;Czech Republic;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Mexico;Philippines;Poland;Russian Federation;Serbia;South Africa;Spain;Ukraine;United Kingdom;United States
   Pfizer
      2013   -   NCT01932372   Japan
   Pfizer Inc.
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SK   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-GB   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-CZ   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc. 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-AT   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-SE   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-NL   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
      2014   Phase 3;Phase 4   EUCTR2013-003177-99-ES   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Pfizer Inc., 235 East 42nd Street, New York, 10017
      2015   Phase 3;Phase 4   EUCTR2013-003177-99-FI   Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Korea, Republic of;Malaysia;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Taiwan;Turkey;Ukraine;United Kingdom;United States
   Shinshu University
      2018   Phase 2   NCT03755466   Japan
   Tampere University Hospital
      2018   Phase 4   EUCTR2017-002753-11-FI   Finland
   Västra Götalandsregionen
      2020   Phase 4   EUCTR2019-004179-38-SE   Sweden
Xeljanz 5 MG FILM-coated tablets
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2019   Phase 4   EUCTR2018-003162-13-IT   Italy
Xeljanz 5MG
   AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
      2019   Phase 4   EUCTR2018-003162-13-IT   Italy
Xeljanz 5MG tablet
   Chong Kun Dang Pharmaceutical
      2019   Phase 1   NCT03868072   Korea, Republic of
Xeljanz XR
   Erasmus Medical Center
      2022   Phase 4   EUCTR2021-004131-84-NL   Netherlands
Xeljanz® 11MG prolonged release tablet
   Pfizer Inc.
      2020   Phase 2   EUCTR2019-002676-14-SK   Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Czech Republic;Czechia;Georgia;Hungary;Mexico;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine
XENP5871
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
Xinfeng capsule
   The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
      2013   -   NCT01774877   China
XMAB5871_0.3MG
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
XMAB5871_1.0MG
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
XMAB5871_10.0MG
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
XMAB5871_3.0MG
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
Xmab®5871
   Xencor Inc.
      2013   -   EUCTR2012-003057-29-CZ   Czech Republic;Hungary;Slovakia
      2012   -   EUCTR2012-003057-29-SK   Czech Republic;Hungary;Slovakia
      2012   Phase 2   EUCTR2012-003057-29-HU   Czech Republic;Hungary;Slovakia
Xolair
   Leiden University Medical Center, Department of Rheumatology
      2010   -   EUCTR2009-017306-36-NL   Netherlands
Xoma 052
   XOMA (US) LLC
      2009   Phase 2   NCT00777816   United States
Yellow fever vaccine
   University of Sao Paulo General Hospital
      2018   -   NCT03430388   Brazil
Yisaipu
   Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
      2010   Phase 4   ChiCTR1900024107   China
   Guang'anmen Hospital, China Academy of Chinese Medical Sciences
      2020   Phase 4   ChiCTR1900026270   China
   Peking Union Medical College Hospital
      2019   Phase 4   NCT03589833   China
   Peking University People's Hospital
      2022   Phase 4   ChiCTR2200055292   China
   Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
      2024   Phase 4   ChiCTR2400090996   China
   The First Affiliated Hospital of Xiamen University
      2022   -   NCT05424393   China
YLB113
   YL Biologics Ltd
      2016   Phase 3   EUCTR2015-002809-12-BG   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-LV   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-HU   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Romania;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-ES   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
      2015   Phase 3   EUCTR2015-002809-12-CZ   Bulgaria;Czech Republic;Hungary;India;Japan;Latvia;Poland;Romania;Russian Federation;Spain;Ukraine
YRA-1909 high dose
   Yungjin Pharm. Co., Ltd.
      2017   Phase 2   NCT03275025   Korea, Republic of
YRA-1909 LOW dose
   Yungjin Pharm. Co., Ltd.
      2017   Phase 2   NCT03275025   Korea, Republic of
YRA-1909 MID dose
   Yungjin Pharm. Co., Ltd.
      2017   Phase 2   NCT03275025   Korea, Republic of
YTS109 cell
   China Immunotech (Beijing) Biotechnology Co., Ltd.
      2025   Phase 1   NCT06978647   -
Z102
   Zalicus
      2011   Phase 2   NCT01369745   United States
   Zalicus, Inc.
      2012   -   EUCTR2011-002392-41-HU   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2012   -   EUCTR2011-002392-41-BG   Argentina;Brazil;Bulgaria;Canada;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-PL   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-HU   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
      2011   -   EUCTR2011-000436-28-BG   Argentina;Brazil;Bulgaria;Chile;Hungary;Mexico;Peru;Poland;Russian Federation;Serbia;Ukraine;United States
ZB002
   Zenas BioPharma (USA), LLC
      2022   Phase 1   NCT05638854   Australia;New Zealand
ZD 4522
   University of Dundee
      2005   -   EUCTR2004-001909-10-GB   United Kingdom
Zhimu
   China-Japan Friendship Hospital
      2022   Phase 1   ChiCTR2200063205   China
ZL-82 100MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 12.5MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 200MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 25MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 300MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 450MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 50MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
ZL-82 600MG
   Chengdu Zenitar Biomedical Technology Co., Ltd
      2023   Phase 1   NCT06055023   China
Zoledronate
   Shanghai Traditional Medicine University Affiliated Guanghua Hospital
      2018   -   ChiCTR1800019277   China
Zoledronic acid
   Carmen Gómez-Vaquero
      2014   Phase 3   NCT02123264   Spain
   Dra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell)
      2014   Phase 3   EUCTR2013-005001-31-ES   Spain
   Karolinska Institutet
      2020   Phase 4   NCT04115397   -
   Osaka City University Graduate School of Medicine
      2018   -   JPRN-UMIN000030828   Japan
Zolpidem
   Mito medical center, Mito Kyodo General Hospital, University of Tsukuba
      2024   -   JPRN-UMIN000039116   Japan
Zostavax
   Pfizer Inc. 235 East 42nd Street, New York, NY 10017
      2016   Phase 3;Phase 4   EUCTR2014-000358-13-DE   Argentina;Australia;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Germany;Israel;Korea, Republic of;Latvia;Lithuania;Mexico;Peru;Philippines;Poland;Romania;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States
Zostavax (varicella zoster virus) vaccine
   Oklahoma Medical Research Foundation
      2012   Phase 1   NCT01506661   United States
Zostavax vaccine
   HaEmek Medical Center, Israel
      2017   Phase 4   NCT03016884   Israel
Zunsemetinib
   Aclaris Therapeutics, Inc.
      2022   Phase 2   EUCTR2021-002860-31-CZ   Bulgaria;Czech Republic;Czechia;Poland;United States
      2022   Phase 2   EUCTR2021-002860-31-BG   Bulgaria;Czech Republic;Czechia;Poland;United States